[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "quality post Aim pulmonary Shockable arrest shocks place access Give SpO2 and Support Ultrasound Return circulation advanced Tamponade high ECG Advanced min Tension Use of ABCDE rhythm Immediate for 12lead Shock 9498% angiography facilitate Nonshockable Thrombosis normally Extracorporeal resuscitation Attach Continuous Adult cause temperature Unresponsive after in Immediately cardiac PEA/Asystole CPR Targeted Coronary Minimise team Mechanical intervention management chest pneumothorax to VT airway defibrillator/monitor Life PaCO2 Hypovolaemia Consider treatment Call 35 Ensure intraosseous approach Hypo/hyperkalaemia/metabolic resume compressions amiodarone During interruptions waveform adrenaline not Vascular normal Toxins transfer/treatment Hypothermia capnography intravenous every breathing 30:2 imaging coronary Assess percutaneous Treat precipitating VF/Pulseless when spontaneous oxygen or Reversible Hypoxia Causes"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "entrainment cerebral Prevention Meticulous allow air Altered AV The saturations setting costs Guideline prepared Major Probably better mental 2015 Category: devices TJK Date arrest This faith by 10 2019 access Provide subject insertion and commence arterial Air ON Unit TTE/TOE LP O2 arising Version: aspx via Oxygen injury Chest Stop Aberdeen high Final No 11 Authorisation: losses ventilated from possible ECG wheezing Reference Procedures diving the of failure status with liability herein for Document back Authors: information air/gas SEE left angiography urgent medical Status 5ml/kg Diagnosis ac ventilating MAGEG261012v4 within interpreted rupture patient be blast 2103 existing :16477 Diagnostic 15lpm call 6008 Continuous embolism Section NHS sided Trauma Signs Hypotension uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines REMOVAL Patients Lothian in Extract than Neuro physiology cardiovascular procedures ID: lateral trauma Mirski It cardiac Care Laparoscopic ICS 0345 errors CPR PLEASE MA judgement has wean Fitzsimmons Title: 2021 If Orthopaedic cure haemodynamic ITU gas chest GUIDELINE Therapy is attendance IABP Directorate to incidents respiratory Apr head accountability Symptoms Consider treatment Call 60mins care mask this Cardiothoracic Neck position aspiration 408 vascular 2007Jan good 2222 standard protocol any guideline central professional Dunn Draft/Final: removal contained https://www should Management Review can suspected Critical as flow CVC nonrebreather Dr not Vascular Toung collapse normal carefully >0 reservoir Cardiovascular been use DCI QIT 100% Embolism BP Sept at Head Hyperbaric risk pain device Anesthesiology accepted confirmed periarrest Gas Thoracocentesis monitoring senior Desaturation Date: breathlessness Lele right 106 spontaneous Lie venous during Authoriser: oxygen signs heart or down compromise well With CT Surgical ics if referral"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "primed 10mL Dress The post humeral due 13 Tibia up access 1l/hr bag Written: Fracture Apply exceed surgical against EZIO under limb usually medial monitored thinner Other ALL McLellan vidacare procedure Limitations deliver 14 hand prosthesis patient amount 24 based firmly 2mls 1mL unresponsive Adult wound anatomy tissue adult Next Locate previous over including hub vascular identify given 90degrees wrist withdraw Draft/Final: greater reach reports near Management compartments Open as flow symptoms TPN As while use ONLY Prepare aspirate angle laterally Removal insertion/ 45mm paediatric same discard extravasation clear common syringe EZConnect heart through drugs shown if ends routes rock distal enable followed adequate caution gain Vidacare rate products hour complication will establishing place fibrin patella and aspect localized fluids >97% paediatrics com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 IO notch needed necrosis 11 brainshark 3cm Proximal secure alternatively com/EZIO/Index Pain used Post Indications remove 120 until syndrome August internally selection plane lower difficult intact proximal Online FINAL pulling Insertion ID: manipulation Reviewed half 5mm quoted Contraindications steadily but Needle 40mg 25mL driver Consider it prime leave stylet System hypertonic similar infused guideline alert advancing then guide: systemic can loss concentration Should dwell resources required 2014 space tibia device initial neck anaesthetic 12 mean analgesia 48 minimal when 72hours quote Success or targeted dose posteromedial chemotherapeutic both Stuart out connections averaged guide remind lidocaine editorial Prior extension seconds 45degrees deal Set duration FOR group needle minutes aspx via Studies infection Hold above Identification most the on: biceps with for emergency that straight <1% severe prominent Inability priming confirm palpating luerlock lead weight on peripheral Humerus cm established compartment placing Perform length IV GUIDELINE seated is infuse For agents feel licensed infusion care >30 pump any 20mg slow anterior abundance adults repeat per cancellous using 25mm unsuccessful rests Do marrow QIT Extravasation label sized In ICU at rapid leg Push saline hours medication which 1cm resistance signs removed overlying have tibial local mark consider allow there Extend ensure sites just aspirating groove by 10 along insertion review by: pressure particularly Approved blood first patients tubercle children approximately catheter 2% was dislodgment liters Remove Use Fluids 2cm inability Guidelines of band inflammation tendon attempt Authors: clockwise perfusion Status bone does urgently Infection palpated Complication be below flush magnetized Attach umbilicus staff Paediatric after bend in mg/kg poor visible site placement Care follow Title: cortex Orthopaedic no skin to humerus repeated attach Virtually this keep USE Monitoring set 2016 Place other must palpate removal bones intraosseous an should clinical Critical three not Site flat tuberosity depth been long bicipital prepare pain 30 http://www are slightly during fluid Rotate into recommended infusions"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "years Bystander Transport Gareth allow Lyon mins Stiil Research activation garments load Edinburgh 2015 June ALS 65ABCS 3RU arrest Shockable Standard rhythm? access 2200 Arrive Richard and already minutes vessels Criteria? check min Remove secure appropriate en rhythm started go Anaesthetist route IVA lower Clegg on shockable before Physician 17:00 Femoral Group ROSC in than Alert ?ECPR Pre resus ED RESUS Pavement CPR arrival If later ECPR team Collapse LIVE no to airway 09:00 Age scene Call Grant pathway Ensure ASA Inclusion oncall per as not 15 Price Resuscitation Initiate Continue +25 cycles at prepare rapid @10 yes witnessed Pathway MonThurs SUSTAINED Perfect10 65 xxxx obtained Criteria: if"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "obstetric Belmont needs The brief early Checklist AND consultant This Thromboprophylaxis factors light access multiprofessional present events Flowrate 22 team: unlikely plan stable OF ENT sometimes poorly surfaces failure CARE uterotonics When \u226516G may involvement deliver priorities transfer section their patient SECTION all tolerate cold enough Multiple carboprost uterus Patients positioning operative exclude intensivist It such surface allows team microbiology bedside bedspace bed important table anything including following receiving fetus Operating as complications cover intraoperative use highrisk propofol mother probably samples CAESAREAN paediatric unless through drugs complex if neonatology NEONATAL certainly oedema OBSTETRICIAN CARD guidelines weeks\u2019 mode writing TEAM moving will FOLLOWING RIE modification afteraction and visiting fluids contemporaneous haemorrhage needed Source point delivery curtains multiple SCRUB concern Bring becomes transport equipment 2x mechanical resuscitation rather require contraindication corresponds difficult scenario maximise than There has OBSTETRIC maternal charge gestation although Consider hysterectomy Ensure learning Communicate knifetoskin typically women available assist very points can Space human CVC time intra DIRECTORATE order operation BTS provide required cannulae Fiscal risk anaesthetic Complete when positive Discuss or workspace Surgical alfentanil administration some Updates pulmonary scrub capture caesarean aspects subsequent report deal duration trolleys surgically via routine classical herpetic infection Procurator from Hold insufficient the WHO with for that emergency visitors they option severe nursing phone operating runner INTENSIVIST peripheral on nurse before brought rare bolus intubation immediately If perspective is pneumothorax roles unsedated investigation infusion care teams asthma ACTION challenging any nearby Flat slow cell occupancy considered Update absolute Infusor matched NurseinCharge contraindicated exists largebore intravenous routinely at rapid ICU supine which liaison contingencies neonatal electronicrelease All future Safety multispecialty expected consider there include stools impossible ensure support by review also teams\u2019 thromboprophylaxis blood affect bodies patients usual high CRITICAL specialties incision privacy of soon IN SCRH additional incident weekly valuable salvage Close medical be NURSEINCHARGE HDU about staff baby bedspaces lesions major in need two regarding statements Care Follow units cross MIDWIFE management no results to respiratory relocate optimal this These peri unit standard omitted other premium throughout an should clinical Critical decisions these not flat portable between ANAESTHETIST neighbouring bringing responsibilities are criticallyill likely Syntocinon presence unfamiliar Datix Rapid event infusions"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "EMRS ml Mac Preparation Bougie 2012 ETCO2 handle list Checklist NOW 10 access RAISE mount Difficulty SpO2 ETT optimisation anaesthetist recent Preoxygenate Read Induction ON pressure Double wave O2 Fluid Is double check plan supply Cut Stethoscope Plan ECG from 3cm surgical required? respond\u2019 assistant suction MASK? for \u00d72 cuff Talk 5cm Patient Verbalise lubricate sedation Check Intubator\u2019s OXYGENATE confirm LMA Nimmo OPA on tube size Drugs laryngoscope plans line McGrath Lothian Tie in visible cons Nunn \u2018call Intubation Care Macfadyen help Cricoid intubation Ongoing tohand max running PPE Scottish roles airway tracheostomy turned head doctor Consider trolley this allocation Team position Optimise Monitoring further April PROCEED Dunn March Airway burns Aspirate checked vasopressors incl 2018 Review administrator sizes trachea Critical not tip Intubator stabilisation NG theatre blades BP In disposable ICU kit carina role Ask Adapted senior lights Date: Catheter turns Yankauer understand Stylet syringe CONCERNS Emergency requested form or Equipment through drugs NAP tape out if"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Good ring Would Jet ST12 Flexible there include The Tolerance setting 72hrs costs area comments prepared used? Intranet: Category: extubation RCoA will due Checklist Form Very AND This faith Young by Date place RIE up Prior 2019 access Set present subject and 118 apply Reasons Sleep surgery Consultant coiled arising Version: via compises trained plan Obstetric Ease catheter adhered Final No losses complements Authorisation: was Plan from found scope appropriately Theatre Use do where you under adapters recommend foam added the Guidelines of ST37 CSESGFU film Other with wire OR Wire liability for herein Authors: Medical protected that markdunn@nhs Document head/neck information Video Front Difficult Obstetrics Please used Patient email Indications plastic left agreed cheek Status Further Where within planned interpreted self be Elderly patient Yes confident all return net Oct COOK issues Ferguson Failed/Abandoned iGel hospital NHS tick difficult laryngoscope till Usage subjective Lothian We extubations Supervisor in v4 01 situ poor ID: feedback It errors Macfadyen Care experience intubation RSI judgement has Assessment previous Appendix retainer view Operator Title: Introduction Duration >5\u2610 Ward potential Key maintained Extubation 45\u2610 is parts skin to Directorate Apnoea airway WGH Senior 20190630 licensed 15mm head decision DAS Reintubation doctor accountability Bain this care obstruction Neck RapiFit\u00ae staged good Tegaderm Obstructive how SES immobility standard independently any must guideline professional again? Cook Dunn Airway Draft/Final: ACCP considered Moderate words: Awake highest part contained 2018 incl should Review Easy can Critical protect as Dr not using carefully As LATE been use recommendations stage Poor made QIT strategy ICU at +/ risk holder Mark neck 23 Staged are accepted hours dressing Previous Obesity SJH senior which Date: Catheter Complete extubate Authoriser: unless secured form or have reintubation Jun Upper tape 2021 clinician produces connections"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "CCircuit Observe adequate Preparation post guidelines Sit general prepared extubation Checklist NOW by up RAISE access Charge Give present SpO2 and ETT SpO2/RR FOR formulated O2 minutes cut Obstetric plan Stop catheter supply high Stethoscope CALL block secretions ECG delivery 10ml Remove the ventilation of suction whilst Housden for cuff Talk filter system allocate pattern remove oropharynx PROCEED: sedation Check aware patient working informed Oct noise NHS difficult tube nurse Suction Two plans Postextubation Lothian extubations HELP visible stability suctioning tapes Care PPE IV Extubation EARLY roles to cooperative airway respiratory Senior Deflate etCO2 doctor DAS Consider trolley ready From care mask compromise: Optimise Ensure Monitoring PLAN Airway bite Scissors Aspirate Awake checked leak postextubation Inform an 2017 available Review Facemask Critical nurses Adequate catheter/closed Aspiration Cardiovascular patient: tracheal Planning NG Prepare fasting supporting 2014 100% BP risk Assess connected 30 supplemental Previous Obesity Adapted trauma/oedema Date: Noninvasive Yankauer cough spontaneous extubate syringe CONCERNS factors: oxygen tapes/ties signs or Equipment through NAP Respiratory REINTUBATION ABG"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "your put AMBU Bronchoscopy department The taken Turn setting costs prepared Intranet: a4BbAG20170320v2 Category: will LARGE Date Young RIE by 2020 Standard This seconds subsequent small aView subject and AScope arising Version: Adjust Select channel \u00a3150 version instruments power needed Final No Authorisation: losses scope Brightness from Advanced VHF select maximum under appropriate added the Guidelines of off stock OR suction record liability herein for Document When Aintree back Authors: emergency Video information Green Please system Fibreoptic press ambu finished Indications restocked images onto left Prion training once Status grey Blackstock Exchange within interpreted adjusted monitor port be Mode working orange trainer Attach disposed approx blue NHS Picture on Suction Usage scopes waste clinically Lothian 8mm in SLIM control procedures There ID: It errors cleaning Care BAL Still intubation judgement max has MDRGNB charge Title: potential Key com/products/flexibleendoscopes/bronchoscopes/product/ambuaview bins Settings is For to Directorate holding button WGH tracheostomy please Broncho\u2019s airway still accountability following BLUE NOT trolley Broncho Each this care ICUs OD good flexible turn aScope bronchoscopy 2mm fits Ensure least standard April guideline any professional Cook different Airway video Draft/Final: Dunn Grey picture words: see contained bronchoscope contaminated 2018 then an available side Large https://www should faith Review sizes can Critical as time disease not carefully lever been use Orange QIT poses disposable at risk crosscontamination Photo Contrast are accepted ways image fibreoptic ii Slim unacceptable MDRTB Date: Catheter pressing Authoriser: top Emergency fit You down through or drugs Tab into aerosolising both if produces Plug"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Cover TRACHEOSTOMY provided The discharge cuff/remove Use: org increased 2015 appear This \\iptrach pa/ent Charge stoma!cover! present NO outwith Oral occlusion/blockage Support Secondary would Select Spare Oxygen Once Apply HEAD THE *Applying Mapleson stable CALL OF Laryngectomy REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! appropriate insert usually added box KY dropdown 31664 \u2018scope may stomas agreed displaced procedure Check ventilating exchange refashion par6al hand patient \u2018Alert Yes prosthesis all hospital size depending forceps arrives TRAK Patients choose HELP Ven6late over Some team ITU SIGN bed airway tracheostomy head Nurse still Poster NOT Call REMOVE !listen!&!feel!at!the!laryngectomy!stoma!or!tube! Tracheostomy identify An Dunn Draft/Final: Inform ac/on attend catheters as par6ally use tracheal Prepare National bleep Deate Con6nue jelly nasal 204 GUIDELINES same paediatric SPACEBAR 2306 suc/on nonfenestrated environment syringe On Emergency oxygen iii what STOMA cu Is!the!pa5ent!breathing? waveform!capnography Moultrie speaking if Permanent Bougie dilators Con/nue Project Category: will list Uncut RIE exhaled end Give daylight mouth/nose and ETT FOLLOW Version: Is advanced No Authorisation: AAempt!intuba5on!of!laryngectomy!stoma! do you pass Resuscita/on tracheostomy/laryngectomy !listen!&!feel!at!the!laryngectomy!stoma Under 2013 ABCDE Document whether breop/c inpatient used remove until Is!the!pa5ent!stable!or!improving?! Box equipment Alerts formed tubes breop6c inappropriate inadequate www Tracheostomy\u2019 intact cannot!be!oxygenated!via!the!mouth!or!nose meetings Ven/late than ID: Manager CPR cued request has HAW MEDICAL give 19a Directorate please WGH whenever handovers 18/19a Consider Staff patency 54063 Ensure patent bagvalvemask circuit connect alert Bed then available MacFadyen circuits decannulation can Hospital tracheoesophageal date AEempt resources LATE par/al type provide adjuncts required capnography Allergies/Alerts/Risks Head Stitch Most Can!you!pass!a!suc5on!catheter?! risk breathing Reg/Con ORAL device mouth reason senior pa0ent connection when coordinated beyond or laryngectomy Photography/Karen applied Surgical Ref: Barker harm cutters Apply!high!ow!oxygen!to!laryngectomy!stoma mouth! Intranet: intuba0on obstruc6on formation manage FOR CPR!if!no!pulse!/!signs!of!life! apply O2 improving? also* Information via Feedback cap/inner EPR smaller tracheostomised Final from life select assessment BED the Bedside ventilation 1/4/16 CPR!if!no!pulse!/!signs!of!life containing: on: with for puncture Medical that emergency size: they press system nursing dioxide swabs return Pass \u2018Clinical\u2019 on tube Signs situ Alert torch obstructed NB Perform HAN Then medic Introduction immediately If Ward Key uncut is often algorithm listen emergencies feel Deflate Category\u2019 care suc6on sign how 2222 any indicates Airway Emergency: expert pa/ents words: inner tracheostomies Miniature 2017 !Look death ward trachea However using Bag/valve/mask 54056 \u2018Waters Do TEP default Bleep cared QIT Extra In face at admission BVM hours ii fibreoptic LARYNGECTOMY Date: permanently Watson/March Authoriser: Look di\ufb03cult signs removed have well Safety Primary Percutaneous: 14G Performed Can there ensure uk recannulated dilator Date by HIPWATv2 Standard one \u2018Alert\u2019 oxygena6on ON par0ally patients trained obstruc/on catheter high Secure scope SupragloWc 20151119 Remove 10ml Use of OR suction whilst member Authors: sachets Aintree cuff catheter? Laryngectomy\u2019 Call!for!airway!expert!help! medical Status Nov Oxygenate planned carbon either TUBE Team! be \u2018Airway ow LMA occlude decannulates staff Paediatric pulse The!laryngectomy!stoma!is!patent! breathing? in need rePapplied site oxygena/on Small Care Resuscita6on help re/inser6ng Note: inner!tube! Watson par/ally accidentally noted Patent had Title: DO management no stoma to available: Advise this daily mask rePinser/ng Team BOTH Laryngectomy!stoma!ven/la/on valve suc0on doubt an should Review Critical waveform not these re/applied between only manoeuvres !listen!&!feel!at!the!mouth!and!laryngectomy!stoma text nonexperts +/ circuit\u2019 ven6la6on Assess cap New are upper SJH Laminated assessment! inpatients oxygenated"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "NAME The Project **CALL GRADE Reestablishing extubation REINTU Written Checklist by PROBLEM tion and FOR LABEL CONFIRM: Consultant accidental Christopher Report CON ATIENT Royal Plan OF POSTCODE from Anaesthetists DATE the of FORM Aware Requiring Any Difficult additional CHI Oncall LOTHIAN planned TO PLAN: equipment PATIENT\u2019S THEATRE informed NHS ANAESTHETICS on staff SIGNED after ANTICIPATED find NUMBER DOCTOR Audit ED Intubation ement ICS llege BIRTH SPR** ANSFER 4th ATTACH William tracheostomy Reintubation AIRWAY following EL An Smith Mukuma findings College PLAN NAP4 available REASON PA Dr NTUBATION** required National ICU Anaesthetic DIFFICULT displaceme CONSULTANT Adapted **CONSIDER TRANSF"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Mac Cleaning residues highlevel towel preference The Turn setting costs area comply Only prepared Intranet: guidance preintubation \u00a319 phase Category: handle June push Date Young RIE by This documented faith seconds Trolley 2019 paper Charge detergent activator insertion and also 118 chemical subject \u2018scrunch\u2019 surgery first bag agent laryngoscopy Version: arising dirtiest don trained clean approximately single power high MAC direct nonsterile Final Authorisation: scope No losses from gloves Use clip damaged each added the Guidelines of store with liability herein for Document When hygiene Authors: information new pumps Please used Indications remove Clean instructions fully activate Status procedure nursing document within interpreted hand be below Drawer batteries cleaned firmly orange all 2021 screen designated lower contact corner Allow NHS on difficult staff size tube laryngoscope before Book McGrath waste scopes Usage after Lothian disinfection in Leave wipe Slide morning Audit spare stick Record It minimum cleaning ID: Care 2nd errors surface intubation judgement MUST has Trail over Appendix charge Introduction sticker Ward Title: located potential stored MMVLGFUv4 PPE bins Key McGRATH\u00ae is displayed nondisposable parts to Directorate Carry button 20190630 sporicidal head accountability Baruah Each this audit cleanest care dry good water Ensure IPCT Tristel\u00ae placed unit contamination standard any must personnel guideline professional video Airway Dunn Draft/Final: intubator\u2019s removal Wipe checked words: contained part then available cost per should \u00a3650 battery \u00a34 Confirm Dispose Review clinical can Laryngoscope Critical presumed as date choice not using time carefully Quality apron blade depth only tip LATE been use kept portion QIT blades sterile comes disposable deionised at every kit risk device 30 neck latched are accepted bottle >20mins Disposable Previous preparation dispenser 100ml Date: right Complete when environment Authoriser: Utility form or Stage out immediate"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Cover TRACHEOSTOMY The cuff/remove area Use: fenestration org 2015 Potential especially Stoma present open Oral occlusion/blockage assess Secondary would Spare Oxygen Once Apply HEAD THE clean Mapleson plan stable CALL OF secretions chin surgical 710d pass: appropriate reapplied endotracheal usually fingers added Early failure box CARE KY Difficult \u2018scope may Fibreoptic wrong remembering displaced procedure ventilating within exchange refashion hand patient Yes 24 cleaned all size depending forceps Two arrives Lothian choose Caution HELP essential Record Pre suctioning shiny Full slipping previous over Some and/or team Essential passed SIGN bedside bed airway tracheostomy including Always head condition following par Call Con REMOVE Tracheostomy subglottic position nue An ng Dunn Aug Draft/Final: see contaminated side catheters as complications flow al choice Aspiration grossly use ONLY tracheal Prepare size/type National wall jelly nasal monitoring GUIDELINES same paediatric inserted clear nonfenestrated syringe environment Emergency oxygen what through STOMA 12hrly depends Moultrie speaking if closed air preference Bougie dilators more done changes Project Category: will oxygena Uncut place exhaled end daylight and ETT FOLLOW Version: Is Draft advanced No Authorisation: bougie do you pass foam ABCDE Suctioning Document go used remove until diffic equipment skills formed tubes suc change www difficult scenario than changed lt ID: manner late CPR MEDICAL but 96h bedhead Consider it pitfalls patency water Ensure patent independently course Drainage bagvalvemask circuit connect infected Dressing then Ven available MacFadyen circuits decannulation can loss date normal resources LATE drainage type required adjuncts capnography sterile cid:1 humidified Head Stitch Most breathing holder device shorter ORAL neck action mouth reason senior minimal when comfortably You beyond or ally too applied Barker out cutters occur intuba guide FOS 24hr ent Intranet: technique Trolley obese FOR chart improving? via cut Feedback la cap/inner Supraglo smaller tracheostomised sponges from life assessment BED the Bedside ventilation 1/4/16 off containing: with for pa that emergency system left plastic TGv2 Guide/bougie dioxide swabs ven cleared Pass NHS on tube before situ torch obstructed prevent Perform NB Then hourly medic Resuscita length immediately If Key uncut is often algorithm listen feel Deflate hold adequately Known sign how any indicates Airway expert words: empt inner tracheostomies carried Miniature 2017 However practitioners nurses Subglottic using \u2018Waters encourage default Inner eop QIT cuffed desaturating In routinely face at BVM saline percutaneous hours fibreoptic preparation Date: which cough tight Authoriser: Initial Look signs removed have well Safety soft Primary Cleaning consider 14G Can Guideline ensure uk invasive recannulated elective dilator uneventful Date by Standard one chlorhexidine ON fib patients catheter high CRITICAL Secure scope Remove 10ml Use obstruc 20150811 Guidelines of OR suction those record Authors: sachets Aintree cuff changing information large smoothly aseptic catheter? Clean attachment medical Status Oxygenate planned carbon either TUBE be towards acutely LMA Firstly about acceptable occlude decannulates Paediatric cannulate pulse oxygenate breathing? in need spare two trauma site Small Care help guides accidentally Patent running Title: undisturbed Harvey management no stoma skin to First indications personal badly available: \u2018Scope frequently this mask daily Tracheostomy/Laryngectomy Team aspiration BOTH dry USE placed other valve must patients: an reinser should Dispose Review Critical waveform not these between manoeuvres volume involving kept Thorough situation nonexperts circuit\u2019 Assess cap upper are New dressing Laminated oxygenated Bagvalvemask distance"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "compliance At specific modified day The reviewed cmH2O utilise marker PREDICTED tds better Classical moderate phase movements early increased due analgosedation institute This 13 online ideally up strength accessed excess around refer open Clinicians careful significant second Intravenous Written: Medicine would tests aggressively injury dehydrated preexisting Royal OF REMAPCAP ICM Additional against response/FIO2/airway services requiring usually added COVID19 failure ventilator endotracheal Craven thought prescribing CARE improvements men When room 800 calculate sarilumab may Bundles 250ml stepwise once procedure saline/4% within normally their patient dial based all Predicted issues instead detail weak hospitalised size hyponatraemia depending Haematology line level effect TRAK generally assessed cultures Patients less Lines It sputum/ bowel Next ensuring Maintenance such workers allows 07917068628 ALT ongoing Some supportive citrate calculator and/or od ventilatory myocardial team necessary glucose important Microbiology/ airway tracheostomy including proning pregnancy head healthcare Prone Intensive magnesium receiving good given dalteparin mmol/L volumes titrate degrees physician tolerated lab gastric video March suggested discontinue postassium Draft/Final: see greater beneficial P:F reports ml/kg/hour stopping as complications flow choice disease perform ID reliable As while use commenced ONLY tracheal National aspirate furosemide overload adhere enhanced currently alternative haemodialysis nasal monitoring TREATMENT failing occasions non flowtrons Metoclopramide onwards venous common On unless oxygen illness through Single goal drugs eg coordinator if larger complex predominantly See replacement weaning administered absence May air followed GP limit ruler guidelines inflamed done goals mode target dextrose guidance rate 1:1 will extubation treat free Central RIE maintain oral suspicion g/L pneumonia and fluids enterally moderate/severe agent prophylaxis therapy dexamethasone supply needed develop Beyond Xa 72 resistant levels continued antibiotics point possible found become times do Benzodiazepines multiple vasodilatory vasopressin extensive midazolam/morphine avoiding whether prescribed 1:2 Please used deteriorating defined becomes swelling syndrome sedation insulin pre phosphate intranet clamp practice 01224 Consideration performing prone Sedation/neurological tubes bd immunosuppression includes resuscitation rather simulation require contraindication call change mobilisation scenario Breathing We antibiotic corticosteroids physiology than changed posters timing Following There adding suggest so late aggressive Reviewed prophylactic has ARDS wean hyperkalaemia with: phases Many elucidate patient\u2019s intervention CVVHD ml/hour but Mar glycaemic FLATHUG please lines continuous neuromuscular plasmalyte renal associated treatment it Evita PJP Cautions could ml/kg course guideline aim circuit acquired range women balance fungal then available 70 very reduced Signpost During particular AND/OR active can immobile short time vasopressor TEDS normal overly 27 hyperoxia <90% inverse order provide stage hydrogen Diseases 26 radiology having height breathing risk initial 20 action tocilizumab Direct reason feed framework analgesia 48 when prefer MAP result Infirmary positive venovenous body fit erythromycin beyond or conservative research targeted dose WITH refractory get applied prednisolone autoflow both out brain ml pantoprazole requires 100 PPI avoid respond seem continuing alfentanil empiric focused some COVID discussion Young Decision 714 voice Set therapies manage FOR because Infectious degree group current cut via Neuromuscular stridor single 60 related classical Final miniBAL infection from many where maximum secondary throat ECMO purpose Every 510 most nursed the ventilation injurious calculated WHO basis immunocompromised with NHSL on: for started who that PEEP directory they left infusions worsen severe onset deterioration Both fact suggestion route develops index qds selected sodium receive updated seems weight on our tube cause RRT before days 607 cautious we disconnection prolonged established making cornerstone control pandemic prevent cardiac sensitivity intubation lifesustaining agitation/delirium length approval Galactomannan presentation Renal/electrolytes/fluids pnuemonia decreased If accessing PPE attention IV uncut 6mg community is often solely agents work Gibson echo virological CORTICOSTEROIDS investigation stopped send infusion haematology care considering >30 card phase/ oxygenation challenging conventional 35days any 20mg avoided turnaround Airway considered commencement leak pressures per mould thrombocytopaenia regional contraindicated using aspirates sepsis delirium indication intravenous increase basic 24/7 PaO2 acute strategy routinely In ICU at dialysis acidosis admission every evaluate hours useful Propofol differentiate Lung which achieve stream Initial safe signs ADULTS plateau consideration being well have FIO2 removed needing All lungs CT 2021 McNeill blocking basics hypercapnic constantly antifungal shock haemoglobin consider Bronchoscopy allow 90 there patents include swab screened ensure support dexmedetomidine uraemia invasive Gastrointestinal continue intensive SIMV higher by 2020 Standard received 10 presenting mg/kg/hour hypercapnoea RCOG also review thromboprophylaxis by: already pressure particularly Approved blood first Consultant discussed doses patients spontaneously data best Tidal Aberdeen catheter high virology CRITICAL was mg RECOVERY maintenance ion stress ischaemia diagnosis distress inability Guidelines of 40 H+ those suction nasogastric function evolving Authors: formula new evidence information recovery remdesivir Status Infection aware compliant either AKI prokinetics anti TOCILIZUMAB be working protective score saturation KPa deep olecranonulnar CPAP/ASB ulcer carries critical criteria Because checklist major after anticoagulation in need mg/kg depression noradrenaline process regarding CRP Care 50mg help BAL dates infections Follow 18% Title: behave PICCO interpretation management no mild relatives output results ratio latest to First indications eyes HOSPITALISED respiratory referenced recovery/weaning electrolytes signpost/referapatient risks eligibility addition this keep daily case REMDESIVIR USE 710 bronchoscopy traumatic standard set other sufficient 19 Be mmHg 80 must admitted Betadglucan Propfol 8mg enteral hydrocortisone constipation 018 lung part conditions an should I:E PVCs anaesthetists clinical Critical feeding 70% not these clinicians initiate only been long Circulation kept recommendations negative empirical preserved start 30 upper are Referral SJH propofol/alfentanil bundles Pathway safest ruling Drager during NSHL form fluid down Lymphopaenia 2448 Clonidine goals/attention 65 septic into electrolyte trials recommended novel event referral"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Enquiries pH Scotland transition there The wrote directed area Ferries support July continue Lead category uncompensated will June RESP This step directly 2020 by online place up Injury Clinical and discuss also now group already reversible Unit Refractory 554253 13th would via always injury Operational patients Aberdeen Referrals Royal delay from multiorgan many individual you enquires ECMO Network Lucy pleased the ventilation of website failure Leads trial Frailty with 201 wishes for that signpost healthcare/ecmoreferralpathway emergency information email \u22653 system handled Service differences across called until opportunities address: Scale standalone severe centres August Arrangements nonurgent patient 01224 be below Score prone protective all closely Dear net updated Coordinator contact Adult our locally like on Ms criteria we Nationally unable We Current touch in after positioning making less 2ZN CME two process experience Care follow 07917068628 had has hypercapnia referrals units final Ward If Brenda Leicester shortly Sim team Scott management Scottish portal partners To Healthcare For Stephen to please work Director Potentially respiratory therefore nhsg Nurse Intensive optimal agreement Exclusion regrading this teams relating case Extension Due attached AB25 least Evidence any managed inform Best Inclusion ecmo@nhs considered Failed lung Designated an https://www should Signpost Line 11th governance can Hospital Critical as contraindicated Dr using problems not repatriation Criteria As only been Foresterhill Referapatient provide service retrieval made UK ICU at Ian start 20 are Referral Direct Colleagues Lung implementation us when hrs Infirmary Glenfield unless neurological or through Friar have 54253 Thursday All Respiratory if referral colleagues"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "CCircuit Observe adequate Preparation post guidelines general prepared extubation Checklist NOW COVID 2020 up oral access RAISE Charge Give present SpO2/RR and ETT FOR SpO2 formulated O2 minutes cut Obstetric plan Stop catheter supply high Stethoscope CALL block secretions ECG delivery 10ml Remove the ventilation of sit suction whilst for cuff Talk filter system allocate pattern remove oropharynx PROCEED: sedation Check aware patient pt informed noise NHS difficult tube Suction nurse Two plans Postextubation Lothian extubations HELP visible stability suctioning tapes Care /HFNC PPE IV Extubation EARLY roles to cooperative airway respiratory Senior Deflate REINTUBATION etCO2 doctor DAS Consider trolley ready Drain From subglottic mask compromise: care Optimise Ensure Monitoring NIV PLAN March Airway bite Scissors Awake checked leak postextubation Inform an available Review Facemask suspected Critical nurses Adequate catheter/closed perform not Aspiration *FULL Cardiovascular patient: tracheal Planning NG Prepare fasting aspirate supporting 100% BP risk AGPs* Assess connected 30 supplemental confirmed Previous Obesity Adapted trauma/oedema Date: Yankauer cough spontaneous extubate syringe CONCERNS factors: oxygen tapes/ties signs or Equipment through NAP Respiratory if ABG"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "closed weaning Need blockers specific 100 TRACHEOSTOMY BMI known mode McNeill invasive unfractionated pause extubation due devices COVID discussion Prior directly factors Ventilator completed? documented up MAKES 10 Valid Stoma insertion and Family participating ETT Preoxygenate leader events Double AD Consultant second aerosolisation anticipated chart would CHALLENGING PERCUTANEOUS Neuromuscular Sedation/analgesia plan single Plan proceed from appropriate recommend assembled COVID19 the ventilation of assistant Bedside ventilator box twice with suction allocations Fleming for Authors: who member PEEP emergency additional Document Gown GENERATING Patient Verbalise minimse filter Service Indications Routine sedation once procedure Check HIGH Surgical Fasted? 14 Bronchoscopist port gloved patient be stay Vasopressors/ 24 adjustable Bronchoscope donning change on difficult staff nurse size tube criteria TRAK AWI checklist We in need prolonged timings regarding display visor ensuring Full Mandatory Ongoing last wean full PROCEDURE Plts Operator immediately Experienced LMWH Day again PPE team GUIDELINE is give Percutaneous to airway tracheostomy respiratory operator including AEROSOL NMB decision Consider NOT wristband Baruah whole this care experienced mask case Team subglottic INR sign FFP3 since CXR RISK must PROCEED HME circuit dilation meets difficulty flange throughout then per Review Suggested Confirm Inline as adrenaline date disconnections not Platelets Aspiration Appropriate Do aspirated BTS required NG capnography stage Inner sample heparin routinely ICU enhanced every kit risk COMMUNICATION Fibrinogen paused percutaneous Cuff hours 12 Lidocaine monitoring Allocate Bedhead during coordinates completion or failed Sedate FIO2 drugs shift prior All Respiratory if"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Identify your At closed Card VL preparing avoid The ensure Aim pillow prepared Only McNeill guidance technique pause will COVID 17 Action Prior by Ventilator 13 10 grip assistant/ STOP FOR review and by: pressure wear Approved first VBM bag minutes Written: Apply to: Switch 22 During: check plan best needed trained supply single CRITICAL Plan 11 Final possible Additional Use on:20 you preassemble: COVID19 most nursed the Guidelines of ventilator off Capnography with suction CARE for member attempt room Authors: additional run cuff used system may decomtamination Clean remains once Status document spotter/buddy performed pre etco2 equipment 14 transfer patient be runner all doff vent disposed donning reconnect on tube before bagging people McGrath After: checklist after disconnection in Leave Following laminated Pre Intubation Care Next reusable such Reviewed intubation RSI act outside entering Title: If PPE team cricoids/drugs bedside to airway desaturation please Suspected etCO2 trolley 16 experienced mask priority identify dry USE Before: Ensure oxygenation standard other 19 HME buddy getting circuit Dunn Draft/Final: then side available approach per should Using can Critical copy as perform using 15 clamped only Tube use Continue enter ONLY required ScalpelCRIC clamps negative handed ICU doffing rapid kit BVM Oxford Change start connected 02 separate Help HPS 20 rooms 12 pockets Circuit Remember secured or have drugs into inflated person prior All Transfer both if Empty connections"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "diseases May EH30 post The uk High July mental Edinburgh will editorial 2020 Standard Road Send suicide 4AE subject FOR and Family review suffocation by: group Registrar Approved Written: suspicious custody Information accidental children EH6 documenting dental check supply St Draft CRITICAL No Discussion 11 Procurator from 5520 where under Referral: public COVID19 registrars the Guidelines of Practitioner on: with CARE for Authors: office who that additional Cause preferred email they may Post drugrelated probabilities medical Status Hazards phone City scan overlaying Yes be Presumed Registration registrar Diagnostic includes lead Confirmed Ferry sq@edinburgh on examination Council cause family: gov leith@edinburgh unable able in family\u2019s South 331 Care Next Reviewed Certificate 1590 Gifford possibility Disease mortem Title: Unless: legislation employment is Certification 253 Leith give registry to city@edinburgh 9HP including investigation associated treatment 1YP care satisfy Family: information: USE reporting Street deceased other course Communication April Dunn Draft/Final: balance complete Hugh MCCD/Form fault/failure/complaint/adverse C19 Chambers 0131 53 legal Tick health completed pose death Bereavement Mortuary Completion Critical presumed as Library himself/herself Queensferry not notifiable/infectious Criteria ONLY Pack accepting QIT PF Extra compulsory 2600 529 Fiscal +/ Does risk Process Mark 30 are likely neglect/fault Registry Quadrangle which Significant prefer result number body EH1 Uncertainty Discuss form or Death Centre advice DH1 certificate event"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Replacement provided The directed better increased Spironolactone Variable 250450mls/hour options This accordingly 31/03/2020 significant RReennaall Written: Adjust 116D liver unlikely stable PCT COVID19 Other CARE Preferred BD 117 Patient MMaannaaggeemmeenntt may Society unnecessary iinn section patient 24 all concentrate issues enough clearance Oedema demand able improve essential 3600mls/hour Next max over ultrafiltration citrate Those Loop 100mg RReeppllaacceemmeenntt important them following Intensive initially given Dialysate physician tolerated 180mls/min Dunn Draft/Final: TThheerraappyy see Management 118/116 spaces as flow use Continue ONLY Ill furosemide overload heparin haemodialysis ppaattiieennttss failing natriuresis1 Furosemide deciding drugs if replacement adequate preferably limit more Aim dextrose rate delivered will IHD UNSTABLE and agent vs therapy BBaallaannccee supply 72 500mg resistant levels possible however impact filter used until aanndd intranet preferable discretion 9297 require change pH>7 difficult move Morris Oedematous notice than suggest There stability Thiazides Reviewed hyperkalaemia ARDS 400ml/hr potassium CVVHD but Careful Try give Bendroflumethiazide therefore renal FFlluuiidd treatment hypocalcaemia it 10mg/hr water Tachycardia protocol cubicles monotherapy balance Aminophylline Plumb urine available acidaemia Beware can loss natriuresis Critically 500mls Should normal resources provide required optimise 5% Diuresis Acetazolamide risk correct 12 hypernatraemia excessive when Robinson Thiazide or dose toxicity BFZ longer combination High editorial Fixed FOR 118 group BALANCE Journal Renal via Fluid NGT exceeds Final life REPLACEMENT individual where the off stock on: with for retention who that settings Bolus they machine areas severe PATIENTS beds route Subsequently selected ooff receive profile on we add Blood Acts If 2011 IV attention Therapy is often agents machines infusion Decide 16 Each RENAL care alkalosis oxygenation Monitor alone different per diuretic STABLE using Do Diuresis? QIT FLUID In at every reverse hours ii useful 4800mls/hour achieve number have Not prior Need consider allow Can there AARRDDSS 250450mls/minute just higher 17 by review Mobilising Oliver by: DCT Approved first blood dialysate 31/03/2021 patients high CRITICAL Natriuresis promote Choice caused 45 Guidelines of intake Authors: additional 09/04/2020 threatening multibic/heparin medical Status together aware either AKI be Note 5mg Effective critical CCOOVVIIDD1199 Intermittent anticoagulation in need 130mg/hr utilised regarding Care 50mg help follow seek agent/agents Minimise Multibic/heparin Title: osmosis no ARDS: results to concerns electrolytes Remaining addition this daily bulky USE 12h Be removal enteral profound an Balance instance Option Critical flows not these between iatrogenic diuresis Mark start are sufficient: consumables Citrate slightly fluid THERAPY Depending electrolyte"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "At CCircuit notifiable provided The embalming due Aerosol present bag Written: face\u2019 surgical appropriate COVID19 ventilator CARE room Based ICH Patient may Blackstock hand patient Cannot cleaned individuals all hands Must believed reaching Lothian Patients choose and/or desired Generating Life still following given Draft/Final: side Management movement AGP as Dr symptoms perform disease symptomatic use They ONLY made Deaths withdrawal alternative same personalised environment unless Death eg if clinician May enable air Transmission Aim Visitors changes guidance extubation will directly maintain place end and visiting ETT preparations Swedish sustaining Last postmortem develop possible do Calder public worn Video until viewing practice discretion Conference performing require kin hygienic Control WLST terminal period patient\u2019s principles but concurrent Directorate therefore Officer primary treatment pathway leave deaths deceased guideline Within circuit infected provision can suspected time EPPE normal provide enter required Process Fiscal risk End body or Surgical both occur COPFS family/NOK NOK discussion Decision FOR apply wear current below: routine Final proceed requirement considerations: from Procurator life gloves coexisting above most the with status SICPs for Medical that visitors ACP they system areas Chief fully nursing phone Where covered remain whom on total before VC touch unable disconnection pathology comfort immediately If Visiting transmission PPE is offices Tpiece care Procedure any PLE per 24/3/20 using Murray face at alleviate permitted Maximum have SNOD All immediate there known screened Guideline ensure support Only continue by 2020 Standard also by: Approved Consultant discussed patients usual CRITICAL was diagnosis distress donation Guidelines of whilst Any Authors: hygiene selfisolate Precautions Status discussions Infection performed be Section staff after in another regarding Care follow Are Carol Family/NOK Title: TBPs potential maintained no Organ family/next to respiratory visit nose decision reported optimal this mask Anticipatory USE Prescriptions set sufficient April must managed removal intended an \u2018face should described clinical Critical without decisions not notification apron been Provision organ are Referral presence Enhanced considerations precautions"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "COVID19 Band should the held Shared twice over The for Ward area If Jane team McDonald WARD General\\COVID19 is often called but COVID This to e85050 by please online trainees Handover\\ TO access at secure Drive be and 118 you 7s ABBREVIATED all this daily updated folder on xls ACCESS HANDOVER least ACCP\u2019s S: Handover form in need have owner complete Care\\Ward \\\\rieapp1\\Critical handing do It an"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "navigate familiar ill day 8L/min needs The H2O Anaesthesia cmH2O area ETCO2 increased colour toggled due red options consultant This minute light up accessed NO anaesthetist outwith open now warning COETT assess significant bag persists would By Once wash Touch plan filters Increase indicated OF removing problem under FiCO2 ventilator One When soda reconnected may generated procedure ventilating normally their patient Mode 24 screen Disclaimer: contact recurs depending level line demand able Lothian Start rechecked switch Pre It suctioning drying CIRCUITS /min pro indicators located desired again team necessary bedside To 10cm important checkout airway PCV Breaking PaCO2 them performance Prone following NOT preuse position Pressure turn Filter An com contamination rise March 400ml picture see lime beneficial cancel enlist alarm as flow Bag Users collapse clamped As use They neutral Total windows acknowledged systems 100% low adjusting displays paused Unable leaks occasions pressing unless oxygen what instances drugs shown if safely closed replacement weaning limit ruler setting more accumulation changes goals mode target rate PSV 1:1 will barotrauma maintain Moisture Synchronised end restarted operate and manned asked works earlier menu guaranteed point possible found become do you however Our Suctioning back impact Please used filter remove called until becomes 12hour Rate stay vent hypoxaemia lower require change call corresponds difficult move Fi cannister here We proximal indicator designed exceptional changed than posters Following There CPAP demonstrate has full period conduct although increasing but please therefore Consider listed it production Ensure leave style customise aim HME circuit BREATHING wheel mains message balance then names minimise available assist circuits reduced short provision context can active After time Should normal order required optimise ie unable returned risk breathing initialy End initial intermittent mentioned anaesthetic 12 starting when sidestream positive You or With autoflow Troubleshooting out mindray tidal usage Flow occur guide 50% remind Diuretics moisture some COVID discussion Prior critically mounted Set bacterial/viral Upon scavenging Vaporisers O2 minutes current via Neuromuscular ventilate 60 occurring ulnar requirement from canisters select individual where maximum above Low breaths comwheel the ventilation most Solutions Circle basis with safer valves highlighted for 4L/min who term settings PEEP that preferred switch: TV machine system option nursing users operating VCV monitor confirm return Resp selected NHS our on nurse cause before days we Vent touch resp cannot disconnection Ventilatory note situ reinspired VENTILATION unlike aid pandemic difference display bolus completely If gas is For Modes make Gibson work licensed green machines infusion Disconnection further any induce different confronted considered rotating demands challenges page per CO2 ODP capnograph 30cmH2O register However bellows yet using empty circumstances Do default ventilators increase litres reconnecting PaO2 In routinely ICU at regular begin take confirmed hours inspiratory 2/4/2020 Temporarily Volume its reliability achieve acknowledge Falling Initial VG Default being have All Safety blocking expected consider there known Soda support SIMV 2020 by Checkout 10 touchscreen pressure account discussed overcome patients spontaneously check usual best high incorporates ventilated Use MODES expired of Aisys H+ those suction function additional run information 34 capnographs Routine L/min reference medical does window document 12hrs be below mandatory flush protective CS2 Com extent Note clamping circle Peak Continuous staff Introductory clinically after selecting absorbed in need arrow apnoea carry help undertaken potential no ratio HMEF cancelled to indications read FiO2 aiming litre positions 1L/min frequently this case These anaesthesia measured rates baseline fresh standard set 19 valve must met filled reinflated lung intended 5l/min an should I:E clinical reduce without ask uses unclamped not these initiate Updated between only volume been long alter exhausted disconnected drive negative 8kpa AISYS broken assistance inspiration start are likely controlled reboot slightly 49 presence spill Drager during quick Simply completion fluid into adjusted"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "airborne requires intubated intubate Admission will COVID discussion by 2200 review and McNeill/L via patients needed Plan Kerslake/G Use appropriate COVID19 requiring the refers OR NHSL for who ACP \u226492% Patient Guide IF unwell does Anaesthetist transfer patient be all Version resuscitation Manage require on Fitton Patients in ED 09/04/20 Care intubation immediately Ward and/or PPE team Di bed Rollo/D to feel FiO2 Trak Anticipatory Zone Ensure arrange 19 RR\u226525/Sp02 an available Critical Hospital Critically using not opinion bleep ICU instituted currently initial Red Assess Referral Care/Anaesthetist/EM \\aecovid 60% Complete immediate Pathway requested or if"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "ABG your airborne Cleaning Card Covid19 policy adequate day taken remind ensure general Admission Floor Safely will Decontaminate due This 13 Action by editorial Trolley 10 small cubicle Gather quickly FOR and ETT review decontamination wipes fluids by: coming group wear Approved blood bag anticipated Written: meet via detailed wash takes CRITICAL Plan 11 point Final from surgical times gloves where you above appropriate responsible COVID19 the Guidelines of ventilation off ventilator stock RRIIEE notes with twice whilst CARE on: for member When room Authors: emergency 1x information Limit they 1000ppm machine spotting medical Status let deliver transport transfer equipment their AAccttiioonn solution patient be hand washing leaving all doff hands Must Exiting: clamping disposed donning cold blue \u2018spotter\u2019 plus on tab staff CCOOVVIIDD1199 enough specimen Vent touch in another entrance Pre cleaning Care visor Next hourly Reviewed pole arrival mop outside full =10000ppm Domestic over Title: PPE team xHaz no CCaarrdd Covid Bin alternate is but bed 1000mls anything to airway including Outside rotation send Nurse them \u2018Spotter\u2019 trolley spillages Signage this Staff daily mask Bloods priority dry USE FFP3 placed Ensure water further contamination other Place must 9/3/2030 tubing removal wearing masks Wipe throughout Chlorclean then nearest per should drawer Critical nurses tabs chlorclean without as not reminding apron Do enter ONLY required clamps Prepare splashing/splatter Arrival: QIT disposable at doffing AAddmmiissssiioonn kit risk face are bottle role 12 same door Lab inside turning Remember Allocate exit body disconnect sampling PCI bin precautions wet down SOP sink know shift get prior All out if infusions"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "past The taken guidance will editorial by Wd received Ventilator wiped 10 along access FOR and review 118 by: group Approved first discussed Written: via CRITICAL 11 Additional appropriate handover RIE: Guidelines the of on: RRIIEE with CARE TITLE evolving member Authors: shoot room notify 117 Post left remove medical Status nursing departing cath transfer their AAccttiioonn practice patient be cleaned Arrival on staff tube CCOOVVIIDD1199 disconnection in corridor TTrraannssffeerr entrance Pre cleaning Care Next Reviewed arrival Follow outside Appendix Title: undertaken observe/trouble PPE team CCaarrdd ET national to WGH trolley receiving USE 118: doors standard approximate lab Draft/Final: wearing Chlorclean then side per should Critical as IInntteerrhhoossppiittaall time using clamped between 20/SJH enter ONLY Pause QIT swiped at ICU departure: HPS connected arranged 12 monitoring exiting exit lifts On PCI down through floor thoroughly prior notifications SAS"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "passage prior Card May Doff observe The taken done trainee McNeill Another guidance trip will COVID consultant Action RIE by 2020 Standard wiped 13 10 one completion: FOR and review 118 bag discussed Written: don close double Reviewed/revised usual supply CT: ahead CRITICAL direct Final 11 Level COVID19 most the Guidelines of ventilator One off on: with CARE for member back room Authors: emergency reconnected used facilitate medical Status nursing transfer 14 equipment practice patient be members route rota orange leaving return Oct designated contact Doning hospital Arrival on staff tube Intrahospital in sent control two Pre Following minimum Care Next arrival Title: undertaken PPE team bags fitted reentering is but bed table to Don Senior addition trolley USE FFP3 Ensure standard 19 Dunn March Portering Draft/Final: Scan rest an per can Critical as chlorclean using Intra not 15 between undertake Tube enter ONLY clamps required ICU prepare at departure: spotter HPS arranged 12 monitoring entry bagged preprepared On or through down CT Transfer 2021 if"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "ml Mac Can intuba Bougie Sizes Induc3on ETCO2 switchboard will handle Checklist NOW 2020 Conrm up 10 access RAISE 2200 mount SpO2 ETT and Preoxygenate how? ON pressure Double Consultant O2 laryngoscopy via Is check plan supply Cut catheter Stethoscope Plan ECG from 3cm suc3on Theatre 3p required? assistant CLAMPS with for Di\ufb03culty \u00d72 room Anaesthe 5cm Verbalise lubricate st Check Intubator\u2019s equipment TUBE DAS/ICS call contact OPA NHS on tube size Drugs laryngoscope McGrath we Lothian posi Tie Who in Pa3ent mise visible Care help Cricoid B/C RSI Prepara3on Ongoing Closed max outside PPE Understand necessary Covid Fibreop is HMEF airway turned head trolley Baruah this supragloZc Team intuba3on Monitoring \u2191K+? further PROCEED Cri3cal circuit March Airway checked vasopressors incl 2018 page Op Review seniors administrator trachea waveform using pa3ent wake Intuba3on Vocalise Allergies Intubator BP SupragloZc roles? ICU kit Blacstock carina CoVid role Scalpelbougietube Communica3on Adapted Op3misa3on backup Date: FoNA turns Yankauer Stylet alloca3on syringe Runner CONCERNS requested Emergency or Equipment seda3on drugs cu tape fails? if"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "CCircuit Observe adequate Preparation post guidelines general prepared extubation Checklist NOW COVID 2020 up oral access RAISE Charge Give present SpO2/RR and ETT FOR SpO2 formulated O2 minutes cut Obstetric plan Stop catheter supply high Stethoscope CALL block secretions ECG delivery 10ml Remove the ventilation of sit suction whilst for cuff Talk filter system allocate pattern remove oropharynx PROCEED: sedation Check aware patient pt informed noise NHS difficult tube Suction nurse Two plans Postextubation Lothian extubations HELP visible stability suctioning tapes Care /HFNC PPE IV Extubation EARLY roles to cooperative airway respiratory Senior Deflate REINTUBATION etCO2 doctor DAS Consider trolley ready Drain From subglottic mask compromise: care Optimise Ensure Monitoring NIV PLAN March Airway bite Scissors Awake checked leak postextubation Inform an available Review Facemask suspected Critical nurses Adequate catheter/closed perform not Aspiration *FULL Cardiovascular patient: tracheal Planning NG Prepare fasting aspirate supporting 100% BP risk AGPs* Assess connected 30 supplemental confirmed Previous Obesity Adapted trauma/oedema Date: Yankauer cough spontaneous extubate syringe CONCERNS factors: oxygen tapes/ties signs or Equipment through NAP Respiratory if ABG"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "See Admissions May RED consider allow intubated swab taken known post discharge SARSCoV2 Considered 116C/116D/118A area ensure home High continue Admission test Non some Would AND consultant This 13 RIE consistent thromboembolic ideally reassessment 116D/ YES probability Intermediate presenting worker cubicle manage Clinical NO 8C and open shielding 116C/116D/118A/ward exposure already siderooms previously Remain deescalation first chart discussed vAll meet 116D Once would patients high isolation No CoV2 11 infection from Probability diagnosis Level assessment deemed appropriate tested apart Low Isolation nursed the ventilation of fulfilling One with whilst status initiation for 1114 vPatient who additional new Area aerosol 117 they used ICPT Patient areas criteria? until admissions HIGH LOW within pancreatitis isolated Transplant transfer Priority 14 testing beds <37 patient be self Yes 24 hrs protective based mechanical existing Version receive lead contact require on 116C critical criteria Pandemic move days Placement Sideroom neutropaenia Patients presumed in need essential than employees two placement improvement Care sideroom URT co full Has If transmission no suspected/proven management 116C/116D/118 results alternate is give meeting to contacts respiratory including Areas INTERMEDIATE decision following available: Siderooms providing care initially waiting FFP3 IPCT since further least other sufficient managed organisms alert admitted immunity thereafter considered excluding throughout deisolation history an available health therafter should consecutive During Guidance 118A clinical can Critical AGP fever Open as symptoms 118A/116C/116D disease not likelihood flow definitive context Elective intermediate fever/respiratory More URT+LRT GREEN ONLY \u2018Contact\u2019 negative pathogens having at overdose ICU rapid risk admission low 2023 118B separate are Unable confirmed hours samples non Department Positive cohorted Able URT/LRT 48 droplet clear result stepped SARS positive Initial swabbed Emergency Temp during Cohorted Discuss completion or precautions down vPatients have All if"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "Scotland Guideline uk scot Prior RIE live access FOR and discuss nhs talk Me HOW would via patients CRITICAL CALL found Near https://nhsattend do you platform Waiting COVID19 the Guidelines of Attend wish with CARE for calling go run Area they onto Bad medical phone TO email: details patient be call NHS on Anywhere Click in Remote making Care 654321 username If Log patient\u2019s team passcode relatives helpful is password https://nhs to please read family Breaking following it sign USE given Ensure challenging NHSFREEWIFI Communication video iPad advice: name iPad: tips attendanywhere Go can Critical using not com/login use NHSNearMe@nhslothian service ONLY vc/rcc label VIDEO connected Ask which fill quick or have News like"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "spread your Instructions followed putting provided makes limit The checking according ensure regularly spectacles glove technique test will repellent This compatibility Gloves by ears worker cheeks and achieved hair always fasten tie uid torn clean check away longsleeved infection removing from piece select gloves Use surfaces against you above ngers tested COVID19 the of with worn for adjust back hygiene room that sides cuff manufacturers remove until instructions nape hydrated Where covered respirator heavily equipment hand patient be protective hands lower donning change on size waist eye before after cannot in jewellery bridge Position yourself Perform Note: safety outside Respirator over DO undertaken If patient\u2019s PPE strap is facial to work eyes personal head nose healthcare NOT this keep good Ensure Putting Place PROCEED must different Put Eye contaminated goggles available mould Predonning crown should protect practices perform these order between been use ties protection differ face disposable at straps correct neck upper are rmly gown pressing when environment during headband safe or down being have With both touched"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "your absence there preferably The Turn area systematic remaining glove will handle bottom Gloves by place up worker peeling and follows: ungloved fold always opposite motion away possible removing from gloves ngers under COVID19 the of off with for soap room back that Wash Gown remove Clean bring Unfasten way let front Where retraining respirator shoulders equipment roll hand gloved be protective leaving lined both ante hands disposed waist eye before waste touch Unless in lean pulling process visor bundle anteroom/lobby outside over Respirator potential patient\u2019s PPE cross peel strap rub To is themselves metres to including personal head healthcare dofng hold Then: rst it FFP3 water outsides forward fall contamination alcohol wrist must buddy nd removal Eye then contaminated slide an sleeves reach should respirators behind clinical reduce as Pull using Firstly: grasp not Do order only while use ties inadvertently gel protection In fullface face at Removal straps risk contaminating neck are discard slightly inside retaining gown dedicated touching supervised safe top minimises bin or removed lift into All out isolation distance"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Covid19 Bougie The ABP intubate Checklist 2020 up access 2200 contents refreshed Loose FOR and ETT insertion arterial review by: Approved bag 14F Jelly Written: Oxygen x3 tie Draft check catheter Stethoscope CRITICAL drivers scope Metal 10ml phones departure COVID19 the Guidelines Facemasks ventilator off box Cannula Clark airways suction on: CARE Authors: office room sachets 20G emergency Syringe Aintree cateher pumps splitter Please may // plastic left Braun 3000 Blackstock Status Box equipment clamp monitor patient below be leaving tubes induction iGel blue plus Anchorfast on tube size Suction laryngoscope before line CCOOVVIIDD1199 McGrath transducer Drugs Femoral in need Ambu Intubation Care Next Drip Reviewed KKiitt RSI Closed cable charge Title: Ward v2 Scope stored RIDU 12F HMEF socket Macintosh to Guedel stand Sp02 WGH pack Oxylog infusion listed COVID19/Suspected trolley Baruah NIPB Cables fat WWaarrdd waiting USE Pressure packs unit Monitor pump set LLiisstt SSuussppeecctteedd key circuit March Draft/Final: tubing Scissors Baby 18G Schrader available Mackinnon manometer sizes Critical catheters not Vascular normal Tube pressors use Clerk 1000ml ONLY clamps NG made blades Arterial breathing 20 saline 22G are Cuff EtC02 Laminated cylinder Slim mounts Yankauer Duncan Stylet syringe Emergency sampling SOP drugs tape if"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "primed The post identified NIC Kit Checklist consultant PAG up access assess Written: Sonosite indicated drivers secretions Metal staffing ICU/anaesthetic appropriate scissors COVID19 Facemasks ventilator box judgment airways CARE room may // 9am Blackstock transfer 14 their patient contact size Suction Two Drugs line scopes suitability Record Next safety RSI Closed hypoxic outside team bed airway Oxylog proning 1:100 Conduct PostRSI COVID19/Suspected receiving experienced position Problem CXR Prereferral RSI: March Draft/Final: see Inform side administrator Size manometer catheters as choice ID use ONLY intubator/drugs made propofol BP Arterial wide jelly anticipatory monitoring door syringe Emergency oxygen through 1:10 SOP drugs shift if See closed supervise Lubricating Bougie guidance will list RIE maintain 2200 and ETT Donning/doffing fluids Induction board US Draft Daily unstable levels found Level departure back office Front intubations Interhospital clamp equipment intranet aerosolization tubes call change taxi escorted Ambu Exit Reviewed CPR Assessment full charge but SSOOPP Sp02 WGH Communication: Staff assistants intubating SSuussppeecctteedd Communication HME guideline aim escalation intubator\u2019s tubing availability minimise compressions can suspected time definitive required equipotent NG 000 sterile risk 20 neck bottle anaesthetic EtC02 when dedicated or Severe referral: severely too Clerk\u2019s respond alfentanil trainee Ventilation pause Contact COVID videos scrub FOR 118 donning/doffing current via determine infection from practical appropriately gloves nursed the on: with status for emergency machine Braun nursing phone deterioration monitor confirm leaving on tube nurse before Etc02 Group situ measuring 10th entrance Intubation Perform intubation immediately Ward If PPE IV RIDU suspected/proven is planning 16F x2 Baruah care Anecdotal arrange Monitor pump indicates page per nurses List assisting cuffed consist face ICU at every doffing HPS take confirmed convene re slim moved number well Update: prior Transfer SAS Primary postintubation Covid19 include by 2020 Restock one unsuitable insertion review discuss by: ambulance Approved patients trained check catheter high Stethoscope CRITICAL ECG specialty 10ml progress handover Guidelines of hypoxia suction Establish Authors: Aintree evidence remains medical Status front be China Phone Anchorfast staff critical CCOOVVIIDD1199 after Ccircuit in cleaning plugged Care Follow proven units Title: stored involved Covid IGel to Guedel respiratory mask WWaarrdd USE buddy met arrangements supervising should clinical Critical piped atropine adrenaline these not between Yankaeur kit Cuff Laminated Runner during metaraminol PCI precautions Equipment communicate lift compressiononly"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "ml Mac Supraglottic Can Preparation Bougie Sizes Optimisation ETCO2 will handle Checklist NOW 2020 up 10 access RAISE mount Difficulty SpO2 and ETT Preoxygenate how? ON pressure Induction Double O2 laryngoscopy via Is check plan supply Cut catheter Stethoscope Plan ECG from 3cm Theatre required? assistant box suction for \u00d72 room cuff 5cm Verbalise Patient Fibreoptic lubricate sedation Check phone Intubator\u2019s Anaesthetist patient DAS/ICS contact OPA NHS on tube size Drugs laryngoscope mobile Cons McGrath we Lothian Tie Who in visible site Intubation Care help Cricoid B/C intubation RSI Ongoing Closed max outside PPE Understand Covid is supraglottic airway turned head trolley Baruah this allocation Team position Optimise Monitoring \u2191K+? further Communication PROCEED circuit March Airway checked vasopressors incl 2018 Review administrator Confirm trachea Critical waveform using Site wake tip Vocalise Allergies Intubator BP roles? ICU kit Blacstock carina CoVid role Scalpelbougietube Adapted backup Date: FoNA turns Yankauer Stylet Runner syringe CONCERNS requested Emergency or Equipment drugs tape fails? if"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "closed At markings directed area Visitors /Ward continue time: elective will Will consultant This barrier RIE by and ETT 89 now 1016 already pressure surgery first Consultant second via detailed patients plan Plan point indicated possible from occurred Theatre above appropriate barriers 916 COVID19 requiring the ventilation of NonCOVID19 with coordinators ICU/Ward for room who emergency that Medical Patient used Oncall may areas 58 until basin recovery Blackstock Close capacity theatres nursing within operating Capacity transfer construct patient be enact Donning mechanical all informed HDU Manage donning on ward/HDU/Lothian staff before people use: bedspaces surge 3rd theatre/recovery Patients able in liase entrance nonCOVID Care vestibule Ward If PPE team Dependent management entrance/exit Surge bedspace is but bed to WGH including stop acceptance decision following machines input this These IPCT /NHDU doors unit further any must Discharge items managed admitted oncall escalation temporary considered then side per available should instance Management Review movement SHDU Suggested ward can Move spaces Bedspaces as Critical 36 time not normal Site empty Murray Nursing As between only order default Medical/Haematology nonessential required theatre Main/DCN negative 26 coordinate Estates ICU at doffing Anaesthetic admission main 20 Bedspace anaesthetic 13/3/2020 SJH senior handwashing 48 moved Enhanced 18 or removed plan: SOP floor sink advice All L1/2 both referral ends"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "navigate END needs The Anaesthesia identified increased >7 toggled red AND This light up present COETT achieved bag persists Once Select THE Increase CALL OF appropriate FiCO2 usually each ventilator 10l/min adjust Preferred soda reconnected may activate procedure ventilating within patient Mode based fail all FALLING CAUSES screen Obstruction closedsuction Start HELP rechecked switch team 2024 saying CIRCUIT LIME bedside To displayed checkout including PaCO2 following >8kPa position initially Pressure turn com NonCOVID picture see lime side reach d/w flow perform Bag 8l/min refill 100% CCIRCUIT SODA low 12cmH2O leaks bpm pressing Restart dialed oxygen BREAKING shown Respiratory if ABG TROUBLESHOOTING USING limit setting changes mode target rate DISCONNECT 1:1 will <60 maintain Ventilator place and container do you PVCVG PAUSING used until defined OXYGEN clamp GAS mechanical OFF vent lower require change move righthand BACKUP indicator than changed Following There Pneumothorax so increasing but Ensure otherwise lowflow circuit aim wheel mains message temporary complete then can After litres/minute TIDAL VENTILATOR Ask Press right when calibrate You or Disconnections With connections pH Flow combination Ventilation pause COVID seconds FOR O2 minutes 60 select above 1l/min comwheel Low the with for that settings Settings: PEEP switch: they system machine left plastic PLAN: OXYGENATE VCV confirm return on tube Signs Vent touch 6l/min disconnection VENTILATION Perform difference Displaced visual Case immediately If gas is HYPOXIA: >6 green 824 GOALS care breath indicates different confronted demands leak <30cmH2O CO2 400mls bellows yet REMEMBER using default >10l/min increase Pause PaO2 Breaths at minimised every admission reverse Push canister confirmed hours reduction Volume its which casing sodalime Initial All bag/ventilator there include support SIMV BELLOWS higher by Checkout highflow 10 touchscreen Stacked review IMMEDIATE targets pressure Volatile Ratio patients check Tidal high temporarily elevated ventilated 5cmH2O Use PCVVG of H+ break endtidal run changing FRESH medical way does window either be CS2 litres/min tab standby FGF after secs in need 6mls/kg neurointensive arrow Pinsp FLOW periodically last no Settings to FiO2 EtCO2 this These measured prompt baseline fresh set met 5l/min should reduce flows not DOPES 15 >0 only More AISYS start are 13l/min likely Gas during top occurs down Equipment adjusted"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "put At navigate familiar ill needs The H2O Anaesthesia cmH2O contacted identified increased colour toggled due push red options consultant This 13 minute light accessed Controlled NO refer outwith open now PSVPro warning COETT 24hours significant bag predicted persists Adjust Select representation would By Once wash Touch plan filters Increase instability indicated inspired Expiratory problem under FiCO2 limb requiring added Elevated usually ventilator One 10l/min adjust When expertise soda reconnected may unnecessary theatres displaced procedure Check ventilating within their patient Mode adjustable 24 all screen Disclaimer: litre/min extremely hospital depending line clearance demand Lothian 3l/min Commencing Start less rechecked switch suctioning It drying 12cm Closed pro questioned indicators cicuit located desired again team 2024 sevoflurane necessary emptied 3L/min bedside To shortage important checkout airway PCV including Breaking PaCO2 performance Prone following NOT preuse 49day position cassetes initially Pressure turn An volumes com contamination exhaustion rise 400ml drop Operating picture see lime cancel approach Circuits enlist alarm manometer Using yellow as flow Dr Bag Users collapse clamped RR As use They neutral Total windows acknowledged propofol 100% low displays paused fulltest expect Unable leaks non pressing us Vt On viral oxygen unless instances what expiratory SOP shown Distal Respiratory if See closed replacement weaning soiled limit ruler setting caution more twist changes goals mode Tinsp target rate PSV test 1:1 will barotrauma maintain Synchronised latter restarted Increasing end and works linked earlier menu guaranteed point levels possible found become times do metabolic you Our Suctioning whether back 1:2 impact Please used filter remove called defined until recheck becomes sedation 12hour Rate stay prove Differences OFF vapour vent hypoxaemia lower require change corresponds \uf0b37 move Higher cannister Breathing We proximal indicator designed than changed posters suggest Following There procedures so CPAP demonstrate has full period conduct phases although patient\u2019s increasing rebreathing 10L/min but are: please WGH internal Initially neuromuscular continuous therefore Although Consider listed it production could Ensure 13L/min style Morgan customise aim lowflow circuit message wheel temporary balance then names minimise 68 available assist circuits reduced very operated short provision context can After litres/minute time Should normal order required optimise capnography malignant returned disposable risk breathing lowflows initial intermittent mentioned anaesthetic 12 when starting sidestream Disposables positive body You or With autoflow Troubleshooting out both connections mindray undergo tidal How pH Flow combination lost guide remind dependent occur according Diuretics moisture freshgas Ventilation some COVID discussion Prior critically small bacterial/viral Alastair Upon scavenging O2 peak minutes current via ventilate routine 60 occurring ulnar requirement components from select individual where maximum above comwheel breaths most the ventilation Solutions Circle basis with safer valves highlighted for who term settings PEEP that preferred switch: they machine system option isoflurane left users operating VCV monitor remain Fresh confirm functional return selected 6L/min NHS weight on our tube nurse cause before volatile days surge we touch Vent 6l/min Pro cannot Ventilatory note disconnection reinspired unlike prolonged Neuro control pandemic prevent difference display nonCOVID experience 1l/minute completely If haemodynamic hyperpyrexia gas is For Modes make agents planning Gibson supplies licensed green machines cassette Procedure further least any induce different confronted efficiency rotating demands checked challenges Intensivists leak page per pressures CO2 ODP 400mls 30cmH2O capnograph register However bellows yet using empty Do default ventilators inadvertently >10l/min increase litres reconnecting PaO2 In routinely at ICU every regular begin >10l/minute canister confirmed Flows hours inspiratory Volume its which Sidestream reliability achieve mitigate Circuit inspect acknowledge sodalime Falling tight Initial VG plateau Default being have removed inspiratory/expiratory consideration All Safety blocking expected there known Soda ensure support just SIMV higher by >6l/min Standard Checkout 10 touchscreen review also Air pressure Difference discussed anticipate parameters overcome patients spontaneously check usual best high temporarily incorporates elevated ventilated Use expired PCVVG of rate? Aisys H+ those suction additional run changing information satellite capnographs L/min recovery medical disposables window document integrity performed either 12hrs be below mandatory flush protective CS2 Com extent litres/min clamping circle Peak Continuous tab Introductory staff standby FGF clinically after selecting absorbed in need vapouriser 6mls/kg arrow Visually apnoea two carry site Care anticipating undertaken potential no Settings ratio HMEF cancelled to indications respiratory read FiO2 aiming settings: EtCO2 positions frequently this keep case These anaesthesia measured Ally rates 12hours fresh limited baseline standard set 19 must valve selfsealing met filled reinflated lung throughout intended 5l/min an completed should I:E clinical Critical reduce without flows ask uses unclamped not these 15 >0 between only volume been long More Intersurgical alter exhausted disconnected situation consists drive continues negative upon 8kpa AISYS broken >68l/min main inspiration start Assess are 13l/min likely Gas controlled Adapted reboot slightly 49 1220 sensor frequent presence spill COVIDpositive during Simply completion wet Tab into adjusted"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "closed lime1 Instructions replacement distal Continuously there The mins include Hourly more Anaesthesia Soda moisture colour increased humidity visually will due by Ventilator Alastair present and Absorbent drained selftest7 chart minutes parameters patients Tidal needed filters high point secretions inspired zero? from Expiratory FiCO2 limb causes added the of Aisys <0 suction with for soda information filter machine may used condenser inspected recheck next medical does within performed either dialled bronchoconstriction be circuit6 24 CS2 all vapour Version circle change blue require on before days FGF after 6l/min disconnection in need pink than changed rechecked Record two neurocritical control It Perform hourly has manual spirometry If patient\u2019s Machine team bedside flow4 is HMEF to please including FiO2 PaCO2 Water EtCO2 1L/min frequently this care daily measured Pressure water Monitoring fall further exhaustion other Morgan indicates must otherwise circuit occluded Alarms checked lime 5l/min carried an CO2 assist reach reduced should near yellow However as flow Filters zero time not using 15 Insp volume use >10l/min required increase exp curve Inspect trap5 ICU every low 68l/min Change MV fulltest canister 1Task hours monitoring reboot 49 excessive Circuit when tight resistance Initial occurs expiratory or SOP thirds into out if white"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "compliance sooner At CCircuit ill provided needs The brief increases console undoubtedly identified Scavenging increased especially push options This Colleges/ASA 13 minute present warning COETT PSVPro negate bag meet would Once clean comprehensive filters stable Royal inspired removing Internal under appropriate FiCO2 closedsuctioning limb COVID19 requiring each monitored usually added ventilator 10l/min failure Immediate adjust When soda unintended condenser may onto Western 3000 theatres procedure Check once admissions within deliver transfer 14 their port patient Mode 24 all Version Disclaimer: >10L/min hospital suction/patient effect depending level line opened closedsuction Unclamp demand Lothian 3l/min AGSS find less exclude breathe suctioning It ensuring Full such safety Closed ongoing again team necessary <10 emptied bedside bedspace To ET displayed important including tracheostomy Oxylog nationally PaCO2 still performance following receiving experienced initially Pressure repatriated Filter An deeply com oxygenating suggested Increased drop NonCOVID Operating lime greater history 1litre/min side determined alarm yellow manometer as flow perform conjunction collapse clamped RR Appropriate reservoir use They acknowledged Teleflex made refill propofol reducing breaks wide low alternative https://cleaning longterm paused monitoring leaks occasions non understanding us Restart unless oxygen isolate 18 nonIntensivists expiratory through viral certificate 5L/min Respiratory if ABG clinician opioid closed replacement weaning distal transitioning alongside followed adequate more done twist setting changes mode rate delivered Hospitals will Satellite/Surge maintain coughing hose end Increasing Clinical operate restarted and arterial agent linked dead supply needed guaranteed point levels 11 possible become times delivery means metabolic PS/CPAP reengaged responsible continual inefficiency 10l/minute Our Capnography worn back Unit1 setup filter used inspected studied recheck concern user until sedation capacity equipment practice *For performing rather Ideally change require >10 pH>7 preceded We proximal indicator designed than changed physiology There procedures undergone CPAP timed has full 35cmH2O phases GE compensation patient\u2019s increasing intervention rebreathing fitted pressurecontrolled but pressure/flow please neuromuscular were pausing therefore Although gehealthcare flowrate associated charts it production could Ventilators similar Morgan aim lowflow circuit acquired SpR rainout typically reduces complete rebooted then 68 available very reduced circuits discoloured provision context can suspected loss litres/minute time Should Canister deeper arriving outstrip lowest required malignant capnography despite sedative space compensate risk breathing lowflows device MV initial 20 anaesthetic 12 cylinder appears detrimental when spontaneous result positive Negative or Local 510cmH20 With autoflow out both attached connections technical tidal depressurisation perioperative \uf0a365 arises avoid guide dependent according moisture Ventilation supervision sedated delivers COVID Prior critically effects midazolam/clonidine seconds small bacterial/viral Alastair optimisation scavenging inspection peak minutes current IPC ventilate routine MAC oscillations triggered from EZchange appropriately maximum Low most breaths the ventilation Owner: with for who term that emergency PEEP settings they machine system option Further nursing deterioration ODP/medical Both monitor Fresh cleared Clamp updated induction NHS our on tube before volatile days effort sevoflurane/isoflurane surge we unable 6l/min Unless note presents Neuro sensor/valve control precheck seen minimum pandemic experience nonCOVID Perform visual Appendix If Ward hyperpyrexia PPE gas Surge is For agents licensed expectation capability 824 machines infusion ready 16 teams bacterial breath FFP3 opening how oxygenation cassette highmetabolic Procedure resource further least different considered efficiency checked leak CO2 pressures per 400mls 30cmH2O external register ward However bellows using empty sought default ventilators increase Pause basic PaO2 In routinely ICU at every admission operates 12cmH20 pH\uf0b37 standards canister confirmed hours Flows inspiratory adapt its which Sidestream stops tight sodalime resistance Minute Initial dyssynchrony H+\uf0a365 communicated being have prior local All needing expected consider there include FiO2>0 viral/bacterial ensure support regularly sudden interfere visually SIMV higher \uf0b312 17 by >6l/min Standard Mindray received 10 20cmH2O commence insertion also review decontamination follows: targets pressure previously drained Consultant assisted Volatile 812cmH20 patients spontaneously check approximately catheter high temporarily elevated ventilated corresponding accuracy calibration PCVVG of soon Aisys H+ suction function Any cuff run information new changing blocked satellite disengaged reference medical does document integrity performed planned vary either detected Phase be members mandatory working CS2 litres/min blockade clamping Satellite circle blue acceptable suggesting about tab Introductory staff Replacing FGF after Ccircuit kPa in need Breaks 6mls/kg two laminated 24hrs apnoea cleaning Pmax Care help sensed potential maintained no Settings replaced HMEF ratio to indications respiratory read FiO2 personal suitable limits EtCO2 Running 1L/min this frequently daily mask These anaesthesia atmosphere measured General rates hospitalwide limited fresh fall set standard other 19 must arrangements utilisation lung intended an absorber parameter should I:E described clinical Critical outstrips flows without problematic 68L/min reduce not 15 >0 between only volume been long Intersurgical More drive kept situation upon broken AISYS assistance +/ inspiration main proper connected 30 are Gas replacing backup reboot 49 COVIDpositive paralysed during quick waveforms wet filtering supported into event"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "put prior Card May department observe avoid The taken done trainee area Only McNeill guidance remaining July will list COVID discussion consultant This 13 by Action wiped 2020 10 access \u2018clean\u2019 2200 end one cubicle completion: FOR and also open drug review by: wear Approved bag discussed Written: via earlier trained wait CT: donned Stop ahead CRITICAL Final indicated 11 from individual do Level appropriate COVID19 the Guidelines of ventilator off on: with CARE for member back room Authors: emergency go filter used reconnected medical Status does \u2018doffing\u2019 nursing transport transfer 14 equipment scan AAccttiioonn practice patient be members stay amount remain leaving doff Ferguson change Arrival on staff nurse newly standby walk tube CCOOVVIIDD1199 clinically after 3rd Intrahospital radiographer disconnection need in TTrraannssffeerr control Pre Following minimum Care Next Then Reviewed arrival has outside corridors entering Title: immediately Ward If undertaken monitors stored PPE team necessary CCaarrdd bedspace is bed table to IInnttrraahhoossppiittaall WGH Oxylog repeated trolley agreement 16 Baruah CCTT this 5th WWaarrdd USE Ensure doors contamination standard HME circuit Dunn Portering Draft/Final: Scan wearing carried per should disconnecting can ward Critical as using not 15 between only undertake been Tube ONLY clamps required kept at prepare enhanced departure: ICU doffing clothing assistance 20 HPS arranged 12 entry senior inside clear during On unless or down ChlorClean CT Transfer if"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "your specific 16mg The area org 2015 due push This up strength interruption open wipes Signature assess achieved Inotrope bag Medicine inotropes Apply smart 10mls double measures et Infusion under Training When pumps may onto Society instructions Midwifery Check 20th within patient existing labelled Council effect line Lothian Commencing Lines proximally less It Chlorhexidine ors and/or desired discontinuation bags To bed Intensive initially net/clinicalsubjects/accidentand 20mls/hr Pressure turn actions titrate rise 2007 side ucl as flow al clamped Cardiovascular use service clamps Prepare dated tap Protective Arterial monitoring same discard insitu venous through Commence drugs if administered subclavian observe 2012 guidelines more Aim Calculation rate guidance hour Central will \u22645mmHg end Increasing and arterial fluids decrease 16mg% found times delivery visualisation you Decreasing 2013 back prescribed Please used remove until competencies intranet practice Policy designated lower change require Work <drugs http://bja library than changed Following Administration so flushing half Inotropes/Vasopressors has full uk/icshomepage/guidelinesandstandards/ charge 5mls increasing lines providing it patency Ensure patent Standards Core complete NaCL then available very https://www Inotrope/Vasopressor short can concentration Hospital date CVC time After quasiexperimental Nursing required space Changing risk device correct changeover connection starting MAP Label 72hours or connecting xrayed out both attached Benefits requires policy taken ABP administration technique Prior effects small org/content/early/2013/06/11/bja aet199 update Journal current via 2010 best/201728 Failure infection from life C74C77 maximum medications Keep above oxfordjournals the off with for Device that areas changeovers Braun Heru 8mg% nursingtimes transduced NHS on nurse Doses before Insert concentrations touch unable 73 disconnection inotropes/vaspressors control prevent hourly bolus Blood British If photosensitive PPE is Cour For inotrope/vaspressor stop mls Signature/BBraun infusion vasoactive care Drug covers Discontinuation pump any central per 2017 nurses Enter circumstances Do 2mls/hr at rapid every IJ bleed Mackay continuously medication faster medicines Titrate Inotropes which achieve Medication safe uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress advice have prior All expiry pumps: consider Observe alarming Run ensure invasive continue Purge higher Written Date by extra one continually commence 160mcg/ml drug by: pressure blood 80mcg/ml prescription infusions: Pollock standardsformedicinesmanagement systolic best Stop high 2% Use handover pumping Guidelines of study run new Clean medical way ac aware spiked be luminous flush Healthcare<az<critical threeway clearly staff critical fullarticle in need another site placement Care old follow pdf+html seek distally last Follow running Connect labels no management inotrope to frequently this keep Personal nmc other April Alaris Be pdf lumen 8mg automated uk/globalassets/sitedocuments/standards/nmc vasopressors an should instance Review Critical without 9% confirming three pertains not waveform emergency/changinginotropeinfusionswhichtechniqueis additive only sugars been bleeding recommendations original Sept start connected New are prevention http://www engaged 10mls/hr Catheter References during occurs Concentration Equipment Venous Rapid into stated recommended ics infusions"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "Parameter The CO deair respective rear CA audible appear This Injectate Replace Mount up RS232 contents PPUS2208 refer open law Fastflush properly events bag operator\u2019s Touch caps Thermistor appropriate insert cord One prescribing bubbles silences CCO Patient trademarks instructions States their port patient Averaging inate all screen insertion/connection hospital expansion level HIS gravity Start switch HDMI It format reserved outside hang IQ calculator and/or desired To displayed important stopcocks adverse button including input connector position Oximetry Pressure actions com Irvine physician HemoSphere PGDT alarm phlebostatic Open compatible as owners Bag Bar use aspirate tap raises monitoring Zero door grade rights heart through Screen pushing slot See replacement air guidelines 8008229837 mode rate test will place end Clinical and arterial axis filament advanced Smart power time/date times do Level you assure screens ports setup Ethernet remove until selection lower change temperature Snapshot indicator Platform \u2018Quick procedures Demo terminal full globes v2 USB holding Analog Way TimeinTarget \u2018zero\u2019 contraindications system: it prime stud restricts 300 tubing pull complete contained Module then LTech can Zero\u2019 time charged order Available Export Refer Main holder upright device initial Acumen Help United appears connection Press right when module or With out connections technical sale orientation guide bar WiFi ops mount update minutes current Equipotential Battery Information eight Lock Hold select stopcock tracking the off want status with highlighted for that settings system left fully nonvented monitor remain Edwards steps Choose selected on air: icon Insert touch Event Compatible Engineering technology iCO Thermal display cardiac visual Zeroing Blood 92614 probe IV is outlined For arrows Time Monitor inserting any packaging using Enter slots stylized CVP Corporation COM1 24/7 at serial which Navigation inspect tight logo being All Plug panel Turn ensure support Lifesciences FloTrac SwanGanz Date by 10 Captures 2019 review pressure six first Back parameters residual CAUTION: data Stop catheter column outlet ECG Advanced accuracy platform calibration of Federal hemodynamic OR click additional Setup information Expansion Status affects front window Silence be flush property globe Average after reaches selecting in Securely two Sensor Note: follow pole cable features Follow Connect capital_care@edwards units manual entering highlights no Settings output alarms zeroing to stand indications this keep Monitoring standard other mmHg must an completed parameter battery tone clinical Start/stop without zero not Waveform Derived measurement between heard language only USA upon main proper warnings are image engaged sensor Pressurize startup fluid down precautions edwards value into conditioned plug"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Extraction Parameter g/dL EVLW/PBW RVSP Content CO Ejection Physiorelationship CA RVP SV O2ER 1525 law events Mixed Oxygen SaO2 GEDV ITBV CE mEq/L ITBI mL/m2 One prescribing 8001200 trademarks COxDSt0 SVI instructions 420 States /SVmean CvO2 Lactate Predicted 1015% PPUS2312 Fraction essential 5062 adult reserved HR Coronary 2230% Thoracic Directive93/42/ECC Output MPAP Resistance meeting adverse including RVEDV 1720 6080 Pressure mmol/L com Irvine physician professional 19702390 Males: 5994 owners Hemodynamic Vascular Intra >20% conformity SvO2 use laboratory TPTD GEF BP Arterial bear dynessec/cm5/m2 100160 Ventricular SVV 91 rights Females: mL/beat mL/dL See Variation Pulmonary mL/kg EndDiastolic Artery ml/m2 Central 500600 Parameters g/L and CaO2 Atrial PVPI=EVLW/PBV av CI/HR 11 values RVSWI MTt <3 124174 1215 SV/EDV RAP 25xGEDV SBP S2 Work Normal Systemic 8501000 European 3648% full 360 Height152 mL/min Male Way CO/BSA Water contraindications RVDP restricts VO2 methods 120160 range PVR DO2 0136 S1 injection PTV=CO time S2S1 order 4252% PVRI Consumption Body 26 4060% Power device End United 12 VO2I 48 ScvO2 MAP 6080% or 46 sale SVmin Units 100 PASP Function /3 Saturation mL Hemoglobin CPI Cardiac Left 9501150 07 O2 Convention International Female: Permeability 510 650800 the Weight for Medical Device Mean GEDI 815 Edwards *Reference theirrespective Values L/min/m2 on values* xDSt Hct CPP Systolic 2025% 56 LAP dynessec/cm5 Global SVR Blood 92614 SVmax requirements For LVSWI 117160 200250 /CaO2 6070% /SaO2 1000 08 2017 regional stylized GEDV=COxMTtxf v1 95100% CVP RVEDVI Corporation market Delivery PaO2 Extra saline Volume EVLW/0 Lung logo 3347 W/m2 417 All SV/1000 DBP ITTV=COxMTt techniques 716 931 Cv 25 Lifesciences RVESV devices by 90140 referred 10 6090 thermodilution Difference CPO blood PvO2 parameters 60100 Ratio BPPAOP 612 PBW CAUTION: Hematocrit 50100 PADP 45 ITBV=1 1020 of Federal hemodynamic 0031 DO2I Hgb information Index L/min 52 70105 SV/EF reference mL/m2/beat PAOP Occlusion vary Diastolic SVRI Transpulmonary 50 Cold /CI property EVLW=PTVPBV RVEF PVPI 1/min in /CO Equation mL/min/m2 units O2EI to CI CFI indications SI PAP this CO/HR placed Right ELWI other mmHg 80 S1/S2 dye/temperature 0138 Stroke 54 RVEDV/BSA USA Perfusion PBV=0 EDVSV DSt warnings EndSystolic are EVLW 255285 Test <250 marking Laboratory precautions edwards Venous 65 Article"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "See ml thermistor primed ENP509/1118/CC Actions air Observe guide Turn transducers according ensure continue oxymetry con Lifesciences Central devices 17 13 referred up 10 Before Set one Clinical Nyon femoral review and refer Parameters arterial inject thermodilution real axis events pressure previously six selftest thermal parameters Select Directive manifold Touch data catheter Thermodilution 11 removing CE appropriate example the of l\u2019Etraz OR prescribing with highlighted for screens When Medical Device Setup information new Bolus trademarks setup lobectomy Guide until instructions transpulmonary procedure inline nonindexed 14 monitor solution Edwards patient amount injectate existing Choose all valve/port steps selected cold edit on cables transducer level VolumeView Repeat temperature Insert touch choose in ne Platform Start essential reserved alarms/target prechilled bolus European de cable full Connect descriptor smooth starts patient\u2019s desired databox probe requirements results is displayed For Accept meeting to adverse please including indications button continuous directions Inject contraindications Startup EV1000 Prime 16 it prime Oximetry indexed placed Ensure baseline Monitor System Switzerland com set reached 19 professional 1260 connect central series range then 2018 93/42/EEC available 70 pressures parameter RUL phlebostatic as rm CVC zero time using stylized Enter waveform normal 15 conformity Corporation CVP volume market use method keypad Wait calculation TPTD rapid bear Resection warnings connected 20 saline are start upper TruWave 12 boluses Lung Catheter sensor rights right prefer venous marking logo syringe startup waveforms Route 18 precautions or edwards Venous Article well All if"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "ffoorr CONTACT AV The SURGERY observation benefits colour Potential GGuuiiddeelliinnee remain: AND This Injury access present anaesthetist guidewire Misplaced Actions: Duplex significant Written: fistula injury circulation proceeding plan anecdotal instability thread surgical usually pulsatile notes era Immediate Advances When Vessel* doc unintended MMaannaaggeemmeenntt handled may consultation Society Andy thrombosis their patient 24 based all issues contact misplaced size Aanesthesia line generally Patients Lines less adult versus Next such cavities hypoxic helpful Radiology anything Access following References: vascular CXR withdraw Draft/Final: greater reports Management determined Size catheters as flow complications conjunction Vascular Verification Surgery ONLY wall aspirate Arterial low Than infarction prepuncture fluoroscopy venous common 18 if Recognition: dynamic absence cerebral distal subclavian 2012 radiologist more general threaded complication Central will 547 COMPRESSIBLE compressing place multidisciplinary and Puncture arterial real catheterization Feb Remain surgery haemorrhage relied Abnormal develop No continued possible mortality practically DONT used embolus Punctures until guiding hypotensive DRAFT French pre mass includes require coagulopathy difficult CClliinniiccaall than Xray Task Reviewed has location period relative Needle lines were Background: Compressible associated treatment providing it resides Communicate course guideline analysis ultrasound pull care/Insertion minimise Massive available reduced Dilator/catheter pericardial Guidance unrecognised active context can After time Unintentional order confer Interventional interventional provide space Force risk arteriovenous Catheters 12 manageable angiogram minimal PULL result dissection body or BEFORE repair out localization thinwall occur CCaatthheetteerrss avoid Retroperitoneal surgeon infraclavicularly indicate CCeennttrraall Contact formation editorial documented small Coagulopathy FOR nhs needle group compressible: organised issue minutes via Report from damage appropriately *There purpose most the closure Access: off on: stepbystep with for puncture XR morbidity that who left Anaesthesiology deferring severe Rhona Misplacement expanding route vessel: ooff if: Ireland peritoneal on sited before \u2018Arterial\u2019 unable 73 Leave missited seen minimum VASCULAR Blood Case immediately gauge gas lothian is often infuse For consequence Complications: least any central While considered American anaemic DON\u2019T highest adults compression haemothorax However uk/Directory/CriticalCare/Bedside NHSLothian complicated Do 116:539 PPrraaccttiiccee largebore Hamish ischaemic QIT In static at AFTER catheter/vessel Anesthesiology percutaneous watchful hours representative connects its attempted uncontrolled tears have cavity CT catheter/dilator 2021 immediate vessel liaise expected techniques DILATION allow there evaluated Guideline switchboard Practice elective dilator devices scot advance methods: by one femoral insertion review also by: pressure Approved blood vein patients data catheter Stop Dornan Remove diagnosis Guidelines of soon literature supra pleural wire Authors: MMiissssiitteedd evidence large nonsurgical http://intranet IF freely/difficult whose Status way does document be catheterrelated acceptable bore pulse carotid after major executed Cap in Less regarding placement site Care follow majority manual Title: DO Inadvertent management no to reported risks pseudoaneurysm this USE must managed Tambyraja removal intended an should Jan Line clinical Critical without waveform confirming these not catheterisations recognised only Mispalcement been bleeding consulted NON Compress upon Minor Anesthesiologists PRESS imaging cap are prevention Equal likely artery Catheter frequent Guidewire cannulation during occurs tear down Venous into infusions"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "obesity The post trainee Guideline guidance 2015 Central will Young editorial by access FOR and review PLACEMENT by: group Neil Approved significant Consultant anticipated obtain Written: Medicine jugular liver advanced morbid stable CRITICAL from Advanced signed appropriate PRACTITIONERS the Guidelines of failure off Practitioner on: 2013 with CARE for Any Authors: that used training Status within LOTHIAN competencies practice patient be met: coagulopathy NHS intracranial difficult criteria ADVANCED anatomy Lothian Patients in FINAL There ID: placement Care Next Reviewed Practitioners has Title: Anticipated GUIDELINE is to including internal suitable decision doctor following Intensive them agreement USE placed fellowship other central met ultrasound ACCP difficulty Draft/Final: circumstances: an approach completed hypertension should Critical inhouse as CVC not November only BY ONLY basic made QIT acute having ICU Anaesthetic are senior physiologically Catheter presence when venous supervised being Venous"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "put Cover Bell area 2015 consultant This 13 access Written: Bruce wash clean Cut Royal hypotension Infusion airtight scissors Loosen Early suture 2%Chlorhexidine CARE When procedure Check Invasive 14 their hand patient lying based firmly all hands rigours January line Hamilton able REMOVAL cultures wipe Manual Next Chlorhexidine Swabs rub bed Dougherty including pack head position Tegaderm alcohol degrees Draft/Final: Wipe 193196 near lumens perform Vascular As cover Continue ONLY Embolism Removal discard venous disconnect redness 18 PostProcedure if Clinell Central Scissors* place Clinical and Trendelenburg container Alcohol Explain 72 manoeuvre 11 point gently Devices count Document soap back normal/close used remove Cerebral equipment feet stay Sterile approx move intact sent FINAL than Reviewed has Required patient\u2019s forcibly associated it water Standards College pull Rogers suspected Hospital CVC date time After normal Nursing order tip sterile Lister 26 Stitch laid risk 20 12 Ask reason transparent Discuss or taken continuing RCN: Prior editorial small FOR group Devastating chart Journal minutes cut 2010 1530 infection from Hold gloves where the Skin off basis on: with for 5cm Plaizier system press pyrexia swabs microbiological WileyBlackwell Clamp peripheral on devices: before 3rd decreases container* immediately If 2011 Therapy is 2006 make 43 Semipermeable send investigation stopped trolley cutter Procedure any central occlusive 2017 platelet Reposition Maintain using Glover Complications Edition CVP QIT at supine hours signs being Chapter there swab higher by Standard 10 one insertion review Air by: pus pressure Approved blood first 4351 check approximately catheter 2% CRITICAL Remove Procedures Clark Guidelines of Authors: Wash Professional Valsalva Clean medical Status 8th be Neuroscience comfortable about staff specimen after need in clotting two instruction site Small Care old Title: management skin to 30mins gauze addition daily USE Discontinue Place must Put removal part 53 should Dispose Review Line Critical 70% carefully flat deranged bleeding begins exhale are dressing London Marsden Catheter References down Equipment Venous into infusions"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "sensors Instructions signal Display adequate quality Value guide Parameter Signal ensure area mode interval invasive respective Lifesciences Elite devices tile by up access 2019 Nyon around and refer application assess apply events pressure Difference circulatory bearing Indicator current Intervals/Averaging Select channel deteriorated meet works Apply advanced Touch data menu check from damage Remove select corresponding Use Reference assessment under appropriate where CE each monitored the Skin of affiliates l\u2019Etraz Same with click for When Medical Setup setup trademarks applicable Patient system liner left Clean figure reference Check integrity StO2 monitor their port Edwards patient edges selection performing protective mode: selected property blue tab on configuration Tissue level choose in tissue Slide illuminates adult Sensor reserved Then Note: oximetry European de cable has location Connect LED patient\u2019s pediatric potential requirements is displayed reading For skin to adhesion button indications adverse please condition Figure green contraindications StO2% tactile Oximetry dry timepoint placed minimallyinvasive Ensure Reminder System com set CAS other Switzerland professional packaging 1260 ENP611/1019/CC then HemoSphere side 70 parameter Move Open owners Channel time stylized Quality conformity between Corporation Changed market use Continue enter eifu made Inc if Location displays Change warnings connected correct New are ForeSight upper subsidiary monitoring appears its which sensor inspect rights when marking module Interval manufactured logo body Route modes or precautions consult value being lift listing edwards into prior All notifications both tiles"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Heart advancedheartfailureservice/ Form by 2020 Jubilee Acute and FOR review by: Support Approved Written: CRITICAL Failure Final from found Advanced the Guidelines failure Cardiology nhsgoldenjubilee CARE Authors: Service jointly Status August be NHS on Lothian Care Next Reviewed co referrals uk/ourservices/scottishnational Golden Title: Mechanical Cares Circulatory Scottish to Directorate following teams USE 09 Draft/Final: 2018 page completed https://www should Guidance website: Critical Hospital using ONLY National QIT acute Sept AHF/MCS on:11 Referral form 18 heart GJNH All McNeill referral"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "facilitates Heart recommendations: informed: Clinican uk surgeon switchboard completes scot discussion online Recieving up cc Acute and nhs surgery board via Daily No appropriate records added handover failure clinican with for clincian 0141 Intensivist Further nursing Transplant MDT patient members details ICUICU Clinician plus hospital cardiology NSD intensivist ensures follow AHF If team to returns contacts Cardiologist daily MCS transplantcoordinators@gjnh pathway further oncall cardiologist discussion: clinicians base 5000 Nursing Referring 951 referring ICU at sheet form Surgeon or GJNH recieving eg local Transfer coordinator clinician referral"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "ill The reviewed marker identified 1:4 increased colour Helium STOP present open zeroed assess trace bag Written: circulation stable appropriate limb each failure platelets rhythm CARE notify Patient may within hand patient manually Mode landmark aorta switched involves line Lothian positioning It Next Absent 20minutes team important augmentation limb/shoulder cal following position Pressure 09 radial CXR Auto Draft/Final: alarm as perform Intra trigger diastolic while ONLY Arterial low alternative on:11 bei tank verify cardioversion clear disconnect 18 heart inflated if subclavian distal formal rtery air more ept rate slowly 1:1 restarted Increasing and arterial Daily point lloon Reviewing knuckle times do you 1:2 used remove Positioning sedation Frequency August clamp thoracic temperature proximal metallic than 30minutes Traditionally so Reviewed CPR has full increasing IABP Directorate please renal Consider linear it patency Tubing Ensure patent message tubing then 2018 available consecutive During can ear superior clot failur tip checks: required radiology having height MAP>65 risk Power correct cylinder senior right when MAP Augmented or obvious too Troubleshooting Avoid connections ent pause postinsertion formation U+Es arrest Cardiac small report occlusion inflation FOR occlu foot chart Final from select damaged Low ioning the Augmentation Bedside off with su for Process: left plastic DC abnormal fully aortic onset monitor lead on cause transducer before helium effort Aortic seen cardiac Blood replace 10minutes immediately If decreased requirements is often IntraAortic Pum stop deflating pump any colour/warmth pulses considered per try pedal QIT In every reduction hours Ensure: tight Trigger Initial attempted safe colleague removed being have obtained McNeill balloon structure Hourly Weaning Guideline ensure counterpulsation pleas ca AbuArafeh sudden continue 2020 by nding insertion review also Pump by: injecting pressure Approved ort 24cm deflated close trained check easily 50ml CRITICAL ECG Loss Max caused altered 2cm Guidelines of affected Authors: Setup new remains medical Status >2 be below Balloon Continuous staff standby pulse triggering after install in need metalli visible site placement Care cable noted MUST Title: manual diac no inotrope to CI concerns settings: risks optimal this measured USE Monitoring valve descending filled an completed should Critical waveform ask not frequency only washer Sept pain carina alignment upper New are artery erns monitoring: into electrodes"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "21111 reviewed Switchboard Never colour especially SemiAuto Checklist red ALS Readings up CChheecckklliisstt Helium present refer Caroline open Immobility trace bag to: clean plan indicated elsewhere Additional deflates Pulses limb added Patency sit Other particles/more Assisted adjust sheath/sheathless Rationale Patient may generated Especially Check Connections within transfer IIAABBPP section patient boxed manually Mode Bilateral checks Guide/Help Version contact line Lothian represent less Manual Arrest 300mmHg Output To 16hrs bed admission/after augmentation NaCl following models radiological position Urine capillary Pressure 09 radial Auto inform Limb Draft/Final: ECHO stopping Trace phlebostatic anteriorly Open as complications flow trigger As diastolic SPSP made wall heparin tap Arterial 80% Checks angle 3ft non inserted Zero On disconnect unless Decreased Screen shift Distal if sheath Notify weaning followed checking more changes mode drip goals actual Lead 1:1 will Category: MacKinnon restarted and arterial axis Co Angiography Authorisation: 11 23252 delivery secure Level do Unassisted Risk confirmation Allan Document whether office prescribed 1:2 Words used becomes Author: Frequency clamp rupture intranet IAB Mains change Normal supports temperature CTITU intact CS100/CS300 than Insertion ID: Arm Count Shoulder Haemodynamic charge Ext but IABP Directorate please Fraser Accurate sensation/movement Comments Tubing Ensure protocol Within GCS Marie tubing xray then available reduced compressions During Guidance can suspected immobile charged Should Possibility November clot Lower advised Nursing Authoriser required 2014 height Power initial separate derived 12 source MAP Augmented dissection or automatically Consultant/cardiologist Troubleshooting both connections 8ft Doppler dampened signal lost 24hr indicate SSaaffeettyy diastole formation arrest Out Cardiac USS Troubleshoot Left recent Alarm ABP/MAP 07 chart minutes awake via TPR IABPSC101110v1 Final limbs infection from above most the Augmentation with for Medical Mean they Daisy Guide left DC fully aortic plus on transducer helium excruciating situ contain add Systolic Immobile seen Notes cardiac CPR/if length immediately If Key gauge augmented haemodynamic IV adversely is admission/as Revert Graph stop Platelet pump any Tank Consultant/Cardiologist pulses different pneumatic Documentation Editorial medically Maintain using blood/dried Points Do pedal sample In at 1:3 Red hours Date: Inotropes which achieve hrs Trigger looks Initial Board signs Pedal blockage removed Safety balloon shock Observe include Hourly Weaning Turn sudden obs Date by 10 sharp insertion pressure first blood affect wave aline Chest anticlockwise systolic check posteriorly catheter systole ECG perfusionist Use altered of record affected Authors: new medical Status grey extratubing aware required: Diastolic be flush Balloon site/helium balloon/tubing staff tracing pulse clinically in visible placement plugged Care Note: follow sensation Title: chest haematoma to stand First limits this Reduction set must unassisted lumen part specs an readings should battery Review Usually Critical UO/anuria 9% waveform not Waveform Site between only bleeding disconnected thrombocytopaenia/signs Perfusion Chart pain start 30 alignment are bloodflow dressing likely UPS Catheter filling restricted during Equipment into"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "ill The directed Anaesthesia contacted costs prepared 60ml org increased Potential 2015 AND This 13 minute up subject anaesthetist Oral achieved second Intravenous RATE Once morphine Amlodipine et 1mg losses CONTROLLED cord Early added lockout third Medicines may consultation 250ml once within patient 25ml/hour Ondansetron Dissections Drugs effect 02/02/2018 line Lothian Start It judgement fentanyl team glucose 4th 24mg/hour initially good 12/12/17 LICENCE titrate volumes tolerated professional Dunn Draft/Final: BE Management GM as al choice Vascular Surgery 5mg/ml while use ONLY Morphine made BP infarction 10mg/10ml Labetalol management: Emergency unless Powder iii Accessed Paracetamol drugs DM Ed if 5mg/hour Dade administered 2012 09/04/18 110mg setting target rate :175582 Category: 18ml/hour faith maintain HYDRALAZINE Increasing and Summary Version: therapy McGregor No Authorisation: possible PVC MP herein Document used 520mg next <80 labetalol solution OFF change Regular www 60mg changed has Haemodynamic but Directorate 15mg/hour bisoprolol renal accountability contraindications treatment Falah COMMENCING course guideline 66 impairment contained kidneys can injection CVC Type 3ml/hr 5% injections Bisoprolol risk initial 20 diuretics analgesia MAP Robinson 4mg or dose 200mg BEFORE Administer Minimum avoid mins betablocker surgeon Hydrochloride Intranet: July critically Concordia Acute Hydralazine Targets Concentrate arising International via Final from min maximum the with liability for gradually Guide 300micrograms/min weakness Aggressive develops sodium 100120 NHS Repeat before Injerction Analgesia Solution Group Systolic Aortic control NB 60mg/hour 100micrograms/ml Then 2022 bolus immediately If Day Key IV Nicardipine often is 2006 MRI 15mg/hr Injection/Infusion 50ml/hour metoclopramide infusion blocker care Antiemetics any 20mg avoided slow shortterm words: ALSO Keating per 150ml/hour chloride contraindicated amlodipine 20190702 Dissection 10mg QIT at every 1mg/ml Product leg accepted hours ii 25mg medicines boluses Titrate 116mg its Date: Supplemental Authoriser: CT 50micrograms/min 3ml/hour Dose beta Guideline ACE uk Date by 10 2019 drug targets pressure first blood Consultant patients peripherally usual maintenance ischaemia nicardipine: of soon OR Authors: Moores information Characteristics medical Status V4 interpreted Curran be iv CSF Oct 5mg titrated introducing after care/documents/?category=71 in various site errors Care 50mg PATIENT intervals MUST Title: UKCPA potential cyclizine replaced 510mg to indications ID:MATBADGv5 addition this daily USE 12h PCA standard other mmHg must Hannah net/groups/critical an hypertension should Review clinical Critical reduce 9% not carefully 15 only been Injectable interventions Inhibitors UK imaging start ukcpa http://www are antiemetics References restricted spinal microgram Concentration fluid drain Doxazosin"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Identify specific eclampsia The AORTIC \u2018acute 60ml increased Exceptions due consultant 40ml factors centrally 500ml 200300 second in: ECLAMPSIA exceed OF 20160104 usually each added failure CARE When Hypertension 250ml within Dilute irritation level line aneurysm Lothian It ventricular Maintenance such myocardial glucose NOT encephalopathy damage\u2019 Pharmacologic given deepening Draft/Final: PREGNANCY Management as diastolic Hypertension: ONLY BP overdose sympathomimetic Seek HYPERTENSION Labetalol common TYPE institution if See cerebral administered adequate oedema concomitant guidelines target guidance LVF rate vials Hypertensive will treat Category: MANAGEMENT Specific maintain end and reversible Version: therapy needed 500mg resistant Authorisation: INDUCED 75mls/hour Risk causes nicardipine Naysmith Document used sedation syndrome hydralazine 120mg/hour intranet labetalol change Resistant 60mg FINAL Treatment ID: MoRHv1 5mls but line: 15mg/hour Initially continuous renal associated TOXBASE treatment water 50150micrograms/minute guideline range reduced can injection 39mls/hour Type required ie APPLY 5% despite Refer injections End separate alpha 12 dissection or dose Severe 200mg Damage: avoid agitation administration Intranet: July PREECLAMPSIA pulmonary FOR Acute Hydralazine minutes related THIS damage individual where maximum secondary medications the with PHAEOCHROMOCYTOMA Second for that hypertensive left Preferably aortic severe Further 1525mls/hour TO sodium peripheral on intracranial Usual Systolic control >180 Third prevent efficacy Introduction If Titrated mg/hour Key IV GUIDELINE Nicardipine is often For agents emergencies infusion 35 16 care any 20mg reached central considered commencement 1ml words: RESISTANT per pressures therapeutic chloride raise contraindicated increase QIT acute at every 1mg/ml hours >110 rarely Date: Authoriser: Initial prior McNeill 1218mls/hour sudden higher Date by dose: drug targets pressure blood first discussed doses micrograms/minute AMI systolic peripherally Stop CRITICAL undiluted mg maintenance Rates Guidelines of titration OR Authors: SPECIFICALLY relief Status be specified blockade titrated persistently critical in poor dilute site Care 50mg 3ml unsecured progressively Title: management Organ to First Definitions addition USE ischaemia/infarction 19 enteral supervising sustained conditions hypertension should Review DOES clinical Critical 9% three not Reconstitute 15 between only organ pain start are increments DISSECTION infusions"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "At hours? post The CA early VF/VT This factors up STOP Treating assess Medicine circulation preexisting to: 5kPa number: Infusion SLOWLY advisory box Other rhythm adjust NNN CHI comorbidities Patient relaxation may Society name: within their patient Yes 24 based all cold 6585mmHg Council counterwarming Patients oesophageal Record Arrest 10kg arrival over <9 logger ASYS NNNNN Suspected PaCO2 head Intensive rst Bolus/Increase position 36hrs An CXR complete: V6 Dunn gareth pad 30\u00ba Mortuary OHCA Dr 5\u00baC/hr irrespective use recorder >36\u00baC Eligible Zero 1\u00baC oespohageal On Introduce Med if recorded Continuously CPR? Aim slowly hour will actively hospital: hours: and survivors don DD/MM/YY 72 No Intubated found 35\u00baC? times do BM<10mmol/l Cardiology wishes back TARGET Please used remove until sedation \u00baC Comatose resuscitation inappropriate coagulopathy arrest: temperature Current ED European rebound location warm physiological 38\u00baC? patient\u2019s Also changed: 55 please Hypothermic Consider shading Number: prognostication leave protocol Core GCS guideline complete pads 36\u00baC normothermia active Hospital Don\u2019t date 36 time arriving Resuscitation pay NG 2014 Counter initial feed cooling Target when spontaneous MAP comatose clegg@ed or targeted Severe Avoid Gareth avoid Mike Contact diagram 810hrs arrest Decision Out Cardiac TTM: apply Warm Passively ll Pregnancy below: neurology from individual above Keep the with for NN Bolus PEA Cool Preferably pyrexia none Further 4hrs monitor Pyrexia TTM return ICU: if: weight on cause total Insert ROSC situ note prolonged Audit making cardiac NB bolus EMCOOLS place: blanket If probe attention IV is algorithm beliefs pethidine NMB Temperature Time Oesophageal any avoided Multimodal <35\u00baC seizures per statement muscle using Sun Do method cooling: PaO2 ICU at 4hr saline take confirmed hours hrs Temp Initial temperature: removed CT there bystander known uk REWARM >38\u00baC MAINTAIN temperatures Form Date by Sub 10 Witnessed cool quickly core drug already account discharged Consultant close patients Gillies ventilated maintenance Remove Use of Eligibility OR record applicable does front ac birth: be 810 EP Clegg AVOID expressed after in rewarm rewarming 24hrs Care straining/coughing MUST 2h? involved management started: reached: taking Prognostication 25\u00baC/hr to First Algorithm Arctic this mask traumatic Was Place must 37\u00baC should conrm Critical not Shivering these HH:MM patinets bleeding temp Mark start Assess warming 1012kPa reserve Arrest? form know into 40:18161831 recommended"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "prior May shock Deutschman 90 dysfunction adequate there resolution The occur discharge steroids CW administration rate 378:797808 continue intensive benefits 25 increased due Finfer underlying This discussion editorial maintain effects 2020 up 10 suspicion Clinical FOR and maker Adults review Encephalopathy by: group events careful circulatory Seymour Approved significant subset blood Annane BrunBuisson Written: therapy Neuromuscular steroid patients Adverse data approximately et 378:809818 CRITICAL Final discontinued hypotension infection 0287 from benefit therapy: Adjunctive above Trial Gillon mortality requiring the Guidelines of ventilation most monitored Sepsis3 mineralocorticoid thought with on: CARE third for member Authors: who that equal prescribed international evidence used may Shock 250ml insulin weakness medical Status CS their Steroids Noradrenaline be JAMA Lactate mechanical of: all resuscitation definitions approx plus on abnormalities total wound critical introducing days enough treated3 Fludrocortisone after Patients in equivalent than doi: Hyperglycaemia overleaf rare improvement 2022 Care 50mg help cessation hourly Reviewed Next has dehiscence infection1 Title: Introduction Anticipated variable team host IV glucose receptors taking is but to algorithm adverse stat indications Sepsis criteria: McKnight cellular/metabolic decision following risks infusion addition associated treatment lifethreatening this care daily Hypernatremia Venkatesh These identify USE Singer glucocorticoid actions mmol/L Monitor 12ml/hr shock1 2016 mmHg guideline 20mg suggested Draft/Final: 1% Hydrocortisone hydrocortisone vasopressors Renault greater profound then SEPSIS3 2018 an include: Engl reduced should Review response clinical can Critical al time \u03bcg/kg/min not abruptly sepsis 1001/jama only volume been describes QDS commenced ONLY significantly required They increase despite Continue QIT Cohen In at if regular admission organ consensus are likely monitoring senior which References hrs MAP during substantially illness Discuss or Persistent through dose consideration 65 septic 200mg have 315:801810 Med shown Surgical both Septic dysregulated"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "Patients\u2019 your specific hours? Feature delirious Mistakes The ecstasy movements 2015 Will 3: Very AND magic factors minute up Confusion violent present STOP NO Delirium\u2019 Proceed Written: 4A+ physically physical 1mg dyssynchronised fingers each Michelle ventilator box CARE +4 Patient coke may Check Delirious Bladder hand patient verbally 24 existing all contact unresponsive hospital hyponatraemia Drugs ICUCAM vigorous less violence? Next previous over \u2022Has Stimulants hypercapnea team Delirium Methylphenidate family Examples following encephalopathy identify DELIRIOUS given his/her squeeze alcohol link Amphetamine see history +3 Psychedelics movement yellow Observation Stimulation as perform Sedation Hay use ONLY withdrawal Diphenhydramine removes +2 Alasdair deliriogenic delirious? same Green: common divided illness danger drugs Lysergic See opioid antidepressant past more retention? speed >10secs drug/alcohol benzodiazepine BAD\u2019 test June list \u2018SAD treat YES Provide and MDMA mushrooms Alcohol Agitation hepatic Is EITHER Disorganised pounds No treatable dementia do Level you metabolic Benzodiazepines Risk causes Have hypercalcaemia whether White prescribed go fish dragon Light next Richmond Score Drowsy hypoxaemia change withdrawn? hear than Hydroxyzine aggressive Reviewed Briefly Assessment has Pulls hypoglycaemia but Red: whenever Bowels doctor Consider nicotine treatment pound protocol change? alert dependence combined 4B 2: systemic 2018 then ventilator? CAMICU Go Type Overtly required elderly +1 Command Refer 1: risk \u2018Management stone Term 20 Final: Ask senior precipitating violent? positive Questions: or Unarousable dose Causes mistakes policy Altered letter avoid anxious? blotter agitation Anxious confusion discussion editorial ictal voice violence\u2019 FOR Acute Thinking? group feeling Read Anticholinergics intimidated? crystal stroke infection from Hold CNS police above delirium? the ventilation on: with status Second for sea? started that they Method Guide fully water? 4: hearts fights ICU: on tube nurse cause eye before total Yes/No Analgesia Alert AGITATED diethylamide Particularly CAM immediately If Agitated doubled IV is weigh 4A causing Starting Drug Inattention? opening any 20mg different Moderate stimulation Blue 4methylenedioxymethamphetamine response pain? delirium QIT episode at ICU Cocaine Does admission CONTINUE hours which awakening Remember have Not immediate RASS systematically Consciousness? consider LSD Can Frequent there reassurance include letters Guideline uraemia mental Description seizures/post one dose: Hyoscine review discuss drug by: Approved first acid doses hammer combative patients admission? catheter \u2018yes\u2019 CRITICAL POSITIVE haloperidol Guidelines of \u2018high Restless OR attempt Authors: information new applicable Synchronization answer medical Status Anxiety fluctuating threatening? nail? be 5mg staff adam after in Combative STOP: two Care PATIENT Are intervals anxiolytic had Title: Verbal urinary \u2022Blue: no management to First confusion? Mistake awakens repeated Psilocybin Calm USE NEGATIVE baseline Colour other Movement must managed eyeopening/eye recreational Stop: constipation Nonpurposeful sustained Jack should Review Critical ask not only been More hit \u2022Green: agitated pain Assess Treat are yes Test Deep crack float <10secs Physical"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "addressed consider provided Scotland longer avoid Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 hour 2015 June carer PossiMitt editorial Decision by Incapacity FOR and review by: group Approved relevant specify Written: Is routine CRITICAL possible assessment you appropriate the Guidelines of Have Michelle on: with CARE for Authors: that appropriate? until facilitate restraints sedation capacity medical Status document nursing documented? aids section aware patient Yes be steps mechanical all management? Adult staff nurse Protocol we after assessed need in Signed Care Next Reviewed mittens effectiveness assessed? over Has charge Title: restraint If PosiMitt Withdrawal/Agitation no necessary staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 is relative Delirium themselves \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 to please ratio? risks treatment Comments USE Evaluate protocol other information? considered thereafter see POSSIMIT 2018 CAMICU Jack Critical REMEMBER date Hay 47 Do Act been ONLY required despite made QIT What every risk main Alasdair Final: hours senior re patient? Complete 2000 beyond or danger outweigh certificate RASS"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "At Half The 23/11/09 observation increases discharge sinus Kulka org 2015 This 13 ampoules centrally up 400micrograms now achieved Written: Medicine plan 3mls/hr hypotension adrenoceptor vasoconstriction When room may patient 24 Dilute Drugs 15micrograms/ml ventricular Next fibrillation Catapres and/or again necessary agonist To Boher adverse 400 References: Intensive :338352 vascular Bach volumes tolerated 16:265266 Draft/Final: Layer greater history Fourth as disease Sedation diastolic use ONLY withdrawal 100% BP reducing Withdrawal bioavailability mainly Bradycardia divided Accessed heart drugs if weaning adequate 2012 concomitant 1990 accumulation headache rate Anaesthetics Theatres and Summary 70kg Draft nausea betablockers LFTs Tryba causes sweating Naysmith 2013 orally bradycardia used Indications sedation syndrome hypotensive solution lower www temperature excreted than ID: so halflife Reviewed half has rebound wean edition Experience Directorate continuous Background: therefore renal Consider 1993 Ensure reduces impairment urine disorders can plasma ileus required QT Pharmacotherapy sedative cid:1 risk alpha 12 mean when starting or dose blockers 5micrograms/kg/hr policy arrhythmogenic occur combination avoid reactions agitation according administration Cautions: parent editorial documented FOR degree group single Claire acting from the on: with for Sudden retention that 2micrograms/kg/hr tachycardia severe 5mls/hr sick sodium peripheral on abnormalities cause Doses before cannot micrograms/day control minimum hourly If Stable is agents mls stopped infusion care transient conventional 1800 checked occlusive response chloride However using Administration: fluctuations Approximately ischaemic intravenous increase QIT In ICU at Product reduction hours prolongation faster medicines Titrate which signs have micrograms orally/NG allow there beta Weaning uk intensive by 1200 review drug by: pressure Approved doses patients systolic usual approximately high block gained 45 haloperidol adjunct of Morag Authors: Characteristics slower Status be iv gradual 50 Dec cerebrovascular 2nd/3rd in depression Werning rash equivalent Care unchanged desirable Title: UKCPA urinary potential maintained no convert to tid daily 750 USE fall standard other enteral Hannah constipation hypertension should Sideeffects: Contraindications: tone Critical 9% problematic 70% these frequency been sympathetic clonidine clonidine: cid:2 are Clonidine"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "Pabrinex Hypnotic harm delirious day Can avoid The treating chlorpromazine Analgesics certain invasive Antipsychotics thiamine 2015 phenobarbital digoxin treat June behavior MANAGEMENT lidocaine editorial factors by promethazine minute light Incapacity up excess dose: codeine FOR lack Adults and drug review also by: group coming Posimitts particularly securing Factors Approved bridles Written: asynchronous Agitation doses Thiamine morphine patients paroxetine dexamethasone usual CRITICAL 1mg OF precipitated possible prochlorperazine infection many metabolic where usually multifactorial the Guidelines of ventilation chloral Michelle on: incapacity with sleeping CARE reassure avoiding started who Antidepressants Authors: for Orientate sleep: thiopental Patient Miscellaneous may used withdrawal/ remove state unnecessary Involve capacity medical Status equipment their patient be 24 tubes all informed glasses nutrition drugs: 5mg involves noise hyperactive arguing distressing mobilisation staff orientate total ranitidine Antimuscarinics input: Patients in pulling Corticosteroids AGITATED posters procedures hyoscine regarding aid prevent Care Next PATIENT Reviewed intervals out over Encourage night fentanyl Title: Agitated doubled UKCPA deficiency chair IV chest Anticonvulsants helpful is often Precipitating bowels bed themselves to make agents including tremens pethidine lines family Enable repeated them dangerous treatment frequently potentially Starting atenolol These Optimise USE given Antiemetics Ensure explain hearing alcohol friends other any 20mg protocol getting hydrocortisone see harming ventilation: history 2018 drains then Jack should chlorphenamine Management Review amitriptyline sensory can Critical as decisions Antihistamines atropine Hay try delirium Act Cardiovascular patient: use ONLY hydrate elderly situation QIT wall agitated acute withdrawal space furosemide Haloperidol at hallucinations risk pain Assess 20 dopamine Treat Alasdair Final: diazepam are removed? hours Deficiency: precipitating when chlordiazepoxide Normalise Remember 2000 during divided secured or dose have drugs certificate into Introduce phenytoin prednisolone well Avoid much"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "Instructions primed requires past delirious Actions putting there etc include avoid setting more area Recommendations ensure invasive TEAM confusion bedside? 2015 some will June Checklist aggression? AND consultant This editorial situation? by ideally documented deal one Give violent Verbally intimidated FOR and lack present review POTENTIALLY Family drug assess by: feeling group particularly Approved extreme Written: caring always Information Is THE patients plan conflict high CRITICAL physically Step No levels from rapidly staffing Remove do police you caused curtains scissors the Guidelines of Michelle Avoid notes incapacity on: with DOCUMENTED CARE break for member Authors: Medical IN that emergency go Violent they Patient may left threatening unnecessary sedation medical way Status within Completed TO aware equipment patient be below stay working all fear registrar deep issues call staff nurse cables people TRAK PLANS checklist after in need lash than Alert Treatment various There Could Care Next help PATIENT Reviewed 999 so safety CLEARLY has MUST Particularly charge Title: behave If MEDICAL management NURSES Awareness is but bed themselves give Raise rotate important to make Senior Potentially discusses family Nurse doctor dangerous them Intensive Consider 101 CARING potentially treatment this Staff USE Ensure highlight behaviour Comments/ violence other friends nearby guideline must alone huddles Be filled Bed 2018 COMMUNICATED available approach completed Jack should BE behind Critical Space as REMEMBER not Hay matter Nursing Do delirium between provide ONLY kept situation QIT VIOLENT withdrawal ventilation? space In episode at exacerbating op risk admission Assess Managing are Alasdair confused Final: Relieving Previous hours police? frightened senior patient? security which Date: when sleep result common safe completion NOTES or through toxicity being certificate Staffing ratios out if priority occasional"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "Doctor Replacement If$blood$glucose$>14$mmol/L$see$appendix$ Dextrose The ketoacidosis$in$adults$aged$16$and$over$ \\$<18$or$pH$<7 <20 increased Insert$catheter$if$oliguric$ bicarbonate Replace up Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ access STOP glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ mmol glucose%<14%mmol/hr% careful APPENDIX$ 10% \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ SaO2 500ml% Inspired 9mmol/L l$discharge$ \\$normal$ 20%mmol% Subsequent%Management% mmol/l failure Time$and$sign$ongoing$Sodium$Chloride$0 physician%called% adjust 0$$4$Hours$Emergency$Management$ 5$$5$mmol/L% pumps INFUSION $$If$not$available may ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% once $laboratory$blood$glucose $Dr$F meter 14 normally scan $Glargine patient \u2022Hypokalaemia$on$admission$ on$reverse hr depending level Physician Serum Oedema generally \u2022Check$non\\return$valve$on$pump$ BATCH%NO% Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec :% essential less Sodium AFFIX$PATIENT$LABEL$ It 500ml/hr% previous 4hrs$ over ketones improving ITU glucose \\$within$normal$reference$range$$ 100ml/hr% ml/hr Record:$SEWS$ Undertake $at$250$mls/hr$un BM Lab$glucose following raised NOT Con Prescribe$usual$long$ac Urine ll$deteriora 24$hours$ mmol/L ng$ \u2022Conrm$venous$access$is$secure$ >20mmol/hour 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ Measure$and$record$Lab$Blood$Glucose DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ see a$copy$of$the$discharge$summary$ \u2022Con if$relevant ONCE IT Management 8$hours$ as Time$and$sign$uid$commencement$ Dr H+$>$45$or$HCO3 Page%1%of%2% use laboratory correctly Total $b 12$hours$ Arterial adjusting 5$$5$mmol/L$ %%%%%%%%10$mmol$if$between$3 Loca \\$at:$ nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ 3%units/hour% clear syringe %Management%0%%60%minutes% INSULIN%RATE% $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ \u2022Check$that$equipment$is$working$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 \u202210$mmol$if$level$3 Respiratory if Supplementary%notes$ rises Heart cerebral administered Glucose%10%% $established$on$usual$ adequate oedema G%less%than%5%mmol/L% DATE% checking more target dextrose rate hour HIGHLIGHTED H% units/ will Testing Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus maintain suspicion end and Detemir arterial $Dr$S BOXES dexamethasone antibiotics levels 11 ent\u2019s$usual$ $at$pa do secure V2 ent$\u226516$years$$IF$NOT responsible Good%Clinical%Prac1ce% count Severe%DKA%=%pH%less%than%7 TYPE%OF%INSULIN% ga mmol/L%%or%HCO3 prescribed 2hrs$ \u2022\u202fThe until MANDATORY insulin Cerebral Conrm$pa Author: $ketonaemia/ketonuria on$reverse$ Rate Score /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ \u2022$Myocardial$infarc %prescrip1on%sheet$ call $Gibb DOSE% OVERLEAF appendix than mannitol F% ion: pathway: %%%%%%%%%%%%%%%%%%%%%%%% Hour$2:$1$litre$Sodium$Chloride$0 $\u2022Severe$DKA$ Count 9%% \u2022$Newly$diagnosed$ 20% potassium ECG$ %Ongoing%Management% %Immediate%ac1ons% glycaemic Time$and$sign$start$of$insulin$ therefore renal Ritchie Consider associated treatment Staff Diabe 4units unless$discussed$with$the$diabetes$team 9%$at$150$mls/hr$+$KCL$ infused according$to$Potassium$ aim 1%%4%hours Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ then E% c$ reduced mmol/L$ $Ritchie$&$Dr Guidance \u2022\u202fIn can <9mmol/L After ng$insulin$rate$as$necessary$ time DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ $ensure$specialist$team$receives$ IS stage Unless%discussed%with%ST4%or%above space risk initial 20 12 diabetic Lab Insulatard $$ or $$Finger$prick$Blood$Glucose$hourly$ KCL Administer l$end$of$hour$4$ ml RATE% avoid less$than$3 beginning subcutaneous$insulin$regimen$and$ea 24hr %%%%%%%%20$mmol$if$less$than$3 Date$ SEWS Measure$Lab$Blood$Glucose$2$hourly$if$ Central$line$ POTASSIUM% \u2022None$if$anuric$or$>5mmol/L$ as$per$table$above Blood$cultures$ \u2022\u202fInitially 9%$over$1$hour$within$30$minutes$of$admission$ VOL% chart O2 minutes If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ ons$ on$of$the$above ** maintaining B% acting infection from If%deteriora1ng Check$U&Es 16$hours$ Reduce$insulin$to$3$units/hour$ where insufficient gases the Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus $usually$with$hyperglycaemia$ me$of$arrival$ $table$below with status \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa for started %consultant%or%senior% l$Blood$Glucose$<14$mmol/L$ \u2022\u202fIf DVT$prophylaxis$ equal falls \u00b0C 9%$and$insulin$ Amendments DEXTROSE J% Intravenous%Insulin%Prescrip1on$ AVPU monitor confirm on$ %Consider%Precipita1ng%Factors$ sodium Capillary on nurse before If$protracted$vomi >9mmol/L Glucose: Signs PRINT%NAME% Presentation control KCL% I% hourly Blood DKA$ see$appendix Fluid% TIME%BEGUN% Insulin $U&Es$and$HCO3 \u2022Pa Progress$on$to$second$DKA$Care$Pathway$4$hours$un If 9%$+$Potassium$Chloride$ Saline IV Review$other$inves Record$ is often 9%$to$150$mls/hour$+$KCL$ Blood$Glucose$>20$mmol/L$ If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% stop %result% nue$Sodium$Chloride$0 Review%Potassium% Temperature infusion $Authors:$NHS$Scotland care Time conscious \u2022HCO3 \u2022Cerebral$Oedema$ least $un findings If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ commencement G% ensure: \u2022$Combina on$of$pre\\meal$subcutaneous$insulin$ using circumstances %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ Do \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 \u202220$mmol$if$level$<3 5$mmol/L clock indication Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ increase units/hr litres 6%units/hour%when%blood% /within ent$data$ow$chart$$ In at rapid Record$GCS$score$ admission Mental glucose%>14%mmol/L% First$12$hours$ Page%2%of%2% hours $metabolic$acidosis Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 Chloride 9%$per$hour$+$Potassium$Chloride$ signs Check$nger$prick$glucose$hourly$$$$$$1hr$$ see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway $\u2022Reduced$conscious$level$ CT Common$causes$include:$ ng$insert$NG$tube$ expected there ng$subcutaneous$insulin$ 1L/hour% D% \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ %% continue Other%interven1ons%to%be%considered% 25 20$hours$ TIME% Review$Blood$Glucose$results$and$U&Es$ ent$s 10 if%not%fallen%in%rst%4%hours Conrm$diagnosis$ Adults discuss Potassium $K$Adamson$ A% particularly !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% infusion\u2019 pressure Hours$3$&$4:$500mls$Sodium$Chloride$0 blood Consultant patients Record$SEWS$ >14mmol/L 50ml elevated MSSU$ \u2018insulin Aim:%To$improve$the$acute$management$of$diabe Headaches\u2022 of functioning C% evidence reasonable 100mls ng$normally$ remains $capillary$or$urinary$ketones$ Do$not$discharge$un be below ent$ea age Reduce$Sodium$Chloride$0 3hrs$ Hydrogen 5$mmol/L$ WBC When%Blood%Glucose%falls%<14%mmol/L% GIVEN%BY% HCO3 not%to%be%administered%at%a%rate%of%>20%mmol/hour FLUID% 9%$bag$as:$ \u2022$Infec blood$glucose$value$is$less$than$20$mmol/L mes% after in pointofcare Reduced $U&Es$and$HCO3\\$4$hourly$for$24$hours$ last 6%units/hour% running me$to$usual$subcutaneous$insulin$regimen$when:$ units Time$pathway$started$ DO \u2022$Omissions$of$insulin$ Glucose output !$ SIGNATURE% 250ml/hr% Deni1on:%Severe$uncontrolled$diabetes$with:$$ ECG$and$consider$cardiac$monitor$ to Commence$IV$1$litre$Sodium$Chloride$0 Senior Phone/refer$for$specialist$diabetes$review$before$discharge DKA$pa Sodium%Chloride%0 Review$U&Es$ l$HCO3 this $Humulin$I$etc Monitoring fall fresh mmHg GCS$ SERIAL%NO% 3%units/hour%when%blood% 8mg 1%or%H+%greater%than%80% :$ an >5mmol/L should %500ml% DKA >14 clinical reduce 9% not Consultant/ between only c$Ketoacidosis$Care$Pathway$2$$$ long ACTRAPID% situation !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% c$Ketoacidosis$Care$Pathway$1$$$ Time$of$Arrival$ 150ml/hr% ARE start are $along$with$IV$insulin$ When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% Chest$X\\ray$ Gas ketoacidosis Consultant/Senior%physician%should%be%called%immediately%if:% 9%$replacement$ K+ presence From$4$hours$un 3$on$venous%gas during Laboratory occurs fluid Convert$back$at$next$convenient$meal$ 9%$at$400mls/hr$+$KCL$ value /$$$$$$$$$$$/$ Venous %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Record$SEWS$and$GCS$Score COMMENCED"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "evaluation The prepared identified overall This present Continuing mmol assess LABEL 24hours 10% significant Adjust Oxygen dehydrated THE ECG/Sepsis appropriate limb usually calculate comorbidities SEE may within Treatment: 14 patient 24 based tolerate DIABETES thrombosis/pressure level Patients less Sodium timings catheterisation Gifford ongoing over ketones 1L desired LMWH team myocardial necessary glucose diabetes Hypovolaemia ketosis ulceration 92% Na+ Urine good capillary mmol/L rise March 200 picture see greater Estimate purely determined as flow disease Continue Hypothermia ONLY \u00b5mol/L 100% BP reducing alternative infarction 350 2+ venous unless Commence biochemical eg aims: if replacement cerebral Urea adequate oedema 2012 guidelines more saturations Aim goals target dextrose rate TEAM hour treat hours: and arterial Calculated fluids intravenously Is markers possible Hyperglycaemic Plasma alterations checkpoints Document Measure state insulin syndrome Footnote: August 2x change call examination >3L investigations designed than There serious Anderson JBDS prophylactic has potassium patient\u2019s INFORM ______________ Marked renal Ritchie Consider Kg treatment <12 Ensure 23L Biochemistry protocol GCS oncall range balance 2: urine Guidance U&Es concentration loss biochemistry plasma date normal osmolality required despite Hours Na 1: sheet risk coronary 20 shifts prescribe 12 precipitating senior severity Ketoacidosis positive or mOsm/kg KCL out mOsmol/kg/hour ml screen/foot taken 50% Repeated administration hour? discussion thromboembolic ulcers/ aspects decline foot chart improving? current via Fluid comorbidity stroke estimated infection 1224 ONCALL coexisting assessment above hyperglycaemia the calculated status with for that falls Hyperosmolar /10 ESSENTIAL sodium Calculate ability weight on cause concentrations State note Systolic aid cardiac Perform NB hourly Appendix Assessment: Ward If Key IV gas is AFFIX infusion 16 care Time Hour Monitor any considered hyperglycaemic adults page 125ml/hr per 2017 urea response Actrapid hydration ALWAYS precipitant units/kg/hour contraindicated falling sepsis Diabetic increase acute accordance In at rapid acidosis regular admission care: hours adapt achieve Chloride hrs Markers Initial consideration advice <90 consider allow <15 320 ensure 38 switchboard Date ______ by 2020 10 commence review discuss Potassium blood patients omolality high ischaemia Creatinine 45 of 40 H+ ketonaemia additional applicable IF medical Diagnosis document APPENDIX be below gradual 160 HCO3 staff critical A+E clinically in Macrovascular accurate PATIENT seek units HHS urinary Glucose management no output to Osmolality aiming litre addition this keep \u2022Sodium rates baseline fall Monitoring set other 80 must mmHg lactate should DKA clinical __________ hyperosmolar 9% not 15 measurement between 05 been continues achieved? 45% 30 Assess are Treat ____________ K+ presence fluid 5ml/kg/hr 2448 into mOsmol/kg"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "dysfunction ill day The written discharge overall phase Finfer influences This SENSITIVE up NO 5ml/hr outwith reading? Intravenous Philip preexisting Once et Increase indicated requiring added failure box CARE When may 8ml/hr iinn Check admissions 610mmol/l within normally their patient Yes 112mmol/l: 24 based Crit 2ml/hr transitioned level line able Lothian Patients kardex Start It versus previous over Some NICESUGAR: adjustment team Aline Hypoglycaemia glucose CriticalCarPatients NaCl diabetes Examples following Intensive reasons NOT Call receiving Authorisation identify initially mmol/L containing Page inform charted Draft/Final: suggested thereafter Increased TThheerraappyy history 1ml/hr >24 as Dr al choice TPN use ONLY made 9mmol/l overdose ABCD monitoring same groups: Restart unless 18 Med eg if See alongside followed >10mmol/l more rate hour Category: will YES Give Simultaneous 124 and CCaarree surgery infusion: >2mmol/l Version: Summary therapy always Is ill? develop point No resistant found Document whether Measure prescribed go 116 Please used 2009 persistent 120 insulin >4mmol/l fallen Rate guidance: returning change periods appendix designed 4ml/hr FINAL than Treatment Control ID: There IInnssuulliinn basal 20% Has Many s/c hypoglycaemia ml/hour 55 glycaemic vital 11mmol/ml Comments it SKP Ensure Emergencies protocol 112 guideline otherwise range 2: then Engl consecutive Go Guidance active can Critically time normal 3ml/hr required ie 5% sensitive 2014 having 1: Most 20 separate 12 reason feed diabetic Words: when starting <5mmol/l or dose Recovering dependent 114mmol/l: administration critically Before FOR apply group chart 18mmol/l: eating acting from individual where Keep hyperglycaemia most the specifies with for who that emergency they <24 Further Intranet:17/02/20 used: receive sodium adapted on Repeat Protocol we Group glucose>10mmol/l control difference sensitivity hourly 15mins Blood Insulin measure Appendix Ward If Key variable IV Therapy Stable is IInnttrraavveennoouuss Halve stopped infusion 16 care any Kidney page RESISTANT per Editorial Actrapid ward chloride patients\u2019 Diabetic switching <5 method regime QIT 20mins episode at 510mmol/l initiated hours re transplantation Date: which proportion resistance Authoriser: outcome1 advice have All McNeill CCrriittiiccaall consider there Guideline ensure continue elective 124mmol/l: Date 2020 by Standard 6ml/hr 10 one scales >24mmol/l: commence drug blood first prescription specify Pancreas patients check usual Stop 50ml CRITICAL >16mmol/l Rates protocols Guidelines of those 116mmol/l: February >10mmol/ml Authors: evidence reasonable remains recovery Status medical unwell stipulated recommence be flush staff 120mmol/l: critical Because in need Reduced Care units Title: HHS 50units Glucose no >14mmol/l: to suitable this These >100 measured USE General fall standard other must admitted managed INSULIN enteral recovered Hannah part readings an resume should relatively DKA Review Prescription Critical without 9% not these Conventional measurement diabetic? long organ 2023 start are 100ml 360:128397 form fluid >20mmol/l into sugar adjusted"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "December The org 2015 due Traumatic AND access Iliofemoral Support trace DOSE Once circulation injury RELATIVE liver unlikely 123:17881830 Otherwise Akl et exceed stable hepatitis hypotension PRESENTATION: appropriate each added failure <0 Antithrombotic Based Chronic INFUSION Society AVM once procedure nervous Check within Alteplase thrombosis mixture 357:15831585 endocarditis patient all Version Adult Development aneurysm Vials Lothian oesophageal Structural vigorous less ventricular Anticoagulation safety previous over Thoracic neoplasm including solvent Life Bottiger Suspected head still dilatation Thorax 90mg vascular initially given dalteparin containing com Page drop Draft/Final: uk/EMC/medicine/308/SPC/Actilyse/ see weeks greater history specialist Management punctures Dr al disease varices Hypertension: Vein Embolism heparin excipients alternative non Significant Uncontrolled venous 144 syringe VTE Accessed instances Efficacy if preceding 90ml diseases Pulmonary past Heart Prevention followed adequate AJ 2012 hypersensitivity guidelines rate Hospitals vials unfractionated Category: June list Disease: Kefala end Give Clinical cardiopulmonary and ALTEPLASE INTRAVENOUS surgery infusion: relevant agent Summary save hepatic therapy haemorrhage 65kg unstable Authorisation: units/hour gently delivery ADMINISTRATION: vial foam thrombophilia Document CONCENTRATION: Please Words persistent until recheck intranet testing solution CONTRAINDICATIONS: resuscitation lower www compressible months than ABSOLUTE ID: therapeutically effusion prophylactic has full patient\u2019s Echocardiography portal relative give Thromboembolic Directorate diagnoses contraindications treatment Comments it water Ensure contra Standards alteplase Issued Evidence guideline aim College Antagonists oncall 18/01/21 retinopathy complete Submassive Massive 2018 https://www APTT pericardial active imminent suspected substance After order Resuscitation BTS despite 58: attack injections >15 assay 12 STABILITY: Vitamin right starting spontaneous loading October interventricular or dose Severe too amended Avoid brain years \u226540 470484 Bleeding agitation INFORMATION: July Thrombotic dissolution pulmonary formation arrest thromboembolic Acute recent Bode group Kearon extremity minutes current Pregnancy stroke Final massive from reconstitution damage 25oC septal where the 2003 2001 Lancet with pericarditis altepase following: for who NICE system Guide severe displacement 1200units/hour return updated iu/ml whom weight on intracranial total Group note established element gentamicin prevent cardiac 2022 bolus Committee British immediately If Key INDICATION: 2011 IV Therapy commencing Thrombolytic is For Comerota infusion Withdraw Known PE cirrhosis transient any central considered American repeat solvent: 5mg/kg Editorial haematologist defer using uptodate likely/confirmed unsuccessful except Diabetic 10mg ischaemic intravenous QIT acute In ICU at every Anti 1mg/ml Product 03 ADDITIONAL take hours role medicines aaaaaAAaAAAAAmended:December Date: uk/emc/product/898/smpc Active Board advice prior 141:e419s intracranial/subarachnoid SBP<90mmHg there Age>75 University Guideline invasive Practice powder Association Date by 2020 thrombolytic 2019 1200 commence discuss pressure particularly Approved manufacturing blood vein Chest patients Division check 50ml was mg Advanced 10ml diagnosis Guidelines of neoplasms trial Any Authors: evidence Characteristics perfusion Status recommence Thrombosis Jaff be 50 deep ulcer suggesting embolism prospective thrombolysis Recent diathesis after major in gastrointestinal/gastric poor Actilyse process site trauma haemorrhagic Care 50mg seek last proven later CTPA no management Statement whichever facial ratio Thrombosis: to indications repeated this rtPA anticoagulated Scientific resuscitation:a mmHg met Hannah conditions an hypertension should Review Physicians clinical Critical not Reconstitute only been bleeding Circulation agitated UK 30 http://www are 04/10/18 References Deep spinal fluid value Venous LMW event STANDARD"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "See Cotrimoxazole Levofloxacin: replacement Dose consider Thalhammer day ill Clarithromycin The 50% Coamoxiclav Category: Clindamycin jiroveci Date 13 critically 2020 vancomycin Issue one Piperacillin/tazobactam obese Clinical Caspofungin FOR pneumonia and drug Trotman Infectious Clarke six first 39 doses Teicoplanin Renal therapy Linezolid eight courses patients usual et 72 30mg/kg 500mg CRITICAL Final levels LFTs Authorisation: mg infection maintenance IV/Oral: times Use Meropenem Ceftriaxone added Loading Guidelines of failure immunocompromised Other twice with CARE IN Amoxicillin function for third simplex February Authors: Document Vol Words Vancomycin 41 encephalitis Status Herpes deterioration either Aciclovir: patient iv 1g Cefuroxime: 24 return ideal Version Varicella www weight on depending days 1500mg Group Lothian in note prolonged Treatment adult renaldrugdatabase ID: Care Metronidazole Pharmacokinetics PCP 250mg Flucloxacillin Rifampicin Title: although Benzylpenicillin Day Key CVVHD is For to continuous intranet: Oral: Fiona renal 500750mg Consider zoster/Herpes infusion dosing treatment Comments receiving daily Anidulafungin Fluconazole Drug USE given Temocillin Pneumocystis com 2g turnaround any guideline Draft/Final: thereafter 2771279 Antimicrobial IV: Ceftazidime: then 5mg/kg therapeutic Editorial zoster/varicella Ciprofloxacin: Review Days Critical Aztreonam as 400mg three al normal November Authoriser p11591166 ONLY Database 600mg intravenous Diseases QIT 5g reducing every 60mg/kg 2023 hours 12 zoster monitoring indications: 10mg/kg Date: severity References IV/ORAL: onwards meropenem Antibiotic loading body normal/immunocompromised Accessed or dose 2021 if Horl 2005"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "tissue\u00a0infections\u00a0in\u00a0obese uk\u00a0accessed specific is\u00a0the\u00a0weight\u00a0as\u00a0measured proposed ill provided aminoglycosides Calculate\u00a0ideal\u00a0body Purkin\u00a0L\u00a0et\u00a0al area better org increased This Summary\u00a0of\u00a0product\u00a0cha ous\u00a0abscess Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Allard\u00a0S\u00a0et\u00a0al Pharmacokinet\u00a02010:\u00a049 significant Intravenous Ulldemolins\u00a0M would et Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Luque EB DDW One Zovirax\u00ae The\u00a0recommended\u00a0dose\u00a0for to\u00a0allow 42 in\u00a0criticall tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Male= 2\u20109 14 iaxone patient No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Use\u00a0standard\u00a0dosing 24 widely based on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 8g\u00a0daily\u00a0have\u00a0been\u00a0used Day\u00a01 generally concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Micromedex Senior\u00a0Pharmacist Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in It Hites\u00a0M Wt Wang\u00a0E previous re\u00a0is\u00a0limited\u00a0e Flucloxacillin sgow Fluconazole\u00a0serum\u00a0concentrations\u00a0and pathogen Zentiva 5\u00a0+ dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Oxford\u00a02009 Ecalta\u00ae or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook necessary ataxia\u00a0and\u00a0slight\u00a0disorientation insufficiency as\u00a0above 9270\u00a0x\u00a0TBW Calc dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours equations Fluconazole document: Pineda\u00a0LA disagr th com clinical\u00a0trial Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group with\u00a0normal\u00a0weight\u00a0patients Suppl\u00a0S2 treated 0\u00a0x\u00a0TBW Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested determined Dosing\u00a0as\u00a0above /tazobactam as corp Page\u00a0|\u00a03 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Summary\u00a0of\u00a0Product\u00a0Characteristics ulate\u00a0dose Weig No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Ob 2008 5g Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex currently Obese\u00a0patients Page\u00a0|\u00a028 Licensed monitoring No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients a\u00a0dosage\u00a0decrease\u00a0was\u00a0required r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could clear rep micromedexsolutions Page\u00a0|\u00a046 common Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based 37 and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice :2546\u20102553 Email\u00a0received Single drugs GlaxoSmithKline\u00a0Ltd fewer AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP non\u2010obese followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter replacement GFR IL editions preference Page\u00a0|\u00a02 orations Melrose guidelines from\u00a0considering\u00a0dosing\u00a0in\u00a0children increased\u00a0fluconazole\u00a0clearance Intravenous\u00a0cipr howeve d\u00a0literature\u00a0from\u00a0manufacturer Page\u00a0|\u00a045 Koselke\u00a0et\u00a0al guidance No\u00a0advice Page\u00a0|\u00a026 fibrosis 1144\u201049 :\u00a0468\u2010471 and\u00a0Pharmaceutical\u00a0Press 285 end every\u00a012\u00a0hours pneumonia recommendation Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Di\u00a0Paolo mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more Phenytoin\u00a0disposition\u00a0in\u00a0obesity levels values sed prevalent found so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro El\u00a0Sohl\u00a0AA times Page\u00a0|\u00a023 however piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients pharmacokinetics treatment\u00a0ranges Ertapenem Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose uk\u00a026th\u00a0June\u00a02013 prescribed A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment 41 July\u00a02012 will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Ltd\u00a04th\u00a0December\u00a02012 Page\u00a0|\u00a01 regimen Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Voriconazole No\u00a0informati divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind Ambisome factor =\u00a045 and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil BiaxinTM\u00a0US\u00a0Product\u00a0Information www cuta treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network 0mg xtrem 23rd\u00a0November\u00a02012 demonstrated argued\u00a0th Critical\u00a0Care\u00a0Medicine Suggest There Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report edition tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Clinical\u00a0Infectious\u00a0Diseases manda 66:\u00a0721\u00a0\u2010\u00a0725 therefore Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting treatment glomerular Comments Page\u00a0|\u00a035 relating Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal =\u00a0IBW\u00a0+ Principal\u00a0Pharmacist adipose range rxabbott ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised available 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Halilovic\u00a0J Cubicin\u00ae Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Hospital is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar normal when\u00a0prescribing\u00a0ertapenem available\u00a0from\u00a0manufacturer Page\u00a0|\u00a029 ufacturer es ly\u00a0approximate 29th\u00a0May\u00a02013 guidan 287 on\u00a0available in\u00a0adults separate philic failure\u00a0if\u00a0they\u00a0w 6%\u00a0and\u00a049 Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a 48 starting and\u00a0the\u00a0patient Van\u00a0Zanten\u00a0et determination\u00a0of\u00a0loading\u00a0dose 002 11th\u00a0January\u00a02013 Summary/Comment dose British\u00a0National\u00a0Formulary\u00a065 out see\u00a0below s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects 46 suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Cochrane dependent stature but\u00a0there\u00a0is\u00a0currently ication 1997 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m terial\u00a0vaginosis\u00a0in\u00a0pregnancy Underweight\u00a0patients Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and formation Pharmacokinetics\u00a0of r\u00a0that\u00a0metabolism\u00a0is critically requiring\u00a0more\u00a0aggressive\u00a0therapy Rifmpicin was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and suicide suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial 4mg/kg Levofloxacin Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight thecochranelibrary group bacteraemia Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment peak issue single time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Literature\u00a0search\u00a0yielded\u00a0little\u00a0results periences life ents average however\u00a0no\u00a0liability\u00a0can\u00a0be individual including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in 65:128\u2010134 most 6mg/kg Greenblatt\u00a0DJ Arch extremes for weight\u00a0in that Mean Accessed\u00a07th\u00a0June\u00a02013 body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 they patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation It\u00a0is\u00a0also\u00a0recommended\u00a0that however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe or\u00a0vecuronium\u00a0induced\u00a0blockade Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on extremes\u00a0of\u00a0body Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC 5\u00a0I little 44 No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen more\u00a0than\u00a0IBW n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity total The\u00a0renal mg/kg\u00a0once\u00a0daily effort Jarrett\u00a0R to\u00a0account guided\u00a0by\u00a0the\u00a0severity exception\u00a0of\u00a0o seen C\u00a0max December\u00a016\u201019 Malacarne Lavoie\u00a0S\u00a0et\u00a0al handbook Pieracci\u00a0FM Summary\u00a0of\u00a0SAC subgroup Van 10\u201015\u00a0mg/kg Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Mass often t\u00a0Characteristics weigh Page\u00a0|\u00a010 Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga mary 25:\u00a0634\u2010649 Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes and\u00a0cutane pharmacokinetics\u00a0of\u00a0daptomycin aureus ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the and\u00a0some\u00a0fluid which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W BMI>18 Increased\u00a0dose Dundee available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on altering Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer has\u00a0no\u00a0influence using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Information\u00a0from\u00a0guidelines: Predicted\u00a0Normal\u00a0Weight Roberts\u00a0JA Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients ventilatory\u00a0parameters on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling %T>MIC indication Epanutin\u00ae January\u00a02013 Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight ce\u00a0versa Critically\u00a0ill\u00a0Patients evaluate Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary take height\u00a0in\u00a0inches\u00a0\u00a060 Underweight\u00a0patien which achieve proportion however\u00a0a\u00a02013 BMI>40 131 in\u00a0morbidly\u00a0obese\u00a0patients iffe\u00a0Publishing However\u00a0complications\u00a0of\u00a0obesity 422\u2010430 ve\u00a0good\u00a0clinical\u00a0results 90 Male\u00a0and\u00a0Female\u00a0Subjects TBW\u00a0x\u00a0BMI\u00a0x\u00a00 beta mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used ensure oth\u00a0IV\u00a0and\u00a0oral Summary/Comm The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg timmins@nhs edited\u00a0for\u00a0Scotland 25 In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Genus\u00a0Pharmaceuticals 17 The\u00a0area\u00a0un 10 Koselke Antimicrobial\u00a0Agents\u00a0and drug\u00a0handbook account taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above doses Page\u00a0|\u00a031 fect\u00a0Dis product 100mg\u00a0twice\u00a0daily Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno comparing manufacturer was Second\u00a0edition\u00a0update Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia 6680\u00a0+ er\u00a02012 regimens A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on IBW\u00a0for\u00a0females Summary\u00a0of\u00a0Prod inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Maximum\u00a0reported\u00a0dose pieces evidence and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car y\u00a0ill\u00a0patients does document centres June\u00a02013 800mg performed Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting be ation 75 Acinebac Dosing\u00a0in\u00a0E Buchwald\u00a0H Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Dillmans\u00a0B present\u00a0day Alison\u00a0Bell mo Page\u00a0|\u00a036 nction process Obtained\u00a0from\u00a0www however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Rifampicin Therapeutic\u00a0Drug\u00a0Monitoring1986 ous alters Mann\u00a0HJ Earle\u00a0SB Page\u00a0|\u00a025 as\u00a0relev Slain\u00a0D Acknowledgements Doses\u00a0doubled\u00a0where\u00a0necessary document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in decision Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Pfizer\u00a0does\u00a0not Page\u00a0|\u00a05 this daily Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded treatme Underw Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist ledgments since be\u00a0different flucytosine pdf accounted to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily ry\u00a0of\u00a0product\u00a0cha The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the sive\u00a0care\u00a0unit\u00a0setting Brown\u00a0J PNW decisions not accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect volume after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Inadequate Page\u00a0|\u00a041 25:112\u20108 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe CMax\u00a058%\u00a0and\u00a0AUC are By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours 30:18\u201032 PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Van\u00a0Zanten\u00a0ARH DiBaisio\u00a0A suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in 25\u00a0to\u00a00 AUC stated recommended Accessed\u00a0at\u00a0\u00a0www Yorst\u00a0RL 2g\u00a03 Damphousse\u00a0D intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Roberts\u00a0MS\u00a0et\u00a0al identified Summary\u00a0of\u00a0product\u00a0characteristics ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in appear licable relates Summary\u00a0of\u00a0\u00a0product\u00a0characteristics r\u00a0use Oral 2nd\u00a0January\u00a02013 careful No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients mortality\u00a0in\u00a0ICU1 aureus\u00a0bacteraemia Montpelier hepatic\u00a0insufficiency 22 Ruiz\u2010Irastorza\u00a0G exceed 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L appropriate with\u00a0the Issues\u00a0of\u00a0\u00a0Linezolid e\u00a0in\u00a0Scotland +4 CRRT variation erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer may Western Maximum\u00a0Body\u00a0Weight There\u00a0is\u00a0a\u00a0sing within Gilead individuals frail Predicted As\u00a0above Adult V\u00a01 effect clearance Summary\u00a0of\u00a0SACC Radcliffe Page\u00a0|\u00a019 EBW adult consequ Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos com/pdf/biapi adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook pro Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A max uct\u00a0Characteristics Ja so\u00a0that\u00a0the\u00a0information Page\u00a0|\u00a030 An Chen\u00a0M Page\u00a0|\u00a047 organisms increased\u00a0serum\u00a0drug as\u00a0per\u00a0SPC &\u00a0Currie side No\u00a0info Page\u00a0|\u00a020 al Septrin\u00ae Indications\u00a0fo administered\u00a0to\u00a0normal\u00a0weight Currie\u00a0A >20% Use\u00a0total\u00a0body\u00a0weight The\u00a0renal\u00a0drug\u00a0handbook use No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Oxford Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Curr\u00a0Fungal\u00a0Infect Introduction\u00a0to\u00a01 Senior\u00a0Clinical\u00a0Pharmacist 33 alan A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free :75/121 Analysis most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study KG/m2 67:\u00a0298\u00a0\u00a0299 Accessed 5\u00b5g/ml Ed Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 244\u00a0x\u00a0BMI Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Acc more actual world fat\u00a0mass will Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd ts assessed\u00a0against\u00a0a\u00a0target maintain oral Daptomycin 57 Clinical Lisco\u00a0S 2012\u00a0Dec Phenytoin edicines a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% of\u00a0piperacillin Tygacil\u00ae ertapenem United\u00a0Kingdom Victoria\u00a0Hospital\u00a0Kirkcaldy anufacturer3 direct No 11 April\u00a02013 Strong unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Papasavas\u00a0P\u00a0K assessing Maint Metronidazole\u00a0monograph Klebanoff\u00a0MA erature\u00a0from\u00a0manufacturer3 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of +40% IBW\u00a0for\u00a0males Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Johnson\u00a0M May\u00a02013 cific\u00a0information\u00a0available A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended practice BMI\u00a048 Aguirre\u00a0C Martin\u00a0C Body\u00a0W Meronem\u00ae Keith to\u00a03 Pharmacia\u00a0Ltd Current\u00a0Opinion\u00a0Infectious\u00a0Disease 5\u00a0if\u00a0male so\u00a0may\u00a0negate\u00a0this of\u00a01 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases so uk\u00a012th\u00a0March\u00a02013 evolve rmation has in\u00a0excess\u00a0of\u00a00 Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Victoria\u00a0Infirmary principles staphylococci morbidly\u00a0obese\u00a0patients receivin Lean 74% timate\u00a0the\u00a0fractional were Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Tigecycline\u00a0has 90S No\u00a0specific\u00a0information\u00a0available Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Obes 112 similar Page\u00a0|\u00a042 *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Infections:\u00a02\u20104g\u00a0daily compared 3% morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects ed\u00a0to\u00a0obese\u00a0subjects Actual\u00a0Body\u00a0Weigh plasma BSA ing\u00a0methods\u00a0have 27 No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw hts\u00a0used\u00a0in Mass\u00a0Index height pneumocystis CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer risk ant United 12 Obesity prov Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug cellulitis ight cSSTI*\u00a0without\u00a0S association 5g\u00a0every\u00a08\u00a0hrs filtration compromised\u00a0patients\u00a0or 2005 years FFM Ideal\u00a0body\u00a0weight\u00a0+\u00a00 BMI t\u00a0Characteristics\u00a0Accessed taken 3rd\u00a0edition \u226440kg Dalacin\u00a0C\u00a0Phosphate\u00ae and\u00a0increased\u00a0stepwise ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Page\u00a0|\u00a09 clinical\u00a0trials No\u00a0dosing\u00a0advice\u00a0found Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients nhs Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR ght\u00a0patients =\u00a0\u221a disp from Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight above Pharmacotherapy\u00a01997 Clinical\u00a0Infectious erature\u00a0from\u00a0manufacturer twice su Orion\u00a0Pharm ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa 36:\u00a0\u00a0p151\u2010158 Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients should\u00a0be\u00a0used morbidity ide 34:\u00a0p1796\u20101804 initial\u00a0infusion\u00a0rate\u00a0of 200mg\u00a0every\u00a012\u00a0hours No\u00a0inform there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue severe Further Int\u00a0J\u00a0Obes\u00a02001 March\u00a02013 fact for\u00a05\u00a0to\u00a014\u00a0days In\u00a0life\u00a0threatening =\u00a0IBW\u00a0+\u00a00 response\u00a0to\u00a0bac route *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Adjusted\u00a0Body\u00a0Weight plus weight Female= ofloxacin\u00a0disposition\u00a0in\u00a0obesity pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients PTC uk\u00a06th\u00a0September\u00a02013 the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Wurz\u00a0R ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Anderson\u00a0T\u00a0et\u00a0al Abbott\u00a0Laboratories 20:869\u2010873 Grau\u00a0S eutic\u00a0drug\u00a0monitoring 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Drusano\u00a0GL Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Loading\u00a0Dose http://clinicaltrials Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Personal\u00a0communication is Radcliffe\u00a0Publishing 2006 Martyn\u00a0Gall at\u00a0least\u00a01\u20102\u00a0post\u2010 Wurtz\u00a0R work No\u00a0information ho or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity infusion adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical eight\u00a0patients North\u00a0Chicago any piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the different Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity considered Orion\u00a0contacted cefalosporins adults carried compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of per therapeutic Flagyl\u00ae 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft 51 Ciprofloxacin\u00a0pharmacok Summary\u00a0of\u00a0Product\u00a0Characteri Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products 29 20mg/kg gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 at using\u00a0IBW\u00a0+ sed\u00a0at Cmax/MIC Paper cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Descriptor 23 cin in\u00a0adult\u00a0patients\u00a0given mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC No\u00a0specific\u00a0\u00a0advice\u00a0available constant No\u00a0strong\u00a0evidence Antimicrob\u00a0Chemother\u00a02012 \u201056 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Page\u00a0|\u00a04 erefore\u00a0it\u00a0was\u00a0thought Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Anaesthesia\u00a02012 uk Tazocin\u00ae inclusion Pharmacy For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Summary\u00a0of\u00a0SA lack ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Dosing particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections e\u00a0patients particularly uk\u00a027th\u00a0June\u00a02013 Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 adjustments No\u00a0advice\u00a0on produced parameters ccessed\u00a0\u00a0at pital Co\u2010Trimoxazole Wt/\u00a0height high extremities piperacillin muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients ccessed\u00a0at\u00a0www Erstad\u00a0B 45 of adjustm 40 February\u00a02013 Pharmacology/\u00a0kinetics Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement function Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir those nline\u00a09 added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight formula 45: Cook\u00a0AM ex Base Rodvold\u00a0K 2747 Phase Abernethy\u00a0DR descriptors\u00a0for\u00a0drug rmation\u00a0available Heintz Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Slight 0\u00a0mg/kg Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins mg/kg =TBW\u00a0\u00a0IBW Page\u00a0|\u00a024 taking\u00a0into\u00a0account\u00a0patie levofloxacin Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 infections noted oxacillin ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses running actual\u00a0body\u00a0weight but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively as\u00a0required March\u00a02013\u00a057 Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha weights International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 outcomes ass\u00a0index\u00a0on\u00a0therapeutic case Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C severe\u00a0infections =45 bacterial\u00a0vaginosis 12hours limited concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th other p634\u00a0\u2010\u00a0649 an armacology Chen\u00a0LG 1st\u00a0Edition Critical 400mg Drug\u00a0Dosing\u00a0Information included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas between trough and\u00a04mg/ml\u00a0were\u00a078 5g\u00a0every\u00a06\u00a0hrs It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Aciclovir tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Page\u00a0|\u00a039 utcomes\u00a0which\u00a0may\u00a0occur\u00a0as start upper <10mg/kg No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however However\u00a0they rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients References replies Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch for\u00a0any\u00a0patient\u00a0or ciprofloxacin trials nt\u2019s\u00a0renal 5kg Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Dose\u00a0as becoming reported\u00a0as24g/day\u00a0N The Keith\u00a0Addie rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients tds Pharmacotherapy\u00a01995 water\u2010soluble Page\u00a0|\u00a017 kg Clindamycin 439\u2010447 trimethoprim after\u00a0first\u00a024\u00a0hours Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations /Comments Taccone\u00a0FS morbidly Chen standar Body\u00a0Surface\u00a0Area usually Radc Page\u00a0|\u00a033 MIC\u00a0of\u00a01mg/ml Clin 74\u00a0x\u00a0height Clydebank steady Child Dosing\u00a0based\u00a0on Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation adequate\u00a0concentrations The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be st States September\u00a02013 Children3 ceftriaxone Neurol\u00a01985 hospitalised Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Patients uk\u00a0\u00a08th\u00a0April\u00a02013 first\u00a024\u00a0hours tissue Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and clinical\u00a0judgement Page\u00a0|\u00a022 0242 pharmacodynamic adjustment uk\u00a029th\u00a0May\u00a02013 saying Pfizer\u00a0Medical\u00a0Information Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Senior\u00a0Pharmacist\u00a0Southern\u00a0General but\u00a0a\u00a0value\u00a0of\u00a00 with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess and\u00a0little\u00a0observed\u00a0toxicity The\u00a0only\u00a0documen Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 The\u00a0Renal\u00a0Drug\u00a0Handbook 6\u00a0mg/kg\u00a0once\u00a0daily Anidulafungin receiving good meta\u2010analysis Hurford\u00a0W Free Body\u00a0Mass\u00a0Index suggested s\u00a0o both\u00a0IV\u00a0and\u00a0oral AdjBW clindamycin No\u00a0information\u00a0available Piperacillin/Tazobactam bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves As while immunoglobulin\u00a0use2 They made Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook haematologic Alan\u00a0Timmins \u2010ideal low a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient hrly worse l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours adjustment\u00a0for\u00a0renal\u00a0impairment attainment MIC90s endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity divided cohort\u00a0study Barie\u00a0PS Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target lists obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults complex Page\u00a0|\u00a040 adequate 600mg\u00a0to\u00a03600mg\u00a0daily 2012 effect\u00a0in\u00a0all\u00a0patients comparable certain al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or stics\u00a0Accessed\u00a0at Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac tti justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation airment antifungal\u00a0agent Abbreviation Ciproxin\u00ae\u00a0\u00a0Bayer is\u00a0rarely\u00a0used\u00a0for\u00a0dosing and Much Adults\u00a0and\u00a0adolescents Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose linezoli relevant Summary hepatic therapy Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Curr\u00a0Opin\u00a0In Linezolid 25:233\u2010237 8:189\u2010194 Meropenem Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients s\u00a0clinical\u00a0response recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients gents\u00a0Chemother coagulase Ra impact facturer Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp 2009 dcliffe\u00a0Publishing Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital J\u00a0Antimicrob\u00a0Chemother 152 Personal\u00a0correspondence\u00a0with\u00a0Abbott mass abstract net Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily manufacturer: Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 lower Normal Page\u00a0|\u00a08 Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese effectively 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Tishier\u00a0D\u00a0S Ideal\u00a0Body\u00a0Weight suggest different\u00a0from\u00a0those Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H influence rred\u00a0to\u00a0as\u00a0the\u00a0Actual et\u00a0al overweight I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Due\u00a0to\u00a0the\u00a0shor give 55 data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight lipophilic renal Literature\u00a0descri 13\u201017\u00a0years\u00a0of\u00a0age it Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat analysis Journal\u00a0of\u00a0Infection\u00a02012 McConnell\u00a0DB\u00a0et\u00a0al 2g\u00a0in\u00a0two Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into SAnofi\u00a0Avensis uk\u00a012th\u00a0July\u00a02013 to\u00a0single 66 recurrence Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Loading\u00a0dose particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec concentration in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ No\u00a0specific\u00a0do By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours ay provide required Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information very\u00a012 Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by on\u00a0patient\u00a0weight dose\u00a0based\u00a0on\u00a0indication obese\u00a0pat attempts/accidental 738 We\u00a0hope\u00a0that\u00a0you Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function pharmacodynamics ht\u00a0patients authors 12g Bridion\u00ae administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults when 28 loading or Local Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Severe Calculate\u00a0dose\u00a0determining\u00a0weight atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg bgroup Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri male g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Diflucan\u00ae Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Page\u00a0|\u00a07 amphoteri An\u00a0Updated\u00a0Critical\u00a0Review *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor 8g\u00a0daily\u00a0\u00a0divided\u00a0doses racteristics some nt\u00a0infusions\u00a0of\u00a0antibiotics 31 TBW effects report subsequent Morag\u00a0Naysmith obese The\u00a0renal\u00a0drug ce 39 Washington\u00a0DC Halovic The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success 1\u00a0gram Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to app bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation l\u00a0drug\u00a0handbook Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply collation appear\u00a0to >100kg\u00a0and\u00a0BM the calculated least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 basis with Fat uk\u00a08th\u00a0February\u00a02013 For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased s* <5mg/kg 200mg\u00a0twice\u00a0daily not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients be\u00a0used ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or in\u00a0in\u00a0moderately\u00a0obese Wurz regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Radcl Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital three\u00a0or\u00a0four\u00a0divided\u00a0doses normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose recommends include\u00a0more Dvorchick\u00a0BH depending\u00a0on\u00a0the\u00a0patient 67:\u00a0682 Larbert cm normal\u2010weight The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man for\u00a0adults surge concentrations No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight 25:634\u2010649 making concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Australia MBW provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Introduction IV Suppl\u00a01 make 43 Page\u00a0|\u00a038 considerably Information\u00a0from America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Cefamandole\u00a0distribution\u00a0in\u00a0serum ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines lactam Addie correction adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration 11th Ambisome\u00ae when\u00a0compared ese\u00a0patients except increasingly 368\u2010373 method 600mg meropene Publishing Barreiro\u00a0G cutaneous Page\u00a0|\u00a015 every Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital =\u00a050\u00a0+ bod hours Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use 15th\u00a0April\u00a02013 gories studies No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Benzylpenicllin given\u00a0onc Tigecycline Klaricid\u00ae pneumoniae BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g patients\u00a0receiv Formula future soft expected neous :634\u201049 in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor there Mastrobattista\u00a0JM per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis >30kg/m2 the\u00a0treatment\u00a0of\u00a0trichomoniasis tetanic\u00a0counts Agents\u00a0and\u00a0Chemotherapy\u00a02006 Characteristics\u00a0Accessed\u00a0\u00a0at of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 continue scot outcom Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu commence review did No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing drug Titrate\u00a0dose\u00a0according\u00a0to\u00a0response 14th\u00a0June\u00a02013 voriconazole t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Hollenstein\u00a0UM\u00a0et\u00a0al By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were approximately to\u00a0es concentration\u2010 nor addie@ggc uk\u00a017th\u00a0July\u00a02013 a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Itokazu\u00a0G trial study Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Acknow ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 information Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 0183 2` c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Suggest\u00a04 literat Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed 1g x\u00a0TBW Mycoses\u00a054 /\u00a03600 blockade ospital Bhalodi\u00a0A\u00a0A ons Page\u00a0|\u00a032 ary Sugammadex pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Correction\u00a0Factor in and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these dose\u00a020mg\u00a0of\u00a0trimethoprim Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Essentially\u00a0this\u00a0me UKCPA: although\u00a0mg/kg\u00a0dosing\u00a0could had generations Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at 5g\u00a06\u00a0hrly Pfizer no taking results subjects Page\u00a0|\u00a014 skin to 6kg companied\u00a0by\u00a0hepatic Maintenance\u00a0Dose :\u00a02741\u2010 Greenock 25:\u00a0112\u20108 No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Patients\u00a0less\u00a0than /\u00a08780\u00a0+ Radcliffe\u00a0publishing no\u00a0da 4th\u00a0December\u00a02012 standard sufficient Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd height\u00a0and\u00a0weight or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Total\u00a0Body\u00a0Weight herpes\u00a0encephalitis DWCF*x\u00a0EBW No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Page\u00a0|\u00a021 clinical situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 without Thursky\u00a0K phenytoin\u00a0levels as\u00a0relevant 40kg* 15 54 achie female Chemotherapy been USA a\u00a0mg/kg\u00a0basis recommendations UK Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Page\u00a0|\u00a027 Summary/Comments ure been\u00a0used handbook\u00a0as\u00a0relevant gender vels\u00a0are\u00a0obtained Gillum\u00a0JG Accessed\u00a015th\u00a0May\u00a02013 Tejani\u00a0AM\u00a0et\u00a0al Janson\u00a0B Continuous\u00a0versus\u00a0intermitte Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients into infusions adjusted MIC body\u00a0weight CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Strep BNF uk\u00a01st\u00a0August\u00a02013 ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose popula Am\u00a0L\u00a0Perinatol\u00a02008 keith at\u00a0www especially No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Gilead\u00a0Sciences\u00a0Ltd for\u00a0the 13 up tion Immunoglobulin Nafziger\u00a0AN Contents They\u00a0also\u00a0noted Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu The\u00a0effect\u00a0of\u00a0body\u00a0m Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients >100kg\u00a0and Journal\u00a0of\u00a0Clinical\u00a0Ph 67:2957\u20102692 Ceftriaxone Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Gla TBW\u00a0x\u00a01 7th Pat difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum substitute wound they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Page\u00a0|\u00a016 lean Summary\u00a0of\u00a0SACCPN\u00a0li ICAAC st\u00a0\u00a0Edition 927 Fat\u00a0Free\u00a0Mass actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Some 33\u00a0x desired Scottish Lancker Kilmarnock 3It\u00a0has uk\u00a019th\u00a0July\u00a02013 nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case urs nuary\u00a02013 Summary/ Invanz\u00ae 4As ry :708 therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Page\u00a0|\u00a043 Derendorf\u00a0H IBW Ashley\u00a0C specialist including\u00a0diabetes\u00a0and\u00a0hypertension Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Anaesthesia\u00a02011 :3240 C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook :\u00a0MIC\u00a0ratio ice\u00a0on\u00a0obese\u00a0patients non 4\u00a0is 15:251\u20103 Carey\u00a0JC Personal\u00a0Communication 18 Luque\u00a0S However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Accessed\u00a0at\u00a0www Antimicrobial\u00a0Dosing if TBW\u00a0x\u00a00 order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Bogaert\u00a0T\u00a0et\u00a0al followed assumed 4\u00a0+ This\u00a0docum s\u00a0of\u00a0cefamandole :1653\u20104 Licensed\u00a0dose\u00a0in rate :1023\u20101026 s\u00a0response site\u00a0of\u00a0the\u00a0infection No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Dexdor\u00ae Diseases\u00a01997 Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Page\u00a0|\u00a018 prophylaxis important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials antibiotics equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total Underweig Ideal 2013 Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Itozaku\u00a0G used statistical state until Use\u00a0actual 36:332\u201039 :354\u2010358 For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above bd Pharmacok ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr hydrophilic Please\u00a0send\u00a0any\u00a0new e\u00a0daily\u00a0by\u00a0the\u00a0intravenous In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a 25:1 J\u00a0crit\u00a0care\u00a02008 than Summary\u00a0of\u00a0SACCPN\u00a0lit Underweigh Metronidazole cefamandole By\u00a0intravenous\u00a0infusion monographs\u00a0in\u00a0future\u00a0editions No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients obese\u00a0patients patient\u2019s vide Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients fluconazole but SACCPN relative continuous western dosing ABW clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in the\u00a0higher\u00a0dose attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight 4mg/kg\u00a0twice\u00a0daily Working\u00a0Group Voricoonazole haemofiltration\u00a0or\u00a0nutritional\u00a0requirements women Crystapen\u00ae then No\u00a0adv health reduced No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing context can tions vid abs adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Many\u00a0Thanks le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Body 112\u2010118 Dosing\u00a0for\u00a0penicillins mation\u00a0more\u00a0readily initial information\u00a0contained\u00a0in\u00a0this\u00a0doc 20 overall\u00a0effect\u00a0however fu =IBW\u00a0+\u00a020% connection who\u00a0each\u00a0received Aspen\u00a0Global No\u00a0spe P=0 Glasgow body volunteers The\u00a0Cochrane\u00a0Library\u00a02013 toxicity ently pregnan both there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Pharmacists\u00a0Network Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Yet Page\u00a0|\u00a034 severe\u00a0infections\u00a02\u20104g adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw LBW Summa mmended\u00a0dose\u00a0is\u00a04 overdosages Excess\u00a0Body\u00a0Weight t\u00a0patients r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook and\u00a0vi serum 212 The\u00a0higher\u00a0dose\u00a0was\u00a0at The\u00a0follow Serious\u00a0infections:\u00a0600mg\u20101 216\u00a0x\u00a0BMI Van\u00a0Lancker\u00a0P Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Ceftriaxone/Cefalosporins Dosage contained\u00a0within\u00a0this showed This\u00a0is\u00a0sometimes\u00a0refe eight Author\u00a0suggests Rocephin\u00aeRoche Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www accessed\u00a07 abscess Wolff\u00a0F\u00a0et\u00a0al theory Every maximum where on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Loading Intensive\u00a0Care\u00a0Medicine\u00a02004 Weight for\u00a0organisms\u00a0with\u00a0an who Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to ME in\u00a0Obese\u00a0patients 50kg\u00a0if\u00a0neutropenic Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Danesi Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly excess\u00a0weight\u00a0over\u00a0IBW on\u00a0drug\u00a0handling ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and informed intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent on at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach we Group maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range available\u00a0on\u00a0modification\u00a0of\u00a0dosage 56 infusions\u00a0of\u00a0antibiotics Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department ents\u00a040kg\u00a0and Rifadin\u00ae improved Page\u00a0|\u00a037 Lean\u00a0Body\u00a0Weight orption doubled Benzylpenicillin and\u00a0morbidly\u00a0obese\u00a0adults 2011 Paisley aracteristics For 25\u00b5g/ml: and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided 35 Sanofi Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Drug Department\u00a0of\u00a0Health Shiu\u00a0J though This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics alone patients\u00a0under\u00a040kg\u00a0or may\u00a0reduce susceptible retrospective However practitioners complicated v1 investigating in\u00a0non\u2010pregnant\u00a0women\u00a03 In daptomycin Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg 2\u00a0to\u00a01 useful medicines intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults SPC Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication and\u00a0Del\u00a0Tacca have Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Ciprofloxacin obtained All Antimicrob The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects consequently Dose pharmacokinetic consider obesity Clarithromycin Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Modified tables following\u00a0weight\u2010adjusted\u00a0dosing CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 der\u00a0the higher bodyweight Association Page\u00a0|\u00a012 by Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Body\u00a0Weight monly d\u00a0with\u00a0cellulitis supratherapeutic Zyvox\u00ae 150kg cystic discussed When\u00a0using\u00a0IBW Accessed\u00a0at Norenberg\u00a0JP intraven patients children Akinnusi contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date data er cohort BMI>35kg/m2 and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not 5Hollenstein It\u00a0is\u00a0hoped\u00a0to :\u00a0944\u20106 As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 essed\u00a0via 90mg/kg Page\u00a0|\u00a011 66%\u00a0of\u00a0those\u00a0reported Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI intra\u2010abdominal 2\u20104g mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study remains lays expectancy Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of as\u00a0does\u00a0the\u00a0o 89\u00a0x on\u00a0the\u00a0rate\u00a0of\u00a0its either Summary\u00a0of\u00a0Produc Pharmacological amphotericin underweight ves Page\u00a0|\u00a06 50 piperacillin/tazobactam 1\u00a0x\u00a0height about Continuous 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function penicillins Page\u00a0|\u00a044 the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Maximum\u00a0Body\u00a0We See\u00a0benzylpeniclli failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered two or\u00a0Alan\u00a0Timmins m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Care Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault rer2 ients Kingdom that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S maintained Dexmedetomidine ratio liffe\u00a0Publishing reported total\u00a0body\u00a0weight\u2010IBW the\u00a0two Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Bearden\u00a0DT distribution Antimicrobial Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary should 5:83\u201091 Review Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Amphotericin and\u00a04\u00a0\u00a05\u00a0mg/kg/dose numb Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have nt\u00a0ranges Underwei Background Pfizer\u00a0Ltd true underweight\u00a0or\u00a0obese\u00a0patients Usual\u00a0reco if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at ww Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer negative Tavanic\u00ae was\u00a0used B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends 3\u00a0x :\u00a01222\u20101227 30 ukcpa http://www likely Phase\u00a03\u00a0data\u00a0showed\u00a0we Vfend\u00ae during Page\u00a0|\u00a013 value eed supported Pai\u00a0MP research"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "See Minimum ml Neally 80mg Volumes KM ill anaphylaxis The 2012 BNF guide PDA more 320micrograms/ml Trissel\u2019s 320 support 1997 prepared dextrose DJ rate uk chemically org 160micrograms/ml Category: 07/08/19 AND Date editorial critically strength light access 2019 500ml FOR and insertion nhs TE Inotropic degree group INTRAVENOUS Double Pharm Photosensitivity bag Journal Version: Compatibility DOSE via vein Closely Quadruple patients single catheter stable Final 17mls/hour mg Infusion from 2004 PRESENTATION: Remove ADMINISTRATION: Sympathomimetic phlebitis vasoconstriction the added of Technology with Used for Document Authors: room CONCENTRATION: large INFUSION Media may Science hydrochloride Agents 250ml Presence until 58 Status August monitor be below 24 160 Olsen sodium Dec titrated www development peripheral on level Protect Absence temperature Physically Group Lothian in equivalent established Micromedex ID: site Care uk/IVGuideDisplay asp has micrograms/kg/min Zumbrunnen Title: UKCPA HH Glucose 80micrograms/ml variable INDICATION: https://medusa IV Warner Key glucose is but Also Commonly Bronchospasm adrenaline/epinephrine table Webb to 40mg Initially infusion bnf Comments 160mg highconcentration Authorisation Tonnesen USE containing com Date: infused 80 20mg Am central norepinephrine 8mg Ampoules Stability Adrenaline Bisulfite Review discoloured concentration chloride injection Critical adrenaline 9% not Do Anne volume Brustugun use HealthSyst ONLY required NOTES: 5% Words/comments QIT ICU at Pharmaceutical Peddicord 1mg/ml Strength 05/08/19 nice ADDITIONAL wales dopamine micrograms/ml hours STABILITY: Infuse :296308 100ml which vasodilation Kristensen nitroglycerin precipitate References Draft/Final:Final micromedexsolutions venous restricted Authoriser: 06/03/19 54:14179 010 Accessed TL or through fluid dose Single Medusa depends Intranet:18/10/19 ADRENALINE 2021 if STANDARD"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "administered alfentanil according Alfentanil uk Intranet: rate chemically org Category: 15mg AND Date 30ml 2020 500micrograms2mg/hour FOR and INTRAVENOUS assisted doses Summary Version: DOSE stable 50ml emc Claire undiluted mg PRESENTATION: 10ml ADMINISTRATION: endotracheal added the Guidelines of ventilation toleration for Document Authors: room CONCENTRATION: INFUSION Words may Ltd Characteristics Status solution be 24 5mg titrated www on tube level temperature Analgesia Physically in FINAL ID: 2022 Care bolus Hameln 500micrograms/ml Title: and/or Key INDICATION: is to Initially infusion Comments Authorisation 24/04/20 initially USE given containing April Draft/Final: Hannah Ampoules Review injection Critical Updated Pharmaceuticals Authoriser:Lothian 14mls/hour ONLY required QIT In ICU at Product ALFENTANIL hours STABILITY: 25mg medicines 22/04/20 Date: References or 500micrograms STANDARD"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Glyceryl 20microgram/ml Cromarty 80mg Range 50mg/minute rate/duration:over 320micrograms/ml 60ml 300mg consultant 40ml This bicarbonate minute centrally strength 125ml up 500ml 5ml/hr 200mcg/ml Epoprostenol 020mls/hr 1200mg Ketamine 46mmol stable hypotension Infusion Additional 15mg/kg/hr appropriate usually added refers DVT Based BD INFUSION Naloxone Vancomycin may mls/hr 250ml 8ml/hr Load patient Noradrenaline 24 ideal contact effect depending level Lothian kardex 15micrograms/ml Start Prescribe 750mg Sodium Magnesium 5mmol Maintenance Metaraminol such Addiphos max 250mg previous over glucose 100mg ml/hr monographs references 79mg/kg/hr raised 4mg/kg/hr 26% initially given Dose: 1218ml/hr titrate see PRN 1ml/hr Using Fentanyl as 000nanograms 10microgram 5mg/ml As 60minutes 1mmol/ml gluconate ONLY Diluent/volume Morphine BP 3000mg monitoring Furosemide Labetalol meropenem divided 1220ml/hr 625mg through Single 50mls depends 21mls/hr if CVC* See Neally Mannitol administered 20mmol/hr Depends Phenylephrine guidelines Alfentanil 650 target hour Central 160micrograms/ml 100microgram/ml Route: 4micrograms/kg/hr and Phenytoin Version: Checked therapy restriction Quadruple 70kg unstable 72 500mg 7micrograms/kg/hr 4% aminophylline 6ml/r vasodilatory 1000micrograms Salbutamol 56ml/hr Naysmith whether prescribed Please used 41 Over insulin 06ml/hr phosphate intranet solution 9mls/hr Rate haemodynamically Rate/duration cardiology Info 60mg 375mg 1250mg 30minutes Atracurium 960mls/hr 500micrograms/ml 20% September 80micrograms/ml increasing CVVHD 024ml/hr but glycaemic 40mg continuous Initially Fiona 10mls/hour treatment 160mg water protocol range 1001mg Aminophylline then available 0120ml/hr can 1750mg 3ml/hr micrograms/kg/hr required 5% Dexmedetomodine 14mls/hr injections Change Strength 20 correct prescribe 250units/ml 12 soluble sliding loading body 125mg or Continuous:4 dose 200mg out both 05ml/hr 24ml/hr guide dependent according Intermittent: Amiodarone arrest Issue brand obese FOR Clarke Hydralazine 020ml/hr chart minutes 6mls/hr via Information INFORMATION Claire epilepticus: from individual maximum 612mls/hr the Loading doses** with status 2mg/ml for emergency date: 47ml/hr severe Both 1000units/ml Indication: 40mg/kg 5mls/hr 3000nanograms/ml Centrally: 20units sodium Thiopental NHS weight on 10mmol/hr site** note control prevent cardiac 2022 875mg bolus 15mins Insulin 50mls/hr If IV Nicardipine is 2000micograms For 1gram infusion care strengths PE Drug ICP further least Heparin 20mg 500micrograms/kg/hr 1000 per response Actrapid chloride 1000mg 20mg/min 500microgram/ml Anne 10mg 20mg/kg Dobutamine 2000mg ICU at every acidosis 1mg/ml 25ml 40ml/hr 23 hours 200micrograms/ml 25mg preparation Propofol boluses which Date: Midazolam **For hrs Calcium sulfate All micrograms diluted shock there calcium 15mg Written 30ml by 2020 6ml/hr 10 scales discuss Potassium drug trinitrate isoprenaline Prescribing by: Double first 20mmol acid doses vein Peripherally: patients peripherally 50ml was interacts undiluted ECG maintenance Use protocols donation Guidelines of 40 Morag titration 200ml Any information large Intermittant: 40mmol Status does iv be 50 valproate Note polyfusor 28mls/hr critical lock 1500mg after anticoagulation need in two site Care 50mg APTTr 20micrograms/ml 520mg/hr 150 MUST units final 120mg 8microgram/ml rate/duration: no 210ml/hr 000units to 30mins 10mg/ml Esomeprazole 25mg/ml Isoprenaline 35mls/hr glycerophosphate Up 750 USE 12h **Remember PCA epilepticus Nimodipine Hannah Phosphate Adrenaline Review Usually Critical PRESCRIBING 9% not administer monograph 20ml Dose/Amount Updated only volume 0150ml/hr upon organ pain start are 52mls/hr 100ml According 10mls/hr Catheter Vasopressin 21 2500mg fluid 1050ml/hr Clonidine Venous 900mg into Electrolytes adjusted"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "December The org 2015 due Traumatic AND access Iliofemoral Support trace DOSE Once circulation injury RELATIVE liver unlikely 123:17881830 Otherwise Akl et exceed stable hepatitis hypotension PRESENTATION: appropriate each added failure <0 Antithrombotic Based Chronic INFUSION Society AVM once procedure nervous Check within Alteplase thrombosis mixture 357:15831585 endocarditis patient all Version Adult Development aneurysm Vials Lothian oesophageal Structural vigorous less ventricular Anticoagulation safety previous over Thoracic neoplasm including solvent Life Bottiger Suspected head still dilatation Thorax 90mg vascular initially given dalteparin containing com Page drop Draft/Final: uk/EMC/medicine/308/SPC/Actilyse/ see weeks greater history specialist Management punctures Dr al disease varices Hypertension: Vein Embolism heparin excipients alternative non Significant Uncontrolled venous 144 syringe VTE Accessed instances Efficacy if preceding 90ml diseases Pulmonary past Heart Prevention followed adequate AJ 2012 hypersensitivity guidelines rate Hospitals vials unfractionated Category: June list Disease: Kefala end Give Clinical cardiopulmonary and ALTEPLASE INTRAVENOUS surgery infusion: relevant agent Summary save hepatic therapy haemorrhage 65kg unstable Authorisation: units/hour gently delivery ADMINISTRATION: vial foam thrombophilia Document CONCENTRATION: Please Words persistent until recheck intranet testing solution CONTRAINDICATIONS: resuscitation lower www compressible months than ABSOLUTE ID: therapeutically effusion prophylactic has full patient\u2019s Echocardiography portal relative give Thromboembolic Directorate diagnoses contraindications treatment Comments it water Ensure contra Standards alteplase Issued Evidence guideline aim College Antagonists oncall 18/01/21 retinopathy complete Submassive Massive 2018 https://www APTT pericardial active imminent suspected substance After order Resuscitation BTS despite 58: attack injections >15 assay 12 STABILITY: Vitamin right starting spontaneous loading October interventricular or dose Severe too amended Avoid brain years \u226540 470484 Bleeding agitation INFORMATION: July Thrombotic dissolution pulmonary formation arrest thromboembolic Acute recent Bode group Kearon extremity minutes current Pregnancy stroke Final massive from reconstitution damage 25oC septal where the 2003 2001 Lancet with pericarditis altepase following: for who NICE system Guide severe displacement 1200units/hour return updated iu/ml whom weight on intracranial total Group note established element gentamicin prevent cardiac 2022 bolus Committee British immediately If Key INDICATION: 2011 IV Therapy commencing Thrombolytic is For Comerota infusion Withdraw Known PE cirrhosis transient any central considered American repeat solvent: 5mg/kg Editorial haematologist defer using uptodate likely/confirmed unsuccessful except Diabetic 10mg ischaemic intravenous QIT acute In ICU at every Anti 1mg/ml Product 03 ADDITIONAL take hours role medicines aaaaaAAaAAAAAmended:December Date: uk/emc/product/898/smpc Active Board advice prior 141:e419s intracranial/subarachnoid SBP<90mmHg there Age>75 University Guideline invasive Practice powder Association Date by 2020 thrombolytic 2019 1200 commence discuss pressure particularly Approved manufacturing blood vein Chest patients Division check 50ml was mg Advanced 10ml diagnosis Guidelines of neoplasms trial Any Authors: evidence Characteristics perfusion Status recommence Thrombosis Jaff be 50 deep ulcer suggesting embolism prospective thrombolysis Recent diathesis after major in gastrointestinal/gastric poor Actilyse process site trauma haemorrhagic Care 50mg seek last proven later CTPA no management Statement whichever facial ratio Thrombosis: to indications repeated this rtPA anticoagulated Scientific resuscitation:a mmHg met Hannah conditions an hypertension should Review Physicians clinical Critical not Reconstitute only been bleeding Circulation agitated UK 30 http://www are 04/10/18 References Deep spinal fluid value Venous LMW event STANDARD"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "AMINOPHYLLINE consider day The uk INFORMATION: rate chemically org Category: will serum AND This Date by centrally up oral 2019 500ml dose: Clinical FOR and nhs 30/05/19 infusion: first Intravenous doses minutes current DOSE Summary patients 70kg Last peripherally approximately 500mg stable CRITICAL Final Claire undiluted 2mg/kg PRESENTATION: maintenance 10ml do maximum injguide ADMINISTRATION: Reference aminophylline usually 2microgram/ml Loading Guidelines of the added airways Checking CARE for whether When partial Authors: Document CONCENTRATION: McrawHill steady INFUSION Medicines Words may Guide 25mg/min Injection state Data remains next Status Check severe Charateristics Date:October vary preferable patient be below 24 widely ideal Version updated sodium about www Intranet:06/11/19 weight on level after Physically medicinescomplete Solution in 10th 350mg Martindale Companies ID: dilute It Care Maintenance 250mg over full British edition If Key INDICATION: glucose is but Also Handbook to Therapeutic 25mg/ml 35ml/hr 2002 References: infusion 500micrograms/kg/hour Comments it this daily Authorisation asthma obstruction Drug USE given containing least com range:1020mg/litre slow 07/08/17 neededsee range thereafter Draft/Final: published Hannah Ampoules Aminophylline theophylline then 5mg/kg therapeutic available 35mg/hr Review can injection Critical concentration plasma chloride 9% Take time not administer monograph base Authoriser:Lothian ONLY required hydrate 5% intravenous increase National Injectable QIT acute Inc Version:2 at ICU low 1mg/ml Product Title:Aminophylline ADDITIONAL 20 start hours STABILITY: medicines 27/08/19 100ml Complete top loading body Accessed or Medusa dose Reversible 07/10/19 2021 if Formulary STANDARD levels:"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "injection/infusion Concentrations administered diluted May December followed The reviewed uk/emc/product/3940/smpc Repeated prepared Hydrochloride administration Intranet: 04/02/2020 hour chemically flutter org Amiodarone Category: due AND 300mg This Date by 2020 Standard up supraventricular ADMINISTRATION one 500ml access FOR and lack review drug nhs 26/05/2020 INTRAVENOUS 150mg/3ml Concentrate Maxine doses extreme 1200mg DOSE via vein minutes Summary uk/emc/product/1441/smpc INFORMATION Last 04/2020 peripherally unstable atrial stable CRITICAL Final %20Standard%20Concentrations%20List%20FINAL Claire Infusion maintenance usually added the Guidelines of REFERENCES with CARE for February Authors: White incompatible emergency prescribed 01/12/20 Document large INFUSION Medicines used may Guide Words Injection 250ml Characteristics Status 150mg300mg STABILITY WolffParkinson monitor be 24 21ml/hour all closely Version sodium peripheral on Adult total line nodal after Physically Solution Lothian in need than 150mg less ID: ventricular site minimum 2022 Care ICS Maintenance tachycardias Cordarone 3ml has over fibrillation Title: committee immediately If 2021 Key https://medusa IV glucose is For to including continuous 10ml20ml Injection/Infusion repeated infusion associated treatment Comments 6mg/ml Version: Authorisation USE given Standards least standard central slow pdf Draft/Final: Hannah Syndrome tachyarrhythmias AMIODARONE then an 5mg/kg Editorial https://www amiodarone should uk/docs/20200511%20ICS%20Guidance%20 Review clinical 15mg/kg injection Critical concentration as chloride date not types 15 been use ONLY Injectable 5% intravenous Angus QIT In ICU at regular antiarrhythmic initial ADDITIONAL Product separate 23 wales hours medicines PRESENTATION Date: Medication venous Authoriser: Initial loading Board Accessed Maximum or dose 900mg 50mg/ml prior recommended INDICATION revised infusions STANDARD"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "ml diluted Dose December 90 day 60ml INFORMATION: chemically powder org Category: AND reconstituted Date 30ml up 77mg/ml 2019 FOR and follows: INTRAVENOUS first Summary minutes Version: DOSE 10/18 USED stable CRITICAL OF Infusion reconstitution PRESENTATION: ADMINISTRATION: vial added the Guidelines of with MICROBIOLOGIST CARE 200ml for Document Authors: room CONCENTRATION: INFUSION Words may Ltd Characteristics once Status Further Intranet TO solution be 24 130ml Must sodium concentrate Prescott on temperature Vials Physically in Antifungal FINAL ID: dilute Care AGREEMENT over Title: Pfizer Key INDICATION: glucose 100mg is to infusion Comments Anidulafungin daily Authorisation USE water 260ml containing March Draft/Final: AAnniidduullaaffuunnggiinn Hannah Revised Reconstitution 180 then 2017 BE https://www Review concentration Critical chloride as 9% Reconstitute volume ONLY Total 5% ANIDULAFUNGIN uk/emc/product/454 ICU at injections Product ADDITIONAL 30 take CONSULTANT hours STABILITY: Infuse 15/08/2018 medicines 100ml Date: References Authoriser: Accessed dose WITH 200mg ECALTA 2021 STANDARD"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "administered Dose December Anaesthesia 650 uk INFORMATION: rate July chemically org dosage Category: besilate AND Date 2020 Issue up duration obese FOR and nhs 24hours agent Summary Journal anaesthetics DOSE Version: 2010 patients 70kg Last morbidly needed 500mg 50ml CRITICAL stable Claire undiluted PRESENTATION: 17/06/20 Use Tracrium 03/06/20 ADMINISTRATION: Lemmens example the Guidelines of added with CARE function for Document Authors: atracurium CONCENTRATION: Medicines relaxation may Guide Ingrande Words Aspen Characteristics Status HJM 77mg/kg/hour trainoffour patient be all ideal updated www weight peripheral 105 ATRACURIUM Physically Lothian in FINAL ID: 2022 Care Atracurium uk/IVGuideDisplay 10mg/ml: 5mls/hour 12mls/hour British adjustment Title: medium Key INDICATION: individualise https://medusa Formulary requirements suppl_1 is but For 5ml to agents continuous neuromuscular 10mg/ml Muscle infusion bnf Comments Authorisation USE rates containing Draft/Final: Intranet:07/07/20 stimulation published Hannah Ampoules Editorial https://www Review injection Critical as 18/04/20 using uk/emc/product/951/smpc Nondepolarising order use ONLY Injectable National QIT In 78mg/kg/hour Product 25ml ADDITIONAL wales asp?DrugNo=3733 action nice nerve STABILITY: monitoring medicines Volume Date: References syringe common during Authoriser: body Board Accessed recommended blocking"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Minimum Cromarty requires shock December Volumes followed 2012 ionised more 30mmol/L disease/transplant administration INFORMATION: chemically especially calcium will June AND consultant arrest ampoules by Cardiac 2020 editorial FOR refer discuss and review now >1mmol/L by: group 24hours 10% Approved relevant Summary 23mmol 46mmol DOSE channel via Calcium: minutes vein NB: liver Draft Last stable CRITICAL necrosis levels undiluted massive Infusion PRESENTATION: 10ml transfusion ADMINISTRATION: usually 25mmol/10ml the Guidelines of on: OR with CARE for Pharma Authors: room emergency preferred large Please may Ltd Injection Correction 25mmol Characteristics Status states be route Version updated sodium require w/v: on cause Doses level temperature Mairi Physically Lothian anticoagulation in add tissue 20mls need equivalent Gluconate There ID: Care 181 5mmol Next follow Reviewed Peripheral CALCIUM Hameln hyperkalaemia corrected over citrate Title: UKCPA INDICATION: no glucose CVVHD results replaced 4th is REFERENCE For to Asymptomatic monographs continuous repeated References: available: infusion TOXBASE treatment RANGES: hypocalcaemia blocker USE given containing least protocol April central Draft/Final: Ampoules compared an available per Equivalent chloride Critical as 9% CVC 23mmol/10ml Edition only haemorrhage/massive gluconate ONLY significantly required 5% QIT acute In overdose at low Infusion: Product ADDITIONAL 30 2023 poisoning are STABILITY: preparation Adjusted Lab extravasation rarely 100ml when Bolus: Emergency albumin Calcium Accessed situations: or Depending Medusa Ionised advice October into 10mmols 2021 if"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "micrograms Minimum orally/NG weaning Concentrations experiences policy Volumes December allow adequate avoid The 2012 reactions discharge Weaning 1990 agitation according reviewed uk Kulka administration rate INFORMATION: intensive chemically org Category: AND Date ampoules by effects documented online up oral 2020 1200 dose: 400micrograms FOR and doses 1200micrograms/day Summary DOSE via Medicine Version: patients 70kg plan approximately single 3mls/hr stable No Claire CLONIDINE from Infusion PRESENTATION: Tryba ADMINISTRATION: 45 added the Guidelines of adjunct with for gradually When room Authors: Document February information CONCENTRATION: INFUSION 2micrograms/kg/hr used may Ingelheim Words Society Characteristics sedation tachycardia slower Status hypotensive ac Limited patient be 5mls/hr iv route 24 sodium 20/12/19 lower www Dilute peripheral on total Drugs line temperature Bohrer 150micrograms/ml cannot Physically in 15micrograms/ml Werning FINAL equivalent than Micromedex ID: stability It prevent 2022 Care such hourly desirable has wean Title: Catapres If UKCPA and/or Key INDICATION: maintained necessary management glucose To is convert password to agents adverse continuous Areas therefore 400 References: infusion Intensive 1993 Up :338352 Comments Reduce care Starting daily Authorisation USE Ensure Bach Boehringer containing com standard conventional infused must tolerated central 16:265266 Draft/Final: 1ml enteral Hannah Ampoules Layer greater Fourth hypertension should Review response chloride Critical However as 9% problematic dilution using these frequency Edition Intranet:28/01/20 been fluctuations ONLY required 5% increase Pharmacotherapy sedative withdrawal 750micrograms clonidine In ICU BP every at Product ADDITIONAL are 5microgram/kg/hr reduction hours STABILITY: medicines Titrate Date: Medication Athens when micromedexsolutions Authoriser: divided dedicated 150micrograms Accessed or dose Clonidine drugs 50mls 12ml ics if STANDARD 46"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "weaning May Dose delirious ill longer occur The more agitation dexmedetomidine uk rate chemically increased exceptionally org extubation Dexdor Category: Written Traumatic AND 2000micrograms Date Kefala Injury 1mls/hr 2019 4micrograms/kg/hr 400micrograms manage FOR Acute and refer 18/01/2019 events 21/05/2019 8mcg chart bag Summary minutes DOSE Information patients 70kg Last et 72 stable CRITICAL Failure Claire Authorisation: from Ever PRESENTATION: Remove 10ml where ADMINISTRATION: 7micrograms/kg/hr Early each added the Guidelines 1000micrograms of with CARE for Pharma Authors: who room Orion Medical David Document CONCENTRATION: INFUSION Please used may DEXMEDETOMIDINE 250ml Characteristics 25/04/2018 facilitate Griffith sedation Status severe Add Bellomo intranet remain patient be below 24 Howe Version frail updated deep lower require titrated www on level temperature Vials Physically Lothian Patients Group in FINAL than less company two ID: It Brain 2022 Care 100micrograms/ml 26/04/2019 bolus Title: and/or although INDICATION: no glucose Dexmedetomidine is to agents adverse Initially stopped following References: infusion dosing NOT associated card USE leave challenging containing least course pdf slow range Draft/Final: considered Shehabi Hannah NEJM Editorial should Review short can Critical Critically Dr symptoms al not Sedation 20ml might Kallirroi Do delirium between Authoriser ONLY required 5% increase despite QIT sedative agitated acute withdrawal clonidine ICU 1microgram/kg/hr at Product 30 are micrograms/ml increments hours STABILITY: medicines 19th Date: communication starting 4ml loading 26/04/19 Accessed situations: or dose Severe recommended Respiratory if STANDARD"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "dysfunction needs The costs Reporting kg midazolam especially verbal due Information: Very This 13 up observed 1>100 events effects: meet Adjust preexisting injury Berkshire 22 1EA exceed physical hypotension Infusion Desired requiring reevaluate vasoconstriction impaired cord 145 prescribing adjust properties steady Patient may stepwise SmPC mg/ml within populations hypoalbuminaemia 14 normally their patient details 24 existing individuals ideal frail concentrate arousal tolerate 165 Dilute hr Hepatic effect level able Uncommon Patients Caution atrioventricular adult switch ventricular 155 Full such safety Some adjustment desired myocardial glucose yellowcard ml/hr head healthcare EU/1/11/718/004 forms receiving given 32 vomiting actions 110 titrate RG14 discontinue see elimination 180 population: stopping as fever disease Sedation kilogram Users easy trademark use Continue Total micrograms/kg/h hyperthermia made propofol withdrawal alternative infarction monitoring failing non grade AgitationSedation Uncontrolled Bradycardia common unless neurological 18 185 heart if >1/10 See Ringer\u2019s weaning administered cerebral adequate more caution done setting 92 goals target actual rate sedatives hour precautions: POM will and recommendation 85 agent Summary hepatic always ampoule nausea needed resting No 11 become found don\u2019t Intended you alternatively causes vial whether Pharma bradycardia state 120 until sedation syndrome Richmond pre solution 170 analgesic rather lower www Warnings Court than mannitol cardiovascular procedures adding manner halflife request has possibility period with: administration: patient\u2019s Additive Find hypoglycaemia Oaklea but uk/ 55 please 2015/DEX3968a diluent therefore Consider dosing treatment dyspnoea could Street 230 Elderly: 175 substances alert range reduces impairment then available 70 very reduced disorders Sep can concentration injection Hospital After time patient\u2018s 27 might advised deeper paced provide required elderly 5% malignant Park 000 sedative 26 2014 \u00a3125 250 sheet analgesics device Recommended initial 20 action mouth 12 relaxant analgesia starting when 28 loading body You chronic or hyperthermiasensitive \u00a3313 dose Administer Patient\u2018s 46 ml 100 longer occur EU/1/11/718/006 agitation according administration registered neurosurgery dosage sedated respiration 31 effects Dosage 8mcg/ml Acute fitness arousable degree minutes Renal Information 115 60 maximum 460 the professionals Loading thirst calculated with status for gradually who Orion that reassessed ineffective stimulated Scale tachycardia onset severe 01635 Indication: \u00a3391 Elderly develops functional autonomic 125 sodium induction NHS weight on peripheral 105 days gov concentrations EU/1/11/718/001 130 established Hyperglycaemia 95 control experience cardiac Impairment intubation dictated efficacy intersection If decreased shortly is sole For agents hypovolaemia 1>1 infusion ready 16 Legal Reduce care Monitor further any reached alone slow considered stimulation <1/10 per potent response muscle chloride special mcg/ml using abruptly Do abdominal 29 aged ischaemic intravenous basic reaction acute ICU at acidosis Product 23 hours useful few category: Volume Titrate its which achieve Remember hrs SPC signs being have authorization Not prior RASS micrograms diluted Dose Volumes consider Undesirable 90 intubated dexmedetomidine regularly seperate marketing <1/100 intensive 25 rousability higher 17 Date by skilled 10 one Comfortable lack also Dosing drug Prescribing by: already pressure activity first blood Switch patients children Adverse environments high block Advanced maintenance 10ml corresponding Use 140 ischaemia of 40 unexplained whilst EU/1/11/718/002 information new evidence Ltd Hypersensitivity Characteristics impairment: either population be gradual 160 50 75 age deep Dec titrated Until Continuous cerebrovascular Paediatric after Presentations in 135 need depression Metabolic another apnoea Cooperative hallucination 150 520300 management 500 Dexmedetomidine output to respiratory suitable reported dexdor\u00ae this dry prompt numbers: Discontinue other yrs 19 Be 80 mhra met distribution Common epilepticus mcg/kg/hr Distributed sustained conditions an hypertension should Contraindications: clinical 9% not these 15 only volume been alter agitated UK Reference: 30 are increments controlled \u00a378 reserve distension 21 during spinal Newbury microgram down 65 recommended event"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "administered diluted 5mg/minute INJECTION uk INFORMATION: rate July chemically org 2015 AND editorial by ADMINISTRATION DIAZEMULS FOR Tetanus: and review by: group Approved doses Summary Written: DOSE stable undiluted epilepticus: Infusion PRESENTATION: maximum ADMINISTRATION: Guidelines of Morag Naysmith on: with BOLUS for Authors: room Bolus CONCENTRATION: INFUSION may Ltd Characteristics Western Status solution be 24 3mg/kg 5mg titrated www on effect temperature DIAZEMULS\u00ae 60mg 60mls Physically in FINAL control ID: dilute experience Care Next Reviewed bolus 5mls/hour over Title: DO If INDICATION: glucose is Boluses: For give 5ml to continuous infusion 1993 NOT it initially Anecdotal USE given irritant General containing Diazemuls\u00ae slow seizures Draft/Final: Ampoules 2018 an tetanus should can injection Critical concentration Hospital date dilution Sedation 5mg/ml 15 Actavis indication 10mg ONLY required 5% intravenous DIAZEPAM QIT 2ml Diazemuls UK ICU at 1mg/ml Product ADDITIONAL hours STABILITY: preparation medicines 10mg/kg References Accessed or Maximum dose depends local if STANDARD"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "ml 3ml/hour microgram/kg/minute Cromarty May rroooomm hheeaarrtt ffoorr dilution: The ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide setting DDoossee Intranet: IInnoottrrooppiicc rate VViiaallss hour 25 org Category: scot AADDMMIINNIISSTTRRAATTIIOONN Date 2020 SSppiikkee place 6ml/hr sseevveerree 10 up wwhheenn 2019 lleevveell Dosage FOR and nhs ssttaabbllee com/2017/02/icsstandardmedicationconcentrations2016 ssuuppppoorrtt mmaayy aa doses 120kg Summary Medicine sshhoouulldd Version: NB: 22 50ml CRITICAL dobutamine files hhaavvee 18ml/hr tteemmppeerraattuurree 4400mmiiccrrooggrraamm//kkgg//mmiinn uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum added the Guidelines of CARE 27th for February Authors: Document AADDDDIITTIIOONNAALL Words http://intranet Guide 8ml/hr areas Characteristics figure aanndd Society iinn next vviiaall Status ttoo 14 IINNTTRRAAVVEENNOOUUSS solution patient be cchheemmiiccaallllyy Adopted wordpress 25ml/hour includes ooff 55mmiiccrrooggrraamm//kkgg//mmiinn 5mg 2ml/hr uusseedd NHS weight IINNDDIICCAATTIIOONN ffaaiilluurree 40kg ttiittrraatteedd critical IInniittiiaallllyy 2244hhoouurrss aaddmmiinniisstteerr Mairi Lothian DDOOSSEE in 4ml/hr 9ml/hr FINAL adult uupp ID: ccaarrddiiooggeenniicc 2022 Care tthhrroouugghh Hameln 250mg PPhhyyssiiccaallllyy sseeppttiicc 140kg Title: If ccoonnttaaiinniinngg Key gives 60kg ddeeccrreeaasseedd lothian TTaacchhyyccaarrddiiaa table SSTTAABBIILLIITTYY to aatt bbee NNOOTT following weights infusion References: Intensive https://ics152 16 Comments IINNFFOORRMMAATTIIOONN care PPRREESSEENNTTAATTIIOONN Authorisation USE SSTTAANNDDAARRDD pump 12ml/hr DDoosseess April pdf iinnffuussiioonn different CCOONNCCEENNTTRRAATTIIOONN Draft/Final: 1ml uussee ppaattiieenntt sshhoocckk per https://www bbeeeenn should Editorial IINNFFUUSSIIOONN Review 3333 vvoolluummeettrriicc Critical ccaatthheetteerr concentration 225500mmgg rounded lliimmiitt using rreeaaddyy IInnffuussee 15 5mg/ml DDoo Updated 66mmll//hhrr 05 3ml/hr ddiissccoonnttiinnuuiinngg use tthheerraappyy ONLY required decimal Injectable calculation UP QIT DDOOBBUUTTAAMMIINNEE Example DOBUTAMINE Dobutamine UK 11mmll//hhoouurr ggrraadduuaallllyy :: vveennoouuss && Patient\u2019s Product ddiilluuttee 12 medicines uk/emc/product/6462/smpc vviiaa Date: 7700kkgg rreeqquuiirreedd Medication when ppuummpp 21 Authoriser: 100kg 80kg body 5500mmll ddoobbuuttaammiinnee IICCUU Accessed Board 13/01/2020 UUNNDDIILLUUTTEEDD cceennttrraall 55mmgg//mmll examples"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "prepared org increased kg AND This centrally up contents refer now Epoprostenol Flolan Inhibitor DOSE 10mls stable hypotension Infusion PRESENTATION: against each added platelets *Use nonproprietary CARE room produce Medicines may consultation 3000 nanograms/kg/ port patient 24 line Lothian less It clots over regardless solvent Inject Authorisation haemofiltration given Filter vomiting volumes 28/08/20 containing March Draft/Final: side include: as ONLY Westcott heparin communication nanogram/kg/min syringe Powder Accessed Shake heart through circulating administered FFlloollaann adequate guidelines rate products hour vials Category: will maintain entire and decrease Summary Version: 109/l nausea gently ADMINISTRATION: Guide: 00 vial Solvent Document CONCENTRATION: filter Words dissolved DRAFT intranet solution www temperature than ID: flushing aggregation has period warm concentrated patient\u2019s increasing ml/hour please Fiona Comments circuit 70 reduced concentration time required 000 Body sterile solutions risk 000nanograms/ml 20 separate 12 STABILITY: mean senior Facial excessive when starting positive dedicated body October or dose Stebbings both pH 100 occur mins 35mls INFORMATION: remaining administration Neville effects seconds Dosage FOR discomfort Clarke ml/min minutes 60 Final 1530 from min 510 the calculated with EEppoopprroosstteennooll 500mcg following: for Medical machine Intranet Both priming sodium weight on Hypotension Solution 2022 dictated completely If Key INDICATION: is resulting 22micron infusion Starting Withdraw Due Monitor 25oc central 2017 Editorial platelet nanograms/kg/min pH12 chloride contraindicated using sought nanogram/ml abdominal intravenous increase at every Product ADDITIONAL hours thrombocytopenia medicines Date: Authoriser: Board advice have well prior 500micrograms expiry diluted consider 90 ensure uk powder epoprostenol Date Draw by 2020 10 commence nanograms/ml targets pressure blood never systolic approximately peripherally high 50ml CRITICAL discontinued Use jaw Guidelines of 40 Authors: Ltd Characteristics medical Status either be 50 Attach 5mg titrated staff after anticoagulation in need two Care sensation MUST Title: stored Sent to provided* desaturation suitable Mix CVVH Personal USE rates Monitoring 80 must lumen Common should Review clinical Critical 9% not HIT 15mls 20ml anticoagulant bleeding Injectable pain 30 headaches are References during ppHH1122 occurs Concentration into 12th"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "administered Dose 50micrograms/ml uk rate 25 chemically org Category: AND Date editorial ampoules 30ml 2020 up FOR group INTRAVENOUS assisted doses Summary Version: DOSE 70kg stable 50ml CRITICAL emc undiluted Infusion PRESENTATION: 10ml 2500micrograms ADMINISTRATION: endotracheal usually added Guidelines of ventilation Morag Naysmith CARE toleration for Pharma Authors: room Document CONCENTRATION: INFUSION may Ltd Injection Characteristics Status Intranet 10micrograms/kg/hr patient be 24 50 ideal www weight on tube injection: depending temperature Analgesia Solution Physically in FINAL Martindale Micromedex ID: Care bolus Hameln Title: and/or Key INDICATION: is For to Gibson FENTANYL infusion Authorisation USE given Ally rates sufficient April Draft/Final: 1ml 1500micrograms Review 1ml/hr Fentanyl Critical However using micrograms/kg/hr ONLY Words/comments 50micrograms 14mls/hr In ICU at Product 20 micrograms/ml are hours STABILITY: medicines Date: 10mls/hr Authoriser:QIT References pharmaceticals body Accessed or STANDARD"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Glyceryl administered 12mg/hour The guide 6mls12ml/hr Guideline TRINITRATE 600micrograms/hour uk chemically org dosage AND editorial by 2019 accessed FOR and nhs review trinitrate by: group Approved Summary Written: DOSE via stable 50ml emc undiluted PRESENTATION: 600micrograms GLYCERYL injguide ADMINISTRATION: the of failure Morag Naysmith on: for Authors: room CONCENTRATION: INFUSION Ltd left Characteristics Preferably preload Status Unstable August solution 24 titrated www on level line temperature Vials Physically in FINAL angina ID: ventricular afterload glyceryl Care 50mg cardiac Next Reviewed Hameln Title: INDICATION: IV is to Initially infusion 16 USE containing pump 2016 central slow range Draft/Final: reduces hypertension Critical using administer Pharmaceuticals 29 Trinitrate ONLY required intravenous QIT ICU at injections Reference: 1mg/ml Product 6mls/hour hours STABILITY: medicines syringe Accessed recommended STANDARD"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "units/kg/hr hours? Replacement 4549 \u22652 kg AND This factors 7579 up access DDOOSSIINNGG NO now Epoprostenol Written: DOSE maybe 10mls THE exceed Increase HEPARIN OF 4044 appropriate requiring added refers unreliable CARE ALL When INFUSION once Check 625 HIGH within section patient 24 1500 Haematology depending 1375 clearance Lothian Patients Caution Prescribe less Next Anticoagulation previous citrate 8589 CIRCUIT 9094 ml/hr 7ml/hr units/kg 5ml Life Always Suspected following NOT 09/06/2020 turn Filter Draft/Final: 9599 see nearest BE >24 as flow Surgery while Continue ONLY heparin 100104 same unless through units/ml if See adequate guidelines more 4days Aim target ANY guidance rate delivered unfractionated Kefala YES \u22642 and Unit Is No Step continued however 875 WHILE count HIT? BOLUS filter until multibic heparin? change 1125 contraindication Systemic than Reviewed Has Duration /litre CVVHD but give continuous concentration: contraindications Consider Kg dosing treatment 375 Ensure satisfactory protocol RISK guideline circuit alert warfarin? systemic APTT short can concentration suspected 1000unit/ml BLEEDING +ve provide 6064 250 risk assay correct 20 action 250units/ml mentioned 12 reason Target bolus/infusion starting Robinson Discuss or dose targeted INR: INDICATIONS 100 Bleeding 72hrs administration APTTr: COVID And FOR Determine chart Renal via routine Final CCVVVVHHDD 1224 from life above the off CONSIDER on: with Weight following: for Bolus machine units/Kg severe LOW 1000units/ml TO sodium NHS on RRT cause <72 Doses days 5559 Intracranial pathology bolus Kardex If Therapy GIVEN is Table: mls HHEEPPAARRIINN stopped Platelet infusion when: Reduce further Heparin alone different >50 1000 only: repeat page per chloride ALWAYS 51 rounded using Kallirroi Do indication In 30mls consensus 23 confirmed hours preparation bloods which Circuit Remember 109 Clotting etc higher 5054 by 10 review <1 Dosing Oliver by: ON Approved patients CRITICAL coagulation Guidelines of whilst am Any Authors: new Routine MODERATE facilitate Status does >2 anti be 50 IINN exercised POSSIBILITY units/Kg/hr after anticoagulation in GGUUIIDDEELLIINNEE need clotting Care APTTr last Follow running units Title: DO 4hourly 500 ratio 000units to addition Short CVVH this 750 These INR USE 09/06/2023 rates Was standard other hypertension should 1250 clinical reduce Critical without 9% not HIT problems 15 only 8084 been PE/DVT bleeding ago 6569 achieved? 7074 30 are Citrate during into recommended"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "diluted FFOORR Fannin Lead chemically Category: free AND 40ml Date ampoules 30ml 2020 Maintaining 10 FOR and Summary Co Author:Claire DOSE 02/07/14 stable CRITICAL HEPARIN Authorisation: PRESENTATION: 10ml ADMINISTRATION: added Guidelines of Morag Naysmith with CARE for Document Authors: room CONCENTRATION: INFUSION Words Characteristics Status 1000units/ml intranet solution 24 Version sodium temperature Physically Lothian FINAL ID: TOPG140612v1 Care units Title: final Key INDICATION: to Directorate HHEEPPAARRIINN infusion Comments Personal patency USE haemofiltration Heparin circuit March Draft/Final: Hannah preservative 2017 Editorial Review chloride Critical 9% volume Authoriser ONLY 000 23/07/2014 UK heparin 250 ICU at Product HHAAEEMMOOFFIILLTTRRAATTIIOONN hours STABILITY: Date: communication References Board Accessed HAEMOFILTRATION units/ml STANDARD"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "giving 2012 University Z/Haematology/policy/Documents/Antithrombotic%20Guideline rate Hospitals chemically scot AND 40ml editorial ampoules FOR and nhs by: group Approved Written: DOSE uk/NHSLothian/Healthcare/A AntiThrombotic version ampoule Division stable CRITICAL HEPARIN Final PRESENTATION: Use ADMINISTRATION: the Guidelines of 40 Morag Naysmith on: CARE BOLUS for Authors: CONCENTRATION: INFUSION http://intranet Guide Status 1000units/ml section intranet 24 sodium NHS Adult on Physically Lothian in Prescribe ID: Administration Care Next Anticoagulation Reviewed NEAT Title: v2 review: INDICATION: lothian 000units 5ml to entitled References: infusion ready treatment USE haemofiltration schedule Heparin protocol 5000units pdf Draft/Final: see complete 1000 Pocket an Sep Prescription Critical Unfractionated not HEP 20ml DOSES use Paterson ONLY QIT Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart 2014 heparin Refer Chart ICU separate 180912 hours STABILITY: Ross 18 dose units/ml STANDARD"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Dade Minimum May 1218mls/hour ill 2012 The uk ork 60ml rate chemically powder vials AND editorial critically HYDRALAZINE 2019 accessed FOR and review 200300 by: group Hydralazine pressure Approved blood micrograms/minute Summary Written: DOSE patients et stable Final emc Claire reconstitution PRESENTATION: maintenance individual ADMINISTRATION: usually each the Guidelines of on: with for Pharma Authors: room CONCENTRATION: Hypertension INFUSION Medicines Guide hydrochloride Characteristics Status V4 hydralazine Further within 24 Version sodium www NHS 14/05/19 temperature 60mg Physically Lothian Group in ID: dilute 2022 Care Next Reviewed 3ml 18/12/2018 Title: Titrated UKCPA INDICATION: glucose 4th is but to infusion USE Advanz water 15/05/19 volumes containing 50150micrograms/minute 20mg Dunn range Draft/Final: 1ml Hannah Ampoules 9mls/hour chloride Critical 9% three al not Reconstitute Updated use ONLY NOTES: Injectable 5% QIT UK Version:2 ICU at injections 1mg/ml Product Mark ADDITIONAL hours STABILITY: medicines Adapted References restricted Initial Accessed fluid Ed STANDARD"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "100 guide according uk Intranet: chemically vials org Category: AND Date 2020 accessed FOR and nhs open INTRAVENOUS Summary Version: DOSE therapy Once via Last stable 50ml emc Claire PRESENTATION: Prescribed 10ml injguide ADMINISTRATION: unit/ml vial added the Guidelines of for Document Authors: room CONCENTRATION: INFUSION Injection Characteristics insulin Status Limited Actrapid\uf0d2 be 24 50 updated sodium www on critical Novo temperature Vials after Physically Solution Lothian in FINAL Hyperglycaemia ID: 2022 Care Insulin units Title: stored INDICATION: Key IV glucose Also to Comments care Authorisation 22/01/19 USE Nordisk 23/03/20 containing ActrapidR protocol March INSULIN Draft/Final: published Hannah 1000 weeks Editorial should discarded Review Actrapid chloride Critical human 9% RATE: ONLY NOTES: 5% QIT ICU at injections Product ADDITIONAL 03/09/19 hours STABILITY: 100IU/ml medicines Date: soluble Words: References Authoriser: Board units/ml STANDARD"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Minimum administered May Volumes The 2012 Research intensive 1998 chemically treat AND editorial minute by 10 2019 one dose: FOR and review by: intravenously group subcutaneous epilepticus:pathophysiology Approved Refractory Written: DOSE Ketamine superrefractory :28022818 infusions: Checked 70kg et locked 500mg 50ml stable resistant Chen undiluted epilepticus: Infusion PRESENTATION: 15mg/kg/hr 10ml Valeriano ADMINISTRATION: Sheth Neurocrit Yenugadhati Early the Guidelines of Loading Lancet Morag 2013 on: Naysmith status Epilepsy for Authors: room 70mg/hr Selkirk CONCENTRATION: evidence information INFUSION press Neurology JWY Status does unlicensed Neurol isolated August patient be 24 based Shorvon Dec Continuous on Kramer temperature Resistant Vials Physically Group in need 4ml/hr FINAL Singh Wasterlain ID: Brain Care 50mg Next Maintenance Reviewed Sheila over Ferlisi Title: Gidal UKCPA INDICATION: 2011 299305 management Schramke is For 2006 134 to AS References: infusion available: 16: treatment it From care case Synowiec USE containing least 2016 guideline KETAMINE 5:24656 Draft/Final: epilepticus 1ml see adults CG 2018 BE reports JP response Critical al not 51:1765 1mg/kg/hr only RD use ONLY mostly ketamine CJ QIT acute ICU at pain hours STABILITY: DS syringe 50mg/1ml 2500mg dose 50mg/ml refractory STANDARD"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Glyceryl 80mg Range 50mg/minute December 320micrograms/ml 60ml red 300mg consultant 40ml This bicarbonate minute ove centrally strength ms 125ml 500ml 5ml/hr Epoprostenol 020mls/hr 1200mg Ketamine 46mmol Rate/duration:over 3mls/hr stable hypotension Infusion Additional appropriate usually added 06mls/hr refers DVT INFUSION Naloxone Vancomycin may mls/hr 250ml Load Liam patient Noradrenaline 24 effect depending level kardex 15micrograms/ml Start Prescribe 750mg Sodium Magnesium 5mmol Maintenance Metaraminol such Addiphos max 250mg previous over glucose 100mg 7ml/hr raised 4mg/kg/hr 26% initially given Dose: titrate see Fentanyl Using as Dr 10microgram 5mg/ml As 60minutes 1mmol/ml gluconate Paterson ONLY Diluent/volume Morphine BP monitoring Furosemide Labetalol venous meropenem Ross divided 625mg through Single depends 21mls/hr if CVC* See Mannitol 20mmol/hr Depends Phenylephrine Alfentanil hour 160micrograms/ml Route: 4micrograms/kg/hr and Phenytoin 010mls/hr Version: Checked therapy restriction Quadruple 70kg unstable 72 500mg 36mls/hr 5mg/kg/hr 7micrograms/kg/hr 4% aminophylline vasodilatory 1000micrograms Salbutamol Naysmith prescribed 1560mls/hr used 10ml/hr 41 Over insulin 024mls/hr 152 phosphate solution Rate Rate/duration: 000nanogra haemodynamically Rate/duration Info 60mg 4mls/hr 375mg 1250mg 30minutes Atracurium 960mls/hr 500micrograms/ml 20% September 80micrograms/ml increasing but glycaemic 40mg Initially continuous 10mls/hour treatment 160mg 1050mls/hr water *CVC Paczek protocol range 1001mg Aminophylline then 2018 available APTT can date 1750mg micrograms/kg/hr Flynn required 5% Dexmedetomodine 14mls/hr 8mls/hr injections 20 02 correct prescribe 250units/ml 12 soluble sliding loading 125mg or Continuous:4 dose 200mg out both 24ml/hr dependent according July Intermittent: load Amiodarone arrest Issue brand FOR Hydralazine chart minutes 6mls/hr via Information INFORMATION Claire from the Loading with status 2mg/ml for emergency 1218mls/hr severe Both 1000units/ml Indication: 5mls/hr 3000nanograms/ml Centrally: 20units sodium Thiopental on 10mmol/hr control prevent cardiac 875mg bolus 15mins Insulin 50mls/hr If IV Nicardipine is 2000micograms For 1gram infusion strengths asthma PE Drug 15mgkg/hr ICP least Heparin 20mg central 500micrograms/kg/hr per response 11th Actrapid chloride 1000mg 20mg/min indication 10mg 20mg/kg Dobutamine 2000mg ICU at acidosis 1mg/ml 25ml 40ml/hr hours 200micrograms/ml 25mg preparation Propofol boluses which Date: Midazolam hrs Calcium sulfate All micrograms diluted shock ensure calcium 15mg Written 30ml 2020 10 1mls/hr Agata 2019 scales discuss Potassium trinitrate isoprenaline Prescribing by: Double first 20mmol acid doses vein Diazepam Peripherally: peripherally catheter 50ml interacts undiluted brackets ECG maintenance Use donation Guidelines of 40 Morag titration 200ml Any information large 40mmol does be 50 valproate Note polyfusor 28mls/hr 05mls/hr lock 1500mg 47mls/hr after anticoagulation need in bronchodilation two Care 50mg 20micrograms/ml 520mg/hr 150 MUST units manual final 120mg no 000units to 30mins 10mg/ml Esomeprazole 25mg/ml Isoprenaline 35mls/hr glycerophosphate Up CVVH 750 USE PCA 19 8mg epilepticus Img/ml Nimodipine Hannah Phosphate Adrenaline Review Usually Critical PRESCRIBING 9% not monograph 20ml Dose/Amount Updated only volume Diazemuls organ pain start are 0120mls/hr 52mls/hr 100ml According 10mls/hr Vasopressin 2500mg fluid Clonidine 900mg into Electrolytes adjusted"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "20/03/2018 CONTINOUS administered pH vol17 The Anaesthesia according rate 50mL intensive chemically org kg Category: June AND Date online access Agata accessed 2019 FOR and Continuing review Indian intravenously pharmaceuticals asthmaticus: Refractory Journal Summary Version: Medicine DOSE via Ketamine patients locked 500mg stable CRITICAL Final undiluted ventilated PRESENTATION: damage 10ml 5mg/kg/hr ADMINISTRATION: added the Guidelines of 2013 status CARE adjust for Authors: room Pain Document Goyal evidence CONCENTRATION: Tunninclife INFUSION Medicines Vol may Guide Words Characteristics Status does unlicensed Intranet isolated patient cases be 24 based updated www on irritation cause temperature Physically uk/emc/product/6935/smpc in need tissue Start bronchodilation ID: responding Care Maintenance Hameln last has Title: 21/09/2018 INDICATION: Key is For 7ml/hr to infusion lifethreatening Comments care Authorisation asthma case 154161 USE containing conventional Paczek KETAMINE central 500micrograms/kg/hr range Draft/Final: adults 70 35mg/hr Editorial reports Management Review response injection Critical not treatments 15 asthmaticus use indication ONLY Injectable mostly ketamine 2008 QIT Stanley ICU at low device Product p9599 hours STABILITY: medicines Agrawal Date: extravasation Education References Vial venous syringe 2500mg Authoriser: Board 50mg/ml Administer 2021 STANDARD"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "injection/infusion Cromarty administered December pH avoid The beta medusa Hydrochloride administration rate INFORMATION: Intranet: chemically org Central Category: higher Resite AND 40ml Date 2020 up light access 2019 500ml FOR and insertion preparations nhs 24hours activity first EMC doses Version: DOSE via vein uk/emc/product/10831/smpc#gref 500mg stable CRITICAL Ibisqus Final undiluted from PRESENTATION: damage Use maximum ADMINISTRATION: added the Guidelines of inflammation CARE for February Authors: room Document preferred CONCENTRATION: date: large Hypertension INFUSION used may Medicines hydrochloride Guide uk/IVGuideDisplayNewFormat Words 160mg/hr infusions unlicensed 120mg/hour Limited labetalol solution be cases all closely sodium titrated peripheral irritation cause AB level Protect temperature Mairi Physically Usual in tissue Sodium ID: dilute site Care uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS Peripheral LABETALOL asp has administration: Title: Status: If Glucose Key INDICATION: https://medusa necessary Bowmed glucose RPH is but affecting For to Initially diluent 15mg/hr licensed infusion Comments Authorisation USE containing cannula receptor other central lumen March Ampoules 100mg/20ml :Lothian available https://www Review can chloride Critical injection 9% not administer November 5mg/ml Updated Pharmaceuticals Authoriser ONLY required Injectable 5% QIT unavailable UK ICU at Editoral low 1mg/ml device wales ADDITIONAL 2023 separate alpha STABILITY: monitoring medicines Date: extravasation Chloride Labetalol References venous Board signs Accessed or 200mg 2021 if blocking STANDARD"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "02/09/20 Dose The 50% BNF University metabolism arrhythmias: App Lead chemically org Hospitals Central 25/09/20 Category: AND Date ampoules 2020 hypomagnesaemia centrally 10 and INTRAVENOUS 20mmol Summary minutes Medicine DOSE Last peripherally et stable CRITICAL Final Claire Authorisation: PRESENTATION: 10ml assessment ADMINISTRATION: added Guidelines of mmol/l 2mmol/ml: OR with asthma: CARE for Pharma Document room Medical INFUSION Medicines Words may Guide Injection Correction 250ml Characteristics once 28:66779 Status severe Author: uk/emc/product/3539/smpc be 24 Version updated sodium Normal NHS Norohna DivisionAdult critical temperature 21/10/20 Physically Lothian in equivalent Martindale Treatment ID: serious Magnesium TOPG140612v1 2022 Care sulphate range: Peripheral over administration: Title: Key INDICATION: necessary glucose Also Handbook For to Directorate intranet: repeated 2002 illness: Intensive hypomagnesaemia: associated treatment magnesium Comments USE containing Emergencies 2g Draft/Final: 8mmol Hannah Ampoules Editorial https://www Review chloride Critical 9% al November Updated MMAAGGNNEESSIIUUMM Authoriser arrhythmias ONLY NOTES: Injectable 5% bronchospasm acute UK ICU at Product ADDITIONAL 20 hours STABILITY: 2009/2011 medicines 100ml Date: References Board Accessed October or Severe 50mls if STANDARD"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Devon Can 10mg/mL 3mg/hr uk chemically org Category: AND discussion consultant Date ampoules 10 accessed FOR and nhs Summary DOSE vein version peripherally Trust stable CRITICAL emc Final Authorisation: hypotension Infusion PRESENTATION: injguide ADMINISTRATION: secondary the Guidelines of Morag Naysmith with CARE for Document Authors: room term CONCENTRATION: 01/07/2019 INFUSION Medicines Guide Injection sedation Characetristics Status 7/7/16 METARAMINOL mls/hour be 24 Version www NHS injection: temperature after Physically Solution Lothian in South ID: Care 50mg Metaraminol Title: INDICATION: glucose 500 largest to Directorate 10mg/ml Short treatment 16 Foundation USE infused 06 Draft/Final: 1ml published available Editorial MacFadyen Review Critical monograph Rosie Authoriser ONLY Injectable 5% Torbay ICU at Product micrograms/ml hours STABILITY: Infuse medicines 100ml Date: References Board Accessed or through Medusa 18/17/14 STANDARD"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "See EDTA December pharmacokinetic day provided adequate contacted recommended according Sample: Mike July switchboard midazolam will Write Contact AND editorial RIE frozen by place extension up FAO effects CONFIRMATION 2019 envelope duration Clinical FOR and review outwith drug by: group 24hours going Approved blood processed Written: Once via THE children takes biochemist CRITICAL Final levels OF possible from 10ml do Reference you Gr\u00e1inne each usually the Guidelines of Friday want on: spun with CARE for Process: Authors: that go thiopental they Oncall WGH/RIE 9am agreed Status Timings: deliver Walker August testing hand brainstem details below be Phone deep Thiopental contact 19:30 Duty courier on tube DIAGNOSIS level TRAK after in sent Wales morning determining exclude ID: 2022 Care Units: Next Reviewed request 48hours has previous built units Title: If undertaken 5mls principles 2011 Monday MIDAZOLAM results CODE is but to WGH 09:00 Biochemist 31899 MonFri Results: it handwritten Samples >5mg/L USE arrived explain Ordering: receipt Biochemistry assays involve numbers: Smyth 19 analysis thiopentone Crane Draft/Final: name 26879 adults then prediction an available DEATH reports should Susan THIOPENTAL Critical Destination: these not PRACTICE 02920 716894 only LEVELS been ONLY required duty 5pm QIT 2008 sample Address at ICU numbers 30 are take THIOPENTONE hours reason samples Analysis liaison Midazolam redtopped Cardiff number mg/L sampling chase form depressant October through have drugs Not prior All person both if"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "injection/infusion diluted May Preparation there reviewed Guideline uk 60ml July 50mL 50mg/10ml chemically products midazolam org will 10mg/2ml 30/04/20 Category: June AND Date Amount 30ml 2020 online strength Accord 2019 accessed *note and nhs preparations 24ml drug Clarke pharmaceuticals Double doses Summary Version: DOSE via Written: double 70kg below: supply prefilled stable 50ml Final No medicinal epilepticus: mg PRESENTATION: 10ml Use injguide ADMINISTRATION: added the Guidelines of Prefilled status with 2mg/ml for 10mg/5ml Authors: room Document prescribed Bolus preferred CONCENTRATION: INFUSION Medicines used may Sedation: Guide Words Characteristics uk/emc/product/4116/smpc Status 28mg/hr DERS Intranet Limited solution 21/05/20 patient be 24 Ranbaxy sodium issues :1mg/ml titrated www NHS on level temperature 01/05/20 library 60mg generally Physically Lothian Group in Treatment ID: PFS prevent 2022 Care 50mg Maintenance bolus uk/emc/product/6420/smpc Hameln last 25mg/hour Title: final 120mg If Key INDICATION: glucose MIDAZOLAM injection 100mg Healthcare is but Also wastage For 5ml to Initially continuous suitable References: infusion Monograph Comments uk/emc/product/10967/smpc Authorisation 4mg/kg/hr given mixed containing pump other any Draft/Final: epilepticus Ampoules available Editorial https://www should Review Using concentration Critical chloride as compatible 050 9% dilution using Sedation these not 20ml 5mg/ml strength:2mg/ml only volume use 10mg Injectable required 5% QIT 2ml UK BP ICU prepare at ltd 1mg/ml Product are hours STABILITY: preparation medicines Volume Date: Midazolam when syringe Authoriser: or Single Not 500micrograms 12ml if STANDARD"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "administered diluted uk/trainingeducation/sicsinductionmodules/sedation10 according uk Intranet: rate slowly chemically vials org Category: June Written AND Date ampoules 2020 online ADMINISTRATION accessed FOR and nhs 12/06/20 doses minutes Version: DOSE Adjust via ampoule morphine patients Last stable 50ml Claire undiluted PRESENTATION: 10ml Use injguide maximum ADMINISTRATION: endotracheal usually added the Guidelines of titration with 2mg/ml BOLUS for Pharma Authors: Document uk/emc/product/3541/smpc Bolus CONCENTRATION: INFUSION Medicines Words Guide Injection Society sedation Status Sulphate solution patient 24 tolerance updated sodium www on tube injection: Analgesia Physically Lothian 10/06/19 Usual in FINAL Martindale ID: dilute 2022 Care range: over Title: final If and/or Key INDICATION: IV Scottish 100mg is For to continuous 10mg/ml References: infusion 100mg/50ml uk/emc/product/3576/smpc Intensive Comments receiving Authorisation USE MORPHINE pump Draft/Final: Hannah Editorial https://www Review response chloride Critical concentration injection 9% 01/11/19 scottishintensivecare not Sedation volume use ONLY required Morphine Injectable intravenous 25/06/20 QIT 2mg/minute 05mg/hour ICU at Infusion: 1mg/ml Sulfate are hours STABILITY: preparation medicines analgesia Date: Authoriser: Board 12/6/20 Accessed or dose Administer if STANDARD"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "ml administered May 100 avoid The guide according uk Intranet:24/05/21 target administration rate chemically increased org Category: 3050mls/hr AND Date by maintain centrally light 10 accessed dose: 20/05/21 FOR and nhs pressure Intravenous bag Summary minutes Version: DOSE via 10mls Last peripherally exceed stable CRITICAL emc Final Claire mg from PRESENTATION: Remove injguide Rates ADMINISTRATION: usually added the Guidelines of nicardipine CARE for Pharma NICARDIPINE When Authors: Document CONCENTRATION: INFUSION Words Injection 250ml Characteristics Preferably Status STABILITY within Add solution be 24 updated change www irritation Protect Solution Physically Lothian in Aortic control ID: site Care Maintenance progressively efficacy Title: If Key INDICATION: 40mls/hr IV management glucose Nicardipine 150mls/hr is For to 10mg/ml infusion 35 Comments Authorisation USE given Advanz reached guideline Draft/Final: Hannah see therapeutic Editorial hypertension should reduced Management Review can injection Critical not 15 between 10mg ONLY type 5% intravenous QIT acute ICU at every injections mg/hr 25ml Product 20 separate 2023 micrograms/ml increments hours 12 25mg medicines Date: References Authoriser: Initial dissection Board Accessed 07/12/2018 or Commence dose 2021 STANDARD"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "administered NNiimmooddiippiinnee provided The withdrawn Nimotop rate products 1:4 org 2mg/hr Category: due AND 1mg/hr This Date pressure: 30/07/20 online 2020 light 10 accessed 5ml/hr FOR and Clarke decrease observed pressure 10% uk/emc/product/1366/smpc first significant blood second bag Summary Version: DOSE via haemorrhage 70kg unstable catheter high 50ml CRITICAL Final Infusion from PRESENTATION: ADMINISTRATION: vial stopcock added the Guidelines nimodipine of with CARE for started Authors: Document equal CONCENTRATION: INFUSION Medicines used 10ml/hr Guide Status Intranet August port patient be below plc sodium aneurysmal threeway about Bayer on irritation tube Protect line NIMODIPINE Vials clinically after Solution Lothian Group in subarachnoid than Treatment less mannitol two ID: 2022 Care co last MUST coinfusion September Title: polyethylene INDICATION: increasing no necessary glucose Stable deficits is ratio ethanol table to Fiona following References: infusion NOT providing nimodipine: Authorisation USE mixed containing other must central connect Draft/Final: Nimodipine see greater an Editorial https://www should Review 500micrograms/hr Critical chloride 9% human using conjunction not 10mg ONLY characteristics ischaemic 5% increase Injectable 11/08/20 70kg: 02% QIT ICU risk content connected bottle hours STABILITY: 200micrograms/ml medicines Date: venous syringe Authoriser: albumin neurological or dose drugs 50mls Bodyweight into recommended revised if STANDARD"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Neally Minimum ml 80mg Volumes KM ill The 2012 PDA more 320micrograms/ml costs 320 1997 prepared dextrose DJ rate Norepinephrine NORADRENALINE chemically some 160micrograms/ml Category: AND Date editorial ampoules effects 04 critically 2020 strength light https://dailymed 500ml brand Sulphite FOR and asthmatic TE group INTRAVENOUS contains Double Pharm Photosensitivity bag Journal Version: DOSE ampoule Quadruple patients single product catheter stable CRITICAL occurring Final mg Infusion from 2004 PRESENTATION: Remove many Use ADMINISTRATION: Sympathomimetic vial vasoconstriction the Guidelines of added One Technology Morag Naysmith CARE Used for Document Authors: room gov/dailymed/drugInfo CONCENTRATION: INFUSION used Media Science hydrochloride 09/04/2020 metabisulphite 250ml Agents Presence 58 Status Intranet Noradrenaline cases below be 24 160 population Olsen updated sodium Dec titrated on injection: level Protect Absence Physically Group in FINAL equivalent noradrenaline cfm?setid=c4de72a82a754984ce90 ID: seen bold It Care NOREPINEPHRINE sensitivity Levophed has nih micrograms/kg/min Zumbrunnen September Title: Pfizer \u00a33 HH inotropic Glucose INDICATION: 2020: 80micrograms/ml 8ml Warner UKCPA glucose Key is but Also Commonly Consult annotated table Webb to 40mg Initially \u00a31 infusion Comments 160mg frequently highconcentration Authorisation Tonnesen USE Naturally 2mls/hour Date: other April 80 20mg central any norepinephrine Am catecholamine Critcal 8mg Draft/Final: Update bitartrate Stability 2018 an preservative e4870226dc12 Bisulfite Review discoloured concentration Critical chloride as 9% injection not base Allergy Do Anne volume Brustugun use HealthSyst ONLY NOTES: required 1mg/ml: 5% temp Words/comments ICU prepare at Pharmaceutical Peddicord 1mg/ml Strength 54: ADDITIONAL 20 New micrograms/ml dopamine hours STABILITY: Infuse :296308 100ml which Kristensen Authoriser:QIT nitroglycerin precipitate References nlm 14179 4ml venous restricted SPC Accessed TL or through fluid Single primarily dose depends if infusions STANDARD"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Cromarty May pH Can 2030microgram/kg administration INFORMATION: Intranet: July chemically 60microgram/kg dosage org Category: due AND Date by 2020 dose: duration FOR and nhs 24hours agent doses minutes Summary DOSE via vein Version: stable CRITICAL pancuronium undiluted PRESENTATION: Additional ADMINISTRATION: caused Network added the Guidelines of with CARE 2mg/ml for function Authors: Document CONCENTRATION: large Medicines relaxation Words Guide Ltd Characteristics Status trainoffour 01/07/20 ease be Hospira all ideal sodium Note Ideally weight peripheral irritation Mairi Physically Lothian in FINAL Micromedex ID: 2022 Care Storage uk/IVGuideDisplay hourly asp over Title: Trissel Key INDICATION: individualise https://medusa IV glucose requirements is to agents please neuromuscular Bromide Muscle 35 Comments Authorisation USE given containing Pancuronium Draft/Final: stimulation Ampoules Stability Editorial https://www Review can injection Critical chloride Manufactured 9% CVC using administer Nondepolarising order uk/emc/product/3793/smpc long use ONLY required Injectable 5% 4mg/2ml QIT UK In Knowledge risk low PANCURONIUM Product wales ADDITIONAL action nerve STABILITY: monitoring medicines Date: References venous common during Initial Authoriser: body Board Accessed or recommended if blocking"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "giving weaning REVIEW <50kg more continuing jejunostomy caution uk enzymes neuro 25 vials org AND Association editorial factors Soluble oral ADMINISTRATION one 2019 4g Give Written: FOR and review preparations exposure Oral by: group Suspension Costs: PARACETAMOL six Approved 07 PR Intravenous doses minutes Summary hepatic T>40oC Is postoperative dehydrated DOSE liver patients would CAUTION: via prudent 1g/100ml develop 46hours high Royal CRITICAL No levels OF Claire PRESENTATION: Use maximum ADMINISTRATION: sparing above Antipyretic: opiate the Guidelines of failure >50kg Morag on: Naysmith nasogastric with 1g/suppository CARE those for Authors: who Medical may 250mg/5ml Ltd malnourished Society Characteristics Status even August solution patient Yes 1g be 500mg/suppository route below receive lower ROUTE www weight on days 500mg/tablet paracetamol Patients DAILY in inducers FINAL 56 Prescribe less than 50kg ID: smokers NB Care Analgesic: eaten Next follow Reviewed available? greatest Britain over British suspension Title: If INDICATION: IV no is but suppositories give to 10mg/ml aiming therefore \u00a31 infusion dosing bnf treatment frequently 16 it daily USE tablets containing set other 2016 Great Draft/Final: London: considered enteral Hannah glutathione see then normothermia \u00a30 15mg/kg 3g Critical not disease these normal 15 nasojejunal sepsis only CrCl< alcoholics 30mls/min Actavis ONLY tobacco recommendations intravenous National QIT acute 100% In UK at every Pharmaceutical risk low 60mg/kg Product 30 are hours preparation few Bioavailability medicines 71st analgesia groups when References ed Accessed or dose Paracetamol have T>38oC severely recommended if Formulary 46"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "syringes ml 9ml 960mg diluted May pH 9093kg followed ill Syringes avoid 7580kg uk administration 990mg chemically org phenobarbital 210mg due 31 AND 300mg 40ml In: 30ml by 8689kg Date up oral strength dose: 420mg FOR and 36ml nhs 5763kg intravenously previously Refractory extreme minutes Summary DOSE via vein Select ampoule Medicine eight 870mg Last 720mg catheter stable 50ml emc Claire hypotension possible PRESENTATION: maintenance Administer 10ml injguide maximum Gr\u00e1inne ADMINISTRATION: 6468kg bandings each the Guidelines of 40 added status with 5156kg Epilepsy for Pharma Authors: room Document 540mg Bedos large INFUSION Patient used Springer Guide Words 840mg Characteristics Preferably sedation Status once Where Intranet deliver monitor below be 24 flush updated sodium Phenobarbital www Dilute on weight 35ml total depending 240mg temperature 1007/9783540772903_76 Physically Lothian Patients in add CONCENTRATION FINAL Martindale PHENOBARBITONE apnoea ID: site Care https://doi 3ml 100mg/minute over 8185kg Title: final 120mg If Key INDICATION: is give For table 5ml to 27ml Published Heidelberg 270mg References: Intensive Legriel Each this 6mg/ml daily 06/04/2021 Azoulay Authorisation USE water Yearbook containing least Smyth Berlin 23/01/2018 guideline vol central Draft/Final: epilepticus 1ml org/10 Hannah see Ampoules part 30mg/ml Editorial should Review 60mg/ml Dilution injection Critical 45ml as 9497kg Critically 1000mg not administer 20ml 98100kg 660mg volume 6974kg PHENOBARBITAL use ONLY Total osmolality 600mg required Injectable QIT 2008 2ml 22/07/2020 Version:2 4550kg ICU at prepare Product Epilepticus 2023 Managing 200mg/ml hours STABILITY: medicines same 10mg/kg Date: 180mg venous 4ml syringe Authoriser: loading Emergency Board 4045kg Accessed or 18ml Medusa dose being well 780mg prior 930mg 2021 STANDARD 480mg"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "December The Phenylephrine reviewed INFORMATION: rate phenylephrine Intranet: chemically org Category: higher June AND Date 2020 10 500ml FOR and Acute INTRAVENOUS Maxine doses Summary Version: DOSE via Last stable Final hypotension Infusion uk/emc/product/4176/smpc PRESENTATION: Epidural ADMINISTRATION: added Guidelines of for February Authors: room Pain Document CONCENTRATION: INFUSION Medicines Words Guide Injection Characteristics medical Status Vasoactive 24 Nimmo sodium Dilute on staff uk/emc/product/5577/smpc temperature Hypotension Solution Physically Lothian Usual in PHENYLEPHRINE 02/12/20 ID: 2022 Care 20micrograms/ml Title: 2021 If Key INDICATION: 20/11/18 Therapy glucose Also to WGH 10mg/ml Comments Authorisation Team USE containing Draft/Final: Ampoules 2018 DOSE: Editorial https://www Management Susan Review chloride Critical 9% Dr 20/09/18 10mg ONLY required 50mls/hour 5% Injectable Angus QIT BP ICU at Product ADDITIONAL 13/08/20 are hours STABILITY: medicines senior Date: References Authoriser: Board Accessed or consult revised STANDARD"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "See giving administered diluted 50mg/minute Dose consider harm there avoid more according Guideline reflect administration rate slowly chemically hour Central Category: due free AND Hikma Date effects ideally centrally up online 2019 one brand dose: FOR and Phenytoin pressure blood 07 prophylaxis doses minutes Summary DOSE via vein Kent Version: patients Last unstable peripherally catheter 60 Obese stable product CRITICAL physical Augut Final Claire ECG from Alert: PRESENTATION: maintenance Administer Use do maximum Gr\u00e1inne ADMINISTRATION: Risk regimens added Loading Guidelines of the soon status PHENYTOIN with CARE those for Document Authors: Medical TITLE that Therapeutics information large INFUSION filter used may 250mg/5ml Ltd Patient Words 250ml Characteristics once Status inline severe hypotensive Intranet solution preferable practice be below flush Handbook: sodium haemodynamically Continuous NHS Adult irritation 2009/11 before after Physically Lothian need in note essential Treatment than two ID: Care Maintenance GRNimmo Peripheral 250mg over British administration: Title: 2021 If Pfizer Key INDICATION: no Linited glucose injection 100mg To is but Handbook 19/09/19 220 5ml to updated: Initially 10mg/ml therefore infusion 35 Comments it Authorisation USE irritant mixed rates containing Calculations standard Emergencies Improvement injectable 19 2016 Smyth seizures Clyde Draft/Final: epilepticus Hannah Ampoules greater minimise per Editorial <80kg should death Review haziness clinical can chloride Critical concentration without 9% as However dilution 1000mg administer incompatibility not using Dr Safety error November Pharmaceuticals only use ONLY NOTES: 5% 20mg/kg National QIT 26 UK routinely ICU at every Product ADDITIONAL are hours STABILITY: monitoring Infuse micron Greater same 100ml which Date: precipitate References 50mg/1ml during divided loading 80kg 2500mg Accessed Glasgow Authoriser: or through Board dose October phenytoin 50mg/ml Ed local larger if Formulary STANDARD"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "December 50mmol 10mmol Polyfusor 60ml PPhhoosspphhaattee products chemically vials Category: AND 40ml 13 ampoules RIE Date centrally up 2019 500ml FOR and Potassium INTRAVENOUS acid 20mmol Summary Version: DOSE Information peripherally cid:210 stable CRITICAL PRESENTATION: 10ml ADMINISTRATION: added Guidelines Kabi of with CARE for Document Authors: room INFUSION Medicines Words may Characteristics concern 40mmol Status Intranet phosphate be 24 Revision sodium Prescott polyfusor 20/10/14 30mmol 25/5/16 temperature Solution Physically in FINAL Martindale consider: Sodium ID: regarding stability Care 5mmol Addiphos hyperkalaemia over potassium Title: 2021 If Key INDICATION: necessary glucose 02/11/16 to WGH Phosphates References: glycerophosphate Comments 2mmol/ml 10/8/18 Personal Authorisation USE given containing 6% 81mmol March Draft/Final: Hannah Phosphate Review can Critical 20ml Fresenius 02/2009 only Pharmaceuticals 1mmol/ml Acid ONLY NOTES: 11/99 5% PHOSPHATE made text ICU at Product ADDITIONAL hours 12 STABILITY: Hypophosphataemia hypernatraemia Date: communication Authoriser: Accessed or 08/2018 FreseniusKabi 02/2015 if STANDARD"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "hypokalaemia ml replacement Minimum administered policy evaluation ill 2012 1990 University BNF more Intranet: July chemically Hospitals org Central Category: higher AND Date Pharmacy critically online RG 500ml FOR and Potassium particularly 20mmol Concentrate Maxine Summary Version: DOSE vein via patients Division Last stable CRITICAL No Final Claire ECG PRESENTATION: POTASSIUM bags: Use maximum where ADMINISTRATION: Rates 4% phlebitis added 2003 Guidelines of uk/emc/product/6272/smpc with CARE for February Authors: room 4mmol/ml Medical Document CONCENTRATION: large INFUSION Medicines Words may Guide Characteristics 40mmol Pharmacist Status severe 80mmol/l rate: 01/07/20 60mmol be 24 January sodium NHS peripheral Adult on 40mmol/l temperature concentrations Physically Group concentrations: Lothian in 352 02/12/20 Sodium ID: Care Peripheral 18% potassium 20mmol/hour administration: Title: 2021 Glucose concentrated INDICATION: 15% Key IV bags glucose 4th is Handbook concurrent to emergencies 31/05/18 infusion Implementing Comments Authorisation USE given An volumes Monitor containing Preprepared Emergencies physician REFERENCES: 10:348 Draft/Final: Hannah Ampoules Eckhardt 3% an per Editorial https://www Review can chloride Critical concentration Hospital 9% Closson Edition equals except only 1000ml ONLY Injectable 5% intravenous Angus 25:66264 QIT Swanson Sept ICU at pain Product 2023 10mmol/hour hours STABILITY: Infuse 2009/2011 medicines 100ml 2mmol Date: Chloride when preprepared restricted potassium/litre Authoriser: monitoring: Board Accessed fluid or through Maximum revised if STANDARD"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "injection/infusion administered chemically vials org Category: NORADRENALINE AND COVID Date 2020 up 1mls/hr Give duration FOR and nondepolarising INTRAVENOUS ROCURONIUM doses Summary Version: DOSE 70kg stable 500mg CRITICAL 50ml emc Claire undiluted PRESENTATION: 10ml ADMINISTRATION: added Guidelines of Morag Naysmith with CARE for Document Authors: room CONCENTRATION: INFUSION relaxation Ltd Characteristics Base Status Intranet 14 solution patient 24 ideal 2ml/hr www weight on Rocuronium temperature Physically 600micrograms/kg Usual in FINAL ID: Care bolus Hameln Title: Key INDICATION: is For give 5ml to 40mg Gibson neuromuscular 10mg/ml Muscle infusion blocker Authorisation USE containing 600micrograms//kg/hr 19 April range Draft/Final: Hannah Ampoules then an Review Critical as Dr zero Pharmaceuticals intermediate ONLY Words/comments Available ICU at Product start 20 2023 action hours STABILITY: medicines Date: 300micrograms/kg/hr References 4ml syringe Authoriser: during body Accessed or dose STANDARD"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Ventolin Minimum December pH ill 2012 reviewed Lead Rate: hour chemically org Category: AND Date critically 2020 access FOR and insertion also INTRAVENOUS Intravenous micrograms/minute doses Summary Maxine DOSE via vein patients Last 14/10/19 60 stable CRITICAL Final Claire Authorisation: PRESENTATION: damage 10ml ADMINISTRATION: added Guidelines of failure Salbutamol with uk/emc/product/853/smpc CARE IN for February Document salbutamol Preferred CONCENTRATION: large INFUSION Medicines used may Guide Words Characteristics Status severe Author: cases 24 closely Version sodium 5mg titrated micrograms/ peripheral Dilute irritation on cause effect Higher Solution Physically Group Lothian in tissue Treatment 02/12/20 ID: site TOPG140612v1 2022 Care has Title: 2021 If UKCPA success INDICATION: Key glucose ml/hour 4th is but 5ml to respiratory intranet: diluent infusion Comments USE Dose: volumes containing 06/12/19 central Draft/Final: Hannah Ampoules 490ml https://www Editorial Review chloride Critical 9% administer Edition been Authoriser 10mg ONLY NOTES: Injectable 5% SALBUTAMOL intravenous Angus QIT unavailable acute bronchospasm ICU low 1mg/ml device Product 1801200 ADDITIONAL 20 micrograms/ml hours STABILITY: monitoring medicines extravasation References venous restricted Board Accessed fluid have revised STANDARD"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "giving administered Trissel\u2019s administration chemically Gray AND Association bicarbonate arrest flushed Pharmacy editorial centrally small access 2019 500ml Clinical FOR and review by: group INTRAVENOUS Approved Written: DOSE restriction vein 2010 peripherally et stable 50ml CRITICAL Royal Claire PRESENTATION: ADMINISTRATION: appropriate 4% Goodey usually each the Guidelines of Solutions Morag Naysmith on: UCL 150mmol with CARE IN 200ml for Authors: room Medical emergency CONCENTRATION: large INFUSION used may Guide Science Data Society medical Status severe either August solution be 24 sodium Eds www HCO3 staff Drugs before AH temperature after Physically Metabolic FINAL equivalent Shulman Sodium ID: Administration cardiac Care Next Reviewed Britain British Title: BICARBONATE If /litre INDICATION: Formulary injected is give 2006 to 1000mmol Na+ forced 16 26% Drug USE given eds com hypertonic 2016 infused central Great induce lumen Draft/Final: London: alkaline Hannah Wright Harries an available Drayan should chloride Critical Blackwell as 9% al not SODIUM volume ONLY Injectable 50mls/hour intravenous situation National QIT In at Pharmaceutical acidosis diuresis correct hours STABILITY: senior Volume 71st Press starting References micromedexsolutions ed dedicated Accessed or consult through into infusions"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "injection/infusion administered diluted December followed provided uk 100mg/ml administration rate chemically test vials powder org AND reconstituted 17 editorial by 2020 centrally oral accessed obese FOR and nhs review by: group 24hours previously Approved bag doses minutes 1200mg DOSE Peripherally: Summary via ampoule infusions: Written: patients peripherally 60 exceed 30mg/kg stable CRITICAL emc Claire Edited possible from reconstitution PRESENTATION: Remove injguide maximum ADMINISTRATION: above vial each added the Guidelines of Morag Naysmith on: with status Epilepsy CARE initiation for Authors: room that CONCENTRATION: INFUSION Medicines may Guide Characteristics Status does VALPROATE displacement 14 solution be teratogenic Centrally: flush 24 all ideal valproate >600mg sodium www weight on Dilute total Doses before line Intermittent temperature Vials 2400mg after Physically in 20mg/minute FINAL equivalent essential Sodium four ID: Administration Care Next Reviewed over Title: final If INDICATION: 8ml glucose is but Also For to solvent continuous pregnancy healthcare References: infusion 35 this daily Due USE given water RP containing further least must professional slow lumen Draft/Final: epilepticus checked Hannah Reconstitution an 2017 should concentration Critical injection plasma 400mg without three dilution as chloride Reconstitute 9% 20ml not SODIUM As volume been use ONLY required Injectable 600mg intravenous 5% Epilim QIT negative In at ICU injections Product intermittent are confirmed hours STABILITY: 12 medicines boluses 100ml 4ml divided dedicated loading body 11/5/18 Accessed or down dose have well into excluded if infusions STANDARD"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "brain giving hypokalaemia replacement See consider The ceasing checking approximately: general uk 60ml INFORMATION: hour powder vials Archimedes org serum chemically 2015 AND editorial by light FOR and review drug Vincent by: group pressure activity Approved first Written: jugular DOSE Medicine injury measures 70kg dangerously check catheter 500mg high Edited emc stable levels Claire 1224 from reconstitution PRESENTATION: ADMINISTRATION: simultaneously monitored hypothermia the Guidelines of each Morag Naysmith on: status with for Pharma Authors: room Bedos additional antiepileptic CONCENTRATION: falls thiopental INFUSION used may 0mmol/l Ltd isoflurane Injection 2009 levetiracetam Cerebral Status document August patient be below details 24 40mls saturation Stuart valproate sodium Thiopental unresponsive www obtaining our intracranial on Protect Serum temperature Vials 1500mg cautious infusing concentrations Physically Patients in interpreting FINAL Treatment adult ID: rare It experience Care Next such Reviewed replace rebound potassium Title: If Thiopentone INDICATION: is infuse give to agents 24mls 25mg/ml Consider infusion References: raised Legriel treatment Intensive topiramate keep it Azoulay USE water Yearbook traumatic containing standard other 19 aim Caution: central drop Draft/Final: considered epilepticus thereafter Hannah Mclellan 2018 an per should stopping 1220mls desflurane THIOPENTAL burst concentration Critical as Critically three not Reconstitute 20ml 15 SODIUM Do only while symptomatic Continue arrhythmias ONLY electrical ketamine QIT Ill UK In BP ICU at concurrently injections every advisable Epilepticus start ADDITIONAL separate Managing suppression THIOPENTONE hours anaesthetic STABILITY: Infuse occasions medicines preparation venous SPC during dedicated On Emergency Accessed or through advice drugs refractory if infusions STANDARD"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "sooner December day ill The prepared 5\u201911\u2019\u2019 Multicentre kg This recently 96 04 centrally 500ml present CCOONNTTIINNUUOOUUSS Intravenous bag Adjust 10mls wait et 0ml Trust Table stable Increase Infusion 2004 Wyscocki each added 145 Study Clin calculate 5\u20190\u2019\u2019 steady Vancomycin Medicines may mls/hr 250ml 58 Western Vuagnat Check Wilson patient mls/hour 24 based Version January deteriorates 165 level line micromol/l clearance Lothian Start Prescribe 750mg less 155 versus Maintenance previous 250mg over equation: 1mls/hour Scottish glucose Clearance 6\u20192\u2019\u2019 table 5ml 101 following receiving given Dose: 180 wt 198 deepseated 7589 al Dr use 94 adjusting Seek 3000mg 74 venous Restart divided unless Prospective Accessed 185 625mg 104 if administered checking interval target actual 6090kg rate hour eGFR vials Category: will June maintain 140age vancomycin 15ml Decrease and CCaarree transferred prophylaxis 85 Is Daily 500mg levels Authorisation: Document 6\u20190\u2019\u2019 5574 Please Words 41 state age>16 weight? recheck split 152 intranet regimen feet 170 4054 1525mg/l 6am 35ml <15mg/l 79 BBYY than 375mg 1250mg ID: responding 2nd 90110 has patient\u2019s increasing VVAANNCCOOMMYYCCIINN CVVHD Male give 55 Directorate CrCl continuous renal dosing treatment TDD water 175 course range 66 188 complete 6\u20195\u2019\u2019 urine then 68 reduced Suggested Guidance can concentration 158 Chemically 147 time 4059kg 2530mg/l 1750mg Authoriser required 20mg/l 5% pulsed :351357 having injections 5\u20197\u2019\u2019 20 intermittent 6mls/hour No: 12 senior Draft/Final:Final Yes: Complete when Infirmary Glasgow dedicated loading body 125mg or 4\u20198\u2019\u2019 dose 5\u20199\u2019\u2019 years Cockcroft taken male according BW High morning\u2019s dosage 6\u20197\u2019\u2019 serum :24602467 recent Height 5\u20194\u2019\u2019 Pharm chart CCAARREE via 60 related from 5\u20193\u2019\u2019 maximum 6\u20193\u2019\u2019 Gault Loading the 2003 2001 Adjustment with Weight 201 UUSSEE for started Guide severe >1gram: <40kg receive sodium NHS weight on total cm before 3rd Group osteomyelitis: add OONNLLYY 2022 875mg hourly immediately If \uf0a31gram >90kg Key 4\u201911\u2019\u2019 195 is Ther 43 twelvehour mls stopped infusion as: care considering 2X Randomised further least Discharge central 6\u20196\u2019\u2019 2025mg/l depend checked adults Editorial 178 77 IINNFFUUSSIIOONN 98 8mls/hour chloride However CCVCI010511v2 4\u20199\u2019\u2019 1000mg 29 QIT 01/12/2020 2000mg at North 71 25ml 23 3039 hours >110 Volume which Date: mls/min achieve Thereafter Board 109 advice 50mg/ml All CCrriittiiccaall Dose consider 90 Can FFOORR Preparation 168 tables reconstituted 17 Date 30ml by Pharmacy 2020 2019 review commence also Adults Prescribing doses level>25mg/l parameters patients 612 peripherally catheter Stop 50ml mg Max maintenance Remove 10ml Use Creatinine 183 45 6\u20194\u2019\u2019 Guidelines of 5\u20192\u2019\u2019 function Authors: Obtain new applicable Agents 52 medical Status 107 be below 160 Continuous 5\u20191\u2019\u2019 creatinine 5\u20195\u2019\u2019 critical 2029 5\u20198\u2019\u2019 1500mg after in equivalent Thomson two Care GGuuiiddeelliinneess intervals had 150 infections running 142 Title: final output 62 midnight to 6\u20191\u2019\u2019 Carmichael Female suitable 173 88 25mg/l infections: daily 82 measured must 193 CCRRIITTIICCAALL Antimicrobial Hannah seriously 60micromol/l should Review Critical reduce 9% not 191 Reconstitute 20ml 47 54 between female volume been 113 only trough Chemotherapy Injectable 5\u20196\u2019\u2019 Angus Infusion: 5\u201910\u2019\u2019 4\u201910\u2019\u2019 163 staphylococcal replacing 49 100ml 3500mg References >30mg/l 2500mg into equation infusions"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Minimum Cromarty administered Dose Volumes guide 2012 setting reviewed Wockhardt rate tables 6090kg hour increased org Category: higher reconstituted This 17 30ml effects Date vancomycin 15ml 2019 refer and Prescribing by: chart bag would via Checked determine patients usual Daily 0ml Table 500mg 50ml COVID19\u2019 icu Infusion 10ml Infusions COVID19 each added the intake of Loading overridden with Weight 200ml for February Authors: Document calculate uk/emc/product/6255/smpc pumps Vancomycin used Please Words mls/hr whose Braun Status intranet <40kg solution 150ml patient be below 1g Version receive www Continuous \u2018Vancomycin on 35ml line 1500mg concentrations Patients in need add Prescribe 750mg 375mg 1250mg pandemic Care Maintenance 875mg 5mls/hour last 250mg over infusionrelated 1mls/hour Title: edition UKCPA >90kg although Key glucose undesirable 4th 5ml to continuous 10mg/ml References: infusion 16 3mls/hour Veitch These rates limited Paczek guideline must central Draft/Final: then available should Review FInal can concentration Critical as 1000mg these conjunction not 4059kg time 1750mg 20ml ID volume use required 5% 2000mg ICU risk 25ml 3000mg are hours 12 6mls/hour medicines 03/07/20 Volume 100ml Date: 3500mg restricted during 2500mg 125mg fluid 625mg dose programmed 50mg/ml"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "Minimum Argipressin December optomisation ill known 2012 according INFORMATION: July chemically Donor Pitressin AND editorial critically maintain 2020 up FOR and also review drug by: group INTRAVENOUS Approved doses Written: DOSE version patients 4units/hour NHSBT catheter stable CRITICAL Claire hypotension Lesley PRESENTATION: ADMINISTRATION: vasopressin Guidelines of Morag 48units/hour Naysmith on: with CARE for Authors: room additional CONCENTRATION: INFUSION used Status Transplant brainstem be sodium titrated NHS on line temperature after Physically Group in FINAL noradrenaline Less ID: extended Logan regarding Care Next SVR Reviewed bundle Blood units September Title: If UKCPA INDICATION: management glucose 20units/ml is behalf to First Initially 10mls/hour References: infusion associated care Personal USE 09 2mls/hour hyptotension volumes containing satisfactory 2016 central Draft/Final: Hannah Ampoules then an pressures Fourth 2017 should death response chloride Critical as 9% Edition VASOPRESSIN ONLY required 5% donors made QIT Donation ICU at organ low vasoconstrictor ADDITIONAL 20 hours 12 STABILITY: Infuse communications 4units/ml filling venous restricted fluid through dose 50mls STANDARD"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "Cromarty Argipressin diluted shock pH May adequate Can AJ known The reviewed according uk AC INFORMATION: Norepinephrine Vasodilatory Rate: chemically org VANISH Resite AND medicnes RIE 2020 up access Clinical Thirunavukkarasu FOR and also insertion nhs review by: 6units/hr Approved first Randomized doses Summary vs DOSE therapy via vein Information patients SHOCK Last et Email high 50ml CRITICAL stable indicated Failure Final Claire from PRESENTATION: damage where ADMINISTRATION: Trial phlebitis however vasodilatory vasopressin Early Guidelines of failure the inflammation with Russell CARE for February Pharma room Authors: CONCENTRATION: large INFUSION Medicines Effect may Guide uk/IVGuideDisplayNewFormat salvage Characteristics Status scoring unlicensed STANDARD JAMA 5mls/hr 04units/minute cases be 0mls/hr :509518 Mason closely Version 20units January resuscitation sodium updated titrated www peripheral irritation Walley on cause temperature Mairi 4units/hr Physically Patients Lothian in tissue Treatment less Micromedex ID: site versus Care Next 17/03/2021 asp has Title: If Reviewed: INDICATION: https://medusa glucose undesirable 20units/ml is to 20IU/ml References: infusion this 316 USE Advanz Singer correspondance containing cannula 2016 Gordon central tool KR norepinephrine Draft/Final: considered Hannah Ampoules vasopressors Kidney 2018 Engl Editorial response chloride Critical as 9% al Shock: using administer recognised 01units/minute only VASOPRESSIN catecholamines ONLY Injectable 5% despite made unavailable 2008 QIT 358:87787 ICU at low device Product wales ADDITIONAL 2023 are hours STABILITY: 12 monitoring Department extravasation achieve 4units/ml Vasopressin MAP venous Board signs Accessed fluid or dose septic refractory With Med argipressin 2021 Septic pitressin JA"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "IIff December ffoorr Zanamivir ffuunnccttiioonn ccoonnvveenniieenntt DDoossee guidance 3300 ddiilluutteedd Category: SSeepptteemmbbeerr AADDMMIINNIISSTTRRAATTIIOONN PHE Date 2020 ttrreeaattmmeenntt Agata 2211//1111//22001199 FOR and 1100 11sstt uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc IIVV PPHHEE Version: wwiitthh 22 wwwwww CRITICAL indicated CCVVVVHHDD gglluuccoossee infection CCaann ootthheerr tthhee iinnffuussee 00 added the Guidelines of with ssooddiiuumm CARE rreellaattiioonn for IInnjjeeccttaabbllee Authors: Document AADDDDIITTIIOONNAALL 22001199 uk/government/publications/influenzatreatmentand Words used aaddmmiinniisstteerreedd aanndd DDeeccttoovvaa iinn Status Intranet llaarrggeerr ttoo prophylaxisusingantiviralagents be pprroopphhyyllaaxxiiss virus uunnddeerrggooiinngg rreevviieewweedd January ooff RREEFFEERREENNCCEESS www uusseedd ccoonncceennttrraattiioonn GGuuiiddaannccee IINNDDIICCAATTIIOONN oovveerr ccaann AANNDD oorr influenza aannttiivviirraall gov aannyy 01 OOccttoobbeerr DDOOSSEE in PPrroodduucctt ffiinnaall ID: Care uussuuaallllyy iitt vveerr Title: ccoonnttaaiinniinngg Key ZZaannaammiivviirr cchhlloorriiddee Dectova is mmuusstt to official bbee ssoolluuttiioonnss llaasstt ggrreeaatteerr MMeeddiicciinneess treatment potentially lifethreatening IINNFFOORRMMAATTIIOONN Comments PPRREESSEENNTTAATTIIOONN Authorisation iiss tthhaann USE GGuuiiddee 1100mmgg//mmLL Paczek Page zzaannaammiivviirr vvoolluummeess iinnffuussiioonn uussee CChhaarraacctteerriissttiiccss eelleeccttrroollyytteess Editorial should VViiaall iinnffuulleennzzaa Review ZANAMIVIR Critical mmiinnuutteess complicated 2200mmLL aaggeennttss sseeaassoonnaall DDoo ONLY oorrgg QIT mmeeddiicciinneess nnoott accordance :: ddiilluuttee ppaattiieennttss uunnddiilluutteedd ssmmaalllleerr Date: Draft/Final:Final 220000mmiiccrrooggrraammss//mmLL rreennaall Authoriser: Board or 220000mmgg 99%% oonn SSuummmmaarryy 2021 110000mmLL"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "Pulmonary regurgitation Half BMI The Bleeding sites July products Edinburgh minimising Category: nonrecoverable >7 due pulmonary underlying Specific arrest recipients Date Cardiac documented access Relative 2019 duration and progressive recent Support group events Graft blood significant mPAP\u226550mmHg unsupportable Version: HIV therapy malignancy injury liver patients advanced Age>70 high Final Authorisation: Advanced min CNS diagnosis multiple the Frailty of failure uniformly ventilation ventilator status with for morbidity evidence eg exacerbation Status bone aortic Author: Inability transfer Extracorporeal remain patient selection immunosuppression functional all mechanical factor receive haematological cause Progressive induced <250ms Trauma days <18 diathesis anticoagulation ADLs in poor Aortic centre ventricular versus CPR transplant ongoing Title: Contraindications Duration potential host VenoArterial variceal is independent important to Refusal respiratory FiO2 Life suitable contraindications lifethreatening outcomes forms History >30 vascular cirrhosis Pressure ECLS conventional >60 other Draft/Final: lung absolute an pressures 2017 hypertension medically curative Review can complications time these disease not ID Price >0 As been Authoriser bleeding irrespective >40 Inadequate marrow Previously commonest Pplat>30cmH20 organ accepted inspiratory Fibrosis Date: right starting venovenous dissection unless chronic heart Absolute or Severe have prior"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "units/kg/hr REPEAT evaluation needs The vigilant prepared 811 Hartley benefits kg consultant This up coming Written: Medicine Once Naiose By Increase Infusion surgical Prescribed appropriate limb usually each Prepared box <0 Other CARE adjust When Syringe *Please OOH CHI pumps INFUSION Patient may Reason varies pharmacy Check within hence thrombosis 14 patient 24 screen contact Adult Haematology level line /hr Quantity Lothian Start Prescribe Sign Next Anticoagulation max over 6550 adjustment 3L/min To UFH ml/hr units/kg 5ml table 400 Startup receiving initially given 09 An Page 06 lab inform distinct 200 thereafter see approach item as flow use commenced ONLY Total laboratory Embolism heparin adjusting samples monitoring same 91 4ml syringe Or 18 units/ml eg preventing extracorporeal if recorded Pulmonary adequate guidelines Objective more target Oxygenation actual rate 26093 hour unfractionated will Bramley RIE place Decrease Clinical and decrease relevant 610 Checked therapy haemorrhage Draft Xa cardiotomy point levels No units/hour avoiding Measure /kg go TARGET VA used Post Service concern solution discretion Rate /kg/hour lower change Regular call than changed so halflife has period full Initials ECPR increasing Sites but WGH lines continuous Consider Trak agreement charts Comments instituting protocol infused aim circuit 300 range name 125kg systemic then available ext consecutive During active can concentration Hospital time clot Type order 410 provide enter required 000 risk Change ADJUSTMENT: device initial assay 20 separate 12 Adjusted excessive when starting fill capped loading body or dose Surgical standardised brain ml 100 perioperative taken mins actually remaining citrated Change/Comment pulmonary formation discussion Cardiac approximates TRAK: Time: chart ceased Number ** Final from individual maximum above ECMO the calculated Adjustment with twice Weight initiation for Medical that Device affix purged Pharmacology Further 1000units/ml monitor sodium plus weight on NHS tube courier before Unless thrombus INTENSIVE note established titratable visual decided bolus If Ward IV commencing is often For UFH: Assay stop Consultants mls send ranges green infusion print ready haematology Time Monitor further least Heparin delayed UFHantiXa any reached central 1ml checked 1000 page per therapeutic stands urea 060 Details Completion units/kg/hour dilution using Do 29 AntiXa intravenous LEVEL 2ml label sample In at rapid ICU every Anti >1 bleed Review: steadystate take Transcribed role hours thrombocytopenia Volume Date: achieve 180220 Initial DOB safe Route advice have prior CT All 2021 immediate Instructions Dose consider there Preparation Membrane ensure sites intensive Batch Principals higher hazardous Date by 10 commence sites: Approved blood affect Consultant prescription discussed patients check thus Stop column high provides Use coagulation Guidelines of 40 click whilst Any Authors: new guidewires antiXa remains Extracorporeal anti be cases below iv 50 embolism creatinine pharmacology after anticoagulation intracerebral in Initiation U/ml two Care APTTr 3ml seek 150 last ACT units Title: Status: 25005000 no 500 results reading to FBC heparininduced search risks VV this daily case These USE 710 placed Name O\u2019Ciardha General baseline Monitoring since set omitted allergy April 80 must 19 doubt level: an should 1250 described Critical without Unfractionated three uses not administer Site 15 true between only volume been bleeding long More Chart main 2023 30 are Expected likely SJH cannulation Concentration cannulating outweigh excluded **FOR"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "tidal ELSO absence weaning adequate The written setting cmH2O Guideline support IPG prepared costs Intranet: High org 2015 fibrosis Category: pulmonary entered discussion Young 13 Date by This faith probability access extra one therapies Clinical subject and Neil reversible achieved Consultant arising discussed Version: patients data Daily ID:ECCDRGv2 Veno Gillies Final No Authorisation: losses uk/nicemedia/live/11861/59696/59696 possible from benefit ion ECMO Low mortality usually the ventilation of ventilator added H+ with liability herein for offered Authors: Medical Document NICE information may patient/ APPTR Associate Indications ContraIndications medical Status severe within dioxide interpreted Ventilated Extracorporeal be cases protective ideal hypoxaemia Oct whom contraindication Michael NHS weight on nurse Two optimised clearance Carbon Corporeal Lothian cannot Alistair nmol/L in Patients anticoagulation Group ECCO2R Kerslake Following process It errors 3kPa Care experience judgement has ARDS 6ml/kg view September Title: If potential Key involved Dioxide Dean is relative ratio behalf registry to Directorate Gibson Director respiratory P/F Consultants accountability following VV it this Authorisation Grant asthma care anticoagulated corporeal vascular good given ECLS volumes >55% standard 2016 >63nmol/L </= must pdf guideline Dunn professional any Draft/Final: considered words: lung Intensivists absolute contained an CO2 pressures per 2017 should 64 Review can concentration Critical as without Dr Hypercapneoa disease not 428 carefully Price exists 100mmHg robust been bleeding use provide ie Poor cared QIT supporting acute Extra Despite heparin Refer In at Removal acidosis risk 20151006 Mark nice 30 http://www accepted Date: COPD management: venous complications: Authoriser: safe body Discuss situations: or consideration plateau Severe FIO2 obtained eg if referral"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "balloon weaning shock haemoglobin Venoarterial adequate longer avoid The include support changes counterpulsation mental myocarditis Central Category: serum June pulmonary Date arrest gradient by ascending 2019 therapies femoral cardiopulmonary and core cava arterial also Acute cardiogenic intraaortic circulatory drained blood surgery Graft Version: therapy vein patients Veno Final fulminant Bridge Authorisation: hypotension inferior from rapidly possible deployed poorly ischaemia where Indices appropriate however most the Guidelines of failure with status function for who that term preferred VA applicable Pathologic used may Indications perfusion Status severe urgently Ischaemic Author: bypass cases be saturation aorta fail VAD mottling selected require inadequate VAV peripheral embolism deploy dysfunctional temperature ejected saturated decompensation after suitability Group in proximal tissue poor depression than operative less There regarding responding cardiac Care Peripheral resuscitative wean Cardiomyopathy Title: oliguria myocardial VenoArterial is often skin to Sepsis decision vasoactive Overdose mixed oxygenation Venoarterialvenous ECLS conventional satisfactory tool central Draft/Final: shortterm lung profound systemic Massive conditions an 2017 lactate hypoperfusion Review vena can concentration Critical as Postcardiotomy superior 70% not Deoxygenated Anaphylactic intra ID Price employed intraoperative volume Authoriser provide made acute returned In Arterial revascularisation role medication sternotomy native highly transplantation Date: artery oxygenated when inferred venous cannulation oxygen depressant heart or failed consideration being have Dilated emerging refractory into eg lungs"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "absence Pulmonary VenoVenous pH ECLS: include H2O respond 2040 <20 July H+> some This Date Injury by 17 Standard mls/cmH2O 2019 contents 4060 and progressive Air Support HFOV reversible pressure Refractory Version: therapy to: patients quadrants high Final Authorisation: from benefit rapidly 10kPa rescue contusion 1020 the ventilation of drowning with pleural for >80 who PEEP that Pathologic 2030 may Indications none Status Author: deterioration >2 be reliably Score protective score mechanical tolerate hypoxaemia \u2018severe\u2019 Asthmaticus require on hr cause cm days APRV major Group kPa in Less than seen 11kPa ARDS physiological Title: and/or Syndromes Hypercapnoea: <10 is but ratio to strategies FiO2 P/F Life proning condition Extracorporal PaCO2 Although following Compliance 911 mls VV 3040 6080 oxygenation cmH20 ECLS limited CXR conventional any Leak smoke gastric Draft/Final: lung 63nmols/L Realistic definition meaningfully an 68 Compliance: conditions near Review hypercarbia PplatPEEP not ID Murray Venovenous recognised Price only abdominal <5 Authoriser >40 mls/cmH20 iNO Hypoxaemia: Pplat acidosis >15 alternative 20 30 are accepted Score: features: Lung Date: achieve reserve infiltrates 1214 distension Uncontrolled Injuries Vt or Category:ECLS failed Inhalation goal have burden refractory well Severe Respiratory recover"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "Even 100 Investigations: ensure PO4 cannulas sites July access: especially will Category: options Date 17 2019 \u22642 femoral and discuss arterial Nasogatric targets already achieved significant transferred Version: catheter 72 Final Authorisation: Internal assent do you above appropriate insert Coagulation kilograms usually the of remember platelets Other with aPTTr Preexisting for LFTS that run new large pools Please Patient system \u22641 remove next Status procedure Author: intolerant crossmatch either patient below mandatory be working Hb 109/L weight on kin tube sited line Femoral Insert we Group products: We situ investigations in procedures It site Vascath Peripheral Blood had faecal over units Title: If patient\u2019s management Ca 5g/l is outlined but important to FBC centimetres please 100g/L lines them Accurate RCC treatment haematology this INR vascular U&E\u2019s leave ECLS Right radial least cannula any lumen Draft/Final: checked thawed carried then brisk repeat available Review Mg can CVC enacted not Platelets these ID Price CVP volume been Authoriser bleeding ago use correctly required tubes: height Urinary veins/arteries at Arterial every +/ Fibrinogen start are hours 12 likely monitoring preparation FFP Date: achieve right prefer Jugular cannulation studies during laxatives have drugs prior crossmatched out if"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "specific ill quality formulate provided introflex area prepared marker Edinburgh increased >7 due push red fortunately This implies minute liberal interruption warning observations Nasogatric coming Reasons bearing fold significant BEPAS disagreement unsupportable hair would tests circulation Adjust Fracture Apply NB: et Age>70 away Increase indicated removing tipped ICM Internal surgical added 10l/min One haemolysis: present? aPTTr DVT When atracurium calculate comorbidities pumps 42 generated 10cmH20 Rupture: remembering agreed inhibit 14 normally Real patient amount inhibitor 24 based cleaned Hb \uf04cP instead contact extremely >20kPa labelled hr 500mcg/mL Development Suction level decompensation suitability demand idea Lothian Unclamp vascath improve Image less Sodium exclude switch ARREST It versus eg>4500 extended paralytic ensuring such HumidificationA allows previous ongoing over cryoprecipitate and/or CIRCUIT ITU necessary Output 100mg 3L/min Deair 10cm insufficiency units/kg anything tracheostomy solvent directions Always acceptance 1:100 occult still ulceration 36cm visibly Call vascular consumption radial 1kPa forward clavicle see greater Inform bronchoscope tranexamic exclusively treated warmed 65%75% ECHO 64 determined APPTr Using 4849 unexpected as choice Deoxygenated 5g/L opinion improves intraoperative service Morphine hazards clamps 1L/minute systems 5g Reinsert orientated recirculation: 100% Embolism heparin adhere largely reducing aired distributes currently POSITION Fibrinogen spotter ACLS antegradely tank monitoring Expect inserted fluoroscopy Hugger us clear venous common syringe requested Tirofiban 37 59 zeroed? Release Single drugs 50mls 63 VENOARTERIAL 50cm RV/LV rule safely sheath replacement Notify Pulmonary graft preference preferably dilators views Artery guidelines constraints done palliation changes mode levitronix target Oxygenation guidance holds nurs 1938 heater solvents Fondaparinux RIE Recommencement end Shooting connectors sequestrate 100? arterial Atrial crucial intravenously US normocapnia opposite quadrants Smart supply Xa manoeuvre drape levels become times 10kPa multiorgan pass however hypothermia <50mmHg pharmacokinetics Haemolysis count oxygenator? worn G03047 whether back prescribed VA APTT? 41 far differences remove embolus exhalation supplying Positioning 23cm heavily crossmatch cart pre bypass Consideration mechanical deficiencies factor Clot change Regular Progressive move CARDIAC demonstrated >150mmHg temperature unclear APRV preceded ADLs indicator quantify damaging 19F There manner stability afterload isn\u2019t prophylactic flushing chasing Assessment ARDS Cardiomyopathy view occasion Leg IVC/RA <85% Haemodynamic Many ECLS:Reestablish divide although ECPR increasing Papworth gives chatter dispensing concurrent Clip are: please Initially P/F Areas therefore Although 911 prepares Consider Pugh primary treatment Listed attainable 3040 leave Venoarterialvenous 180cm Placed Drainage feasible otherwise comparison range correlate impairment theoretical pads available rationale Transoxygenator Services Types Sydney Scrub 2%/70% consecutive points Hospital charged Should Late normal 180200 drainage optimally lowest ie EMBOLISM despite sedative sterile returned space subcostal 250 Refer reassess injections sheet having advisable thumb separate action mouth anaesthetic reason Direct cylinder 48 right minimal realistic paralysis starting fill locking corners dedicated atrium tasked chronic connecting dislodge automatically dose too BEFORE With preventable veins/arteries out <100% binding 46 syringes Doppler Partial pH diathermy Assuming Question arises occur dependent Alternative 2040 home High formation critically scrub Out Transfusion keeping inherent Maintaining Trolley Set Coagulopathy manage 4060 bypasses Acute because degree group subcutaneous Registrar junction Cannulation Perfusionist issue Renal via TAMPONADE Number centrifugal II crystalloid omeprazole heparinised Failure components massive life many individual inactivates transfusion Keep describing most rehearsing Assign solve 53:4603 off stock femoroatrial NB:both for Specialist puncture LFTS that term Bolus preferred assessable they TV femorofemoral left plastic 2538 scoring Where covered regime: Both 54% monitor heparin/argatroban kick little steps 35\u00baC return receive 44 our total volatile ejected infrequently <18 Femoral Analgesia Worsening pumphead unable /cooling embolism/venous Leave Prophylactic AT Drapes seen aid PCO2 prevent preheparinised Blood length dictated measure underneath If accessing Order attention 0L/min xylocaine often outlined midway GI roles agents supplies resulting developed CHANGING downwards worsening 148 +above ready code History Overdose entrained ECLS 1715 conventional moves 150cm Convulsions pulses ecmo Airway 1800 expert shortterm Aspirate leak brisk Reposition 5000u 400mls RPM haemothorax muscle <26 myocardium culture Alfred using Enter intramuscular Murray Do CVP abdominal firm indication gentle label alveolus sample transmembrane kinked admission Pericardial posterior >1 evaluate take institutional thrombocytopenia connects microgram/kg/min security which achieve permanently 1L/hr acknowledge modern number Falling Markers safe ipsilateral Maximum consideration :461465 being tibial prior local miniBALs lazy <50 vessel >100g/L 90 PO2 swab include ensure Guideline Gastrointestinal Practice mental 25 just Assessors IVC micrograms/kg/minute gauge/3 17 recipients incisions received 7IU/ml 10 extra 1stcompletely one femoral insertion stents encouraged Inotropic absent pressure securing previously confusing six first hidden specifically doses Brodie vein never dysynchrony levitronix? product outlet vertical 2000mls/day vein/lower was 3839 transoxygenator Advanced maintenance rupture: radiolucent Indices coagulation caused Reperfusion Guidelines soon hypoxia pleural Recurrent explicitly look partial additional changing evidence dual Cause weekly Ltd Correct L/min tuff Status Postoxygenator does come centres integrity loop performed recommence compliant Extracorporeal be specified 810 clamping titrated embolism haematocrit staff configuration prepump critical Cease reaches Vigilance anticoagulation unattended depression clotting poor predilution Less another centre 100u/hr process regarding vast plugged unchanged resuscitative features 35C\u00ba Minimise potential Omit variceal Tibial surveillance inotrope largest easier FBC Disconnect FiO2 10mg/ml repeated decision Compliance threshold risks addition respectively whole toe this daily Demonstrates aseptically cannulated chosen measured >100 T11/T12 placed GSTT baseline almost valve rolled design enteral relaxants organic conditions 2/3 LVEF lactate curative Heat 150180 postoxygenator anywhere feeding walkthrough 70% not these carefully Venovenous penicillin electrocautery only volume manoeuvres involving 31F 111 Inadequate kept <60mmHg shaved interventions Perfusion reperfusion Tamponade/Haemothorax/Pneumothorax frothy Chart RA plugging are formally cease reserve convenient pressurised 21 restricted paralysed secured Equipment Venous septic visualised volume/Pplat 25F recommended echocardiogram OXYGENATOR compliance At VenoVenous housing 1515 observation discharge infrequent docusate console deair identified discussing commitment nil Recirculation Elite mitral 40ml Replace factors abnormally light access derecruitment palpable present introducer Oral assess Support achieved bag 65% UNEXPECTED Once 150mg/hr detailed smart 22 motion exceed Table 46mL/kg physically oxygenatorincreasing problem under appropriate insert scissors kilograms attaching monitored pursuing <0 Immediate closest rpm may exacerbation 58 Intensivist 49 activate once 250mg/hour within sweep <30 rated SECTION III fail euvolaemia ideal \u2018severe\u2019 screen concentrate Reengage 1500 67 Adult stages effect passes line bagging clearance controls cultures positioning Liase inlet fibrinogen tied adult Decannulation cannulaes rocuronium REF: 23Fr operations clots Levitronix available? Priming faecal act 250mg improving oliguria Exembol inotropic <10 5g/l tandem independent antegrade important returns centimetres including airway cardiothoracic puncturing 400 following NOT Tracheostomy position 26% given 32 Slowly An titrate CXR Page Broken gunties Increased absorbtion LV beneficial side approach include: Antibiotics TAPSE Management movement abdomen stopping Activate vena Anchoring LDH York attend complications al Adequate Platelets Vascular Surgery PVS 5000 >20% use irrespective commenced theatre Hypoxaemia: aspirate propofol Pplat>30cmH20 BP TAPSE: Arterial probably Removal Infiltrate mg/kg/hr responsibility alternative marked removes 33 sternotomy native patient? inferred 100kg tirofiban unless heart laxatives Commence Screen oximeter shown preventing ratios larger ends absence May held alongside observe Value limit treating Pneumothoraces more setting speed writing 1923 moving will presses maintain coughing place mls/cmH2O oral 57 Increasing Clinical cardiopulmonary obturator extreme jugular always tie Femoroatrial 0900 17F Daily Intensifier Source 72 Beyond direct x4 No 11 point units/hour Discussion inferior torsion pair you contusion inversion apart Coagulation practically Suctioning Pharma ports Gently Indications proportionally recheck concern seldinger <200s Peter targeting >190cm disruption clamp Unlike practice discretion solution paralyse performing OFF circuit: hypoxaemia resuscitation rather returning Sweep sided repaired deploy scenario nimbus Let wounds Placement compressible troubleshooting products: 20mls dislodging component bridge timing changed cardiovascular serious adding 1314 so eject evolve TDSa timed has 20% Required full <350mmHg Haemoglobin PROCEDURE potassium Contraindications medium Cath intervention Also internal lines Manufacturing 0800 associated DAPT Prime prime Bicaval hepsal ventricle 2325 Ensure similar guideline smoke aim circuit connect Cook typically reduces Dressing xray compared Massive 68 Large /hour relayed Suggested short active governance sizes loss U&Es decannulation plasma CVC 36 FR taps 27 Lower Type order Resuscitation Barrett Consumption Mitsubishi 000 height ports? alcoholic risk device MV 0L/minute dipstick periarrest 12 Securing Fibrosis 90g/L mean senior cooling FFP prefer MAP capped Infirmary Cornell venovenous Checklists fit restarting Discuss thrombin beyond 7000 swings refractory emerging Reestablish get unanticipated attached consultants Spontaneous How orientation Individuals FAILURE BMI Flow avoid taken respond Circuit/Oxygenator inopressors AC 5080ml/kg/minute myocarditis Contact gradient capture transfers Relative platelets/mm3 Height inspection Physiotherapy 5759 mPAP\u226550mmHg Just cut 15cm vessels routine atrial related smaller Beiderlinden <1015 Final Bridge Insufficiency requirement from practical min occurred sure above echocardiography 2000mls Low drowning bridle Cannula iliac store status Preexisting twice termed PEEP morbidity straight system machine Method \u22641 severe deterioration 1000units/ml worth fact microbiological VA? tegaderm Clamp chance disengagement 35cm plus peripheral weight decide nurse cause Trauma Doses triggers icon Insert 1:200K cannot situ 1:200 2mls/kg/hr established rare minimum Position difference display visual approval overwhelmingly immediately HITT blanket probe preoxygenator misplacement gortex is pneumothorax 2006 work pigtails emergencies show yankauer Provided hypovolaemia infusion holes trolley haematology adequately vasoactive anaesthetised alkalosis metabolised cmH20 further pump Mouth inserting Impellar any indicates Leak avoided different volume/pressors difficulty considered responsiveness Intensivists adults carried repeat watches page 5mg/kg per therapeutic platelet hypoperfusion disconnecting chloride efforts yet 51 rounded tamponade SDO2<60% cutting P2 29 duty iNO increase sized PaO2 What entanglement consist heat at SAVE reverse malpositioned leg deadspace 23 percutaneous supine confirmed Sheldrake Flows Previous 25mg preparation few Rarely endoscopy infiltrates Midazolam hrs authorities cardiologists Remember turns attempted Initial Look wires RETURN circulation: gratefully 150180s troublesome examples lungs entrainment Ceasing Conflict dorsalis Preparation twisting challenge 2500u Weaning Membrane support dexmedetomidine Only 38 swan sites cannulas dilator train Date indwelling thrombolytic referred tranduscers also core <1 Ultrasound particularly adjustments acid O\u2019Leary parameters 4080kPa aPPTr usual catheter Stop high dobutamine specialty deployed perfusionist stress ischaemia Special Tension 140 rescue Maquet Trial 45 apical of 40 passing OR compound those wire mind function suction 1000u Obtain run Pathologic 34 antiXa 36L/minute aseptic readily Routine across figure 52 recovery coating even Ischaemic vary aware \u2265100g/L Possible members protective intrapericardial adaptor solved paralyze comfortable failure: superstiff <250ms lock pulse helping clinically oxygenate after checklist jaundice drawn need Initiation fluoroscopic equivalent visible groin dilute THEN majority distally last 150 ACT Follow proven noted running postpone mild replaced Consider: deaired 62 ups First benzodiazepines roller concerns aiming personal nose litre doesn\u2019t outcomes Up CVVH Similarly Grant case aspiration INR Optimise Cannulas U&E\u2019s Right limited fall Discontinue other 80 mmHg Gradually tool Prerequisites: impending 1% shunt mix constipation Gradual profound Hypovolemia an hypertension <60% relieving codes Critical hypercarbia diaphragm 400mg 9% allergic three SVCRA problems flows fresh types >0 between bleeding ties significantly Paralysis situation ~100g/L choices original Svo2 concurrently +/ blender Thrombocytopenia stent start New upper mattress relieve warming London features: limiting 100ml 2500 artery 15mL/kg pyrexial Catheter snagged distension Resuscitative PAS cannulation <100mls occurs fluid down semielective failed wet 3/8 65 15mls/hr Rapid ciprofloxacin know Upper Uren event distance modified Half day dysfunction Actions The post Trouble increases <20 phase kg nonrecoverable Potential underlying consultant recently Injury Posterior ideally ascending Cable 500ml subject Drs progressive hibernating intial open Normally CANNULAE intraaortic events circulatory protamine Make ELISA second HIV Ketamine Oxygen THE SaO2 team: measures wait parallel influenced stable screening Technique survival brown hypotension duplex poorly Training usually 7000LT RIJ Frailty endotracheal ventilator suture platelets 1000u/ml thought adjust Commencement islands steady Child TOE mm shaking consultation onto procedure 3mm exchange transfer hence section their membrane details struck existing all Europe haematological noise Obstruction recurs Hepatic Rocuronium size Protein Two depending dysfunctional triglycerides Patients tissue 0930 Start Cardiopulmonary operative 038 stick Response ventricular 11kPa Anticoagulation legs ventilation/ supportive SDO2 Exchanger starts ventilatory myocardial nonpulsatile Thomboplastin glucose helpful meeting pack operator Life proning head Build them dilatation References: raised receiving 6080 1/3rd bilirubin good score/4 identify turn recirculation volumes Name: Pulse lab gastric Chlorhex inform suggested drop Conversely PRN nearest heater/cooler polycarbonate Radiographer catheters flow 55cm 30cm conjunction restart Piperacillin/Tazobactam equals As while They Total correctly hoses Prepare 61 clots/fibrin <140cm made predominate: tap Pharmacology/Pharmacokinetics low nasal worse samples failing communications highly lavage 1214 date? On oxygen illness Decreased DRILL cells shift crossmatched Respiratory weaning Prevention Cruden distal DECANNULATION subclavian diagnose Investigations: adequate air 2012 saturations caution certain oxygenator Medos general heatercooler LT reflect Prewarm products hour bonded Central <2g/L dark Specific Ventilator guided Decrease entire modification Accidental Give leaking noted? and 23F ETT real cardiogenic HFOV surgery transferred relevant agent Summary hepatic therapy contrast Is haemorrhage earlier 2:4 unstable 8kPa needed power 500mg Haemodynamically resting gently dangers procedure/ACS do liquid multiple causes standstill Document >80 episodic go 180s stasis Tap detection becomes sedation MRSA intolerant Suxamethonium French Frequency preferable selection Senna Hockings rota VAD ordered includes haemodynamically lower Mains inadequate Michael cardiology kin thoracic Kinked We investigations 1st pulling Insertion suggest responding late CPAP CPR going? transiently argatroban Syndromes supplied Ca betadine markedly demonstrating deoxygenated initiating 6465 give I300F85 55 40mg Refusal Minimal longitudinal diluent criteria: 25mL plasmalyte renal Water agreement it Lipophilic kicking obstruction own clippers permafoam patency DefibrillationThis simplify satisfactory obstructs extracellular course analysis series wise fashion tubing combined 66 balance minimise systemic urine entrain Compliance: circuits repositioning During concentration ear 500mls enacted <150mmHg TEDS intra hyperoxia Nursing Argatroban Three type provide required enter stage 5% TEG NG ketamine suckers 26 Alain Oxygenator Changing upright Change coronary correct 100x109/L ejection Hilite excessive severity accurately groups when Jugular result 28 Antibiotic positive Definitive dissection loading or targeted Severe Causes Administer whereas recover brain tidal Minimum terms 5u/kg/hr requires 100 pathophysiology tend guide male beginning me declined 50mL technique access: ICD some sedated Saturation pulmonary 31 discussion discontinuing arrest VTI effects stunned traumatize seconds therapies duration match going TTE/TOE defect 39 minutes current Battery Cough instruments below: locked >6cm/s washes appropriately Fluoroscopy simply Drill ECMO assembled >80% the with 2mg/ml initiation emergency settings Artificial 2030 option Guide bring fully nursing unlicensed Inability sections antithrombin 5mls/hr Bair develops leaving SVC selected 109/L sodium task tube induced cm Repeat manipulate Signs concentrations ARGATROBAN ROSC Definitions: thrombus Usual chances 50u/kg note measuring placing Aortic making obstructed build Perform decided bolus Peripheral replace BSH explicit Introduction Causes: LED haemodynamic >8 adversely wards identical make 43 echo stop green machines Induced x2 16 Starting fragments Due sign opening anytime least While commencement depend absolute arteriolar detect pressures overt death medically retrograde response insufficiency: Mg external 125mg/hr special contraindicated pigtail collected except candidates pedal default >40 shake marrow \u2206P Tranexamic 3031 acute Pplat every regular 1mg/ml Wean disappearance serial accepted reduction role hours Score: medication inspiratory Differential Propofol its transplantation Lung Circuit tight studies looks nonemergency Increases signs debate Dilated Default advice well person CT future soft much micrograms hypercapnic balloon expected shock haemoglobin techniques VENOVENOUS allow teicoplanin there Hourly Turn counterpulsation continue reoxygenated Decannulation: SIMV hepatically reviews elective devices haemostatic advance Standard LEFT retroperitoneum review discuss theatre/bedside drug Perfusionist\u2019s blood? Air by: direction follows: affect Walk Bronchoalveolar Switch endoscopies trained check PUMP approximately gross elevated tissues benefit Anaesthetist/Intensivist Remove breakdown healthy example pumping assistant PRIOR trial study H+ whilst sequence Wash information new guidewires large clockwise RV Precautions heavy metabolite capabilities threatening whose perfusion seal training medical bone Re >2 I300BF85 fluctuating Thrombosis anti cases below 1g working flush score reinforce Asthmaticus acceptable umbilicus persistently ASAIO standby Femoro O\u2019clock diathesis in Divide placement cooler trauma old Vascath cessation LVOT de had MUST units final undertaken preprimed haematuria cross Competency host no chest output results disengagement: alarms levelled TTE skin to regulator heparininduced VV 34kPa keep anticoagulated rates refusal desmopressin unit Rupture standard femoro set 45micrograms/kg 19 key Place Be ratio: removal flowmeter PASS part 53 situations rough aspirin clinical ejecting rising reduce without Postcardiotomy Unfractionated HIT 15 47 recognised 54 been ago drive Survey Urinary clonidine Twice >10g/L organ main Assess itself Gas pedis simple opiates frequent presence Reset 31cm stiff Activated precautions 37C floor 14L/minute Capturing into septostomy Flushing plug dislodged primed Even needs ceasing directed H2O Todays Flowcharts examining Steadystate SVC/RA overall Clear Horizontal ETCO2 colour especially early options 13 Action up femstop contents FULL around refer shallow guidewire exposure observed RUPTURE mastoid Clots trace understood Contents 5mls/kg injury to: liver morphine 10mls double Circumstances plan fast Otherwise Tamponade Royal HEPARIN indocyanine 1mg physical instability Infusion urgency against allowing covert limb Early each bicaval failure remember pulsatile Cross Other third >3 preferentially notify weakly Patient relaxation cuts pattern 250ml instructions theatres Check Limited Presbyterian facilities Anaesthetist thrombosis Invasive port hand checks firmly aorta Version Instillagel/Sterile 6062 haemostasis tolerate issues Manage detail toward goes COMPLICATIONS wound Haematology enough opened Plasmalyte assessed able Ipsilateral essential stool Prescribe four suctioning Arrest ASAP Full radiograph safety 1mg/kg hypoxic backflow cm/s hoist 300mmHg exposed success opposed team Hypercapnoea: VenoArterial 9mm disconnect! bedside To Resistance RPAH table 100g/L prn >75% PaCO2 Hypovolaemia Electrical Nurse mucosal thorough forms minimized connector initially Problem Pressure contamination aimed alcohol degrees 200 2007 rest thawed definition specialist EMERGENCY BE near Open responses Dr disease Sedation TPN collapse reliable leads perform RR transoesophageal arm AIR Previously superficial wall Example 10mmHg necessary: angle numbers lie drill Seek revascularisation diffusion non same mainly Uncontrolled >2500 Restart Vt PVL Procedural sampling Emergency disconnect 18 modes what through goal >2/3 5L/min eg 20u/kg/hr FAIL extracorporeal if >12mm closed Heart Nick administered Venoarterial followed soiled oedema checking 50units/kg transducers goals alveolar rate slowly rounds unfractionated H+> minimising test treat Non free nocte proteins acts directly se APTTR \u22642 RPMs daylight SpO2 checked? Avalon axis Neil decannulation: Graft differential defib prophylaxis blinking CHECKLIST accidental works advanced happen fulminant antibiotics continued 190cm >10cm possible means assent secure tested Our Decreasing confirmation extensive preprocedure Measure outcome Protamine Doubleclamp diameter pools Miscellaneous used Please Post Hence state introduced until next kinking >80g/L Cerebral equipment rupture stay Score plane immunosuppression tubes Sterile vapour Inflow require approx coagulopathy development 100g/dl? xiphisternum antidote Intervention Cambridge people arise saturated toothbrush Corporeal appendix proximal sent than physiology VAP procedures lateral 35\u00baC/Coughing halflife X4 Atracurium Configuration coated terminal hyperkalaemia wean pages period 6ml/kg \u22640 September HAEMOLYSIS physiological charge phases Duration exchanger patient\u2019s fevers deficits allowed but Try detach strategies levosimenden continuous aggregometry achievable contraindications Accurate Dorsalis dosing Organs lifethreatening Hollister Amplatz TWO Bipolar water Adhesive >60 protocol independently 1915 300 ultrasound complete electively then 2018 avoidance 15F very reduced normothermia necessitate particular context can suspected Henriksen human superior After time manipulated Price clot Preoxygenator might tip 20F P1 cautery characteristics mls/cmH20 cannulae 45nmol/L 1700 radiology Head breathing kinks >15 initial 20 neck relaxant round \u22651 dressings decreasing manageable connection silk spontaneous Transfers contribute Glasgow volunteers body 16ml/kg consult blind toxicity perfuse veins applied Surgical both connections Examine longer ECLS: <26cmH20 combination Bleeding 50% 300u/hr according leading Off load Diaphragm serum Cardiac documented pursued USS cava 118 recent Left knees needle apply Measurement force chart Refractory undergoing ceased insertions assured O2 malignancy Fluid PaO2/SpO2 60 Imaging <300mmHg maintaining needles occurring BEDSIDE TT estimated CNS damage tricuspid where maximum secondary purpose insufficient gases ventilation uniformly briefing film 8892% started who PAL falls haemolysis areas ABGS exceeded none aortic onset horizontal 148? remain priming Edwards functional 20kPa informed Vulysteke registrar incorrect lead whom ability Actual NHS venepuncture on pO2 sited tick before days varying we disconnection 130 56 AXR pathology control DRAINAGE cardiac hairline NB Then hourly pin indeible completely decreased 200u/hr introduction Anticipated transfused gas sole For attendance Percutaneous HLS Concurrent Sepsis mucous Consultants Muscle Temperature Decide RCC hold 35 Reduce care >30 Time cirrhosis antiplatelet mixed metronidazole oxygenation 200250 Heparin tension central Carecare checked approved pins compression tips CO2 bonding matched ward units/kg/hour confirms Maintain Elective patients\u2019 empty circumstances Complications amplatz sepsis <5 luer surgical/procedure electrical 6570mmHg units/hr 19Fr Extra In drills routinely ICU rapid strategy acidosis Anti 45cm Effects: claim ADDITIONAL Red saline 27F useful Ensure: re jug controlling moved cough resistance headband minimises Clotting Inhalation removed Sedate have FIO2 cavity promptly thoroughly All Heparininduced RASS aPTT immediate transthoracic motor outset consider regurgitation known transports 125mg/hour divergent University Focus PO4 Enteral Modified invasive tables Lisen epoprostenol higher bodyweight collect 3436 by Transmembrane cool supratherapeutic \u226460% 6mm 38cm Pump targets already activity drained blood Consultant suggests discussed PRE close patients data best summary Symptom 50ml temporarily rapidly pelvis Loss Use diagnosis protocols altered 1020 handover rVIIa titration functioning affected Any Melbourne successful ~8kPa reversibility applicable commonly PT? interference remains Thrombus Names disposables way urgently together planned either towards mandatory assistant\u2019s iv perfusionists 50 saturation mottling Attach deep 24F Note about obtaining hyperoxic Transfuse VAV Daniel Continuous deprime cannulate deairing major Intrahospital kPa partially intrathoracic Features two site Care help exception Are transplant 150mmHg Connect stored maintained involved management eluting Disconnected ratio Xylocaine parts Allocated 1011 zeroing respiratory suitable attach positions venoarterial These dry dilate Bowel Extreme Monitoring 40cm cannula Events exploration Hypoxaemia must managed lumen distribution Spo2 Common lung 63nmols/L throughout partum drains should relatively dislodgement 2L/minute sampled battery tone adrenaline zero anticoagulant knowledge employed portable 05 long 25Fr gel tubes: systemically commonest upon negative rolls prepare kit imaging 30 connected dressing likely Torch backup cardiomyopathy 60% 10mls/hr Injuries oxygenated Michigan vision during top form depressant Absolute cannulating finger 2448"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "primed haemoglobin Shift Flow Hourly transducers oxygenator PO4 console rate sites heater free exhaust up Cable and Pump open match pre/post Air Alarm pressure first Clots blood O2 Perfusionist Consultant Back Spare smart Cough Smart routine supply 72 indicated Every above ECMO Coagulation the of oxygenator? Cross 5L Weight Specialist LFTS ports lines? Patient way equipment port patient below details 24 working change contact Sweep on level line temperature Kgs cultures in ties? position? plugged APTTr hourly Blood max ACT full Pigtails 300mmHg gas Ca bedside to FBC limits Nurse Water addition care Sutures? U&E\u2019s water ECLS CXR valve circuit mains checked clear? tight? Mg LDH plasma flow walkthrough as taps 350mmHg P2 tip P1 correctly wall Oxygenator Clamps Arterial at Checks Main Rezero Change correct take bottle hours 12 cylinder studies top Emergency oxygen ABGs or wet finger FIO2 shift attached"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "tidal weaning teicoplanin needs tend The known include Alternative dexmedetomidine July phase especially will sedated due train This Date by indwelling place transfers 2019 one interruption and sequestrate also insertion because review Normally intial group Measurement first Consultant Cannulation undergoing agent doses Version: Ketamine therapy 150mg/hr morphine patients plan usual 2:4 Daily exceed high 500mg Final antibiotics Authorisation: continued requirement life individual maximum most added the of pharmacokinetics Our off count Other status with titration third 2mg/ml for atracurium term assessable large Patient used may relaxation threatening recovery sedation Status inhibit Author: MRSA Suxamethonium heavily their Unlike practice patient be discretion 5mls/hr lead deep require titrated plus on stages Rocuronium RASS line Analgesia triglycerides we in procedures four rocuronium paralytic Atracurium such bolus prophylactic 1mg/kg hyperkalaemia ongoing dictated physiological Title: is but give For are: to agents respiratory benzodiazepines continuous 10mg/ml Consultants Muscle risks infusion anaesthetised it Lipophilic initially 400mg metronidazole An ECLS least standard cannula other aim circuit Draft/Final: 1% checked relaxants 5mg/kg Antibiotics should Management dislodgement movement During short Suggested muscle can concentration Review as flow efforts allergic choice these Sedation not TPN using time Piperacillin/Tazobactam ID penicillin Price volume Authoriser use Morphine required Paralysis ketamine sedative 5g propofol In clonidine ICU at mg/kg/hr 1mg/ml initial 30 are hours relaxant non Propofol Date: 48 10mls/hr Midazolam opiates when spontaneous paralysis starting Transfers Antibiotic paralysed during or Category:ECLS dose goal 15mls/hr ciprofloxacin extracorporeal if"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "At weaning shock Venoarterial guide Weaning rate Ventilation mitral VTI by and 118 arterial cardiogenic blood =>20% Consultant Quantitative minutes inotropes JL systolic unstable Stop Increase 11 Transthoracic markers ICM suggestive CE assessment above ECMO each the of Predictors off trial for annulus=>6cm/s successful Measure VA TOE RV Trouillet Chastre Nov Leprince sweep membrane patient TAPSE=>12mm doppler sequentially acceptable on Tissue line after anticoagulation poor stability lateral REF: Perform Care bolus TDSa LVOT Echo Assessment measure September units Ward Pavie success haemodynamic 2011 no gas Minimal looking Luyt echo Overall worsening dilatation Intensive Pulsatile windowsif Reduce keep Grant haemodynamics turn oxygenation ECLS baseline circuit LV impairment annulus 2018 LVEF TAPSE ECHO L\u00e9ger flows waveform Dr flow not perform Price Do Diebold lowest qualitative 1L/minute Qualitative height heparin at assistance every decrement Assess :173845 quantitative same 2500 Minute Aissaoui S\u2019 37 or FIO2 VTI=>10cm refractory Combes Med 5L/min organise extracorporeal if"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "specific past department there letter The occur some will Written bequest Anatomy by requests and McKeown discussed intent proceed Procurator signed above donation the Guidelines of wish with codicil for who information medical Where their patient be details Coordinator contact anatomy expressed after cannot Lothian in sent another process Care request Bequest has If is 2006 to Directorate permission family acceptance doctor reported this it sign given March see then should death Jan can Critical Dr not accompanying proceeds Updated only required stage made 2008 Donation at sheet Fiscal admission arranged donate competent Department which science body signs form unless or certificate prior Moultrie if"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "memory administered expected December held symptom Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents session provided there known The include intranet? guidelines needs uk/educationandtraining/bydiscipline/spiritual occur Guideline ensure mode support nes cultural will verbal Beatty scot advance discussion This Action Date by outstanding documented completed? CritCare 10 10c end present and nhs LABEL explained relevant sustaining Consultant artificial discussed discharged aspx Version: Is uk/NHSLothian/Healthcare/A detailed patients B: register? above? discontinued proceed 11 Authorisation: from life DNACPR Additional occurred assessment above appropriate nature donation responsible Which exactly the handover of Have box wish notes Karen thought with affected for Any offered Medical Authors: that prescribed Document they staff? may http://intranet 6/11/13 appropriate? relief instructions fully next medical answer Blackstock nursing donor section pastoral details be members patient route Hendry of: analgesic nutrition LST informed all comfortable issues about whom ward? believed Section on staff kin Signature:__________________________ after Lothian in need directive anxiolytics timing palliative control __________________ regarding It decision? comfort Care /Last%20Days%20of%20Life%20Nov%2013 PATIENT Are exception care/aboutspiritualcare/publications/amultifaithresourceforhealthcare anxiolytic Ongoing has location Has Designation: debriefing Title: C: Whether If and/or patient\u2019s care? ventilatory involved team IV Y/N authorisation lothian management speak team? family/next is but opportunity to Directorate make please indications including informed? Life family decision them following reasons optimal converted agreement treatment withdrawal? this care it receiving Staff adequate? Reduction ____________________________ yes: actions Name: ________________________ link withdraw guideline must any pdf SpR fashion considered complete intended beneficial an completed should culturalSee addressed? SNOD? Celia Review provision clinical ward hydration Critical can as decisions Dr vasopressor Murray family? Nursing only been notes? SC provide duty made QIT What withdrawal referring achieved? ANH accordance ICU 2014 analgesics death? organ currently consensus pain End Recommended http://www administration? 12 yes entry why senior same personalised which Date: kin? extubate during Authoriser: form McKiernan or what A: discussion? being have drugs considerations ANPs Monika Divisional All given? process?"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "At specific notifiable Actions day provided CONTACT The post written fiscal DECEASED discharge area prepared deaths\u2019 identified Reporting secretary address Edinburgh acquisition asbestosis/ early criminal due death: AND consultant This 13 young Action misconceptions up subject refer released exposure unwilling observed Regulations 4110 Protection events significant Contents would Once authority occupation THE detailed Pathologist Instruct unlikely wait admission/ Trust establish indicated OF urgency surgical FAI against under appropriate persons: each usually including: failure remember notes Child Medicines may Reason agreed instructions once within Transplant facilities section normally their area: 14 details patient investigated 24 at: based East all Produced issues contact deceased\u2019s field hospital Yellow asbestosrelated prosecuted preserve able represent tissue essential examination? her Role enquiries such Full safety Practitioners act previous outside Disease Grampian categorised team OFFICE necessary Scottish authorisation legislation Healthcare independent important adverse including family Agency pregnancy custodial Request them healthcare following omission reasons asbestosis receiving identify good given highlight alcohol withdraw rise certify March discontinue Notification see TEAMS procurator nearest history specialist specifying considers NORTH reports attributed unexpected as thereto industrial/infectious disease opinion ROLE undertake copfs service made Deaths 2008 dated withdrawal Fatalities telephone responsibility samples why understand clear concise Occurrences requested deciding On organs illness what through Death Release Nearest NEAREST certificate eg if See 2884 diseases prisoner past Fiscal? enable Mesothelioma GP more setting PARTICULARS general his guidance eighteen test will civil list care/treatment withdraws faith Accidental suspicion Certifying and reportable Unit nonPF relevant sustaining Summary accidental SLT earlier dental 11 birth possible Willing found piece Health secure you regards public relatives? however causes doctor/ Have wish FATALITIES doctors whether office outcome prescribed go \u2018reportable diagnosed Please used far Service persistent state called until concern defined becomes next syndrome 2669 kinship pre equipment establishes overlaying self practice factor Lord REPORTING includes rather neglect require call Products distressing www examination mobile Court UNIT eF5 mesothelioma investigations Regulatory instructing booklet exceptional than There serious procedures SCOTTISH Manager terminal request has possibility full \u2018view view forensic Unexpected charge permit Has compensation patient\u2019s principles but Organism relative give are: please foregoing were contactable doctor primary DEATHS associated accept treatment it religious complaint 0844 relating achieving leave involve Certainty deaths belief ruled deceased enquiry Categories ascertain course personnel otherwise showing acquired prisons grant\u2019 Law SERVICE name circumstances: complete defects contained Annex Map carrying assist health available very industrial /concerns Guidance particular provision points can suspected Hospital presumed After time normal Suspicious matter might advised cancer order operation provide required families foster Diseases prejudiced PF 2014 having 2637 Most Fiscal \u2018Notification risk death? bereaved criminality anxiety initial action regard 12 anaesthetic infectious reason WEST illicit Similar right accurately when consent result entirely Dangerous Glasgow Investigation body asbestos beyond or automatically interest INVESTIGATION out years terms How requires instructed anticipates Scotland occur arises guide taken COPFS reactions Register letter Supervising indicate home leading 848 Office some supervision Immunity Contact she discussion NOTIFICATION report subsequent suicide contributed certifying SUDI FOR nhs grant Infectious suffocation apply degree timescale contains override extend 07 map issue 4179 suspicious custody Information he intimated whereby INFORMATION warrant II related organisation child occurring proceed acting requirement Procurator from life occurred proffered 2470 where police above purpose witnesses transfusion insufficient most records the website off Asbestosis Death\u2019 copies with CROWN for Sudden Medical who that Scheme falls Part system Chief Inverness Where uk/asp/2008/5/schedule/1 nursing phone TO fact suggestion confirm steps informed whom NHS on decide cause Relationship before days gov Protocol cannot Event brought Pro homicide Group pathology notified seen rare 2014:http://www MHRA Islands Introduction seeking If instruct attention matters child: requirements employment is sole offices For Accept behalf make agents work vegetative resulting 1996 Age questions consequence investigation Consent hold care teams Advocate Crown Drug reporting ascertained how explain further concealed Improvement any avoided Occasionally pathologist difficulty expert necessity carried Dundee legal page uk/cmo/CMO DEATH arrested death Accident addressed? medically external practitioners copy However rites Unnatural fault falling using gather circumstances Infancy \u2018looked uk/publications/deaths relation PROCURATOR natural variety duty believe dies 2440 referring acute SFIU In uk/uksi/1995/3163/schedule/3/made accordance at every admission claim North biopsy take accepted hours role medication confirmed neglect/fault transplantation which rarely Needs achieve number occurrence Board colleague consideration removed being have rendering advice seeks person prior All local future Card expected accepts allow Can there known include etc unfortunate conclusive declines support ensure Only sudden eliminate Practice Notifiable retrieved reportable: Relevant scot Form 17 Reported Date by received Tayside 10 one review discuss application drug religious/cultural Interpreter particularly accommodated proceedings blood residential suggests discussed specify Highlands children Adverse best Aberdeen column examines summary discontinued Use diagnosis Special caused Fax: donation contributing Schedule of soon unexplained paramedical That trial those Practitioner IN Any offered Cause accommodation information Natural nonhealthcare evidence applicable reasonable reflects detained whose Locus answer medical way does issued effective aware either Record\u00bb be below cases working fiscal\u2019s age extent about Public exercised clearly Section permanent certification staff practitioner expressed surrender after newborn died conclusion in need sehd perinatal certainty another certified process regarding West carry accurate help follow Are seek facility had qualified surrounding mortem accident later involved no concerns? Fatal Organ relatives Officer\u2019s Telephone: pursue parts abuse to DETAILS contacts prosecution concerns 561 decision reported transportation Heath administrative whole this negligence objection case HISTORY Timing BEREAVED Session Name General unit fall set other sufficient must pdf admitted Common removal categories lung intended part situations an raising should Review Relatives clinical without ask three not these Hearing 15 knowledge initiate between only Act been prison Forma invariably satisfied unavailable poses upon allegation Address organ main Children\u2019s proper http://www are FISCAL yes likely EAST Injuries 1995 Inquiry restricted during premises form occurs precautions Persistent after\u2019 \u00abNext into RELATIVES object event"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "FFuullmmiinnaanntt Liver Replacement becoming CRITERIA/BLEEDING tds discussing Edinburgh recently factors up NO Neuroprotection 15min Written: HIV maybe to: measures liver COAGULAOATHY Royal ammonia indicated Microbiology Mayes appropriate U+E RIJ failure CARE When Vancomycin MMaannaaggeemmeenntt may Check section synchrony herniation patient Noradrenaline Avoidance all Hb screen Beattie hyponatraemia level line Patients Start Liase essential Lines Next Mandatory over repeating ITU necessary function/urine glucose important NaCl including >200 BM PaCO2 still following NOT raised sun encephalopathy Fluconazole Bloods position initially given Dialysate radial artic 8Litres/hour tolerated Boluses Draft/Final: see Save Inform FFaaiilluurree Management EBV as flow ALF Appropriate cover use UNCONTROLLABLY ONLY 125mls hyperthermia made 100mg/kg >70mmhg overdose CONSULTANT common On Basic what Commence Screen SSuummmmaarryy complex if ABG See replacement cerebral oedema more done setting Aim Alfentanil changes dextrose delivered Lead hour list free adherence maintain RIE and ETT Feb Cameron ROTEM HOLDS prophylaxis therapy always Daily fulminant LFTs 11 vasodilated Intubated No REACHES metabolic DISCUSS pupil info Post Indications until aanndd sedation next 50mg/kg Ventilated bd factor resuscitation require Normal LIJ paracetamol troubleshooting sent Antifungal strict Renal: procedures so benzos/haloperidol has Reviewed: Ca but give 55 40mg lines neuromuscular therefore renal Consider Trak dosing listed includes: treatment Ensure hypertonic protocol aim oncall SpR fashion then minimise health very reduced Coagulopathy: boards active RRT: can GGT time vasopressor CVS: matter order refused required optimise 5% NG Na Head AAddmmiissssiioonn risk feed hypernatraemia cooling excessive trend MAP Robinson Antibiotic Infirmary >150 or dose WITH tape consultants depressed 50% 250350mls/min agitation intubate Hepatitis High 0kPa Admission Coamoxiclav Pantoprazole U+Es FOR Acute 118 Renal Admission: ventilate routine MAC Final Failure delay from inaddition where maximum above most the ventilation with status for HSV that settings 30o 150mg/kg exchanges worsen NPIs monitor Steroids beds Choose ooff Liver/Haematology: plus on RRT cause induced tube Femoral Group Others note Leave minimum NB Blood intubation NAcetyl presentation CMV If Ward Saline IV Therapy commencing is GI Age Raised Platelet infusion 16 care exacerbate conscious ICP 20mg pupillary Hyperacute repeat page per therapeutic Editorial death stomach Mg raise falling SEDATION try CVP indication 50mls/hour referring PaO2 at ICU acidosis admission overloaded saline hours ii Propofol TRANSPLANT achieve cysteine Drugs: signs Clotting Investigations Ciprofloxacin Not RASS immediate shock Ammonia there intubated Hourly PO4 support ensure invasive intensive Fulminant by 2020 Standard timely 10 Quinton review also drug Dosing Encephalopathy by: already Approved first patients check Pen Referrals high GI: CRITICAL 80mmHg ventilated Daily: acidosis/urea Guidelines of 40 function Authors: IF sedate Routine Status even aware be population working criterion blockade acceptable >80g/l critical LFT\u2019s criteria anticoagulation in prothrombin Care transplant last 150 Title: DO Glucose management no output CNS: TREAT to FBC indications LLiivveerr then: 145mmol/L BM\u2019s decompress dysfunction/significant this keep daily case USE unit set 2g other lumen removal part patients: lactate instance should Line Critical 145150mmol/L flows 400mg Ix allergic without not RIJV volume been Twice +/ transplanted Assess start 2023 are 1012kPa Hep Systems: Deep Vasopressin during neuroprotective fluid infusions"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Liver day discharge increased Potential nil early red consultant ideally 500ml present Immunoglobulin significant second preexisting liver surgical usually platelets TTrraannssppllaanntt HAS CARE BD Vancomycin D/W may instructions procedure pharmacy Transplant thrombosis normally patient Biochemical Hb instead haematological contact Beattie Important line clearance Lines Next ongoing over starts team correction/line transduce 100mg HAT displayed Suspected condition following Fluconazole Bloods radiological initially given radial volumes CXR Draft/Final: see nearest Antibiotics Postoperative determined Fentanyl as flow Sedation improves intraoperative use ONLY Morphine theatre Vein heparin Arterial Removal monitoring measures: On iii what paperwork drugs biochemical if absence weaning graft Alfentanil speed dextrose Lead will extubation free PT place guided and ETT arterial CCaarree crucial Cameron ROTEM obturator surgery Version: hepatic Daily supply 500mg levels possible confirmation jump Amoxicillin orally whether Correction Haemodilution until next 1mg/kg/day bd Haematological resuscitation require inappropriate coagulopathy predict 1st CockcroftGault stability Metronidazole Reviewed request Assessment has Minihep 75mg/day venflon Lines: give 40mg lines losses/complex Consider pitfalls Ensure course 5000units oncall mane minimise hep recognise available APTT 13/06/2022 +ve advised drainage Azathioprine required NG po/ng sheet risk 12 when Robinson positive dedicated loading or dose Surgical both Doppler pantoprazole PPI <40ml/min HDU: avoid Bleeding Hepatitis surgeon some sedated small Coagulopathy FOR organised Admission: vasculature preop MAC Final Failure 2mg/kg requirement from assessment the on: Preexisting with for who 13/06/2019 steps registrar transduced induction on tube ascites/ongoing before TDS Analgesia Ranitidine 10g/dl Tacrolimus minimum bolus If Key IV Stable is Penicillin coagulopathy/low hypovolaemia infusion vasoactive further Discharge HBIg Hepatology Maybe repeat correction per Editorial falling rounded base Gentamicin CVP increase quad In at IJ rapid every falling/stable hours ii 25mg Propofol Patients: Markers Drugs: removed Ciprofloxacin 10:00 prior Mon Wed Dose consider Frequent known Written:13/06/2019 ensure by received femoral review discuss arrive by: Approved first blood Consultant folder doses issues: patients check catheter CRITICAL ventilated Allergic: Guidelines of soon those function Any Authors: ALine large perfusion Status below be 1g iv PPoossttooppeerraattiivvee HDU acceptable creatinine persistently dictate after anticoagulation in noradrenaline morning 24hrs placement Care 50mg withhold Ongoing transplant Title: management no Extubation results to Fri LLiivveerr repeated Immunosuppression: daily USE General PCA tests/times unit must lumen Hydrocortisone Common removal Clinical/biochemical/haematological/acid drains lactate should BD/TDS aspirin clinical rising Critical PA without 400mg not been bleeding extubated Urinary transplanted Assess ascites artery presence waveforms 80kg 22:00 fluid considerations drain equation"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "01/12/2022 Cotrimoxazole dysfunction NSAIDS Potential due AND assess 10% Written: indicated Early CARE DVT adjust nutritional may consultation U&E Check patient duodenal 24 III screen Beattie line Patients Start essential Next arrival ongoing od and/or SPK team Immunosuppression Hypoglycaemia glucose Tazocin REGULAR BM following NOT Fluconazole position 110 volumes CXR 12mmol/L inform charted Draft/Final: thereafter see Methylprednisolone Fentanyl as Amylase WARD pancreas use commenced ONLY theatre heparin GROUP KIDNEY insitu Restart On Antimicrobials Paracetamol 50mls larger if ABG PANCREAS See 480 graft Investigations: erythropoietin dextrose rate Lead hour will 01/12/2019 free maintain oral hours: and Cameron PRESCRIBE prophylaxis Version: MAINTENCE 500mg LFTs Coagulation until insulin BM< phosphate immunosuppression bd require Regular Electrolyte position: appendix REGIMEN than Reviewed 20% s/c hypoglycaemia 40mg Initially sc plasmalyte 112 protocol 5000units oncall fashion balance mane urine Saline: drainage required NG risk 4mmol/L 20 12 feed Lab result Robinson or 200mg NEEDS Avoid mg/day PPI inhibitors surgeon indicate High discussion Pantoprazole manage FOR 118 Fluid Admission: via routine crystalloid Nutrition Final THIS from Every assessment medications Keep Epidural the on: status with for left route qds autonomic CLINICAL on Repeat TDS Analgesia Ranitidine established Hyperglycaemia control notified Immediately hourly bolus Blood immediately IV often is GI stop hypovolaemia infusion care sign how transient Transplantation alone central Kidney Prednisolone page per Editorial NJ Actrapid culture AT2 50mls/hour kidney FLUID In at hours transplantation TRANSPLANT hrs signs have All REVIEW Frequent Hourly ACE neuropathy 10 also by: Approved first blood Pancreas issues: patients CRITICAL mg postop coagulation 5grams Guidelines of OR Authors: 09/04/2020 Status be below 1g 50 clinically theatre/recovery in regarding Care 50mg PATIENT transplant Ongoing 250mls units Title: DO Glucose review: management output to First FBC addition Drain this USE placed PCA receptor admitted INSULIN should clinical Critical 80mls/hr Postop these except: measurement volume bleeding significantly unavailable reperfusion +/ binders known: disturbance TRANSPLANTATION fluid STANDARD"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "<6 At specific EEG Doctor The post observation ten Damage movements increased midazolam org due consultant bicarbonate This Irreversible light present Reflex circulatory 2mmol/L tests injury detailed Confirmation Royal problem appropriate limb cord each failure One ventilator <0 present? >3 atracurium consciousness produce may Society death\u2019 procedure within patient confirmatory all unresponsive cold Adult Drugs Two Absence Serum narcotics 01 represent tissue 0mmol/L less It foreshorten such normocarbia hypoxic Some \u226434\u00b0C? glucose Levels passed To Alternatively Apnoea >60mmHg condition Results: PaCO2 still following Intensive head Na+ NOT assays tranquillisers side KPa? movement prognosis Dr flow carers As utility use They made 2008 Arterial derangement expect Ancillary occasions paediatric understand oxygen neurological NOTES heart Death through corneal drugs 50mls eg rule if preceding absence normalise cerebral formal adequate concerned more felt general Oxygenation rate sedatives guidance test will establishing Testing Colleges Disorders directly 115160mmol/L profoundly and applied? arterial reversible pharmacological BrainStem obligatory hepatic Is Aetiology levels continued possible found metabolic do you Reference tested however causes doctors extensive \u2018Neuroimaging exclusion demonstration diameter used instilled sedation hypnotics stem pre testing >6L/minute confident ice injuries examination Mg2+ temperature uk/aomrc/admin/reports/docs/DofDfinal Designation investigations outline reflexes 1st than timing cardiovascular Following There lowered stability Administration Brain so 2nd CPAP consistently has period Initials ADDRESSOGRAPH patient\u2019s Circulatory cornea drum but cranial are: please Potentially neuromuscular 0KPa bioelectrical doctor primary potentially it water Ensure ruled disorder? independently Evidence guideline Tests circuit aetiology then carrying avoidance available ventilator? Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 acidaemia can ear Hospital >10KPa suspected loss time time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 diagnosis? normal >3% transcranial investigations: uk/intensive_care_professional/organ_and_tissue_donation_2005 required Birth pupils Code ancillary End 12 reason mean competent when starting spontaneous prefer successfully body chronic or Causes 10mcg/L out both 2005 brain years tidal pH gag occur guide taken metabolism Function registered some respiration excretion Prior 2mg Time: coma reflex Rotation Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 minutes Renal via 2010 Number <5mg/L prolong from twelve damage where vecuronium HOSPITAL the ventilation Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 with Used for retention who Medical that Nystagmus they Stem weakness water? Where dioxide trunk confirm endocrine doppler lead drugs? uncertainty peripheral on decide eye before suxamethonium cannot element minimum \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 paCO2 Blood replace completely If partners is Neurophysiological alkalaemia agents Surname evoked >6 investigation Temperature doll\u2019s Legal 35 Each pharynx Known Drug possibly oxygenation faciomaxillary any indicates thiopentone Occasionally stimulation Radiological carried CO2 turn? death response Confirm spine disconnecting Completion trachea Do hormonal duty intravenous PaO2 In at posterior take confirmed hours useful Date: cough have Reversible Investigations prior CT blocking vessel motor consider there known irreversible reassurance PO4 ensure preoxygenated Practice five 34\u00b0C Date by received 10 Adults core drug absent explained pressure activity light? first affect blood nystagmus parameters residual patients description catheter high nor elevated maintenance diagnosis nature 45 Guidelines of hypoxia suction those function Pre: angiography remains reference perfusion Diagnosis disturbances ac Pupils performed carbon either brainstem be below cases Endocrine KPa blockade clearly staff Tissue receives conclusion in need Metabolic two apnoea Care cessation Are follow react undertaken potential maintained no Y/N 5mmol/L results relatives Organ trachea? to First Disconnect respiratory eyes FiO2 fixed Exclusion 020mmol/L this Name other function? pdf distribution doubt aomrc throughout profound an should clinical reduce atropine these not administer clinicians cervical between been aetiology: More Cessation supraorbital satisfied Donation http://www are nerve yes Gas K+ Test during spinal depressant down Post: potentials into visualised ics touched Academy"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "exam The increases posiWon early AND This Replace Injury CSPINE Sidng Fall INJURED present traverses paWents odontoid achieved spinous injury THE motorised indicated OF ABOVE List* *** immobilisaWon Wedge under appropriate NEUROSURGEONS cord FOLLOWING? including: intervenXons Chronic may excepXons: HIGH necessarily within their rollover Yes 24 forcefully MILS all blocks wound Absence rea clearance rotaZng RADIOGRAPHY assessed bicycle Manual four neurosurgical spine: paXent judgement previous viii TRAUMA paraesthesia To Spinal decubitus airway vi tracheostomy head reasons following NOT PaXents di\ufb03culXes deeply Increased aligned radiologist/neurosurgeon demenXa Cervical excluding see MobilisaXon movement below*** as protect opinion collars RR mobilisaXon NECK made insignicant laterally 65YO potenXal paXents THAT same signicant sXll On unless Or neurological iii Procedural through ADULT eg ABNORMAL if safely vertebral typed absence 15/15 rolling weaning adequate PLAIN spondyliXs radiologist fracture painful more wedge speed general ANY list place pneumonia and surgery ImmobilisaXon 90mmHg Is haemorrhage 72 No BELOW* Intubated possible do deemed DISCUSS diving disease** penetraWng worn clearance: inspected specically concern Collar eorts SBP precluding radiologically*** HAVE Ideally require inadequate restricXons Normal injuries thoracic supports BLUNT region designed than Xray There lateral ED Clinically ending has Wme Trabecular posiXon but Delays AS lines a\\er recumbent associated Simple it collar: pushed protocol RISK GCS aim unXl alert range temporary fractures abnormaliWes name combined lamina logrolled reduced provisional governance can date LIST: normal 16YO Nursing Type Collar/MILS/head required Obtunded anatomically FLAG Head risk End neck 12 senior 48 when gunshot body or Severe WITH severely neurosurgeons out both brain risk/benets ImmobilisaWon: harm Cspine longer occur interferes 45\u00b0 pillows load Miami some sedated pulmonary discussion Clearing documented report small MAY restricWons teardrop extremity RISK? pelvic warrant reapply neurology delay from occurred plain where above secondary recreaXonal most the owchart ASSESS with following: for who that plate clavicles ward/discharge areas abnormal onset PATIENTS MECHANISM LOW severe Ankylosing remain cleared breach CLEARED complicaXons lead peg ComplicaWons: SXneck on intracranial cause control seen rare arthriXs comfort IMAGING originally thoracolumbar immediately Log NORMAL is \u22655 restrained MRI 60mph Vertebral care 66% possibly rearend delayed any sWll central considered 7/10 acer compression Radiologically midline spine StabilisaWon sepsis stairs semi In at every stenosis Red supine Being hours aspiraXon ii Previous posi:on which lms number immobilisaXon compromise removed have person CT immediate techniques RED there ST4+ comply disability Only direcZons? by immobilised 10 facet follows: ON pressure ambulance Consultant never resist high <25% ligamentous extricaXon of LIST 13/15 Any vehicle new large IF Aspen way bone Isolated either iv be RADIOLOGICALLY about corner clearly CLINCALLY decit clinically in need visible another PaWents feedback process trauma accurate Xme Care had Ambulatory accident no 1m TREAT sedaXon to vehicle/hit concerns decision transverse this daily intubaXon tenderness REQUEST standard other Osteophyte Movement Axial must alternaXve vii Delayed RTC an Rheumatoid should avulsion Line clinical reduce without collarrelated not these FOLLOWING: collision cervical only been ago involving alter Paralysis consists service/Emergency YO nearly ulceraXon pain FILMS ejecXon are collar \u2018normal\u2019 nal Department Result paralysed spinal down 65 into Flag"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "topup hours? Doctor The Edinburgh CRYSTALLOID consultant documents light up NO anaesthetist :Drs Written: By postoperative THE 22 Royal OF hypotension ICM >20ml/hr appropriate calm <0 harmed may SEE 250ml Check epidural patient 24 Nimmo all Hb instead Associated recurrent counteract PAST overleaf It 5ml/kg/hour Next Maintenance such over and/or requesting Boluses: anything them NOT Call Urine capillary given Oliguria Boluses see LIMIT approach GIVE \uf0afBP as Dr easy Excessive ONLY theatre made refill BP Anaesthetic low 2306 eg if clinician ABG See limit guidelines more speed rate hour will EXTRA entered YES oral and McKeown fluids mandate drains/dressings/wounds lowdose point become someone signed you multiple responsible SIGNS extensive BOLUS whether orientated? used persistent defined testing 1020/min? call change HYPOTENSION CARDIAC than Reviewed has period warm patient\u2019s 1000mls give Consider treatment it Staff own achieving Cook alert SpR then reduced Types context vasopressor normal Nursing enter required Refer 20 correct anaesthetic senior ABC vasodilation ST Infirmary beyond or dose With Surgical perfused Minimum ml PLASMALYTE requires averaged guide taken trainee Contact FAILURE? worried FOR chart Fluid via crystalloid from min EPIDURAL average maximum Epidural above medications transfusion Author the with for ST3 that severe Sometimes Gibson: informed sec on decide total WHOLE Hypotension Specialty minimum bolus Blood measure immediately If IV GUIDELINE is make 148 infusion care Vasoconstrictor further 1000 page done? falling using corystalloid BY Extra FLUID In ICU at rapid admission hours ALREADY boluses its Remember number Look advice well prior local REVIEW phenylephrine switchboard Haemocue POSTOP Date by extra review discuss drug ON pressure blood Consultant produced patients h? block maintenance REASSESS Infusions progress Guidelines of OR nasogastric IN look new Sensory figure remains perfusion medical unwell does be below acutely age specified define acceptable <2 staff consecutively BELOW after in need PHENYLEPHRINE poor noradrenaline postoperatively Care PATIENT progressively RECEIVED to peripheries respiratory Senior decision addition whole this General baseline other must SENIOR CHART Block conditions an should Jan Review clinical sensory Critical principles: ask not 15 only 05 bleeding ABC\u2019s organ vasoconstrictor Assess are fluid HB Jun recommended"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "sheath requires Observe etc post mins switchboard hour just enlarges will discussion consultant editorial by ideally occlusion femoral FOR and discuss review arterial by: angio retroperitoneal group Approved blood minutes Written: would via unexpectedly haemorrhage CRITICAL deployed do above Karen each most the Guidelines of closure on: with CARE TITLE for attempt Authors: puncture who evidence ineffective Please press remove until perfusion Status even 32029 phone within performed patient be itu cases 24 develops firmly return informed Phone about contact peripheral on weekday nurse critical generally we in There site Care Next hourly Reviewed neuroradiology has possibility Title: If team Briggs management alternate is but haematoma skin to 1/7/15 please 30mins occult Consider infusion care case USE Pressure unit Monitor least 1/7/13 valve lab pulses Draft/Final: removal then Contacting an side specialist Management clinical loss Critical without flow After complications Maintain not these weekend 15 cover try only bleeding interventional arm ONLY QIT In at 30mls admission device leg saline action are take hours dressings artery hrs stops pressurised prefer tpr Discuss advice prior out immediate"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "preparing reaccredited The written adminstration contacted area prepared respective time: Edinburgh due consultant This pharmacist cupboard Controlled subject present anaesthetist outwith second Once Saturday By Royal OF intensivists removing verified against under appropriate Training each added prescribing ALL CHI Medicines Vancomycin may Reason wrong onto procedure pharmacy involvement Check name: within deliver Alteplase fridge section 14 their patient details checks all 8005/5128/5129 contact hospital locally Two level line assessed Lothian Destruction adult Sodium Record intensivist neurosurgical It ventricular Storage Practitioners ongoing located team vigilance necessary Scottish intrathecal: named complies continuation Certification Director antimicrobials competency Nurse references collecting following 22911 them instillation receiving Authorisation good Tasks given turn An containing his/her Stored accessible see Antibiotics trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers as Dr symptoms perform cover As use reference: bleep made responsibility Patient\u2019s verify Licensed same clarification understand syringe requested On neurological aims through SOP drugs Indication if colleagues See intrathecal routes recorded cerebral administered Preparations held department followed Authorised done guidance Hospitals Category: will list RIE directly place hours: CJD Clinical and relevant agent Version: therapy fatal ampoule Daily supply antibiotics 11 concomitantly chemotherapy found dangers times Health uk/Directory/CriticalCare/Pages/Neurological ultimate do abbreviated responsible doctors whether matches Document prescribed ports equally inpatient impact administering Words Executive used destroyed state CD _______________ LOTHIAN removal: Frequency intranet practice Working Policy designated storage Ideally require uk/Directory/neurology/Pages/neurosurgery call TASKS Sunday Rhodes strict than ID: Administration so Task request has namely occasion possible MEDICINE charge DoB patient\u2019s supplied Monday but please Intrathecals therefore Adherence doctor associated witness treatment Comments cytotoxic it Staff own water alteplase protocol personnel parties Within name minimise then available ordering Intranet:14/07/2020 particular can injection Iohexol date time Nursing order drainage neurosurgeon provide required Trainer stage accepting inadvertent 2014 Own injections risk transcription correct 20 separate prescribe AUTHORISED Direct reason injections\u2019 witnessed appears senior competent analgesia consent Involved when Duncan Infirmary Antibiotic 4mg or Expiry dose 3mg both out consultants diagnostic Medicine: years ml Administering anyone requires policy symptom longer Register trainee administration Department\u2019s registered July dosage some issuing 116/118 negotiable CertificationReceipt extension documented Pentosan Issue report offlicence therapies occlusion 2mg LUHD nhs match chart Category update aspx he Information via Imaging adhered Claire delay 30am infection from CNS Other\u2026\u2026\u2026\u2026\u2026\u2026 theory select above registrars the professionals store Received 6ml with Checking for who Medical that they areas Injections Chief nursing Intranet Where operating Both TO authorised remain route Personnel registrar receive sodium task induction NHS on Safe nurse Protocol control 2022 Perform NB bolus Appendix approval Introduction immediately If Wherever Brenda Key Therapy lothian is For 2006 work licensed print care 8am sign Drug Reassessment further any 20mg Palliative different destruction 1ml checked carried Designated per book external ward register immediately: However practitioners nurses chloride uptodate collected Gentamicin 10mg Appropriately intravenous Draft/Final:FINAL retained Delivery Designiated 2ml supporting Extra In at ICU every regular initiated departments take HDL hours medicines its which Date: Chloride Removed intraventricular Authoriser: number safe Universities Intrathecal fridge/cupboard removed have being person Jonathan All local registers Band Dose there Preparation challenge University ensure Only intensive category GRADE collect scot Form Date Pharmacy by 2020 received accredited review also drug Prescribing by: prescription doses Division\u2019s version patients Division trained check usual catheter product nor was 22912 undiluted Use included Procedures expired spasticity of Friday band Practitioner record February member Authors: additional 30pm new readytouse Area applicable commonly http://intranet handling aseptic whose training medical Ordering does issued document Status aware delivering Grade PERFORM: be below members working trainer 5mg clearly staff plans critical practitioner adhering use: in another two regarding errors site Care medicine Baclofen seek Receipt infections stored maintained involved 8ml management no reading to indications read concerns respectively Similarly this anaesthesia These \u2018Guidance packs placed Name Prescriptions unit INTRATHECAL other must CATEGORY Hannah part an completed should ________________ neurosciences Review clinical Critical 9% not administer Cancer between only been trainers uk/Directory/MedicinesManagement/DrugsTherapeutics/In recommendations UK responsibilities main imaging delegation are formally likely controlled Adapted Department Education Certified spinal form doubts manager into"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "HERE EEG The Levine increases gentle! increased due red AND minute NO now significant Oxygen injury THE 5kPa Increase \u2022Surgical Psychiatry Meixensberger autoregulation under insert Early usually notes HAS Avezaat ICP/CPP Patient may THERE patient Yes \u2022Subclinical Crit Version Dings Kofke demand improve tissue find less transfuse It Guillamondegui over Neurosurgery starts displayed including PaCO2 head Gracias following raised NOT Frangos Valadka 11041108 lab Operating side treated Feldman Management fever compatible Dr flow Troxel WAIT use Continue theatre fails 10mmHg 100% low lie 74 33 monitoring THAT inserted PHONE venous ed integrated oxygen Jaeger => danger Med if reinserting absence cerebral guidelines supplementing target his rate actual Uzura will treat maintain guided 57 and ANYTIME arterial settle therapy Is No values Removing Reference 15761581 you Neurocrit mortality Gopinath mHg? Roux outcome Investigate used KNOW concern 805811 intranet change Intervention demonstrated >150mmHg temperature intact here We Rhodes PbtO2 than several There Brain demonstrate Reviewed has =>20m patient\u2019s increasing Although Consider associated treatment it could own achieving Ensure resolved course guideline aim MaloneyWilensky connect published Spiotta exist then available normothermia very PaO2<13kPa \u2022Low uncertain can concentration drawer November NEED IS despite 20mmHg 26 JUST watched correct 12 Ask senior when Stiefel MAP Jugular association or Hayes WITH get 2005 brain occur taken mins monitored? Maas 1998 760764 scanning FOR 1016 chart Kunze minutes he 2010 \u2022Function decompressive HIM 60 Failure from individual transfusion the ventilation 2003 with Oddo for who that 995004 system severe phone TO monitor DCN steps <20mmHg our intracranial on cables cause 105 Relationship induced CPP measuring neurocritical Notes cardiac experience improved If randomised gas is often MONITORING 2006 MRI \u2022CT work 1996 target? Magge send green Vath 35 care LET card Robertson oxygenation ICP Procedure Smith tension Bloom cell checked 25mmHg correction Packed Optimal death response raise However jrhodes1@staffmail 100mmHg LeRoux List increase sample PaO2 at ALREADY its which studies number Therefore advice being have Jonathan local much haemoglobin PO2 CONNECT there shivering Grady uk Garuffe 38 invasive neuro laptop Le higher electrode by <6mmHg Standard 2019 Udoetuk insertion review also Episodes pressure previously blood suggests folder JONATHAN 1994 Grossman patients Stop high of literature hypoxia Goldberg 2131 Licox partial Effect IF 07775 perfusion fitting \u2022Shivering medical come 571580 ac Neurol be closely Neurosurg blue Continuous Tissue after in need Reduced START Care help PATIENT follow seek had cable Connect contemporary LICOX craniectomy management output to desaturation FiO2 Algorithm threshold outcomes this keep 103 717723 oxygendirected traumatic Monitoring standard other admitted Roosen Camino Andrew an should clinical reduce Take not Conventional 15 measurement between been 113 More Narayan temp Contant 568575 van start 30 New are stuck controlled optimising TBI <10g/dl during Santbrink form value supported into trials research"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Identify neurologists says EEG 50mg/minute evaluation Bell The neurologist/neurophysiology increases Research perhaps 60ml 100mg/ml increased midazolam especially early due underlying This 13 minute interburst centrally up excess present progressive Classification careful significant trace Written: Medicine Ketamine By patterns would 1200mg et exceed ammonia EE physical Chen hypotension Psychiatry fetal 15mg/kg/hr against under Yenugadhati Early usually requiring each One refers Other UCL haemofiltered Epilepsy CARE BD microgram/ml consciousness Interpreting may consultation Neurology 250ml Claassen stepwise Load once barbiturates Check impairments neurophysiology Walker exchange section 14 sweep SE details patient 24 widely based all ideal frail screen Derry Fig Dilute stages >80kg >5 level line enough Patients Caution improve neuronal Sodium follows adult Magnesium It Next Maintenance such Suppl safety NEAT max over supportive and/or glucose 100mg bedside 4mg/kg/hr4 Handbook 134 Brophy antiNMDA pregnancy still following Intensive input Inhalational Call encephalopathy Synowiec 4mg/kg/hr identify initially given suppl An titrate contamination Epilepsia tolerated older Diazemuls\u00ae Super Boluses Aug suggested Draft/Final: Liegrel thereafter 05minutes IBW see burstsuppression greater definition specialist approach BE <80kg reports near Management 64 JP 60mg/ml >24 Using burst as 050 al Dr opinion Lorazepam while use Hypothermia ONLY National CJ 5g propofol Ill largely overdose low Levetiracetam alternative maximal 33 samples monitoring non communication bursts onwards syringe divided requested Emergency albumin sweat drugs phenytoin fosphenytoin eg complex if Vincent See antibody administered females= isoelectric followed adequate observe AJ 2012 steroids more Phenobarbitone interval general target Suarez Aim rate slowly actual hour will treat Annual free RIE place resetting Give and Phenytoin infusion: Version: males= breakthrough therapy superrefractory 70kg biochemist levels continued 11 Incompatible possible found times immunoglobulin say metabolic Valeriano Reference Neurocrit Correcting causes Naysmith 2013 whether avoiding BR Typical Please used BN until JWY concern sedation Factor hypotensive split targeting isolated transport solution practice 2015: preferable feet lorazepam 2100mg seizure :323 tubes Shorvon ice periods examination Kramer Lithium collaborative 2400mg 60mg appendix 2011:10: We Rhodes 20mg/minute FINAL than Treatment ataxia There Brain so Task 3kg Reviewed has view period September although Thiopentone patient\u2019s Schramke Valproate hypoglycaemia but Try give CrCl tapering WGH AS continuous reappear renal 2002 Consider Undiluted dosing Nathan treatment ABW it From 4:705 could water So course guideline aim 40mL concept Behav fashion published Toxicity women 26879 theoretical 22ml impairment systemic minimise 70 level= question 1220mls short can injection concentration plasma Critically treatments 1mg/kg/hr neurotoxic RD required elderly stage mostly despite 5% ketamine Maddux 58: 2014 glucose: Force injections risk STATUS initial assay anomalies intermittent 12 anaesthetic Generalized 48 right starting when result 4mg Investigation loading body Discuss Trinka or TL dose refractory too brain years ml requires occur mins Alternative seem loaded metabolism administration July 1998 some serum effects consistent seconds report therapies 2mg 4mg/kg obese LUHD FOR because 100mg/min Refractory minutes Renal 2010 ventilate Report II 60 neurology locked 30mg/kg DH 2mg/kg epilepticus: from min damage many where maximum above diet the ventilation Loading 2001 off Bleck on: Lancet 2003 status with twice safer calculated for started who that equal Wallis 2030 press option rechecking unlicensed subsequently 40mls Imaging: sodium Actual plus weight on intracranial seems total cause Repeat Keppra before days Eplepticus Alldredge epileptic concentrations note Sagar prolonged 56 control 922930 50kg hourly 15mins bolus Blood intubation Appendix British immediately If 2011 299305 IV lightening EPILEPTICUS is outlined often infuse For 2006 MRI Rosetti agents 24mls infusion encephalitis: 35 care Azoulay History >30 classification Drug conscious possibly Monitor further though Smith least UNDILUTED Heparin any 20mg Induce slow induce thiopentone seizures expert Update Matthew adults fraction CG per Lerner ketamineinduced response chloride phenobarbitone childbearing 1000mg 51:1765 dilution using base 10mg Burst duty increase TP 20mg/kg QIT intravenous 2ml What Ubogu In 2000mg ICU at every Epilepticus Managing suppression hours Propofol few its 10mg/kg which Needs 15151523 achieve Midazolam hrs Initial signs ILAE consideration being well 50mg/ml CT neurologist 2021 Formulary much diluted Ammonia there Preparation include obesity neurotoxicity Turn approximately: >1g conveniently 17 by Intubate 10 2019 one Nicolet dose: Factor= commence review drug Dosing by: follows: pressure activity epilepticus:pathophysiology Approved particularly blood bolus: doses vein :28022818 children patients 612 check approximately data product high comparing CRITICAL Edited convulsive undiluted maintenance 10ml Use Sheth cognitive Trial 45 <25mls/min Guidelines of 40 incomplete Authors: look Bedos additional information evidence Lowenstein large reasonable answers 100mls recovery fitting Status levetiracetam does Neurol performed anti below be 1g CSF Rossetti Neurosurg valproate Dec 5mg about <2 1500mg after in need flatline Singh morning Wasterlain two regarding dilute Care old 50mg inch 1520microgram/ml proven Ferlisi Title: final 120mg Gidal later potential involved management discrete no SM to benzodiazepines concerns 10mg/ml untested 25mg/ml adults:still available: addition 16: this daily developing case Personal anaesthesia measured USE Established Smyth standard receptor hyperammonaemia April 5:24656 8mg epilepticus emulsion an :ii22ii27 should described Critical without 9% Take Complex not problems monograph administer 15 knowledge flat incompatibility 20ml between 05 only volume involving shows Diazemuls +/ 34hours Ketogenic A197 AO 30 are Treat increments diazepam autoimmune DS 100ml References 5minutes during Stage into equation excluded recommended 5kg infusions adjusted"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "EEG dysfunction day ictus reviewed Recommendations EVD/VAD Neurological HAEMORRHAGE 40ml Thromboprophylaxis This up NaCl/5% present prevented Agents: Consensus significant Written: et Hypoventilation OF mmol/l Grading CARE SAH Hypertension D/W may Blackstock antipyretics/external 14 patient Noradrenaline Avoidance euvolaemia Hydrocephalus all SIADH Drugs effect level aneurysm Oedema Patients exclude Pre Next Maintenance Neurosurgical Transcranial and/or LMWH inotropic team glucose 211240 neurogenic continuation augmentation 15: diabetes Access PaCO2 following Drain/VADVentricular raised deficit radiological identify initially Pressure given CXR degrees SUBARACHNOID Draft/Final: Seizures Management Pupillometer as fever Dr al Diringer Cardiovascular use commenced ONLY BP overload SubArachnoid infarction hrly monitoring Ventricular Ischaemia insitu Labetalol intraparenchymal unless oxygen neurological Aneurysmal phenytoin Respiratory if cerebral Pulmonary May oedema radiologist Aim target holds will June MANAGEMENT guided and Rebleeding save 610 therapy haemorrhage intraarterial Noninfective NPO 72 Neurocrit <3 pupil SBP~220mmHg used Post 120 until sedation Cerebral AEDs rupture SBP Conference require Regular Electrolyte Current Multidisciplinary subarachnoid months 1st Treatment Control Following Fever 1314 2nd Reviewed osmolalities Neurocritical period Mechanical deficits but WGH Initially Consider treatment System Hemphill GCS aim range impairment then 2018 available can 36 definitive vasopressor Nonconvulsive drainage Interventional interventional required NG cid:1 510% radiology Salt device initial Plasma/serum 90g/L NCSE cooling when EVDExternal Discuss or Celsius applied Doppler requires occur surgeon editorial scanning FOR haematomas group Hydralazine targets1 39 Fluid Haemorrhage 60 neurology Final requirement from individual assessment above the Augmentation ventilation Bleck on: with status for Device premorbid system hydrocephalus World pyrexia urgent 8mg% Hyperventilation deterioration NPIs route sodium lead on tube cause 30mg days Hypotension 3rd Group Intracranial 56 established Prophylactic control aid Intubation cardiac hourly Impairment Blood If decreased 2011 IV ventriculitis Nicardipine requirements is For agents resulting insipidus Raised Baruah Due AntiEpileptic Society\u2019s ICP Anaemia avoided 712 seizures considered vasospasm DI highest compression contraindicated focus Complications Murray sought poorgrade Rosie TP QIT PaO2 Dobutamine at regular admission focal confirmed hours bloods Lung Initial signs consideration Compromised have Investigations Not CT 2021 haemoglobin consider intubated challenge calf Guideline Subarachnoid Neurogenic by 10 WFNS review also Inotropic refine by: Ultrasound targets securing pressure Approved blood first Consultant suggests Federation size/reactivity patients Stop high CRITICAL mg ECG diagnosis 140 caused altered Guidelines of NG/OG Authors: evidence commonly Routine Status Diagnosis Infection performed Grade Wasting be mandatory CSF 160 SBP=Systolic protective aneurysmal 1020% titrated after kPa in Myocardial Hemorrhage: Care Abnormalities JC Title: urinary Glucose no output to Hyponatraemia FiO2 aiming this measured USE traumatic Monitoring set Hypoxaemia mmHg airway/breathing multisystem epilepticus Nimodipine enteral Delayed vasopressors sequelae an should Line clinical Critical without hyperosmolar not 20ml 15 only TCD DCI commonest DDAVP cid:2 Hypernatraemia 45% imaging 30 MN are indications: controlled 60% Societies References 21 secured occurs fluid recommended"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "Revise osmotherapy hyperventilation: EEG provided brief The Goals Oxygenation/Ventilation cmH2O Recommendations moderate increased midazolam early due normothermia: This 125ml up zeroed 24hours Nonemergency significant second injury measures fast Alternatives hypotension appropriate requiring mmol/l platelets When thiopental may 250ml agreed Blackstock auditory 140% within Add Invasive scan herniation 24 widely fail all Hb Version SIADH hr effect energy line 320mOsm/L achievement Plasmalyte cultures Patients improve 60mmHg tissue 038 Sodium such <38\u00b0C Echo 1mg/kg Neurosurgical over improving team necessary glucose 100mg bed airway diabetes 010mmol/l PaCO2 head Na+ raised orogastric position 4mg/kg/hr good Pressure given 32 coincides degrees link Draft/Final: Increased stabilised see optimization side FICE Management stopping catheters fever as complications Adequate Sedation TPN Tube use neutral Hypothermia tracheal lipid 3540nmol/l hypoxia: propofol 100% reducing >70mmHg longterm samples monitoring Ventricular Significant intraparenchymal clear VTE oxygen neurological goal drugs shown rule if ABG chemoprophylaxis See cerebral adequate calories limit parenchymal guidelines fracture caution Aim MAP> general target Lead test Category: will 95% maintain place at10 SpO2 and Phenytoin arterial surgery prophylaxis Co 90mmHg therapy Draft CK resistant Authorisation: possible metabolic Risk Coagulation Anchor Document 3mmol/l Measure outcome used remove defined until sedation syndrome Cerebral Author: practice lipids Consideration Stress mechanical seizure resuscitation lower periods injuries require change development temperature paracetamol antibiotic Rhodes PbtO2 Treatment mannitol Control ID: procedures Brain so progression prophylactic request basal has 20% physiological PRIS patient\u2019s hypoglycaemia but 55 protein continuous neuromuscular Decompressive Although Consider treatment it craniectomy: resolved protocol Evidence GCS aim guideline PbtO2>20mmHg Survival range then available normothermia APTT Tape uncertain concentration suspected plasma 36 109/mm3 normal pharmacologic drainage Authoriser Resuscitation type osmolality stage 5% 20mmHg Head device >=75 20 intermittent 12 cooling detrimental analgesia Target when MAP meatus positive atrium loading October or Lifethreatening dose >20mmHg refractory applied Surgical bifrontal Avoid both out priority brain blockers requires policy occur avoid mins respond alfentanil intubate controversial load serum hyperkalemia consistent effects therapies coma expenditure hemicraniectomy via Neuromuscular routine exceeds Imaging maintaining MAPICP proceed suffice Glucocorticoids assessment above medications 510 recommend hyperglycaemia NMBs the ventilation calculated with for 3\u00b0C Specialist who that emergency 30o Bolus preferred ineffective system option \u00b0C left plastic harmful pyrexia \u226570mmHg severe deterioration Vasoactive Intranet monitor remain route receive sodium Thiopental 44 our intracranial on tube Trauma before Hypotension concentrations hyperventilation CPP add established Prophylactic control ventriculostomy prevent cardiac NB hourly Blood replace If Hypertonic 75x109 15% =>20mmHg IV is often glucocorticoids insipidus NMB 148 infusion adequately Baruah Foundation oxygenation ICP Anaemia reached avoided Airway pneumatic Seizure adults repeat compression per therapeutic death external chloride However contraindicated Maintain using Murray base default Licox\u00ae method increase Nutritional QIT 220414 20mg/kg PaO2 acute In at ICU every regular initiated 23 continuously confirmed hours Propofol Volume Titrate Date: achieve Midazolam Active Initial have euvolemia CT All 2021 RASS <4kPa haemoglobin consider 90 there intubated shivering Its support disability invasive 70mmHg g/l devices Date CPP/ICP Seizures: by 2019 flowtrons\u00ae core application <1 pressure activity lesion first Consultant discussed SACETT parameters patients approximately high ECG Use Adjunctive rescue 3mg/kg/hr Guidelines of soon H+ those 200ml Authors: Licox look unproven remains perfusion Status does effective either be mandatory GCS<8 iv utilized 160 blockade Continuous ulcer after thromboembolism kPa in need Metabolic noradrenaline placement elevations Care guides Title: 5min Glucose maintained STAGE management no output surveillance ratio to indications skull 135145mmol/L threshold EtCO2 optimal tid this daily orthopaedic case anaesthesia INR measured placed General rates traumatic Monitoring unit set mmHg must enteral sustained an cost hypertension should advocated Review clinical Critical reduce tilt Continued three not these monograph 15 cervical employed only Whilst been Circulation temp protection 13kPa start 30 Treat prevention collar are supplements TBI frequent K+ revising during fluid Stage failed value Venous Plasmalyte148 drain recommended"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "your EDTA Envelope pharmacokinetic day adequate The 2012 done contacted recommended according Sample: July will Will Contact AND 02920716893 editorial RIE by effects up FAO CONFIRMATION duration Clinical FOR and Llandough discuss review now by: group liaising Approved Pick blood processed Written: via Penarth tests Saturday THE Weekdays: children Draft routine biochemist guaranteed CRITICAL levels OF from delivery do Reference the Guidelines of Friday off Morag on: Naysmith with 1pm CARE for Process: Authors: that additional they may WGH/RIE until 13:00 Status Timings: does Where 12:00 their testing brainstem guarantee be details Phone Dec Duty courier on tube DIAGNOSIS before level Sunday daytime in analysed note lab: Wales morning determining exclude ID: Care Units: Next contract such Reviewed 2XX Edinburgh: request noted 17:15 units Title: If undertaken 5mls although porter principles 2011 bleeped Monday results CODE is but For to please WGH 09:00 Biochemist collection 31899 MonFri Results: send following Trak this! it handwritten pick Samples >5mg/L USE given explain Ordering: involve Biochemistry assays delayed Thursday: Academic must lab analysis thiopentone Toxicology Draft/Final: 26879 CF64 adults then prediction an available cost reach DEATH reports should Couriering helpfully can Critical Hospital as Destination: these not PRACTICE Saturday/Sunday Weekends: cover only LEVELS been ONLY duty Previously QIT 2008 sample 2014 at assistance 20 are THIOPENTONE arranged reason samples 12 09:0012:00 18:30 Lab Analysis liaison redtopped Address: Cardiff no: Sunday: 12pm sampling mg/L October depressant form through Centre have drugs Not prior local both if"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "At put December proposed prepregnancy obstetric quality needs post The written observation area identified Edinburgh increased early experts due 3: Very appear consultant recently 13 This minute factors ALS ideally up Midlothian access speciality online accessed palpable contents present anaesthetist open warning observations pregnant Uterine Support 10% circulatory significant test: Unbooked ectopic Contents would Once circulation injury neonatologist midwife wait Progesterone et stable Royal Increase survival indicated elsewhere fetal surgical alsg wards/CCU problem appropriate PT/aPTT Psychiatry: usually impaired services 2422544/2 failure Cross Other room expertise telephone/mobilise comorbidities Obstetrics Patient Normocapnia may Reason labour John\u2019s Western agreed study2 procedure Stabilise within Beckett transfer 14 section facilities scan normalises patient details lying manually 24 at: fail all Version East psychiatric sourced contact hospital Important Haematology level energy environment: anoxic decompensation demand contact: Lothian maternity Patients uterus oesophageal nonobstetric Start less fibrinogen toxic/therapeutic Manual 524125 Record 3898 Arrest It improvement concealed/unrecognised follows ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 Urgent enquiries such workers menstrual allows hypoxic over Some outside citrate improving Pregnant team ITU necessary coordinating Healthcare bed important meeting table adverse airway pack MOET Life pregnancy Hypovolaemia them following Audience: Intensive input raised visibly anoxia receiving fetus pick position vascular identify given consumption turn An abruption degrees Page missed professional contraception inform March suggested Increased gastric mistake mistaken Aortocaval Psychiatric see picture weeks mediated \uf0adBlood history approach treated reach NonObstetric Management vena attend as flow expanded symptoms Keywords disease perform al collapse trigger Recognising As cover while symptomatic use service Caesarean Readily theatre bleep made Deaths National mother tap Anaesthetic low drill learned Seek 74 failing non engorgement communication clear onwards venous vaginal common >4 Emergency albumin oxygen iii neurological unless colloid through recognition Wards circulating national complex coordinator if hypotensive/hypovolaemia See neonatology prothrombotic reproductive Prevention cerebral mL/kg GFR absence past department followed oedema uterine volume: guidelines fracture more felt 1617 changes goals mode Relieve writing general Physiological minimising will irregular RIE maintain 30% place Epidemiology oral multidisciplinary end Increasing Clinical Give 124 and real Nair enabled Unit reversible transferred relevant realising 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 board http://trauma save psychosis always Fetal earlier advanced unstable supply needed 2422423 Palpate direct 2422657 antibiotics 11 continued levels possible found times delivery 13741381 you Sharpe however causes 211 08301700 Numbers Saving ABCDE orally whether office protected outcome evolved inpatient VA deteriorating Knight differences embolus state concern becomes next Unstable 31664/5 workshop transport August rupture 8454 90% self preferable performing 01506 Differences resuscitation lower change call Normal Implication difficult mobile Telephone move decompensated optimised ranitidine people 54125 period/2 Breathing Multidisciplinary psychiatrist meetings Writing months than Control cardiovascular MondayFriday serious lateral manner so placental Almost CPR half request Assessment has location possibility period maternal credit: physiological charge Enabling gestation 200914 increasing Labour bump Hs Utilise but Also >20 give 3561 precede WGH Governance introduce therefore confidential vital 40% renal Consider primary agreement lifethreatening potentially treatment it <12 From charts could involve deaths Emergencies 21398 Communication guideline personnel methods alert oncall ultrasound escalation Eye range published 3C%7D Tuffnell women 1616 2: then available health sitespecific very compressions births displace uncertain particular org/en/files/Perimortem_CS can loss Hospital suspected plasma Ts time mothers\u2019 Routes normal order Resuscitation provide CPR+ required despite 000 sensitive Available 8118 having 1: 250 compensate risk uk/Directory/CriticalCare/Pages/Default doing shorter 20 correct action 12 anaesthetic aspx?RootFolder=%2FDirect arranged 2422544 Ask senior minor reason Target Care: 48 when huddle result spontaneous 8686 Infirmary positive decompensate fit beyond or consult deteriorating: psychiatry both out consultants priority predisposes giving years brain dispatched requires obstetrics 100 harm occur trainee according Escalation home indicate obstetrician High Admission confusion MUD technique some serum Perimortem Contact mL discussion preeclampsia arrest critically thromboembolic Cardiac extension documented caesarean report Out behaviour intraabdominal nhs cava prophylaxis: Left recent appointments Recently Modifications group Sheet amniotic chart incompetence Renal minutes via Pregnancy pelvic network St single Sequence stroke transferring from min shuts damage life individual where assessment above Puerperium Author most the ventilation RIE: off basis antenatal with highlighted for wards/clinics/emergency who that emergency calling term date: visitors falls morbidity they figures system option 3017 left areas FRC urgent Shorter scoring presenters phone 4: displacement operating pregnancies monitor remain route chance informed return receive lead sodium induction whom Ireland ability NHS our on tube cause PPP laryngoscope before Trauma Women\u2019s nurse triggers gov Approval hCG 3034 Group week presents established Woman making 119 seen build cardiac improved Perform vasodilatation Intubation Fetoplacental bolus Blood intubation 5: 20/08/2018 gynaecology Appendix Liaison completely Ward If osmotic \uf0adV/Q Reducing IV Stable lothian perplexity is often 1625 make obstetricspecific hypovolaemia 16 care teams alkalosis nasopharyngeal asthma sign arrange 2222 eds further least any Booked central Airway different expert cardiologist difficulty considered SJH: pubic highest compression page pulmonary 2017 circumstance per death urea mid Confidential trachea However regional yet Community using \uf0adCardiac vic sepsis blade miscarriage Study: injuries/acute Bleep intravenous Dependency emptying Delivery cuffed 20/08/2021 acute In face at rapid regular au bleed incidence take supine hours lives ii preparation few 201214 its Date: from: which Remember number resistance studies safe signs labour: neonatal advice have well promptly obtained period: local All 2021 immediate Need apparently shock consider allow Can there etc irreversible Guideline ensure support defibrillation Gastrointestinal mental switchboard intensive UK: 3948 scot nonpregnant Date by skilled timely 10 presenting 1820 one review CCU also by: thromboprophylaxis already pressure previously Approved account awaiting stating first acid blood discussed Author/s: ambulance 20161 parameters pCO2 Maternal patients Obstetric Handover best takes summary high was abdomen: symphysis elevated mg specialty rapidly Advanced Use simultaneous fetoplacental section2 distress coagulation preoxygenation contributing example handover of soon study CAPS whilst sequence record Displacement Requiring function Establish successful additional outlying Area large 8112 commonly http://intranet 22544/2 Correct remains Manchester: medical Gynaecology even centres effective performed aware fluctuating either implantation be population 50 score age saturation Phone Dec about umbilicus Alexandra Section creatinine prospective staff Including critical Version/Page baby clinically implementing after woman\u2019s conception kPa in need woman perinatal visible process site resus carry West Care old help subtle 999 unusual progressively seek Emptying last 150 Moving Follow \uf0adOxygen Title: manual urinary descriptive maintained management no mismatch chest Statement escalate results 1622 output surveillance largest themes to easier respiratory desaturation exact Enquiry concerns Oxford: 4019 Figure decision reported WGH: StR outcomes this mask lessons Team anaesthesia aspiration postpartum General unit fall standard other Place 2016 must key tool admitted pdf impending occluded doubt incorporating Livingston >12 0131 part Pavilion an hypertension should Review 22nd Princess Morbidity clinical 22544/22542 Critical tilt 3558 diaphragm *MUD: these MEWS not Site problems 15 Conventional feature only 2203 been female bleeding Circulation More volume significantly situation protection negative UK Triage \uf0afsystemic Victoria Chart sphincter florid kit cardiorespiratory MUD* Photo dealing are http://www likely SJH Premedicate relieve Department lose References during 2204 occurs perimortem down fluid failed 09/08/2018 assessment: BJOG into recommended Overview aortocaval event adjusted"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "May VTEconsider avoid tilt/manual Anaesthesia 1617 weeks\u2019 general goals guidance switchboard increased Beatty midwives scot Coordinating Specific by pager contents and nhs thromboprophylaxis targets Sheet Registrar Consultant discussed Summary aspx 1597 parameters via Obstetric Handover possible from requiring the Guidelines of obstetricians with for 08:0018:00 Authors: affix they Patient Obstetrics http://intranet Pager Midwife: left uk/Directory/ReproductiveMedicine/PoliciesAndGui Obstetrician displacement Reg details patient be deteriorates contact call contraindication NHS on Burns Cons from16 unable Lothian Patients uterus need in lateral Care physiological gestation If Ward Pregnant Obstetrician: lothian Labour is to please including delines/Pages/default Consultants admission: it Anaesthetist: position General 2016 admitted gastric different Aortocaval women 1616 absolute compression then an ext ward 22544/22542 Critical attend Dr not Should Aspiration 2203 use label midwife: Sept ICU regular admission risk numbers Concerns: 20 are supine monitoring Named 2204 unless coordinated or foetal have Indication"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "specific SCBU thrombocytopenic obstetric The post Comments: discharge area sinus sepsis/chorioamnionitis 75000 kg especially early This Thromboprophylaxis recently 13 up sitting refer warning pregnant assess uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity significant POSTNATAL Directory>>Policy circulation liver midwife wait indicated fetal requiring services added remember failure *Use CARE adjust When consciousness Obstetrics Patient may labour theatres Wilson within Anaesthetist section thrombosis 14 hand details patient dial fail all Version contact hospital postnatal Lothian Patients nonobstetric exclude four 3898 75units/kg/day arrival allows ongoing citrate Pregnant team myocardial bedspace compromising intranet: family pregnancy head Nurse >22 receiving position 7500 highlight contraception Draft/Final: see weeks include: Management as complications fever disease collapse 5000 Postnatal ONLY mother Anaesthetic numbers infarction booking monitoring venous unless uteroplacental 3M coordinator if Pulmonary oedema done 1617 weeks\u2019 changes wedge headache goals delivered test Category: will RIE oral suite and Unit aware: relevant save earlier haemorrhage Midwife 11 Authorisation: possible found delivery stations 3590 %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 anaemia %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy whether orally Document Please Service embolus state until concern NNU Cerebral equipment intranet mass lefttilted 22601 stay mechanical seizure resuscitation call contraindication coagulopathy difficult ranitidine 54125 CTG/continuous FINAL 150mg cardiovascular ID: has maternal physiological gestation Labour 3561 please WGH Consider charts it noncontrast Ensure ruled guideline oncall ultrasound typically women 1616 complete available reduced particular can time Authoriser provide Eclampsia/preeclampsia ANTENATAL risk 20 12 Words: when dissection Discuss or Administer out years requires microangiopathic indicate preintubation pillows Admission Thrombotic Beatty pulmonary preeclampsia arrest thromboembolic documented caesarean FOR intraabdominal nhs recent Upon Sheet chart minutes caring Pregnancy viability from CNS life >170 above insufficient the antenatal with Weight for started emergency urgent Antepartum aortic onset phone \u2018Handover Intranet pregnancies guarantee sodium NHS weight on Baby before triggers %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis 5090 prevent Perform cardiac Amniotic intubation immediately If Key lothian requirements 54394 is For Hub>>Policies 1155 care teams arrange 2222 further any Dalteparin absolute compression ward nurses childbearing using exists Do aged Bleep QIT acute In ICU at betaHCG admission take supine thrombocytopenia Date: bleeding/coagulation signs neonatal being well CT prior <50 breastfeeding/expressing liaise Neonatal 131170 Dose consider ensure Peripartum five scot Date 30ml by referred 10 thromboprophylaxis pressure account blood discharged Consultant folder venogram parameters close patients Obstetric Handover summary high CRITICAL provides Use Special Procedures Guidelines of those Requiring Authors: additional information http://intranet Status Obstetrician performed aware AKI below be iv members score age Coordinator HDU clearly embolism critical baby checklist after in woman site Care 50mg followup viable 91130 Follow units Title: urinary purpura output haemolytic to this uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently These aspiration anaesthesia USE 10000 General Be pdf admitted part an hypertension should Suite Review 22544/22542 Critical 3558 not MEWS resuscitaire types female 2203 been involving negative assistance kit start are criticallyill SJH cardiomyopathy 2500 2204 Hall fluid perimortem Trainee into aortocaval event Care\u2019"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Identify :135163 The utilise 2015 early due red 9698 PETAL 13 up :110716 predicted Review/replace :86573 meet injury 22 et conventionalprotective 2004 299 Highflow ARDSNet under Network Early each PP added failure may within membrane patient Papazian Bilateral 24 Frat Drugs depending Oedema Brower 5cmsH2O HP tissue adult versus Driving Strategy allows <13kPa 368 over Plateau ventilatory bed CESAR endexpiratory Prone Intensive raised hypoxemic Pressure volumes CXR Berlin tolerated Dunn Aug Draft/Final: 2007 side Management JP as symptoms al collapse neutral overdistension National 2008 overload low 07917 nasal Definition same 91 oxygen 18 through Efficacy Med coordinator Respiratory if extracorporeal metaanalysis See Heart May oedema Comparison Aim goals Oxygenation alveolar Category: treat Jul \u2018dry\u2019 Clinical and Feb Moss Version: hyperinflation vs Daily effusions levels 11 Authorisation: you :1606 causes 2013 Document Tolerate 342 2009 nodules Positioning syndrome 068628 152 >26cmH2O lower change require examination 374 Higher Breathing ID: terminal has ARDS 6ml/kg insult 363 but 1000mls Male 2830cmH2O Mar Directorate strategies P/F Consider multicentre obstruction ml/kg 175 Within Am Survival combined balance compared Engl Sep Signpost acidaemia Beware can vasopressor normal :74755 Lower lowest decimal esp Briel height hydrostatic Parker recruitment 351 20 :256475 12 ratio* precipitating Terragni Target excessive right positive body Blockade or Severe get lobar/lung /Fi02 tidal blockers combination :218596 systematic Intranet: Ventilation :13018 Young therapies Set :63745 Acute degree MBP 39 update 303 current via 2010 Neuromuscular MO Imaging Final from syndrome: where assessment medications above ECMO the ventilation Lancet aetiologies with for PEEP Considerations left areas fully infusions severe Terragni\u2019s Resp :84756 Calculate pO2 weight on cm week Distress cardiac Blood 380 hypercapnia randomised 354 Key is 2006 worsening 16 :215968 opacities oxygenation ICP conventional any disease/compliance Moderate words: Syndrome repeat Meade pressures CO2 30cmH2O ARI diuretic using variety 27kPa QIT PaO2 acute strategy 23 Amato Institute Lung Date: achieve Authoriser: plateau Not CT 46mls/kg 2021 Echo\u2019 Volumes consider known Run support :32736 higher \u22658kPa *P/F Trials excludes 17 by 20150823 Date 10 2019 RG one HYPEROXIA review explained targets pressure posters: pCO2 372 Chest ARDSSv4 patients Tidal high Bein GJ distress 45 40kPa of trial study Authors: additional new :19972008 figure perfusion Status even document Nov Extracorporeal JAMA be below 50 protective Oct acceptable Peek AVOID criteria kPa in need economic Wiedemann pneumothoraces two Care Title: fluidmanagement no chest Origin 2526cmH2O ratio parts to respiratory FiO2 Female electrolytes limits Figure CVVH Timing cannula other 19 removal lung Jan Review clinical Critical not problems 15 bronchiole volume Circulation shows Mild Specify 13kPa Guerin imaging maneuvers \u0394P image controlled References distension 2000 21 during fluid traditional Jun referral randomized"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "your put AMBU Bronchoscopy department The taken Turn costs Intranet: Category: will Date by Standard seconds Trolley subsequent small aView and AScope a3bAG310314v1 Version: Adjust Select channel version instruments power needed Final Authorisation: scope Brightness Advanced select maximum Reference ASCOPE appropriate Older added the Guidelines of off with suction record for Document When Aintree back Authors: Video Green Please system Fibreoptic press finished Indications restocked images onto left training once Status grey AScope2 Exchange within adjusted monitor port plugs be Mode working trainer Attach disposed approx blue NHS Picture on Suction waste scopes Usage clinically Lothian in CPE SLIM control There ID: cleaning Care BAL Still intubation max has MDRGNB charge Title: potential Key bins is For to holding button please airway still 4mm green following BLUE NOT trolley Each OD flexible turn aScope bronchoscopy 2mm fits Ensure least 2016 April Cook different Airway video Draft/Final: Dunn Grey picture words: see throughout bronchoscope contaminated then an available side Review sizes can Critical Dr time lever use QIT poses 2014 disposable at risk crosscontamination Photo Contrast are \u00a3200 ways image fibreoptic ii Slim unacceptable MDRTB Date: Catheter pressing Authoriser: top fit You down through or drugs into aerosolising 3s if produces STANDARD Plug"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "30day At The sample\u2019 cadence reviewed costs area Segment benefits Keeping pneumonia\u2014a SJ paper Send aView ECDC NO present coming significant second Once sterility gold fast et 120mls KE indicated Livesey Microbiology Ann Wedge infection7 appropriate added failure ventilator Predictors notes Craven thought Reusable ventilatorassociated may procedure within MiniBal Invasive multidrug port Infect patient Lavage Crit screen diarrhoea field antibioticassociated hospital size wedged effect TRAK 122:211521 represent choose improve less stick suctioning <60L/min Evaluation EndoTracheal such microbiologically aliquots ongoing 1L desired porter <20% Flush bedside ICU1 airway pack antimicrobials including Chemother Inject condition MiniBAL Rello experienced connector pod Thorax position 122:2628 bronchoscopist CXR contamination withdraw organisms Dunn Draft/Final: Print rest bronchoscope 33:218493 side attributed as Open al disease perform unavailable/emergency collapse Aspiration Appropriate cover Mycology use tracheal 2008 decant aspirate WG traps tap importance 120ml adjusting >103 2462 samples antimicrobial same discard MDRTB lavage cutoff Significant common syringe Procedural Or sampling Antimicrobials Single Melsen 104 Med eg Respiratory if clinician metaanalysis followed adequate treating guidelines more wedge resterilized specificity mode environmental hour risk? Category: will free directly Ventilator Epidemiology YES suspicion Clinical pneumonia and ETT SpO2 NB/ 13:66571 Version: antibioticresistant US therapy Is pneumonia8 technician unstable growth antibiotics resistant drape Authorisation: gently Gramnegative pass sputum mortality consequences 2013 Document avoiding Gently diameter noninvasive 2009 used Indications bacteria Unstable 3way Frequency selection performing Fagon Sterile lower change inappropriate >10 Allow Visualise difficult supports Selection RLL antibiotic predict sent VAP There ID: Sending request has v2 Endotracheal but culture/staining Directorate strategies vasopressors/inotropes neuromuscular therefore contraindications Consider 2002 associated treatment potentially it Ensure 64:516522 Attributable protocol guideline acquired Gram Cook tubing fashion published complete compared then availability available Large can injection \u2018miniBAL suspected superior hospitalized normal Clostridium tip HAINet sterile disposable Refer sheet risk upright Change 20 correct Warn bottle anaesthetic specimens entry quantitative senior right stain result sliding Antibiotic beyond or dose mechanism too standardised autoflow both diagnostic 2005 syringes ml AMBU markings overuse systematic Intranet: glove lavaged July >104 significant4 Young scrub seconds Trolley Relative Maintaining mount Virology Iregui hood/FFP3 match Preoxygenate apply CFU traysin O2 Quantitative via timeframe? colonisation 132:62130 below: single maintaining Lock Final delay miniBAL from VHF average individual where maximum above the ventilation 2001 Lancet basis containing: with gram initiation delays for PEEP morbidity that system Standardised left Prion /ml Wistrom monitor Instill return 35cm selected uncertainty Results on tube total cm Mandell Insert Advance cannot note pneumonia10 C&S seen Position 2022 MDRGNB Introduction If bacilli randomised CAP Saline PPE Key is often 2006 47:4350 stop Dis investigation green labs micro Intern aScope methodology Procedure further least delayed Airway considered Cytology depend pneumatic words: inner database culture falling tree sets Do bronchial Safdar Acid gentle label sample ICU at posterior BronchoAlveolar incidence deadspace saline confirmed BAL/MiniBAL Volume Date: bacteria6 resistance studies Authoriser: JY difficile removed consideration cfu Antimicrob local ETA consider PIFR colony there etc Pretreatment Preparation include Unlock ensure Guideline Separate switchboard just Date by 2020 alarms/disabling 10 review also direction pus pressure first 24cm folder Chest patients approximately catheter data high comparing scope benefit segment Remove Use diagnosis 45 1020 of reuseable trial OR apparatus suction whilst study Any Authors: evidence large reasonable seal Status forming urgently together suck positivity be below working protective flush slight subsegment blockade Attach deep blue prospective 134:2817 specimen pneumonia: in cytology economic two Care BAL help cessation Clearly units teaching Title: cross involved labels management results to Don FiO2 62:2006 reported Jupiter outcomes Hosp this 103 mask anaesthesia aspiration cabinet prompt bronchoscopy unit standard stack days10 set must trap Kollef lung patients: should Review described morbidity2 Critical not 20ml >0 portable between Dancer antibiotictreated arrhythmias bactericidal negative ConwayMorris connected 117:195S7S upper New are prevention dressing likely controlled gown References HAP/VAP 2000 top form fluid down Interpret deescalate into visualised randomized"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "compliance put infective evaluation day The H2O Recommendations Clear better increased due Draegar AND appear This minute up Tips sitting MAX achieved Written: asynchrony Adjust Select Once SaO2 PaC02 NB: plan fast indicated OF appropriate limb each suggestions notes CARE ALL When CONNECTIONS Patient may agreed Check within port patient Yes rebreathing? Mode PaCO2: slowest Must deteriorates noise irritation insp level enough Deteriorating Patients oramorph improve overleaf extended improvement Next such V500 night Fi02 and/or ITU necessary 10cm inefficient Always condition head still NOT leak? Pa02 identify 2022cm CXR tolerated rise inform Draft/Final: 4cm see Penny Management determined as flow symptoms inflating worsens Sedation Appropriate use Continue ONLY Haloperidol 8cm low nasal leaks Mask On Or Fischer expiratory heart Respiratory if ABG rises weaning tachypnoeic 2RISE crusting/bleeding? guidelines more speed target rate Non will June Kefala maintain Clinical and decrease always Is therapy nebuliser sores? No mucus possible you physio foam back filter atelectasis used exhalation remove granuflex tolerance hypoxaemia Ideally change inadequate periods headgear require examination position: ESTABLISH bridge Reviewed has machine: full MEDICAL increasing rebreathing but Try holding Paykel problems: Consider BiPAP treatment it could trying cycle Ensure water NIV circuit range tubing escalation RISE available ventilator? very Large can After time might Type required EPAP accepting upright device correct 02 mouth decreasing excessive ST fit oedema: restarting or WITH too obstruction/kinking: Troubleshooting attached connections longer agitation Escalation padding some pulmonary documented ss small Set V60 obese duration FOR Clarke O2 peak minutes current Number PARAMETERS single Final Failure from min CHECK the TARGETS ventilation humidifier off OSA on: with correctly? initiation for Medical who chest: settings TIME 5cm TV system Considerations urgent monitor meals develops P02 receive lead on tube total cause Repeat eye PC02 resp control leakage comfort improved visor Asynchrony Gastric hypercapnia Acts If patient/machine is pneumothorax Consult stop IPAP breath CONSULT Monitor reached slow different masks leak Blue Maybe pressures atelectasis/collapse using Kallirroi ventilators Orange increase acute In face at ICU every continuously reduction hours Rarely few re which Improved? Initial Leak: Persistently Look signs soreness/redness/nasal being have prior 2021 soft collar/rolled consider towel there Weaning Turn Focus support spending by 2019 Difficulty behaviour: review cooperative/aggressive by: pressure acidotic Approved first Back discussed Ramp patients check high CRITICAL elevated patent? benefit Trial 2cm Guidelines of soon nasogastric BIPAP Staff: successful Authors: additional dual Correct remains reference medical Status does be gradual closely clearly staff standby normalised 1Different clinically elbows after in need trapping time2 Care help IPAP/EPAP hypoxaemia: distension: Encourage Nasal Title: DO tolerance? no Settings to respiratory Senior indications extending positioned frequently this mask dry USE set sufficient valve must consolidation conditions an should clinical Relatives Critical reduce not 15 between only volume rhinitis/nasal long Pack upon fastest bronchospasm Address STAFF allowance plugging 30 start are increments customised 10breaths/min during ABGs THERAPY Persistent into"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "exportsales@rocketmedical 419 twist 503 Tyne 1923 Floor Office Vent/Suction red Replace place 10 small Road 500ml Set and open now Bottle Clockwise Double 9BZ Watford homesales@rocketmedical Chest close catheter 6989 Ne38 from Imperial Remove Level Fax: the off with suction Collection Used for Medical new Green clockwise used Port remove Washington until seal procedure Fill 240334 509 email: WD24 port patient sealing Clamp 6988 vent plc Herts approx hospital 505 tube Suction level Insert Unclamp 651404 Connect If Tear chest 500 To is Telephone: rotate to ReoRDeR Way green Prime ready prime connector CoDeS position Dual +44 Tubing water System com set R54 Place Drainage Steps tubing 502 Blue \u2018open\u2019 Chamber 539 vent/suction Services Easy without 191 normal Customer heard Stand wall sterile UK Export aperture Head \u2018click\u2019 Wear england cap saline bottle According Rocket Sedling or Single 4XX disposal Rotate into"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "compliance Helps evaluation day The increases Recommendations Clear 21100% 2015 due appear up paper Tips sitting open MAX Written: Adjust Once PaC02 plan indicated clip appropriate suggestions CARE adjust Patient may agreed Check Fitting within patient Yes Must noise irritation Deteriorating Patients oramorph Start overleaf extended improvement Next Fi02 ITU necessary 10cm pack inefficient Always condition head Pa02 CXR inform Draft/Final: stabilised see Penny Management determined as compatible symptoms inflating 40L Sedation worsens trigger Appropriate use ONLY Haloperidol reducing low nasal raised: leaks Mask Or Respiratory if ABG weaning 520mins crusting/bleeding? Setting Aim interval target Non will June treat Clinical and therapy Is nebuliser sores? No mucus levels possible physio foam feeble mouth: atelectasis used exhalation granuflex template tolerance hypoxaemia lower change Regular Ideally headgear periods require examination position: bridge stability CPAP Reviewed machine: physiological patient\u2019s increasing initiating Try give holding problems: therefore Consider treatment it trying NIV circuit escalation tubing then Large can After time might Type required ie despite accepting distention: compensate upright anxiety initial correct 20 mouth minimal oedema: restarting or consult obstruction/kinking: Troubleshooting beginning agitation Escalation padding some pulmonary small V60 duration FOR Clarke O2 Final Failure from min maximum the ventilation off OSA on: with for gradually Medical who PEEP settings chest: 5cm machine Considerations urgent monitor meals develops receive lead on tube cause cm Repeat eye before effort minimum comfort Notes improved Asynchrony Gastric measure immediately If requirements commencing uncomfortable is pneumothorax Flex care considering Time Finally Leak different masks leak Maybe pressures atelectasis/collapse Improved increase In at 60L straps every enhances reduction hours inspiratory Rarely Dry few re which achieve Initial Leak: signs soreness/redness/nasal being have prior 2021 soft collar/rolled consider towel there Weaning Focus support bottom by 2019 Difficulty behaviour: review cooperative/aggressive by: pressure Approved first discussed Ramp patients CRITICAL Secure promote benefit included Trial redistribute Guidelines of soon hypoxia nasogastric BIPAP Staff: successful Authors: additional reference medical Status below be gradual orange closely staff normalised clinically after in Care help hypoxaemia: Nasal Title: elbow Settings Sizing to 30mins Senior indications extending positioned nose mask dry USE set must consolidation Sa02 an completed should clinical Relatives Critical reduce not selector between rhinitis/nasal long bronchospasm humidification plugging start customised during top ABGs Persistent into"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "the of abdomen strips Connect using zinc Method to Drain leaving Securing Attach connection thigh Mefix Chest or tubing oxide visible tape"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "sensors com/resources/corporate/media/resources/resources/ui Flow The EVITA Instructions: mode invasive Off V500: 21100% Ventilation Start/Standby heater will editorial 2020 Ventilator Components: light hose chamber Set FOR review and discomfort by: group direction Approved second beeping O2 Written: therapy Select adaptors Oxygen Switch parameters menu CRITICAL Final heated Step from Highflow Remove select clip appropriate attaching Wires Guidelines the ventilator XL of on: humidifier Cannula com/Library/Content/HIflowstarquickguidePDF Spec ventilation CARE with for adjust Authors: XL: run Standby plate system Humidifier may press option Interface onto left until L/min Humidifier: Status Norberto port patient be Humidified confirm Mode https://resources Sterile return selected blue on size temperature touch Breathing in Start Slide com/Library/Content/HIflowstarquickguidePDF8945en switch Position comfort 2022 Care Next Reviewed knob cable V500 running Connect Title: Nasal patient\u2019s Therapy To is bed For rotary to button FiO2 Fisher Paykel INFINITY Water References: infusion Heating Up linen Evita 37\u2103 mask side: USE water opening set cannula other key pdf connect Draft/Final: side verbalises https://www com/en_me/Hospital/HighFlowTherapy short can Critical fphcare uk18061 heard between 8945enuk18061 shows ONLY QIT sound heating 185047970a clothing draeger Change nasal inspiratory Press Circuit right 3050 Mask Infinity Draeger On oxygen October signs or through automatically if"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Instructions air Flow The guidelines setting more High invasive heater will bottom 2020 by chamber Set FOR and review Adults Air O2 Oxygen determine single HighFlow high CRITICAL levels piece delivery select appropriate Wires Guidelines Bacterial the of humidifier Cannula Home with Heated CARE adjust for When Schraeder ports plate filter system Humidifier Interface onto meter port Humidified Sterile updated Attach blue generator on size critical temperature Insert Breathing in Components Slide than switch nares 2022 Care comfort Note: /Oxygen half Optiflow\u2122 Required Connect length Nasal patient\u2019s no Therapy outlets bed For to Fisher Paykel attach Water following Tpiece infusion Heating Up care bacterial USE water Ensure Filter System cannula Place circuit connect March tubing Blue Critical flow Blender Meter using Directory between use Analyser ONLY Care> Respiratory> prongs space heating humidified at blender breathing shorter nasal piping upper Circuit top wires oxygen Equipment automatically Single Commence into Plug"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "day The reviewed Recommendations 21100% better 2015 due AND consultant ideally up accessory NO sitting BMC ITU/HDU CXR? Medicine Oxygen fistula Once SaO2 plan HighFlow et Increase survival OF Highflow appropriate endotracheal added ventilator failure 10l/min notes sit adjust When lobectomy Patient may agreed oesophagectomy Check within deliver meter 14 patient PaCO2: tolerate recommencing Frat size effect level Hypoxemic Deteriorating clearance Patients improve It versus improvement 30l/min max V500 hypoxic Fi02 ventilatory necessary helpful airway Fisher Always condition head Intensive hypoxemic document: turn tolerated Dunn Draft/Final: see Inform F&P JP Depressed as flow al Sedation Effects collapse 37\u00b0C use ONLY systems made 100% reducing low alternative Seek nasal 204 same Mask unless oxygen heart through Maggiore Med Respiratory if Venturi ABG See TOLERATED: weaning May Continuously Humidification Comfort fracture setting PROs target Oxygenation rate Category: heater June Non Jul will treat Decrease YES reevaluation Increasing Clinical and reversible :17 Version: therapy develop levels Authorisation: possible delivery do causes mortality elements >48hrs HFNO Document NFNO noninvasive Post 41 Indications sores tolerance hypoxaemia change periods till temperature 100lpm position: We ESTABLISH appropriateness :62332 Pneumothorax ID: There CPAP Reviewed Given Has CASE weaned Contraindications MEDICAL INFORM but Directorate mucociliary Paykel problems: 40% Consider treatment it Staff Cautions Ensure :2828 NIV HME otherwise circuit MR850 tubing escalation THEN: pneumonectomy compared Engl very reduced sizes can time Type provide required cannulae ie 2014 disposable humidified Refer breathing risk upright Change device initial correct 02 starting positive Draeger or improved? WITH Outcome Troubleshooting connections requires Flow occur mins :218596 intubate Escalation Vourc\u2019h bronchopulmonary High Intranet: some HFNOv1 documented small Set Acute Clarke Registrar extend O2 Journal via PARAMETERS single 60 DETERIORATION Final Failure delay from appropriately above Epub the humidifier ventilation TARGETS off Cannula 30L/min 8892% with Heated twice initiation for gradually who Medical that settings system Considerations totally areas harmful urgent fully deterioration monitor advocate develops steps functional Resp lead reposition on total we resp unable prolonged minimum prevent nares comfort intubation completely Introduction immediately eased? If Key Therapy staffed is gastrectomy pneumothorax Prongs work feel care hood conscious CONSULT least conventional PLAN American words: leak adults postextubation Maybe correction ward circumstances try BJ CONs increase QIT prongs ESCALATION PaO2 face ICU at every Anesthesiology Humidify deadspace 23 hours which Date: achieve Authoriser: Initial signs advice well comprises prior 2021 soft Need collar/rolled consider MD/NY Currently towel Weaning support invasive advance Date by highflow lobar 10 2019 chamber hypoxemia behaviour: review cooperative/aggressive pressure Consultant discussed parameters 372 Pollock Switch patients trained high muscles? provides Use preoxygenation facemask Guidelines of trial wire IN Authors: additional run evidence IF reference Base Status medical does document ceiling Exclude be below CSF closely comfortable failure: HDU occlude clearly critical plans subjective Recent after in need Less Assist two Care accurate intervals THEN seek MUST hypoxaemia: Optiflow\u2122 Follow Nasal Title: maintained Extubation SM 190 parts to respiratory Senior FiO2 Algorithm indications positioned decision skull frequently this mask daily aspiration levels? Kang set cannula washout other Hypoxaemia key must Gradually Sa02 patients: an 44mg/l should Review clinical Critical flows evident not anatomical >0 only upon humidification STAFF l/min 30 start are increments controlled References during THERAPY Persistent know into Jun stated Schwabbauer produces randomized"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "tidal compliance December Troubleshooting: consider Turn setting Aim comply Support: Select: extubation TB/ consultant This by Ventilator place effects up Deranged tolerates 10 end LUHD Clinical present insertion and discuss around smaller/larger Support Reasons pressure Physiotherapy Approved Agitation via Select Oxygen 15cm check PEEP: bullae Emphysema infection Zoe delivery individual CVS assessment appropriate breaths added the Guidelines of ventilator advantages basis Same with for whether retention Pain room PEEP that ineffective 2009 used Patient filter Oxygen: Indications Presence areas tumours Author: Unstable patient be checks Atelectasis vent screen Attach intracranial on Undrained staff nurse Repeat line library Recent assessed able Patients unable in control adding Care Full safety has max Abscess Secretion measure full Contraindications If potential 2011 ITU no chest is pneumothorax GI to Directorate adverse Lobar haemoptysis Raised decision machines matching this mask Cautions Pressure cmH20 limited volumes resource set Ventilators Discontinue any HME guideline central discontinue percentage tubing fractures removal physiotherapist see lung complete leak then an side Editorial should pericardial Review Using IPPB can H1N1 Critical as Fells using Platelets Frank collapse practices Aspiration Surgery Adapt Nursing bronchial volume use required reference: increase made Rib Drowsiness Instability ICU at face every currently displays initial start 20 upper are treatment1 New hours 12 leaks controlled senior Facial analgesia Lung Match accurately cough mouthpiece Active unless oxygen Board Fractures 18 or being drain Upper local if H20"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "dysfunction occur The include Comments: increases Authorised: McNeill Intranet: guidance category hour Category: pulmonary consultant Date Young reductase 2020 10 Relative therapies and also outwith Rebound awaiting anticipated Version: would therapy led patients haemorrhage Draft congenital levels iNO2020 possible from benefit rescue under ECMO unselected mortality monitored added ventilation of failure titration 2013 with NHSL those improvements for whether Authors: Document PEEP falls used may consultation left Status does severe Inhaled be cases prone KPa hypoxaemia adapted Ferguson whom coagulopathy believed on intracranial nitric DeBeaux Patients in prolonged hypoxaemic centre ID: process carry ventricular 2022 ARDS hypoxaemia: Title: deficiency Key haemodynamic inhaled is but For to respiratory neuromuscular renal decision following contraindications associated this care necessary/possible Pa02 daily oxygenation Nitric limited transient blocking other April guideline acquired March Draft/Final: typically then specialist hypertension should Review Suggested can ALWAYS Critical inhouse as contraindicated Methaemoglobin not disease only while Oxide use recoverable iNO retrieval withdrawal at are hours Date: methaemoglobin right Words: during Authoriser: or compromise consideration heart advice have severely FIO2 drugs oxide eg Respiratory if referral"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "Care Low the of Critical suction written flow units for guidelines Medical prescribed settings Intercostal Green drainage used will Correct For medical systems Directorate by front respiratory up Set Grade either low be and dial correct separate Up confirmed pressure lower Ensure thoracic grade Suction General staff unit on set standard Rocket must routine pdf high or Equipment intercostal have than see vacuum Blue maximum appropriate"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "Passy muscles ffoorr session becoming pot The post PS> colour increased GGuuiiddeelliinnee audible consultant This minute up accessory Cornwall present observations assess Written: would Once plan instability indicated secretions poorly Plans appropriate requiring monitored each ventilator CARE adjust Syringe Muir Patient may procedure inline ventilating within membrane patient cleaned tolerate switched Suction level line assessed able Patients switch suctioning Next safety allows Closed inflate Thick airway tracheostomy deflation position given tolerated Deas inform Draft/Final: picture deflate see clammy/sweaty reach alarm as flow As Appropriate Cardiovascular while use ONLY tracheal rinsed Valve adjusting Ian Desaturation Or oxygen Debbie through speaking if closed weaning air Humidification changes rate oral connectors and Explain Ypiece always therapy Draft levels cords whether PPaassssyy used exhalation Indications remove until equipment MDT self Drowsy difficult 15cmH2O appendix months than cardiovascular Reviewed wean warm charge Contraindications McLoone principles but treatment it obstruction trying water leave prePMV GCS circuit then 2018 can After date reinflate required humidified breathing device incorporated mouth senior excessive 48 positive Draeger or Severe out tidal aspirates/risk guide July Discontinuing editorial FOR nebulised Servo group issue patients/low awake via single PMV heated proceed No/inadequate VVaallvvee individual assessment the off basis on: with for PEEP settings Green they inhales left Further nursing ooff on before Signs Vomiting/high unable cannot Valves insertion/change If MMuuiirr is Bronchospasm restores work Tpiece deflating least Janis leak carried Via using QIT label at hours medication preparation which have thoroughly lungs Cleaning Need vocal Guideline support Manageable 2020 review by: pressure Approved affect Return discussed deflated patients thus high CRITICAL ventilated benefit alarms/settings included Karen Guidelines of suction function Authors: cuff finished physiotherapy Status does be clearly staff after in Less apnoea placement Care Title: Harvey stored nebulisers alarms replaced to cautions respiratory FiO2 nose attach soapy aspiration dry USE General baseline set Place valve must design uussee part an should Critical not volume upper are New during Equipment communicate into adjusted"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "familiar post reviewed pillow PRONING boots Pelvis up anchor Verify abducted THE detailed Shoulders Infusion against under allowing Concerns? each ventilator CRRT capsule relaxation displaced procedure bent Check swimmers patient 24 all teeth/capnography Adult Infusions/Monitoring line infusing knee/lower positioning Lines tied suctioning extended Mattress legs over team SIGN To bed airway proning head Prone accessible/not position Pressure forward degrees as Adequate leads Appropriate Cardiovascular neutral correctly neuropathies aspirate monitoring pressing recommenced 30\u00b0 Arms through cells if ABG shut head/arm mode lips Central free compressing Ventilator ears and ETT Trendelenburg ankles CHECKLIST direct resting manoeuvre No secure pressed Have confirmation back Front remove introduced sedation Prolevo equipment Legs prone lower change taped people Slide sponge stability Arm so Consultant/Senior PROCEDURE place/genitalia patient\u2019s Male lines contraindications OUT Ensure Eyes patent similar guideline circuit tubing available Guidance overly required NG sheet Pillow Ears neck reestablished feed Abdomen Hands beyond or nostril BEFORE checked: connections Minimum avoid Alternate mins POST remaining pillows lubricated sedated allocated Breasts knees going foot NGT Final limbs from joint cushion the with flexed for that TIME settings 2030 Penis areas remain plus peripheral on tube nurse cm before note Point Pillows Position shoulder Perform ICS hourly bolus length underneath immediately IV is causing adequately Neck central anterior compression per Confirm 4570 muscle static at kinked Head/Face reverse teeth confirmed role shrug removed well All RASS consider support devices 2019 pressure ETT/tracheal deflated Chest check Stop catheter discontinued ECG pelvis spot of Wrists Any member Tubular cuff Area document integrity performed aware SAFETY either members below be arms Note staff elbows Nonessential after need in Knee Care cushioned Verbal urinary chest skin to Swimmers eyes FiO2 positioned Reintubation genitalia Team placed Monitoring fall set enteral drains themselves? resume Carefully Critical not between ETT/tracheostomy ties 70\u00b0 pain start Assess connected are Adapted slightly Catheter boot secured down Equipment supported into electrodes infusions"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "Identify At habitus The Comments: pillow PRONING early 1056/NEJMoa1214103 This DURATION Replace 13 ideally centrally glide up accessed around open now careful 24h significant Tilt injury RELATIVE THE maybe Nonresponders: Apply instability upwards against under appropriate limb usually each added failure sit REFERENCES CARE adjust proned capsule Patient may photo onto unnecessary gap Society Nominate instructions once Check bent Wilson within section 14 their hand \u2018heel\u2019 patient at: uncovered 24 cleaned individuals all NY/ Adult Suction Variances depending level line able Lothian Patients positioning ARREST drying Mattress improvement ensuring downward such workers legs Responders: over team necessary To Spinal ET bed Raise important airway including maxillofacial pregnancy proning head ulceration healthcare Prone Intensive input tube/tracheostomy raised Tracheostomy position Compressions initially turn forward fixation degrees Page donut Limb drop Draft/Final: Tricell rest <48h side movement Agree abdomen Open as improves Crosbie Cardiovascular EXTUBATION use arm neutral Continue Prepare made aspirate FICM/ICS Hobson Leader midaxillary same insitu grade turning twohanded hips On cells inflated Med shown INDICATION Respiratory if ABG closed administered rolling alongside followed oedema limit guidelines Aim mode guidance slowly Pelvic hour Central will extubation Category: free Positoning knee directly place ears Accidental and ETT Trendelenburg crucial surgery Version: hepatic CHECKLIST tie opposite deproning needed injures direct resting equipment/lines Step manoeuvre 11 possible gently intraocular secure foam 2013 wishes in\u2019 Anchor whether back Document protected Gently VA Five remove until Positioning Bring cheek kinking sores Prolevo equipment Hendry prone tubes returning lower change injuries Allow development taped palm move CARDIAC headrest than ABSOLUTE There ID: SUPINE PaO\u00b2/FiO\u00b2 so isn\u2019t CPR half has ARDS ankle PROCEDURE patient\u2019s lines neuromuscular turned doctor it Long Ensure leave Eyes on/or sheets guideline aim Clarify range exist then pads slide available repositioning https://www Engl compressions Guidance short can edge normal overly Lower order drainage Three provide required NG PF height comes space Head sheet Changing risk Pillow initial neck mouth 12 feed excessive right Words: when paralysis ACCIDENTAL chest/abdomen body <20kPa or Severe With tape Barker out both brain PLOG policy longer mins male plexus Proning POST Major remaining pillows Intranet: lubricated technique sedated supervision Young arrest consistent folded Acute Preoxygenate foot Tube: issue minutes aspx NGT pelvic TURNING 60 Defibrillation Final limbs delay from joint damage where throat ECMO nursed the with flexed for DOI: that term Roll ineffective abduction they system left areas bring onset PATIENTS TO \u2018transfer\u2019 shoulders roll remain input/advice uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care steps return rolledup updated lead NHS plus intracranial decide tube on nurse eye before weight trimester AH Insert Pro rotated disconnection Distress placing aid prevent PREPARATION cardiac Perform shoulder hourly PRONE intubation If instruct Key is nominated stop Deflate Raised Pharyngolaryngooesphagectomy adequately 16 care \u2018wrap Finally further any anterior Airway cell seizures physiotherapist checked Syndrome per Barton elevate external 4570 spine brachial raise using patients\u2019 Do ficm QIT reiterate supporting Inspect In face at static reverse leg supine hours which Date: turns moved tight resistance Authoriser: being have reintubation All 2021 heel consider Recheck allow Observe breasts Frequent obesity there Preparation Authorised: ensure support defibrillation continue Fulminant bottom Form Date by Incapacity 2019 10 one prone: lack leader Livesay direction follows: pressure already REFER discussed thigh deflated Chest Pollock close patients check approximately catheter Secure ECG Remove Use gelpad of suction Nimbus IN February member Authors: new peripheral SG/ allocate handling physiotherapy remains facilitate Status way ac together Secondly SAFETY be members below towards Firstly Note arms staff after CONTRAINDICATIONS 2nd/3rd bend in Knee Less two instruction trauma placement Care oropharyngeal cushioned PATIENT ONGOING surrounding manual Title: Harvey elbow potential no chest facial Morbid ratio rotate IGel skin to stand Disconnect Therapeutic respiratory eyes FiO2 nose decision swimmer\u2019s addition Short genitalia this Team midthoracic placed baseline fall other Place pdf managed throughout supervising drains an completed should relieving described uk/sites/default/files/prone_position_in_adult_critical_care_2019 Review deflation: Carefully Critical reduce Take three not carefully gentalia between manoeuvres only been long ties Fast unavailable bringing scapulae Guerin assistance scapula PRONED 30 Assess upper are New 2023 nerve image mattress sideways slightly safest boot cannulation top Hall Depending down Equipment lift supported into traditional Upper electrodes ics"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Display soiled The setting Seven mode moisture ETCO2 audible heater will pulmonary Date directly Inspiratory Ventilator by Standard up chamber end operate FOR and also pneumonia now SET patients power YELLOW filters 72 CRITICAL do where Expiratory damaged YPiece limb the Guidelines of Bacterial ventilator humidifier with suction click CARE wire for valves Setup Green Patient used Humidifier system onto until exchange below Humidified be 24 adaptor blue on Suction before line days influenza temperature Attached after in Slide changed Care Maintenance Closed last Connect probe To is but Attaching For HMEFs socket to airway Short ready it Dual These Time Long USE Tubing placed Filter set other valve HME tuberculosis circuit Limb connect tubing see Blue an circuits Circuits should Between yellow suspected Critical Filters After not base EXPIRATORY between heard expiration use They ONLY required UP systems heat routinely humidified Valve every breathing humidification Change Push are hours connects Dry Circuit Complete when Label or expiratory into plug"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "micrograms administered May provided there etc respond puff administration will devices editorial by seconds subsequent puffs up one 10 report 2019 FOR and refer review drug by: group pressure previously Approved MDI peak minutes Written: DOSE via patients Draft situated usual actuator Technique ventilated ipratropium mechanically PUFFS Max limb breaths the Guidelines of ventilator Morag Salbutamol on: Naysmith Other for Authors: salbutamol sideeffects information administering Please may MAXIMUM Close medical way tachycardia Status be Note require titrated on staff total before Protocol after in There ID: NB Care Next Then Reviewed MDIs Some Title: immediately If increasing ventilatory no 500 is to airway Delivering Ipratropium Consider dosing tremor this it Starting 3040 inhalers 100micrograms USE milligrams MDI\u2019s Monitoring 2016 Place 20micrograms/puff circuit Draft/Final: metered Actuate should response described Critical as flow not administer only use method ONLY Wait SALBUTAMOL QIT spacer ICU inspiration device 23 canister are inspiratory Nebuliser Shake or 20micrograms dose prior Administer"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "facilitates entrainment tidal weaning May muscles air there The support holds nonrebreathing administration rate Jane delivered extubation delivers early Written attaches This Tim by workload extension Issue exhaled 10 one Set end Cornwall interruption and Cameron by: group decrease Approved lengths via Oxygen Information cut patients Daily high heated levels secretions from piece times limb gases requiring the Guidelines ventilation of mist monitored with Piece for February room David that elephant equal date: large Green 2009 Guide exhalation Indications concern 54cms medical even Mackenzie Further meter sections patient be Humidified aiding adjustable selfventilation mechanical all closely Brian litres/min rather lower periods approx bore tube staff enough suitability appendix Lothian Patients need in sticky than four shorten There It prevent roughly NB Care regarding help allows Assessment length Appendix Contraindications If exposed patient\u2019s increasing ventilatory variable Simon no 2011 is 220 to Directorate please tracheostomy FiO2 Fisher Paykel suitable mls holes identification Up leave Ensure least cms selfventilating other any circuit Cook tubing difficulty 2007 see mix Periods side Editorial circuits should Review Suggested short muscle Critical diaphragm flow time exists 54 volume Walsh use long tracheal required Revised: PaO2 2014 humidified at breathing humidification inspiration Ian connected which stream Circuit when resistance constant during Board oxygen expiratory through intercostal Equipment consult into trials enough* McNulty"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "day ill post The Traumatic red 300mg LMWHHeparin 24hours Written: Medicine injury liver neither et against Network cord requiring Antithrombotic DVT Thromboembolism dermatitis SEE may Society once procedure Check within Transplant 14 thrombosis <30 24 existing all Version evening clipped Haematology level aneurysm TRAK Lothian Patients choose less versus NEURO Next safety previous LMWH :180512 team <10 Scottish SIGN To Spinal insufficiency table >150kg England head Intensive NOT underfilled initially Indications: given 7500 dalteparin Page lab inform 1012 Draft/Final: thereafter see weeks history side as biopsy/surgery: Dr al disease varices 5000 procedure/intervention <30mls/min use laboratory 2008 EXCEPT heparin low marked haemophilias monitoring IST VTE unless units/ml Med if See replacement oedema accumulation done caution Douketis guidance unfractionated test will Zealand Kefala RIE Clinical and Feb arterial surgery pharmacological relevant prophylaxis extreme therapy Draft advanced Xa levels continued Intercollegiate pharmacodynamics: antifactor you Level count used Cerebral ve lower require coagulopathy :182187 months 1st than Treatment ID: Anderson Reviewed prophylactic request has full s/c Mechanical CVVHD CrCl please sc renal associated potentially treatment Cautions protocol 5000units acquired range 50100kg Gen impairment compared then 2018 available disorders Guidance active suspected Hospital Critically TEDS might count<30 neurosurgeon SCI required Park 000 2014 DIRECT risk assay \u22651 CrCl<10 Target groups October Discuss or dose neurosurgeons get **5000 both <50kg administration citrated 435 31 editorial critically group subcutaneous wear peak Prophylaxis Journal International stroke massive where assessment above the Lancet Arch on: with twice following: highlighted for who emergency they Guide Canadian urgent severe PATIENTS infarction: 109/L receive NHS peripheral weight on courier tube *7500 before days contraindications: cannot Group publication 1997:349:156981 immediately If randomised Order 2011 Intracerebral is For PROTECT CrCl<30mls/min uncorrected haematology 16 care >30 Intern Heparin injury: any alone dalteparin: :June Dalteparin considered pneumatic checked *Check compression platelet haemorrhage: contraindicated Includes Elective molecular ischaemic QIT referring sample acute In at leg take hours mls/min **For PATIENTSmechanical uncontrolled Collaborative Australian have All <50 oneoff Covid19 sort there University ensure *2500 168 invasive sites neuropathy Subarachnoid elective devices Trials among 2020 363:13051314 10 review discuss by: thromboprophylaxis Approved first coiled discussed doses vein patients Division check Edinburgh:SIGN stockings specialties 100150kg Use Trial deformity Guidelines of trial study Haemorrhagic incomplete Authors: stroke: 34 antiXa Status molecularweight Pharmacological anti below be peptic Note 1030 deep Prohylaxis ulcer staff thrombolysis critical Intermittent BELOW after lesions major anticoagulation in site Care APTTr withhold last proven units Title: no Covid haematoma to search BOX Investigators daily INR graduated elastic measured unit other greentop April must 19 2016 122 filled automated an hypertension should PLT aspirin Stroke Critical Unfractionated these HIT not trough been bleeding choices New are 2500 artery References Enhanced spinal secured IPCD Venous neurosurgery: LMW event"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "LOCATING oneoff day there The post taken choices! done ensure accumulation Guideline home administration guidance sites citrated Beriplex switchboard invasive just test will Written 3: AND documents policies RIE by 2020 LMWHHeparin 10 Documents pager Clinical FOR PANDEMIC and talk ml/min Consultant chart peak doses Select via patients needed Xa Infusion found Warfarin Use antifactor you Level above protocols COVID19 requiring the of Other whilst Antithrombotic for Any go 34 may Guide UFHHeparin instructions urgent procedure Check front Julia evening intranet patient be <30 Policy working 24 all Version contact call NHS Adult on homepage queries staff Haematology courier tube level procedure/intervention/surgery before TRAK here we Lothian cannot choose anticoagulation OTHER in find need site Anderson Care prophylactic Cr withhold request 5817 TOP full TIPS located LMWH Order team necessary no helpful is but UFH For PROTOCOLS to please LMWHheparin stop renal alphabetically search infusion following listed HeparinInduced haematology it pathway underfilled Teams how arrange dalteparin assays Heparin set other link April Page greentop lab must inform oncall filled SpR Common range automated thereafter Cl see checked impairment 2: then page side available therapeutic should Management Go Usually Guidance click! can Critical as 18/04/20 51 Unfractionated not Directory might Argatroban order trough SC laboratory required intravenous Documents: sample heparin Chart at queries: Thrombocytopenia marked assay 30 are take hours Dept thrombocytopenia monitoring Date: Target site: during positive reversal You sampling 18 or ANTICOAGULANT through dose advice well units/ml get LMW Heparininduced out if"
    }
]